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ABSTRACT 
Reproductive hormones are recognized for their diverse functions beyond 
reproduction itself, including a vital role in brain organization, structure, and function 
throughout the lifespan. From puberty to reproductive senescence, the female is 
characterized by inherent responsiveness to hormonal cyclicity. For most women, a 
natural transition to menopause occurs in midlife, wherein the endogenous hormonal 
milieu undergoes significant changes and marks the end of the reproductive life stage. 
Although most women experience natural menopause, many women will undergo 
gynecological surgery during their lifetime, which can lead to an abrupt surgical 
menopause. It is of critical importance to better understand how endogenous and 
exogenous reproductive hormone exposures across the lifespan influence cognitive and 
brain aging, as women are at a greater risk for developing a variety of diseases after 
menopause, including dementia. Using rodent models, this dissertation explores how the 
etiology of reproductive senescence, that is, whether it is transitional or surgical, 
influences the female phenotype to result in divergent cognitive outcomes dependent 
upon a variety of factors, with an emphasis on age at the time of intervention playing a 
key role in brain outcomes. Furthermore, the impact of exogenous hormone therapy on 
cognition is evaluated in the context of surgical menopause. A novel rat model of 
hysterectomy is also presented, with results demonstrating for the first time that the 
nonpregnant uterus, which is typically considered to be a quiescent organ, may play a 
unique, direct role in modulating cognitive outcomes. Neurobiological mechanisms 
associated with reproductive hormones and aging are assessed to better recognize neural 
correlates underlying the observed behavior changes. The overarching goal of this 
 ii 
dissertation was to elucidate novel factors contributing to cognitive aging outcomes in 
females. Collectively, the data presented herein indicate that the age at the onset of 
reproductive senescence has significant implications for learning and memory outcomes, 
and that variations in gynecological surgery can have unique, long-lasting effects on the 
brain and cognition. Translationally, this series of experiments moves the field forward 
toward the goal of improving the health and quality of life for women throughout the 
lifespan. 
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CHAPTER 1 
GENERAL INTRODUCTION 
From early in embryonic development to the end of the lifespan, hormones play a 
vital role in regulating many functions in the body, without which an individual could not 
survive. The functional role of hormones —particularly reproductive hormones— 
transcends species, highlighting their necessity and importance. The intricate interplay 
among hormones acting on many body systems results in particular phenotypes that 
influence the health and survival of the organism. It is now known that the role of 
reproductive hormones goes beyond reproduction itself, and these hormones have crucial 
functions in many systems, including the brain. Understanding how reproductive 
hormones influence human development, reproduction, the brain, and cognition has been 
of substantial interest in the last several decades. This dissertation details investigations 
utilizing rodent models into how endogenous and exogenous reproductive hormone 
exposures across the lifespan influence cognitive and brain aging, with an emphasis on 
reproductive senescence. I explore how the etiology of reproductive senescence, that is, 
whether it is transitional or surgical, can influence the female phenotype to result in 
divergent cognitive outcomes dependent upon a variety of factors, with an emphasis on 
age at the time of intervention playing a key role in brain outcomes.   
A Brief Primer on Mammalian Sexual Differentiation 
For a behavioral endocrinologist, it all begins with sex. According to the long-
standing model based on a plethora of research, for mammals, sexual differentiation of 
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the gonads results from a cascade of events initiated by the chromosomal constitution of 
the animal (Figure 1a). This model is traditionally linear: chromosomal constitution leads 
to gonadal constitution which leads to phenotypic constitution. If the Y chromosome is 
present, testes develop, testosterone and other hormones are secreted, and male internal 
and external genitalia develop. If no Y chromosome is present, ovaries develop, no 
testosterone is secreted, and female internal and external genitalia develop. Thus, under 
this tenet female genital development is thought to develop by “default” – in the absence 
of gonadal hormone stimulation. This widely accepted model of default genital 
development for the female has been updated as the field garners new information. A 
series of gene transcription factors have been implicated in a more active process of 
ovarian development. For example, the FOXL2 gene is a notable contender to be an 
ovary-determining gene. As the earliest known marker, FOXL2 is necessary to 
differentiate testes development from ovary formation, and it plays a key role in actively 
suppressing SOX9, a downstream target through which the sex-determining-region Y 
(SRY) gene induces testes formation (Georges et al., 2014; Kalfa et al., 2008; Schmidt et 
al., 2004; Uhlenhaut et al., 2009). Furthermore, female mice without Foxl2 (Foxl2-/- 
mutants) do not undergo normal ovarian follicle development, experience pervasive 
neonatal follicular atresia, and are sterile (Ottolenghi et al., 2005; Schmidt et al., 2004; 
Uda et al., 2004; Uhlenhaut et al., 2009). Depleting Foxl2 can trigger a cascade of events 
including upregulation of genes that produce male phenotypic gonad development 
(Garcia-Ortiz et al., 2009; Ottolenghi et al., 2005; Uhlenhaut et al., 2009). Foxl2 may not 
only be critical during prenatal development, but also across the lifespan (Uhlenhaut et 
al., 2009). In fact, experimentally-induced Foxl2 loss in eight-week-old mice resulted in 
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ovarian granulosa cells morphing into Sertoli-like cells, and thecal cells beginning to 
upregulate an enzyme controlling testosterone biosynthesis (Uhlenhaut et al., 2009). 
There are likely other genomic processes acting in concert with Foxl2, but this recent 
evidence provides novel pathways to explore with regard to sexual differentiation and 
active development of the female phenotype. In addition, there is fascinating ongoing 
work in the field of sexual differentiation to better elucidate the role of gonadal 
hormones, as well as the newly recognized unique impact of genetic sex, as direct factors 
in the phenotypic outcome of an individual (A. P. Arnold et al., 2004; Bakker & Baum, 
2008). Indeed, non-linearity may exist in the genetics-determines-gonads-determines-
phenotype model, such that the resulting phenotype is directly influenced by genomic 
mechanisms, which likely work in synergy with gonadal hormones and even epigenetic 
effects (McCarthy & Arnold, 2011; McCarthy, Arnold, Ball, Blaustein, & De Vries, 
2012). These intriguing new discoveries continue to modify more traditionally-accepted 
models and will aid in elucidating the complex nature of sex differences and steroid 
hormone effects on multiple systems spanning early development to reproductive 
senescence and beyond, impacting the phenotype throughout life.  
 
Brain Sexual Differentiation in Mammals 
In mammals, the traditional model of sexual differentiation of the brain parallels 
that of the genitalia, maintaining that if testosterone exposure occurs early in life during a 
defined critical window, it exerts permanent effects resulting in a male phenotype. This 
traditional model also holds the tenet that if the brain is not exposed to gonadal steroids 
during this critical window, this will result in a female phenotype. Therefore, in this 
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model the “normal” female phenotype has been considered to be organized by default. 
The updated model builds upon abundant research and the traditional framework, 
incorporating new evidence and views (Figure 1b). Accumulating behavioral and brain 
data have demonstrated that in fact, normal female brain development and organization 
depends on estrogen exposure, and that female brain organization is an active process that 
is not by default.  
A flow diagram depicting sexual differentiation of the mammalian brain and 
phenotype is presented in Figure 2. For the purposes of discussion here, masculinization 
is defined as the induction of the male phenotype, feminization as the induction of the 
female phenotype, demasculinization as removing the potential for the development of 
male traits, and defeminization as removing the potential for the development of female 
traits. A phenotypically “normal” female is both feminized and demasculinized, while a 
phenotypically “normal” male is masculinized and defeminized. Much of the research 
leading to our understanding and defining of these processes has been done in rodents; 
hence, the work discussed in this section is largely based on rodent experimental 
evaluations. Regarding the process of sexual differentiation of the mammalian brain, 
testosterone is released from the gonads, and is thought to lead to masculinization in the 
male via direct and indirect routes. Indeed, testosterone readily crosses the blood brain 
barrier and is converted in the brain to 17b-estradiol via the aromatase enzyme. 
Numerous rodent studies have shown that high doses of 17b-estradiol can be 
masculinizing to the brain and behavior, including reproductive and non-reproductive 
brain areas and behaviors. Why then do female rodents not experience the same 
masculinization from estrogen exposure during gestation? Alpha-fetoprotein (AFP), a 
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transient plasma protein circulating during fetal development, has a high binding affinity 
and capacity for the estrogens rodents are exposed to during gestation (likely maternal in 
origin) (Figure 3). Once bound to AFP, the estrogen compound is sufficiently large such 
that it can no longer cross the blood brain barrier, effectively preventing estrogen-induced 
brain masculinization and defeminization in females during the early perinatal timeframe 
(Figure 3) (Attardi & Ruoslahti, 1976; Benno & Williams, 1978; McEwen, Plapinger, 
Chaptal, Gerlach, & Wallach, 1975). Bakker et al. assessed the principle that AFP 
prevents estrogens from exerting masculinizing and defeminizing effects in the brain by 
testing female mice without AFP (Afp-/- mutant); consequently estrogen could enter the 
brain in the Afp-/- mutants (Bakker et al., 2006). These Afp-/- mutant animals did not 
exhibit female-typical sex behavior and had increased male-typical sex behavior 
compared to wild-type female mice, supporting the tenet that when AFP is not present, 
estrogens enter the brain and subsequently masculinize and defeminize (Bakker et al., 
2006). Moreover, females lacking AFP had male-like quantities of tyrosine hydroxylase 
expression in the anteroventricular nucleus of the preoptic region, an area important for 
female reproductive function, and administering treatment of an aromatase inhibitor to 
the mother during pregnancy (effectively attenuating estrogen production and exposure in 
the fetus) produced a normal female phenotype for the measured variables in the female 
Afp-/- mice that was similar to that of wild-type females (Bakker et al., 2006). This 
research provides further support that estrogens exert brain masculinizing and 
defeminizing properties during development, and that the presence of AFP can prevent 
these actions in the female. The system is really quite remarkable. Indeed, in rodents, 
AFP levels become undetectable in the brain after post-natal day (P) 7 (Ali, Kaul, & 
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Sahib, 1981), around the same time that the ovaries increase in activity and produce 
detectable levels of gonadal hormones (Mannan & O’Shaughnessy, 1991; Picut et al., 
2015; Sokka & Huhtaniemi, 1995; Weniger, Zeis, & Chouraqui, 1993). Because the 
female brain seems to have an extended period of sensitivity to gonadal hormones 
beyond the neonatal period (discussed in more detail in the section: “On the framework 
of organizational and activational effects of ovarian hormones on the brain”), these 
estrogens of ovarian origin are likely necessary for normal female brain development, 
and they can now access the brain during this time since AFP no longer attenuates brain 
access (for review, see: Bakker and Baum, 2008; Toran-Allerand, 1984).  
We would be remiss if we did not note that the questions of sexual differentiation 
of the brain in humans are difficult to address due to the obvious ethical considerations of 
systematic experimental manipulation. However, some work, including in human brain 
extracts and cord serum, has questioned whether AFP binds to estrogens in humans in a 
manner similar to rodents; thus, the role of AFP in human sexual differentiation is still 
highly controversial (Ali, Balapure, Singh, Shukla, & Sahib, 1981; Nunez, Vallette, 
Benassayag, & Jayle, 1974; Swartx & Soloff, 1974). Nonetheless, sexual differentiation 
and the role of AFP has been extensively studied and characterized in the rodent model, 
providing a solid foundation and framework for understanding the role of gonadal 
hormones in sexual differentiation of the brain.  
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On the Framework of Organizational and Activational Effects of Ovarian 
Hormones on the Brain 
The turn of the 20th century was abound with empirical evaluations in the field of 
sex differences and behavior. In the early years of this research, Parkes described 
“internal secretions of the ovary” (Parkes, 1927, p. 1663) as critical to development, the 
menstrual and estrous cycles, and pregnancy maintenance, and that injections of “extracts 
of corpus luteum” (Parkes, 1927, p. 1665) disrupt the normal estrous cycle (Parkes, 
1927). Young and Beach began investigating these internal secretions, later known as 
gonadal hormones, and their relationship to sex behaviors in the 1930’s and 1940’s. 
Beach found that gonadal hormones had sex-specific effects on the presence or absence 
of phenotypic mating behaviors, and that these behaviors could be manipulated by 
altering hormone levels. For example, his laboratory found that testosterone propionate 
induced male-typical sex behaviors, in addition to female receptivity sex behaviors, in 
female rats that underwent ovariectomy (surgical removal of the ovaries; Ovx) prior to 
the onset of puberty (Beach, 1942), and that gonadally intact males demonstrated female-
typical sex behaviors, in addition to male-typical sex behaviors, when given large doses 
of androgen in adulthood (Beach, 1941).  
In 1959, Phoenix, Goy, Gerall, and Young posited the theory of organizational 
and activational effects of gonadal hormones (Phoenix, Goy, Gerall, & Young, 1959; 
Young, Goy, & Phoenix, 1964). This dichotomy is based primarily on the parameters of 
gonadal differentiation and on androgenic actions in the male. A myriad of research has 
ensued in the area of sex differences and sexual differentiation of the body and brain. 
Many of these investigations are based on the classic concept of critical periods in which 
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gonadal hormone exposure must occur at just the right time during development to 
effectively and permanently organize an organism to respond normally upon sexual 
maturity. In the 1970’s, Jost and others studied embryonic development of the gonads, 
postulating that testes develop earlier in gestation and by an active process, while ovaries 
were considered to develop in the absence of testes formation (for discussion, see Jost et 
al., 1973). These classic and landmark studies were critical to the field, driving further 
research and contributing to the establishment of the long-held dogma that many female 
systems develop by “default.”  
Organizational effects of hormones have varied definitions depending on the 
discussant, but they are typically operationally defined as permanent and occurring early 
in development. Activational effects of hormones are typically operationally defined as 
transitional, depending on the immediate presence of the hormone for the effect, and 
occurring later in development. Under the tenet of this traditional model, sex differences 
reflect the organizing and permanent actions of sex steroids present during an early 
development critical period, while activational effects “activate” underlying previously-
organized substrates specifically in adulthood. In the landscape of traditional as well as 
newer models, organizational and activational effects of sex steroids work in concert. In 
fact, although early sex hormone exposure plays a significant role in organizing brain 
substrates driving sexually differentiated behaviors, many of these effects are realized 
only with exposure to the activating sex hormones; in many cases, the “male” or 
“female” phenotype is expressed normally only with the activational hormone present 
(Beatty, 1992). As a result of this synergy of organizational and activational effects, 
“male” and “female” brains are not likely to respond to the same circulating/activating 
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hormones in an equivalent fashion because the structures being activated have had 
different prior organizational hormone exposures and organizational consequences 
(Beatty & Beatty, 1970). 
Evidence accumulating over the last few decades has blurred the traditional 
operational definitions of the organizational and activational dichotomy, especially 
regarding the temporal distinction wrapped into the definitions. More recent views of the 
organizational/activational tenet suggest that the temporal parameters should not be so 
strictly defined, and that the distinction between effects is not necessarily linearly related 
in time. Rather, whether “the induced changes represent permanent or transient effects, 
whenever in life they occur” (Fitch and Denenberg, 1998, p. 312) should provide the 
distinction. Examples of findings blurring the traditional dichotomy include activation of 
ear wiggling sexual behavior in female rat pups by estrogen, when pups were as young as 
six days of age (Williams, 1987), and non-transient alterations in brain morphology 
following post-pubertal sex hormone manipulations (Bimonte, Fitch, & Denenberg, 
2000b, 2000a; Bimonte, Mack, Stavnezer, & Denenberg, 2000; Bloch & Gorski, 1988; 
Pappas, Diamond, & Johnson, 1979; Rodriguez-Sierra, 1986).  
Nearly 30 years ago, researchers were already rethinking the idea that 
organizational effects occur only early in development. A variety of brain regions and 
behaviors are differentially impacted by exposure to estrogens and/or androgens, with 
females showing extended sensitivity to hormonal manipulations and changes in 
anatomical and behavioral outcomes (for review see: Fitch and Denenberg, 1998). For 
example, Rodriguez-Sierra showed that estradiol benzoate administration on P25 (prior to 
puberty but after neonatal brain organization) modified synaptogenesis in several brain 
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regions within days after estrogen treatment, and that these estrogen effects may be sex-
specific to females (Rodriguez-Sierra, 1986) Research from the Denenberg laboratory 
found that ovarian hormones actively feminized the corpus callosum, and that this effect 
was not reversible within the extended timeframes into adulthood that were assessed. 
These data indicate that the permanent, potentially “organizational” effects of ovarian 
hormones can extend into adulthood for females (Bimonte et al., 2000). Moreover, in 
females there is flexibility in the window of sensitivity for normal feminized brain 
organization. There has been extensive research on the corpus callosum that nicely 
illustrates this idea. It is known that in the normally developing rat the organizing effects 
of androgen on the male corpus callosum end by P1 (Bimonte, Fitch, et al., 2000b; Fitch, 
Berrebi, Cowell, Schrott, & Denenberg, 1990; Fitch, Cowell, Schrott, & Denenberg, 
1991; Mack et al., 1996), but the female corpus callosum is sensitive to ovarian hormone 
input at least up to P70 (adulthood). Pre-pubertal Ovx enlarges, or defeminizes, the 
corpus callosum; ovary transfer post-puberty on P70 can counteract this effect, resulting 
in a smaller (feminized) corpus callosum in adulthood (Bimonte, Fitch, et al., 2000a). In 
addition, there is evidence that neonatal estrogen exposure is necessary for brain 
feminization later in life. Exposure to the estrogen receptor blocker tamoxifen from birth 
until Ovx on P25 resulted in a larger corpus callosum size even after estradiol was given 
starting at P70, whereas animals that had normal ovarian hormone exposure until P25 
Ovx responded as would be expected to exogenous estradiol administration beginning on 
P70 — the size of the corpus callosum was smaller in a feminized fashion. One could 
interpret these findings as meaning that the presence of ovarian hormones through the 
first 25 postnatal days of life allowed estradiol to later feminize the corpus callosum. If 
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estrogens were not impacting the brain during this early timeframe, attenuating estrogen 
receptor stimulation would have had no impact on the response to the activating effects of 
estrogens when given later. Collectively, these studies implicate an active role of ovarian 
hormones in organizing the female brain, and an overall extended period of sensitivity in 
females relative to the period of sensitivity in males.  
 
(Re)organizational Events Across the Lifespan 
It is possible that non-transient organizational hormone events in the brain can 
continue across the lifespan, challenging the long-held dogma that organizational effects 
are limited to the neonatal period of development, and supporting the updated distinction 
of the organizational and activational dichotomy depending on whether the effects are 
permanent or transient, irrespective of the life timeframe during which they occur (e.g. 
see Arnold and Breedlove, 1985; Fitch and Denenberg, 1998; Rodriguez-Sierra, 1986; 
Stewart and Kolb, 1988). For example, Bloch and Gorski found that in gonadectomized 
male rats, sexually dimorphic structures within the preoptic area are impacted by 
exogenous estrogen and progesterone administration when given in adulthood, with 
results indicating some feminization since the response was in the female direction 
(Bloch & Gorski, 1988). Moreover, while it is clear that gonadal hormones play a 
significant role in organizing the brain during early development, there are other 
hormonal exposures that can result in seemingly permanent effects on the brain, even if 
they occur later in life. An extended and systematic series of studies from the Juraska 
laboratory has beautifully shown that puberty marks another period of architectural 
remodeling in the brain, including alterations in neurons and glia, and that ovarian 
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hormones play active roles in these events (see Juraska et al., 2013, for review), which 
could be considered reorganizational effects. Evidence from our laboratory extends the 
idea of reorganizational effects to exogenous and synthetic hormone exposures, testing 
the permanence of effects of hormones that are taken by women. We have recent data 
suggesting that exposure to the synthetic progestin medroxyprogesterone acetate (MPA) 
in adulthood — even if that administration is discontinued — negatively impacts female 
rats’ working memory performance with detrimental effects persisting up to four months 
after transient exposure is terminated (Braden et al., 2011). While the impact of MPA on 
cognition could be considered activational because the brain was organized early on to 
respond to hormones, even a transient exposure appears to have a long-lasting, and 
potentially permanent, impact on the trajectory of cognitive performance with aging. 
Hence, this pattern of effects resulting from the adult transient exposure to this synthetic 
hormone might be considered a reorganizational event.  
Pregnancy is another life event marked by potent steroid hormone changes; some 
of these changes appear to result in long-term brain and behavioral effects in females 
such that they respond differently to other hormonal exposures later in life compared to 
females who have never experienced pregnancy-related hormone changes. Might this be 
considered a reorganizational hormone event? Parity not only impacts maternal behaviors 
in rats, but it also induces changes in spatial learning and memory performance, stress 
behaviors, and alterations in related brain measurements (Gatewood et al., 2005; Kinsley 
et al., 1999; Macbeth & Luine, 2010; Macbeth, Scharfman, Maclusky, Gautreaux, & 
Luine, 2008; Pawluski, Walker, & Galea, 2006). For example, there was a reduction in 
number of amyloid precursor protein immunoreactive cells in the hippocampi of parous 
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rats compared to nulliparous rats (Gatewood et al., 2005), and a noted increase in 
monoaminergic activity in the olfactory bulb, and BDNF in the hippocampal CA1 region 
and medial septum, in multiparous versus nulliparous animals (Macbeth et al., 2008). 
Additionally, an acute (10µg) injection of 17b-estradiol, 17a-estradiol, or estrone 
increased the number of BrdU-immunoreactive cells in the dentate gyrus of middle-aged 
Ovx multiparous rats compared to age-matched virgin rats, indicating that previous 
sexual or reproductive experience impacts responsiveness to estrogens later in life (Barha 
& Galea, 2011). Of note, parity (i.e., pregnancy, lactation, and pup experience [Kinsley et 
al., 1999]) involves other hormone fluctuations, including a significant and extended 
increase in progesterone levels accompanying the increase in estrogen levels, and these 
gonadal hormones likely act in concert to result in the observed long-term changes in the 
brain and behavior associated with motherhood.  Less is known about the long-term 
effects of pregnancy experience in humans, but research suggests that there are changes 
associated with hormonal fluctuations during and after pregnancy that affect future brain 
morphology and behavior (Glynn, 2010; for discussion, see Macbeth and Luine, 2010). 
Clearly, gonadal hormones act upon a variety of systems and brain structures that 
work together to result in the observable outcomes of hormone actions. Many of these 
observations have been carried out at adolescent or young adult time points, and we note 
that these hormone exposures likely influence the trajectory of aging such that the brain 
has “activational” responses dependent not only on the organization that occurs very 
early in life, but also to reorganizational events that occur across the whole lifespan, 
including very late in life. These long lasting (potentially permanent) effects of estrogen 
exposures, such as from pregnancy, exogenous hormone administration (e.g., 
 
14 
contraceptives, hormone therapy), and menopause, may be considered “reorganizational” 
rather than “activational” as their effects appear to persist long after the initial exposure is 
terminated, and they have been found to change the trajectory of responsiveness later in 
life. This is not mutually exclusive of the waxing and waning in sensitivity to estrogens 
across the lifespan; indeed, a decrease in sensitivity does not mean activational or 
reorganizational effects cannot occur. McCarthy notes that the developing and the 
reproductively senescent time periods may have more in common than previously 
recognized (McCarthy, 2011). Research elucidating how steroid hormones organize the 
brain throughout life can yield insight into optimizing the hormone milieu during 
menopause, including providing perspectives and considerations for menopause 
trajectories and hormone therapy options.  
 
Reproductive Hormones and the Brain 
Ovarian hormones, and particularly estrogens, are potent modulators of the brain, 
including in regions known to affect learning and memory. All steroid hormones are 
derived from the cholesterol molecule. Three types of estrogen are present in humans, as 
well as in rodents: 17b-estradiol, estrone, and estriol (Kuhl, 2005). Of these, 17b-
estradiol is the most potent and abundant naturally circulating estrogen during the 
reproductive life stage. In addition to many peripheral tissues, the brain contains ample 
estrogen receptors (ERs), including both a and b subtypes. 17b-estradiol binds to 
estrogen receptor (ER) ERa and ERb with the strongest affinity as compared to estrone 
and estriol. Estrone binds these receptors with the next strongest affinity, and estriol 
binds these receptors with the weakest affinity of the three estrogens (Kuhl, 2005; Kuiper 
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et al., 1997). Moreover, 17b-estradiol and estrone bind ERa and ERb with about equal 
preference, while estriol, though a very weak estrogen in comparison, has a slight 
preference for ERb compared to ERa (Kuiper et al., 1997). The hippocampus, a key 
brain structure for learning and memory, contains both a and b ERs, with greater levels 
of ERb than ERa in humans and rats (Foster, 2012). Because ERa transcription 
processes are more active than ERb, ERb may, in part, serve as a regulator for ERa, at 
least in the hippocampus (Bean, Ianov, & Foster, 2014; Han et al., 2013). Indeed, the 
ratio of ERa to ERb may play a chief role in how estrogens ultimately impact behavior. 
Estrogens may act through traditional signaling pathways, as well as exert rapid non-
genomic changes associated with a third receptor type referred to as GPR30/GPER1, a 
membrane coupled receptor (Bean et al., 2014). Many of these cognitive brain regions 
that contain ERs are sensitive to changes as aging ensues. Thus, estrogens can impact the 
brain and its functions across the entire lifespan in various contexts.  
 
The Female Reproductive Cycle and Menopause 
During the reproductive life stage, the ovary is the main synthesis site of 
circulating sex steroid hormones, including estrogens, progesterone, and androgens. 
Estrogens are primarily synthesized by growing ovarian follicles, progesterone 
predominantly by the corpus luteum after ovulation and in small amounts by growing 
follicles, and androgens by both ovarian interstitial tissue and the adrenal glands. The 
production and regulation of these hormones are mediated by the hypothalamic-pituitary-
gonadal (HPG) axis. The feedback loop begins with the hypothalamus, which produces 
and releases gonadotropin releasing hormone (GnRH) into the anterior pituitary gland, 
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initiating the synthesis and secretion of the gonadotropins follicle stimulating hormone 
(FSH) and luteinizing hormone (LH). FSH and LH are two key hormone regulators of 
ovarian follicle development and the ovarian cycle. The human female reproductive cycle 
is approximately 28 days in length and is divided into the follicular, ovulation, luteal, and 
menstrual phases. During the follicular phase, estrogen levels progressively rise as the 
ovarian follicles mature as a result of signaling from FSH. Immature ovarian follicles 
undergo various developmental stages over the course of several months and are 
classified by size and the different cell types that comprise the growing follicle (Figure 4) 
(Gougeon, 2010; Gougeon & Chainy, 1987). Once estrogen levels reach a critical 
threshold, the LH surge occurs and triggers ovulation of one mature ovum per month. 
The luteal phase begins after ovulation, wherein the remaining follicle develops into the 
corpus luteum and begins to produce progesterone in preparation for a potential 
pregnancy. If the mature egg is not fertilized after ovulation, it degenerates and the 
menstrual phase occurs in women. FSH signaling from the pituitary gland stimulates 
maturation of ovarian follicles, thus beginning the follicular phase again.  
It is a well-accepted tenet that women are born with a finite pool of immature 
ovarian follicles. Histological follicle counts and mathematical models of ovarian follicle 
reserves estimate an average of 295,000 follicles per ovary at birth to 180,000 follicles 
per ovary at puberty; as the menopause transition approaches, estimates are reduced to 
between 100-1000 immature follicles per ovary (Gougeon, 2010; W. H. B. Wallace & 
Kelsey, 2010). At puberty, the ovulatory cycle begins as a result of the maturation of the 
hypothalamic-pituitary-gonadal (HPG) feedback loop. Women experience regular 
ovulation, and therefore a consistent menstrual cycle, for about 40 years. Approximately 
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400 eggs are ovulated across a woman’s reproductive life stage; the remainder — and 
vast majority — of ovarian follicles undergo atresia, or programmed cell death (Baker, 
1963; Hsueh, Billig, & Tsafriri, 1994).   
Around the fifth decade of life, once the follicle pool is depleted through natural 
atresia and ovulation, the ovaries do not generate a sufficient amount of estrogens and 
progesterone to sustain the normal uterine cycle. Although the natural transition to 
reproductive senescence is not completely understood, it is clear that it is not an abrupt 
event; rather, it is thought that when a critical threshold of remaining ovarian follicles is 
reached, women begin to experience the transitional phase to menopause, which involves 
intermittent ovulatory cycles, significant fluctuations in ovarian hormone levels, and 
variable but rising FSH and LH levels. This process culminates with an eventual 
cessation of menses and infertility, referred to as menopause, and occurs at the average 
age of 51-52 in women (Hoffman et al., 2012; NAMS, 2014). This gradual menopause 
transition may last up to ten years prior to the final menstrual period and thus the end of 
the reproductive life stage (Harlow et al., 2013). In addition to these physiological 
changes, women often report undesirable symptoms including hot flashes, genitourinary 
symptoms, and changes in sleep, mood, and memory during the menopause transition 
(Mitchell & Woods, 2001; Weber, Maki, & McDermott, 2014; Weber & Mapstone, 
2009). As a result, women may opt to take hormone therapy (HT) to attenuate some of 
these undesirable symptoms. Estrogens have been shown to have beneficial effects on a 
myriad of body systems, including cardiovascular, bone, and brain health. However, 
estrogens’ actions are complex, and often exert beneficial effects only when given at a 
fitting dose, through the ideal route of administration, and with appropriate timing and 
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duration of the treatment (Koebele & Bimonte-Nelson, 2015; Turgeon, Carr, Maki, 
Mendelsohn, & Wise, 2006; Wise, Suzuki, & Brown, 2009).  
In the early 2000’s, findings from the Women’s Health Initiative Memory Study 
(WHIMS) challenged the tenet that estrogen-containing HT has protective effects against 
global cognitive decline, mild cognitive impairment, and probable dementia risks when 
the large, double-blind, placebo-controlled clinical trials indicated that some forms of HT 
increase the risk of probable dementia development when administered post-menopause 
(Coker et al., 2010; Espeland et al., 2004; Shumaker et al., 2004, 2003). The WHIMS 
findings propelled the field forward; the window of opportunity and other hypotheses for 
therapeutic benefits of estrogen-including HT arose, with a particular emphasis on 
cognitive aging (Daniel, 2013; Maki, 2006, 2013; McCarrey & Resnick, 2015; Rocca, 
Grossardt, & Shuster, 2010). Specifically, the window of opportunity is thought to be a 
critical period, likely during the early stages of the menopause transition wherein 
estrogenic HT may confer a benefit to memory systems and delay the onset of cognitive 
decline or dementia (Maki et al., 2011). Thus, the field is focused on furthering 
understanding of the menopause transition to help identify a critical window for 
therapeutic benefits and possible intervention to lower risk factors associated with aging 
and menopause. 
Of note, the window of opportunity is likely not a singular factor, but could be 
thought of as a profile that encompasses several constitutive elements associated with 
aging and menopause, such as the age at which a woman begins to transition, the length 
of time since the impetus of the transition, exposures to both exogenous hormone 
administration (e.g., oral contraceptives) and transient endogenous changes in ovarian 
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hormone milieu (e.g., pregnancy), as well as maternal family history of menopause length 
and symptomology, and gynecological surgical interventions. This broad spectrum of 
factors is often difficult to assess in the healthy aging woman; indeed, much of our 
insight into human factors comes from studying disease states, which may be a 
confounding factor itself. Rodent models help us to systematically explore brain and 
behavioral effects associated with timing in this critical window (Daniel, Hulst, & 
Berbling, 2006; Foster, Sharrow, Kumar, & Masse, 2003; Gibbs, 2000b; McLaughlin, 
Bimonte-Nelson, Neisewander, & Conrad, 2008; Talboom, Williams, Baxley, West, & 
Bimonte-Nelson, 2008). These models can teach us the optimal parameters for timing, 
duration, dose, formulation, and routes of administration by allowing direct manipulation, 
while also permitting control over factors such as parity and previous exogenous 
hormone exposures. Furthermore, rodent models are useful to assess the cognitive effects 
of variations in menopause etiology, including a transitional model of menopause using 
4-vinylcyclohexene-diepoxide (VCD), and surgical models of menopause, including 
ovariectomy and/or hysterectomy models, all of which will be discussed in detail below. 
 
Rodent Aging and Reproductive Senescence 
Before we can fully appreciate rodents as valuable and appropriate models for 
menopause and aging research (Brinton, 2012; Van Kempen, Milner, & Waters, 2011), 
we must first acknowledge some key differences between human and rodent reproductive 
senescence (Downs & Wise, 2009; Finch, 2014). Rodents have an estrous cycle rather 
than a menstrual cycle. The rodent estrous cycle differs in several ways, including that 
rodents’ uterine lining is reabsorbed rather than shed via menstruation. The estrous cycle 
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occurs every four to five days and consists of four phases — proestrus, estrus, metestrus, 
and diestrus — that involve similar ovarian hormone fluctuations to the human menstrual 
cycle (Figure 5A,B) (Burger, 2006; Goldman, Murr, & Cooper, 2007). Around 9-12 
months of age, rats and mice typically experience irregular estrous cycles, aptly termed 
estropause. A constant/persistent estrus state is common, wherein the estrus phase is 
prolonged and anovulatory cycles may occur (Figure 6A). Animals may then transition 
into an anestrous state, where ovulatory cycles halt and low levels of gonadal steroids are 
present  (Clemens & Meites, 1971; Huang, Steger, Bruni, & Meites, 1978; Lu, Hopper, 
Vargo, & Yen, 1979). Rats, more often than mice, will also pass through a phase of 
repetitive pseudopregnancy prior to transitioning into an anestrous state, or they may stay 
in a pseudopregnant state for their remaining lifespan, wherein they ovulate irregularly 
(and sometimes supraovulate), resulting in corpora lutea that are maintained for an 
extended period of time producing high progesterone levels (Finch, 2014; Lu et al., 
1979). Rodents also experience dysregulated HPG axis activity in estropause, including 
decreased LH release responsiveness to estrogen signaling in middle-aged rats 
(Scarborough & Wise, 1990; Wilkes, Lu, Fulton, & Yen, 1978). A chief difference 
between humans and rodents is the presence of potentially mature ovulatory follicles in 
the aged rodent. Rodents experience some natural ovarian follicular depletion and are 
also suspected to have a finite follicle pool (Gosden, Laing, Felicio, Nelson, & Finch, 
1983); however, some preliminary evidence for adult neo-oogenesis in rodents has 
challenged this idea (J. Johnson et al., 2005; J. Johnson, Canning, Kaneko, Pru, & Tilly, 
2004). Because a hallmark of human menopause is complete ovarian failure, it is 
important to keep these differences in mind when choosing an appropriate animal model 
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of menopause. Several rodent models of reproductive aging are implemented in the 
laboratory to aid in understanding of brain and body aging and the menopause transition, 
considered in detail below. 
 
Ovary-Intact: A Model of the Aging Hypothalamic-Pituitary-Gonadal Axis 
Similar to women, rodents experience regular reproductive cycles in adulthood, as 
well as age-related dysregulation of this cycle and the HPG axis, ovarian changes, and 
gonadal hormone fluctuations. Many researchers have utilized the ovary-intact female rat 
as a model of human menopause to evaluate the changing brain, pituitary, and ovary 
interactions with age (Downs & Wise, 2009; Kermath & Gore, 2012; Wise et al., 2002). 
Phyllis Wise’s research, beginning in the 1970’s, demonstrated that as aging occurs in 
ovary-intact rats, changes occur in the rhythmicity of hypothalamic GnRH release that 
initiates the LH surge. These alterations, originating in the brain, precede observable 
changes in normal estrous cyclicity in aging rodents (Wise, 1982b, 1982a). These 
alterations are particularly evident during the proestrus phase, wherein a LH and FSH 
surge precedes ovulation. Wise’s laboratory found that middle-aged animals had lower 
pre-ovulatory circulating estradiol levels, and that before the LH surge, there was a 
temporal delay in rising GnRH concentrations in the median eminence, which connects 
the hypothalamus to the pituitary gland and facilitates gonadotropin release via the 
hypophysial portal blood stream; decreased serum LH, estradiol, and progesterone levels 
following the LH surge in middle-aged animals point to an age-related disruption in 
circadian rhythm function that consequently alters normal estrous cycle patterns (Wise, 
1982b). Wise and others have also found that the amplitude of the LH, FSH, and 
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prolactin surges was reduced in middle-aged, ovary-intact animals (Cooper, Conn, & 
Walker, 1980; Wise, 1982a). These landmark studies gave rise to the theory of aging of 
neural pacemakers, which suggests both chronological and endocrine aging are crucial 
factors for understanding the transition to reproductive senescence, and that the brain 
plays a significant role in these processes. Using the ovary-intact rat model, the Gore 
laboratory has evaluated aging and its relationship to neuroendocrine control and 
feedback mechanisms. This team found increased GnRH mRNA levels in middle-aged 
and aged rats compared to young control subjects; yet, gene transcription for GnRH 
decreased with age, pointing to a potential posttranscriptional mechanism for the age-
related increase in GnRH mRNA (Gore, Oung, Yung, Flagg, & Woller, 2000). GnRH 
and LH release are, in part, mediated by excitatory glutamate signaling via input from N-
methyl-D-aspartate (NMDA) receptors; alterations in these inputs likely disrupt positive 
and negative feedback mechanisms of the HPG axis regulation (Gore, Oung, et al., 2000). 
Although the number of GnRH neurons does not appear to change with age, there are 
age- and reproductive senescence- related changes in the gene expression of the subunits 
that constitute the NMDA receptor (Gore, Oung, et al., 2000; Gore, Yeung, Morrison, & 
Oung, 2000). Gore and others have suggested that during aging, there is attenuated 
NMDA receptor-mediated glutamatergic activation of GnRH-producing neurons in brain 
regions important for HPG feedback (Arias et al., 1996; Gore, Oung, et al., 2000; Zuo, 
Mahesh, Zamorano, & Brann, 1996). This disrupted balance between excitatory and 
inhibitory neurotransmission is related to the transition to reproductive senescence 
(Kermath & Gore, 2012). These alterations in neuroendocrine function may occur prior to 
animals displaying outward behavioral or estrous cycle abnormalities, and would likely 
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be difficult to target studying human clinical populations. Therefore, utilizing the ovary-
intact rat model to evaluate the natural age-related cellular and molecular changes in 
brain regions involved in normal reproductive functioning and feedback is crucial to 
understanding neurological changes that occur in women, and to the development of 
novel therapeutic targets to mitigate negative symptoms associated with age and 
reproductive senescence. 
A drawback to modeling menopause in the ovary-intact rodent is the difference in 
the ovarian follicle reserve and steroid hormone changes as aging ensues in the rat 
compared to women. Because rodents do not typically exhibit follicle-deplete ovaries by 
the onset of reproductive senescence like women do, circulating gonadal hormone levels 
in an aged ovary-intact rodent do not closely resemble those of menopausal women. 
Women in the post-menopausal state have very low circulating levels of 17b-estradiol 
and progesterone and significantly elevated FSH and LH levels (Figure 6B) (Burger, 
2006; Timiras, Quay, & Vernadakis, 1995). Rodents, on the other hand, experience 
several reproductive-aging states and typically maintain moderate circulating 17b-
estradiol levels, despite HPG axis dysregulation (Lu et al., 1979). Variations in the onset 
and expression of HPG axis changes in the ovary-intact female rat could add undesirable 
variability to this menopause model; however, as we gain understanding of these 
changes, and if we acknowledge these variations when interpreting findings, we can use 
this natural variation to our experimental advantage. Vaginal cytology monitoring is a 
common, minimally invasive way to monitor estrous cycle activity (Figure 7). Yet, 
vaginal cytology can become erratic in middle age due to dysregulated HPG axis activity. 
If a researcher intends to use a particular hormone profile of a middle-aged rodent, such 
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as constant estrous, for an experiment, it is likely that only a subset of animals in a colony 
will fall under this profile at the appropriate age and timing for the experiment. While 
studying the natural diversity that occurs in the ovary-intact model and taking these 
estrous cycle variations into account benefits correlation data evaluations, it is limiting in 
causal-type inferences. It is preferable to methodically control reproductive status and age 
at evaluation in experimental animals in order to dissociate the specific effects of 
reproductive senescence from advanced aging, since confounding factors due to age 
alone may muddle results. 
 Some stocks or strains of laboratory rodents are considered better models than 
others for aging research. One example is the National Institute on Aging’s (NIA) 
recommendation to use the Fischer-344 (F344) inbred strain for aging research due to 
their longevity and well-defined aging patterns. Of note, Fischer-344-NIH rats were 
initially bred at the National Institutes of Health breeding facility and used for a number 
of years. As of 2016, due to breeding challenges, the F344-NIH strain was shifted to the 
Charles River-derived Fischer rat background (F344-CDF). The F344-CDF strain has 
minor genetic variations from the F344-NIH strain, but overall has significant overlap in 
genetic identity. Thus, as of the present time, F344-CDF rats are the standard strain 
utilized for much of NIA-supported research (National Institute on Aging, 2019). 
Sprague Dawley and Long Evans are also commonly utilized rat strains in aging research. 
Most laboratory rodent colonies do not have aging animals in stock; those that are 
available are often limited to retired breeders. In menopause research, reproductive 
history is a variable of chief importance – indeed, several laboratories have demonstrated 
that sexual experience and parity influence cognitive and brain outcomes (Barha & 
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Galea, 2011; Cost, Lobell, Williams-Yee, Henderson, & Dohanich, 2014; Gatewood et 
al., 2005; Macbeth & Luine, 2010; Macbeth et al., 2008). For example, these studies 
suggest a history of pregnancy is related to enhanced spatial memory performance 
compared to nulliparous animals, and brain responsiveness to estrogen treatment may be 
influenced by reproductive history. Thus, when employing the ovary-intact rodent model 
for aging and menopause work, scientists must be carefully consider the stock or strain of 
rodent as well as their age and life history to obtain an appropriate aging model for their 
research questions regarding the transition to reproductive senescence.  
 
Ovariectomy: A Model of Surgical Menopause 
The gold standard in the preclinical field for evaluating gonadal hormone effects 
in female animal models is the ovariectomy, or surgical removal of the ovaries, often 
abbreviated Ovx. Rodent anatomy differs from women in that rodents have a bifurcated 
uterus, called the uterine horn, which accommodates large litters (Figure 8). The standard 
Ovx procedure is to bilaterally excise the ovaries, oviducts (i.e., the fallopian tubes), and 
tips of the uterine horn from the peritoneal cavity, leaving the ligated uterine horns intact 
(Olson & Bruce, 1986). Full recovery from Ovx occurs within one week. Ovx most 
accurately models surgical menopause in women. Ovx is an ideal model to evaluate 
specific effects of gonadal hormone deprivation and subsequent exogenous hormone 
treatments on the brain and periphery because it creates a “blank gonadal hormone slate.” 
As an example, estrogens may be administered after Ovx, alone or in combination with 
other ovarian hormones, with variations in the type of estrogen administered, dose, route 
of administration, and treatment duration while controlling for interactions with 
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endogenous levels of sex steroid hormones. Combined exogenous therapies, such as 17b-
estradiol plus progesterone, may be used to evaluate their interactions on a particular 
system, more closely modeling HT regimens that many menopausal women take. Our 
laboratory and many others have utilized the Ovx model to evaluate the potential for 
neuroprotective effects of exogenous ovarian hormone administration on the brain. For 
example, administering HT to Ovx females has been shown to enhance performance on 
mazes evaluating spatial memory compared to Ovx females that were not receiving 
estrogen treatment (Bimonte-Nelson, Francis, Umphlet, & Granholm, 2006; Bimonte & 
Denenberg, 1999; Daniel, Fader, Spencer, & Dohanich, 1997; Daniel et al., 2006; 
Markowska & Savonenko, 2002a; McLaughlin et al., 2008; Talboom et al., 2008). Higher 
circulating 17b-estradiol levels have been associated with better spatial memory 
performance for both young and middle-aged Ovx rats (Talboom et al., 2008), and 
chronic, long-term exogenous estrogen plus progesterone treatment enhances radial-arm 
maze performance in middle age (Gibbs, 2000b). Importantly, the Ovx model has also 
shown limitations of efficacy in gonadal hormones, including some estrogens. For 
example, when estrone, a weaker metabolite of 17b-estradiol and the main component in 
Premarin, was given at a tonic dose to middle-aged Ovx rats, it had a negative impact on 
spatial memory at a high dose (Engler-Chiurazzi et al., 2012). 
A drawback to the Ovx model in the context of translational research is that the 
majority of women retain their whole reproductive tract throughout the menopause 
transition. While removing the ovaries prior to the onset of reproductive senescence 
allows researchers the control to evaluate the impact of particular hormones without 
aging as a confounding factor, the age at which Ovx occurs in rodents may also result in 
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divergent effects (Chakraborty & Gore, 2004; Diz-Chaves et al., 2012), particularly for 
cognition (Foster et al., 2003). Additionally, the sudden loss of ovarian steroids is not 
characteristic of the majority of transitionally menopausal women; compounded with 
this, the post-menopausal ovary continues to release androgens and low levels of other 
steroids (Mayer, Devine, Dyer, & Hoyer, 2004; Mayer et al., 2002). Consequently, the 
Ovx model results in a considerably different hormone profile, as well as an altered HPG 
axis, compared to animals with an intact reproductive tract. Nonetheless, the Ovx model 
is a classic technique that merits much praise for its utility in evaluating novel 
phenomena in the context of aging and menopause research. While it is imperative to 
understand the impact of specific hormone and drug effects on the brain and body 
systems with a “blank gonadal hormone slate,” in the context of the menopause 
transition, these factors associated with reproductive senescence do not operate in a 
vacuum, and understanding how exogenous hormone formulations interact with intact 
systems (i.e., a more representative model of human menopause) is translationally 
important.  
 
4-Vinylcyclohexene Diepoxide: A Model of Transitional Menopause 
The drug 4-vinylcyclohexene diepoxide, or VCD, a metabolite of 4-
vinylcyclohexene, is produced when the industrial chemical butadiene is utilized to 
manufacture various plastic-based goods (Chhabra, 1989; Hoyer, Devine, Hu, Thompson, 
& Sipes, 2001). VCD is used commercially to reduce fecundity and species proliferation 
of rodent pests without the use of hazardous poisons that endanger the environment (Dyer 
et al., 2013). In the early 2000’s, VCD was introduced to biobehavioral animal research 
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as a rodent model of transitional menopause because it was found to selectively target 
and deplete the non-growing ovarian follicle pool in rodents via atresia, resulting in 
accelerated follicular depletion and eventual ovarian failure in rodents (Borman et al., 
1999; Devine, Sipes, & Hoyer, 2001; Flaws, Doerr, Sipes, & Hoyer, 1994; Hirshfield, 
1991; Hoyer et al., 2001; Hu, Christian, Thompson, Sipes, & Hoyer, 2001; Hu, Christian, 
Sipes, & Hoyer, 2001; Kao, Sipes, & Hoyer, 1999; Mayer et al., 2004; Mayer, Dyer, 
Eastgard, Hoyer, & Banka, 2005; Mayer et al., 2002; L. N. Springer, Flaws, Sipes, & 
Hoyer, 1996; L. N. Springer, McAsey, et al., 1996; L. N. Springer, Tilly, Sipes, & Hoyer, 
1996). VCD is thought to function through accelerating atresia in primordial and primary 
ovarian cells —but not disrupting growing follicles — by altering the expression and 
distribution of the Bcl-2 family of proteins that regulate apoptosis, including Bcl-xL, 
Bax, and Bak proteins within ovarian follicles, thus initiating cytochrome c release into 
the cell cytosol, triggering downstream caspase signaling activity, all of which are related 
to accelerated follicle atresia (Hu, Christian, Thompson, et al., 2001; Hu, Christian, Sipes, 
et al., 2001; L. N. Springer, Flaws, et al., 1996; L. N. Springer, McAsey, et al., 1996; L. 
N. Springer, Tilly, et al., 1996; Van Kempen et al., 2011).  
The introduction of VCD as a model of transitional menopause has been an 
integral contribution to science. This innovative model more closely mimics the human 
menopause transition compared to the ovary-intact or Ovx models by effectively 
depleting the resting follicle pool but allowing for the retention of follicle-deplete ovarian 
tissue, resulting in an ovarian and hormone profile more similar to a vast majority of 
women undergoing the natural menopause transition who retain their reproductive organs 
in the post-reproductive life stage. In rodents, VCD is typically administered via a series 
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of intraperitoneal injections ranging from 80 mg/kg-160 mg/kg (Devine et al., 2001; Frye 
et al., 2012; Hoyer et al., 2001; Mayer et al., 2004, 2002; L. E. Wright et al., 2011). 
Recently, an oral bait has been developed for rodents that contains a combination of VCD 
and triptolide, a Chinese herb thought to accelerate the follicular depletion of later-stage 
ovarian follicles (e.g., pre-ovulatory antral follicles) (Dyer et al., 2013), which could be 
used both in the laboratory to decrease the number of necessary VCD injections and to 
target later-stage follicle development, as well as commercially to reduce wild rodent pest 
populations by further decreasing fertility. This model is still undergoing development 
but is an excellent addition to the VCD-related models (Dyer et al., 2013). The chief 
drawback of the VCD model is that it is toxic in high doses (Chhabra, 1989). However, 
the use of VCD in the laboratory has been refined as a model of transitional menopause 
and no significant effects have been indicated on other organs under appropriate 
administration regimens (Devine et al., 2001; Frye et al., 2012; Hoyer et al., 2001), 
although it may be an acute stressor to the animal during drug administration. Animals 
may decrease in body weight during injections, but generally return to baseline weights 
after drug administration.  
Resulting serum hormone and gonadotropin profiles after VCD-induced follicular 
depletion have been shown to be similar to the hormone profiles observed in ovary-intact 
menopausal women (Acosta et al., 2010, 2009; Mayer et al., 2004, 2002; Timiras et al., 
1995); it is noteworthy that gonadotropin and sex steroid hormone profiles from VCD-
induced follicle depletion may vary based on species, dose, age, duration of 
administration, and length of time since VCD administration (Frye et al., 2012). In 
addition to the circulating hormone profile produced by VCD, this is an excellent model 
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of follicle atresia in women. Ovarian follicle counts are considered a reliable marker of 
reproductive capacity. In clinical research, antral follicle count (AFC) is often used as a 
biomarker for reproductive capacity in the context of fertility (The American College of 
Obstetrics and Gynecology, 2015), and more recently, in the transition to menopause 
(Hansen, Craig, Zavy, Klein, & Soules, 2012; Hansen, Hodnett, Knowlton, & Craig, 
2011; Hansen et al., 2008). AFC may be a more accurate marker than circulating serum 
gonadal hormone and gonadotrophin levels, as these levels fluctuate erratically in the 
human menopause transition (Hansen et al., 2011). Because the VCD model allows for 
the retention of post-menopausal ovarian tissue, researchers can now evaluate how 
ovarian follicle count relates to reproductive senescence in rodents. This model can also 
inform our understanding of the impact of intact post-menopausal ovarian tissue with its 
continued release of androgens, particularly androstenedione (Mayer et al., 2004) and the 
relationship to other low levels of circulating steroid hormones from extra-ovarian 
sources, such as the adrenals, breast, and adipose tissues in the post-menopausal life 
stage. Overall, the VCD menopause model has a substantial advantage over the ovary-
intact and Ovx models in that it results in an ovarian follicle and circulating steroid 
hormone profile more similar to the majority of women transitioning into the post-
menopausal life stage.  
The VCD model is growing in popularity in the field of menopause and aging 
research. Our laboratory has implemented the VCD model in the context of spatial 
memory performance, and showed that transitional menopause differentially impacts 
spatial memory as well as the efficacy of the estrogenic HT, conjugated equine estrogens 
(CEE; tradename: Premarin) compared to Ovx animals (Acosta et al., 2010, 2009). 
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Others have shown VCD-induced reproductive senescence is associated with insulin 
resistance, bone loss, atherosclerotic lesion development, and changes in anxiety-like 
behaviors (Mayer et al., 2005; Reis et al., 2014; Romero-Aleshire, Diamond-Stanic, 
Hasty, Hoyer, & Brooks, 2009; L. Wright et al., 2008), all of which can be negative 
health risks related to aging and the menopause transition in women. These studies point 
to the benefits and utility of the VCD model, and suggest that it should be further tapped 
in the context of menopause research in order to elucidate novel therapies in an intact 
system. 
 
Hysterectomy: A Novel Model of Gynecological Surgery and Menopause in Rats 
Hysterectomy, or the surgical removal of the uterus, is a common gynecological 
surgery performed in women, second only to cesarean section (Carlson, Nichols, & 
Schiff, 1993; Centers for Disease Control and Prevention, 2010). Although hysterectomy 
rates have declined in recent years, an estimated 600,000 surgeries occur in the United 
States annually, mostly for benign reasons such as endometriosis, pelvic inflammatory 
disease, uterine fibroids, cysts, or abnormal bleeding (Carlson et al., 1993; Corona et al., 
2015; J. D. Wright et al., 2013). In approximately 50% of hysterectomy procedures, the 
ovaries are removed at the time of hysterectomy. This is usually considered a 
prophylactic measure to avoid an increased risk of developing ovarian cancer or other 
complications following hysterectomy, but results in an abrupt, surgical menopause 
(Hoffman et al., 2012; Whiteman et al., 2008). The majority of these procedures are 
completed in women prior to the onset of menopause (J. D. Wright et al., 2013). Thus, if 
a woman retains her ovaries at the time of hysterectomy, which is true in about half of 
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hysterectomy cases, the ovaries are thought to continue to function normally until the age 
of natural menopause onset. Evidence from research at Mayo Clinic and other 
laboratories indicate that there is an association between hysterectomy, both with and 
without ovarian conservation, and an increased risk of dementia development later in life; 
this risk further increases with a younger age at surgery (Phung et al., 2010; Rocca et al., 
2007; Rocca, Grossardt, Shuster, & Stewart, 2012).  
There have been few evaluations of hysterectomy using a rodent model. Those 
that have been completed are focused on physiological measures such as serum hormone 
levels and ovarian follicles. Early investigations into the role of hysterectomy on 
endocrine function suggested that the uterus may alter pituitary RNA activity and play a 
role in regulating hormone and gonadotropin synthesis and release from the anterior 
pituitary (Biró, 1979; Biró & Eneroth, 1989; Biró, Eneroth, & Ritzén, 1983, 1988; Biró, 
Ritzén, Hall, & Eneroth, 1984; Biró, Ritzén, & Eneroth, 1987; H. Spies, Hilliard, & 
Sawyer, 1968). Another experiment where hysterectomy was performed in rats at six 
weeks of age found increased ovulation approximately three weeks later, with an increase 
in ovarian homogenate-derived 17b-estradiol levels and aromatase activity (Tanaka et al., 
1994). Other evaluations 50 or 100 days after hysterectomy showed no changes in serum 
ovarian steroid hormones or FSH levels, but evidence of accelerated ovarian aging 
(Tapisiz et al., 2008), while a longer interval after hysterectomy surgery indicated 
increased serum FSH levels as well (Özdamar, Ülger, Sorkun, & Müderris, 2005). To 
date, there have been no systematic evaluations of the role of hysterectomy on cognition. 
For this dissertation, I created a rodent model of hysterectomy to methodically test the 
impact of the surgery on spatial learning and memory. In this surgical model, the uterus 
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(i.e. the uterine body and uterine horns) are surgically removed, while the ovaries and 
oviducts remain intact. In the ovariectomy + hysterectomy model, the reproductive tract, 
including the ovaries, oviducts, and uterus, are removed. This model fills an important 
gap in the literature regarding the effects of uterus removal on cognition, and more 
closely models the most common surgical procedures that occur in women. That is, 
ovariectomy with uterine preservation is the gold standard in rodent models of 
menopause; however, this surgical procedure, although growing in popularity, is not as 
commonly performed in women as uterus removal with or without ovary removal. 
Chapters 7, 8, and 9 will detail the results from this novel rodent model of variations in 
surgical menopause and the implications of these findings for women’s health and 
healthy brain aging in the post-reproductive life stage.  
 
Reproductive Hormones and Cognition 
 
Estrogen and Progesterone as the Traditional Key Ovarian Hormone Players 
As noted above, female mammals typically experience a cessation of reproductive 
capacity in mid- to end- of life. Most animals are not long-lived following reproductive 
senescence; humans are one of the unique exceptions to this rule. People are living longer 
than ever before, with the average female lifespan surpassing 81 years in developed 
countries such as the United States (Murray et al., 2015). However, the age at menopause 
does not seem to be changing with increased longevity (Sherwin, 2003). This means that 
women are now living in a postmenopausal state, with significantly reduced circulating 
ovarian hormone levels, for a substantial part of their lives. This underscores the need to 
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understand the effects of aging and related hormone loss on the body, including the brain 
and its function.  
There has been ample research, both in basic science and human realms, 
suggesting that the loss of ovarian hormones has a negative impact on a variety of body 
systems. These adverse effects are especially robust when an abrupt hormone loss occurs, 
such as that associated with ovariectomy (Ovx; the surgical removal of the ovaries). 
Ovarian hormone loss is associated with a decline in cognitive function both in humans 
(Nappi et al., 1999; Rocca et al., 2007; Sherwin, 2003) as well as in animal models 
(Daniel, 2013; Frick, 2015; Koebele and Bimonte-Nelson, 2015; Korol and Pisani, 2015; 
Luine, 2014). Animal models have provided an excellent framework to elucidate the 
effects of ovarian hormones on the brain and behavior. For example, seminal preclinical 
work in the field of neuroendocrinology, aging, and cognition has shown that Ovx 
impairs spatial memory performance, and that subsequent estrogen treatment can 
improve memory performance following Ovx, at least for a period of time (Bimonte & 
Denenberg, 1999; Bohacek, Bearl, & Daniel, 2008; Savonenko & Markowska, 2003; 
Talboom et al., 2008; M. Wallace, Luine, Arellanos, & Frankfurt, 2006). Interestingly, 
transient 17b-estradiol treatment after Ovx can enhance memory performance, as well as 
increase hippocampal choline acetyltransferase (ChAT; the synthesizing enzyme for 
acetylcholine) and ERa levels, even after the estrogen treatment has been terminated 
(Rodgers, Bohacek, & Daniel, 2010). However, timing of 17b-estradiol replacement is 
critical; spatial memory performance was improved only when hormone treatment is 
initiated immediately after Ovx, but not after five months of hormone deprivation (Daniel 
et al., 2006). It is also notable that estrogen replacement following Ovx is more 
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efficacious in young and middle-aged animals than in old age (Diz-Chaves et al., 2012; 
Savonenko & Markowska, 2003), and that chronic estrogen treatment can improve 
cognitive performance, but only after priming with a cyclic regimen of 17b-estradiol 
injections (Markowska & Savonenko, 2002a). Moreover, animals’ responsiveness to the 
enhancing effects of 17b-estradiol or estradiol benzoate changes with age (Foster et al., 
2003; Talboom et al., 2008), which may be related to estrogen receptor expression in the 
hippocampus (Foster, 2012). ERα and ERβ are associated with a range of intracellular 
signaling molecules that are rapidly activated in the presence of estrogens. Remarkably, 
Ovx animals receiving hippocampal lentivirus injection of ERa, which increases ERa 
expression, displayed enhanced spatial working memory, even in the absence of high 
circulating estrogen levels (Foster, Rani, Kumar, Cui, & Semple-Rowland, 2008; Witty, 
Foster, Semple-Rowland, & Daniel, 2012). Lentiviral delivery of ERa to the 
hippocampus also increased phosphorylated extracellular regulated kinases (ERK1/2; 
discussed in more detail below) in rats, suggesting that signal transduction pathways 
important for learning and memory are, in part, moderated by estrogen receptor 
expression and activity (Witty et al., 2012). Taken together, these novel findings indicate 
that serum estrogen levels alone cannot necessarily dictate or predict cognitive outcomes; 
they are part of a complex and interactive system involving many cellular and molecular 
mechanisms that impact memory performance in a collaborative fashion.   
 Of note, estrogens do not operate on the brain and body in isolation. Progestogens 
are a class of steroid hormones that include endogenous progesterone and synthetic 
progestins that bind to the progesterone receptor. Progesterone is an important component 
of the reproductive cycle, and is especially critical for the maintenance of pregnancy. In a 
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non-pregnant female, the main release occurs during the endogenous female reproductive 
cycle via the corpus luteum after ovulation; with follicular depletion and ensuing 
menopause, corpora lutea formation is attenuated and therefore there is a lack of elevated 
progesterone. In a broad context, the scientific study regarding the impact of the shifts in 
progesterone across the female lifespan is important because of the systematic and rapid 
alterations in progesterone levels across the regular reproductive cycle in adulthood, 
markedly elevated levels with pregnancy, as well as the decreased levels that occur into 
old age. The effects of progestogens specifically on the brain and its functions is also a 
crucial growing area of research; in fact, the work is yielding strong evidence that 
progestogens have marked impacts on brain areas integral to many reproductive and non-
reproductive behaviors, including translating effects to cognition.  
Interestingly, our laboratory has found that the beneficial effects of estrogen 
treatment on spatial memory can be reversed by concomitant progesterone administration 
(Bimonte-Nelson et al., 2006), and that administering the synthetic progestin 
medroxyprogesterone acetate (MPA) to Ovx rats impaired performance on a spatial 
working memory task (Braden et al., 2011, 2010). However, it seems that progestins are 
not unequivocally harmful to cognition. Our laboratory and others have recently 
demonstrated that different classes of synthetic progestins commonly used in HT 
formulations, including levonorgestrel and norethindrone acetate, can have differential 
effects on spatial memory performance compared to MPA (Gambacciani et al., 2003; 
Simone et al., 2015; Tierney et al., 2009). While MPA administration has been shown to 
produce detrimental, long-lasting cognitive impairments (Braden et al., 2011, 2010), and 
norethindrone acetate dose-dependently impaired spatial memory, levonorgestrel has 
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been shown to have a null or even enhancing effect on spatial memory performance 
(Braden et al., 2016; Prakapenka et al., 2018). In the context of translational research, 
finding a null effect of a progestin is a better outcome than the generally detrimental 
effects of MPA; that is, it is preferable for women to use a progestin that will have no 
effect or a beneficial effect on memory, rather than utilize a known cognitively impairing 
option like MPA. Thus, these novel findings regarding the differential effects of 
progestogens on cognition warrant further investigation into progestin type, dose, and 
timing of treatment to produce an optimal brain aging profile while maintaining the 
important protective effects that progestogens provide for other body systems.  
 
Androstenedione: Long Ignored but not Unimportant 
Androstenedione is an androgen synthesized by the adrenal glands and interstitial 
ovarian tissue, as well as by the thecal cells of maturing follicles. The aromatase enzyme 
converts androstenedione to estrone and 17b-estradiol; androstenedione can also be 
converted to testosterone via the enzyme 17b-HSD; both of these androgens and their 
metabolites can impact the brain and cognition (Bimonte-Nelson, Singleton, Nelson, et 
al., 2003; Camp et al., 2012; Mennenga, Koebele, et al., 2015). In the context of 
menopause, research shows that, while estrogen and progesterone production declines 
substantially with reproductive senescence, the postmenopausal ovary continues to 
produce androgens in rodents (Mayer et al., 2004) and in humans (Fogle, Stanczyk, 
Zhang, & Paulson, 2007). In fact, it has been estimated that in the postmenopausal state, 
the ovaries continue to produce about 30 percent of the circulating androstenedione levels 
and 50 percent of total testosterone levels (Vermeulen, 1976). Recent research in 
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postmenopausal women shows that exogenous testosterone can enhance memory (Davis 
et al., 2014; Davison et al., 2011), but endogenous testosterone levels may differentially 
impact cognition, such that a lower testosterone to estrogen ratio is better for memory 
performance (Joanne Ryan et al., 2012). Thus, the cognitive effects of androgens likely 
depend on a woman’s background hormone profile in the postmenopausal state, and 
should be taken into consideration when interpreting the effects of ovarian hormones on 
cognitive outcomes.  
Although the effects of endogenous and exogenous estrogens and progestins have 
been the focus of research related to cognitive function, the role of androgens 
(particularly androstenedione) in learning and memory remains somewhat elusive. Our 
laboratory has shown that in a transitional menopause rat model, animals with higher 
naturally circulating androstenedione levels tended to make more working memory errors 
on the water radial-arm maze (Acosta et al., 2009). Given that androgens can convert to 
estrogens, we recognized this novel finding could inform important innovations in the 
realm of hormone therapy options for women. Thus, intrigued by this correlation, we 
continued to explore the role of androstenedione on memory in the middle-aged female 
rat. We found that in middle-aged Ovx rats, a high dose of androstenedione impaired 
spatial working memory as well as reference memory on the Morris water maze (Camp et 
al., 2012). Androstenedione can be aromatized to estrone, an estrogen that we have 
shown to impair memory in the Ovx model (Engler-Chiurazzi et al., 2012). 
Consequently, our laboratory systematically evaluated whether the apparent 
detrimental effects of androstenedione on memory were due to binding to the androgen 
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aromatase enzymatic activity via anastrozole reversed spatial memory impairments in 
young Ovx rats, but blocking the androgen receptor did not prevent detrimental effects on 
memory, suggesting that the conversion of androstenedione to estrone influences 
cognitive performance (Mennenga, Koebele, et al., 2015). Collectively, these findings 
point to a crucial role of androgens, a long ignored yet ostensibly critical factor in 
understanding the role of the hormone milieu on cognition in the menopausal woman. 
Future research should continue to focus on understanding how circulating androgen 
levels impact the brain and body of aging women, and how maintaining a “golden ratio” 
of androgens to estrogens may be key to preserving cognition in the postmenopausal life 
stage.  
 
What About Those Gonadotropins? Cognitive Effects of LH and FSH During 
Menopause and Aging 
 The reproductive system in females is regulated by communication and 
interactions of numerous hormones from the hypothalamus, pituitary, and ovaries. Thus, 
ovarian-derived steroids, such as estrogens, progesterone, and androgens, are not the only 
hormones to become dysregulated with age and reproductive senescence. Research in 
recent years has indicated that changes in gonadotropin levels, namely FSH and LH, have 
a major role in cognitive changes and risk factors for developing age-related 
neurodegenerative disorders. FSH and LH are glycoprotein hormones released from the 
anterior pituitary, and they each have critical effects on body growth and maturation, as 
well as reproductive functions. FSH is released to stimulate the growth of immature 
ovarian follicles, resulting in a gradual rise in circulating estrogen levels during the first 
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half of the cycle. Once estrogen levels reach a certain threshold, an LH surge occurs, 
which triggers ovulation and concurrently initiates corpus luteum development from the 
remaining ovarian follicle, which produces progesterone in preparation for egg 
fertilization. Once the follicle pool falls below a critical threshold, typically in midlife, 
the normal feedback from the ovaries back to the hypothalamus and pituitary becomes 
disrupted. Thought to be a compensatory mechanism, increased FSH and LH levels are 
released in the system’s attempt to stimulate normal follicular growth and ovulation. 
Seminal work from the laboratories of Dr. Andrea Gore and Dr. Phyllis Wise has 
provided evidence that perturbations in the cyclic release of GnRH and subsequent 
release of gonadotropins occur before alterations in regular estrous or menstrual cyclicity 
becomes apparent, and that changes in NMDA receptor function may play a key role in 
disrupted GnRH release and feedback (Gore et al., 2000a; Gore et al., 2000b; 
Scarborough and Wise, 1990; Wise, 1982).  
Some human research suggests that it is the alterations in gonadotropin levels, 
over and above declines in circulating ovarian hormone levels, that result in the cognitive 
changes observed during aging (Webber et al., 2005). In fact, higher circulating FSH and 
LH levels have been associated with neurodegenerative disease and pathologies in 
clinical populations (Bowen, Isley, & Atkinson, 2000; Bowen et al., 2002; Short, Bowen, 
O’Brien, & Graff-Radford, 2001). Basic science research using rodent models has further 
substantiated this tenet. For example, Dr. Gemma Casadesus and colleagues found that 
transgenic mice that overexpress LH receptors performed more poorly on hippocampal-
dependent Y-maze task, while LH receptor knock out mice were not impaired, despite 
increased circulating LH levels (Casadesus et al., 2007). Furthermore, this group has 
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shown that pharmacologically down-regulating serum LH improves cognitive 
performance after Ovx in wildtype and a triple transgenic mouse model of Alzheimer’s 
disease (Blair et al., 2016; Palm et al., 2014); in wild type animals, decreasing LH serum 
levels beneficially affects memory performance, even after exogenous 17b-estradiol 
treatment is no longer effective in enhancing memory following Ovx (Blair et al., 2016). 
In addition, our laboratory has shown an inverted U association between LH levels and 
cognitive performance in middle-aged female rats. Specifically, for animals with their 
ovaries (sham and follicle-deplete), higher LH levels were associated with poorer 
memory performance. Conversely, for Ovx animals, higher LH levels tended to be 
associated with better memory performance (Acosta et al., 2009). It is clear that in 
addition to circulating ovarian steroid hormone levels, gonadotropins also play a part in 
mediating cognitive performance, and these effects likely depend on background 
hormone milieu. Overall, these exciting findings point to novel pathways that are 
necessary to explore to fully understand the impact of a dysregulated hypothalamic-
pituitary-ovarian feedback loop, especially regarding the transition to reproductive 
senescence as related to the trajectory of cognitive aging. 
 
Aging, Ovarian Hormones, and Altered Neural Systems 
 The brain is a highly plastic organ. It adapts and changes throughout the lifespan, 
constantly revising and redacting information in order to adjust to an organism’s ever 
changing environment. Neural systems and biochemical mediators are affected by many 
factors that are modified with age and interactions with the environment. A fundamental 
factor influencing the brain beginning early in life is sex steroid hormones. It is well 
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established that androgens and estrogens play a key role in organizing the developing 
brain and set it up to respond in a particular way following sexual maturity of an 
organism. Many of these neural systems and molecular pathways that are impacted by 
age and reproductive hormones are also associated with learning and memory processes. 
Here, we have focused upon the cholinergic and GABAergic systems, which are two of 
the most well-studied neural systems critical for learning and memory processes that are 
concomitantly impacted by age and ovarian hormones. The effects of age and altered 
ovarian hormone levels on dendritric morphology, as well as ERK1/2 signaling, a ERa-
linked signaling pathway, are also discussed. 
 
The Cholinergic System 
Age and ovarian hormones, both endogenously circulating and exogenously 
administered, impact a myriad of factors in the brain, including, but not limited to, 
growth factors (e.g., neurotrophins), inflammatory response, immune response, 
mitochondrial function, and the cholinergic system. The latter involves the 
neurotransmitter acetylcholine, which also has diverse functions in the brain. One of 
acetylcholine’s significant functions is to act as a key regulator of learning and memory 
consolidation. The basal forebrain is a primary synthesis site for acetylcholine in the 
mammalian forebrain. It is known that there are long-range projections from the basal 
forebrain to frontal cortex as well as the hippocampus, crucial brain structures for 
learning and memory consolidation. Beginning in the 1980’s, landmark research has 
indicated that age impacts morphology and functionality of the brain’s cholinergic 
system. For example, aged animals showed a decline in ChAT and acetylcholinesterase 
 
43 
(AChE; the enzyme that breaks down acetylcholine) activity in the basal forebrain and 
hippocampus (J. E. Springer, Tayrien, & Loy, 1987). Recently, the Bizon laboratory 
reported a decreased number of ChAT-immunoreactive (ChAT+) basal forebrain neurons 
in aged males rats compared to young adult male rats (Bañuelos et al., 2013). By 
examining p75NTR expression, a growth factor receptor that often co-localizes with 
cholinergic neurons, Veng and colleagues reported a reduction in density and presence of 
healthy cholinergic neurons in both aged male and female rats compared to younger 
animals (Veng, Granholm, & Rose, 2003). Aged males exhibited smaller cholinergic 
neuron somas compared to younger males, while aged females did not show a reduction 
in mean soma size (Veng et al., 2003). In addition to age-related alterations in cholinergic 
neurons, Ovx has been associated with a decline in ChAT activity, while subsequent 17b-
estradiol administration restored ChAT activity in the female rat basal forebrain and 
projection sites into the frontal cortex and CA1 region of the hippocampus (Gibbs, 1994; 
Luine, 1985; M. Singh, Meyer, Millard, & Simpkins, 1994).  Further, lesions to the 
medial septum and vertical/diagonal bands of the basal forebrain resulted in impaired 
spatial memory performance and prevented the memory enhancing effects of 17b-
estradiol (Gibbs, 2002; Hagan, Salamone, Simpson, Iversen, & Morris, 1988). It is 
important to note that age and ovarian hormone loss do not necessarily affect the number 
of ChAT-producing neurons in the basal forebrain, but do impact the functional integrity 
of the cholinergic system (Gibbs, 2003). Recently, it has been shown that GPR30, a 
membrane bound G-protein coupled estrogen receptor distinct from ERα and ERβ, 
exhibits co-localization with basal forebrain cholinergic neurons and likely mediates 
some of the estrogens’ effects on both basal forebrain cholinergic integrity and resulting 
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cognitive outcomes (Hammond & Gibbs, 2011; Hammond, Nelson, & Gibbs, 2011; Ping, 
Trieu, Wlodek, & Barrett, 2008). Thus, ovarian-derived hormones likely play a 
significant role in the neuroendocrine modulation of the cholinergic-hippocampal 
pathway. Most research on this subject has been evaluated in the Ovx model, where the 
ovaries, which are the endogenous source of circulating gonadal hormones, are surgically 
removed, and subsequent exogenous hormone therapy is administered. The effects of 
estrogens on cholinergic neurons in the basal forebrain are not always consistent. For 
example, many studies have shown that after Ovx, exogenous administration of 17b-
estradiol can increase ChAT+ neurons in the basal forebrain (Engler-Chiurazzi et al., 
2012; Gibbs, 1997); it is of note that other estrogen types initiate varied effects on this 
measurement. For example, tonic administration of estrone, a weaker metabolite of 17b-
estradiol, failed to impact ChAT+ neurons in the basal forebrain (Engler-Chiurazzi et al., 
2012), and the synthetic estrogen used in oral contraceptives, ethinyl estradiol, decreased 
the number of ChAT+ neurons in the basal forebrain following chronic administration in 
an Ovx model (Mennenga, Gerson, et al., 2015). These diverse effects of estrogens on 
one system highlight the complexity of estrogens’ actions in the brain, and underscore the 
importance of taking multiple factors into account when assessing estrogens’ effects on 
the brain and other body systems, such as type of estrogen, dose, route of administration, 
and timing of administration (for review, see Koebele and Bimonte-Nelson, 2015). 
 
The GABAergic System 
To add complexity to understanding the system, many cholinergic projections 
from the basal forebrain synapse onto ɣ-aminobutyric acid (GABA)ergic cortical 
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neurons; GABA is the primary inhibitory neurotransmitter in the brain and an important 
neuromodulator for normal cognitive processes, including hippocampal and cortical 
function. Acetylcholine release onto these GABAergic neurons in the hippocampus may 
modulate hippocampal theta wave oscillations through both direct and indirect pathways; 
these hippocampal theta rhythms play a role in regulating memory consolidation and 
synaptic plasticity (Dannenberg et al., 2015). The basal forebrain also has long-range 
GABAergic projections to the frontal cortex and hippocampus, both of which are thought 
to play a regulatory role in normal neural activity. Among its many roles, GABA 
signaling in the brain is a key regulatory factor in normal memory formation and 
maintenance (Kalueff & Nutt, 1997; Katz & Liebler, 1978). Inhibitory GABAergic 
neurons and signaling appear to become dysregulated with aging (Shetty & Turner, 1998; 
Stanley & Shetty, 2004). Animal models with altered GABAergic signaling, both 
systematically and with normal aging, show altered cognition with changes to the system, 
both in relation to cognitive aging and other psychiatric disorders (Bañuelos et al., 2013; 
McQuail, Frazier, & Bizon, 2015).  For example, the Bizon laboratory found that younger 
animals had better performance on the probe trial of the spatial reference memory Morris 
water maze compared to aged rats. The basal forebrain was immunohistochemically 
processed for ChAT and glutamate decarboxylase 67 (GAD67; a synthesizing enzyme for 
GABA). For GAD67-immunoreactive (GAD67-IR) neurons, there was no overall 
difference between young and aged rats. However, when aged rats were sub-classified 
into spatially- unimpaired and impaired groups, aged-spatially-impaired rats were found 
to have significantly more GAD67-IR neurons compared to both young and aged-
spatially-unimpaired animals. Further, this group showed a negative correlation with 
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spatial memory performance in aged rats, such that a greater number of GAD67-IR 
neurons was associated with poorer memory performance (Bañuelos et al., 2013). This 
laboratory also recently found that aged male rats have impaired performance on a set-
shifting task, and that poorer performance on this task was associated with fewer 
GABA(B) receptors in the medial prefrontal cortex of the aged animals, but not the 
young animals. Directly infusing a GABA(B) receptor agonist into this brain region 
enhanced performance on the set shifting task for the aged animals (Beas, McQuail, 
Bañuelos, Setlow, & Bizon, 2017), suggesting that cognitive changes with age are in part 
modulated by GABAergic signaling.  
 In addition to age-related changes in the GABAergic system and subsequent 
memory performance, ovarian hormones influence the GABAergic system. While some 
research suggests 17b-estradiol can influence GABAergic signaling in the hippocampus 
(Wójtowicz & Mozrzymas, 2010), the majority of studies thus far have focused on the 
role of progesterone and GABAergic functioning. For example, our laboratory and others 
have shown that progesterone decreased GAD65+67 protein levels in the hippocampus 
and increased GAD65+67 protein levels in the entorhinal cortex (Braden et al., 2010) as 
well as decreased GAD activity in several brain regions, including the dorsal 
hippocampus, as measured by kinetic studies (Wallis & Luttge, 1980). Furthermore, an in 
situ hybridization study revealed that 12 hours after treatment, progesterone, but not 
MPA, reduced hippocampal mRNA expression of the a4 subunit of the GABA(A) 
receptor (Pazol, Northcutt, Patisaul, Wallen, & Wilson, 2009), suggesting that different 
progestogens can have variable impacts on the GABAergic system. We recently showed 
that in a middle-age Ovx rat model, progesterone administration resulted in transient 
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working memory impairments on a spatial memory task, but concomitant delivery of 
bicuculline, a GABA(A) receptor antagonist, obviated these memory impairments 
(Braden et al., 2015). Finally, the recent finding that cholinergic neurons may also co-
release GABA adds an additional level of complexity wherein the full impact on 
cognitive function has yet to be determined (Tritsch, Granger, & Sabatini, 2016). 
Nonetheless, whether there are sex differences in how GABAergic circuitry and signaling 
are affected by aging, as well as how endogenous alterations and exogenous 
administrations of other sex steroid hormone levels impact this system, remains 
somewhat elusive and warrants further investigation. 
 
MAPK/ERK1/2 Signaling Pathway 
A wide range of intracellular pathways and kinases are known to be important for 
normal learning and memory processes (Giese & Mizuno, 2013), many of which are 
recruited downstream of estrogen receptor activation. One pathway in particular, the 
extracellular signal-regulated kinases, known as ERK1/2, p44/42, and classical mitogen-
activated protein kinases (MAPKs; in humans, ERK1=MAPK3), has diverse functions in 
regulating learning and memory (Atkins, Selcher, Petraitis, Trzaskos, & Sweatt, 1998; 
Bozon et al., 2003; Fasano & Brambilla, 2011). Estrogen receptors are thought to activate 
ERK1/2 via production of cyclic adenosine monophosphate (cAMP) and/or interactions 
with growth factor receptors. Age-related brain changes in ERK1/2 signal transduction 
have not yet been extensively studied; however, one experiment found that aged male rats 
had decreased ERK1/2 activity in the cortex compared to younger rats (Zhen, Uryu, Cai, 
Johnson, & Friedman, 1999). Further investigations into how aging alters ERK1/2 
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signaling are necessary to elucidate whether aberrant signal transduction has functional 
consequences on cognitive outcomes across the lifespan. Given that ERK1/2 is 
ubiquitously expressed throughout the brain and other organs, it is important to evaluate 
potential age-related changes in multiple cognitive brain regions, as well as consider sex, 
age, and hormone status as factors influencing ERK1/2 expression and signaling. Indeed, 
in recent years, 17b-estradiol has been proposed to regulate ERK1/2 activity in both in 
vitro and in vivo studies. Dr. Karyn Frick’s laboratory has demonstrated that 
intraperitoneal injections and intracerebroventricular or hippocampal infusions of 17b-
estradiol activated ERK2 and enhanced object recognition memory (Fernandez et al., 
2008; Frick, 2015; Lewis, Kerr, Orr, & Frick, 2008). Temporal parameters may impact 
the outcome of estrogen effects on this system; in aged Ovx rats, the amount of time 
since Ovx (and therefore ovarian hormone deprivation) impacted subsequent effects of 
17b-estradiol on ERK1/2 phosphorylation, which were dependent upon brain region and 
time since Ovx (Pinceti, Shults, Rao, & Pak, 2016). Additionally, findings from Dr. 
Thomas Foster’s laboratory revealed that ERa lentivirus injection directly into the 
hippocampus of middle-aged Ovx rats (i.e. animals with low endogenous estrogen levels) 
increased ERK1/2 phosphorylation and enhanced memory performance (Witty et al., 
2012), suggesting that estrogen receptor activity, and possibly brain-derived estrogens, 
can activate and alter signal transduction pathways critical for learning and memory 
formation.  These novel findings point to ERK1/2 signaling as another important 
biochemical mediator to investigate in the context of aging- and menopause- related brain 
changes. The interactions between ERK1/2 and the multitude of other hormone-linked 
pathways on learning and memory processes are only beginning to be explored. Further 
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investigations in this newer field of how ovarian hormone fluctuations and aging impact 
these biochemical signaling pathways are currently underway. 
 
Delta (Δ) FosB: A Proposed Biological Marker of Long-Term Brain Changes 
Immediate early genes (IEGs) are genes that are rapidly and transiently activated 
following extracellular activity. IEGs do not require new protein synthesis to exert 
meaningful effects on the brain and periphery (J. I. Morgan & Curran, 1989; Sheng & 
Greenberg, 1990). While IEGs are not limited to the brain, they have been found to play 
important roles in many neurobiological processes, including synaptic plasticity and 
memory (Minatohara, Akiyoshi, & Okuno, 2016; Sheng & Greenberg, 1990). Among the 
various IEGs, IEGs in the fos family hetereodimerize with jun family IEGs to eventually 
up- or down-regulate gene expression (Nestler, Barrot, & Self, 2001; Ruffle, 2014). 
Though c-fos is one of the best-characterized IEGs, it has a short half-life of 
approximately 60 minutes and expression rapidly declines afterwards, making it difficult 
to evaluate long-term effects in the brain (Carle et al., 2007). In recent years, it has been 
discovered that ΔFosB, a transcription factor encoded by the IEG FOSB, has unusual 
stability compared to other IEG transcription factors due to its lack of degron domains on 
the C-terminus that are present in the full-length FosB (Carle et al., 2007). The absence of 
these domains prevents rapid ubiquitination and degradation of the protein (Carle et al., 
2007). In fact, ΔFosB has been described as a “sustained molecular switch” because it 
can be maintained at detectable levels in neurons for weeks to months following initial 
activation; indeed it has been touted as the “longest-lived adaptation known to occur in 
[sic] adult brain” (Nestler et al., 2001) and has a long half-life compared to other 
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transcription factors (Carle et al., 2007; J. Chen, Kelz, Hope, Nakabeppu, & Nestler, 
1997; Ulery-Reynolds, Castillo, Vialou, Russo, & Nestler, 2009).  
Delta FosB has primarily been investigated in the context of addiction, such that 
ΔFosB is upregulated in the nucleus accumbens with repeated drug exposures and 
remains elevated even after drug cessation, suggesting a role for ΔFosB in drug 
dependency (Nestler et al., 2001; Ruffle, 2014). This work indicates that ΔFosB can have 
long-term behavioral effects. Indeed, ΔFosB has been shown to be upregulated with 
stress, indicating a potential role for ΔFosB in hypothalamic-pituitary-adrenal axis 
function (Ruffle, 2014). This sustained IEG also increases gene expression of CDK5 in 
the hippocampus and other regions, a gene that is related to phosphorylation of synaptic 
proteins, and thus synaptic plasticity (Ruffle, 2014). Notably, overexpression of ΔFosB in 
mice has been shown to result in an upregulation of genes within the nucleus accumbens 
that are also upregulated with cAMP response element binding protein (CREB) 
expression (McClung & Nestler, 2003), which is another transcription factor implicated 
in many processes, including its crucial role in memory formation. Interestingly, an 
extended overexpression of ΔFosB in mice results in an opposite up- and down- 
regulation the gene expression seen with short-term ΔFosB overexpression, at least in the 
context of drug reward pathways (McClung & Nestler, 2003). More recently, 
overexpression of ΔFosB was found to transiently increase CREB protein levels in the 
striatum of male mice and in vitro (Enwright et al., 2010).  
It is plausible that CREB and ΔFosB expression may work in concert to produce 
long-term changes in gene expression and behavior not only in the context of addiction 
and reward, but also in other brain regions that regulate learning and memory processes. 
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Recently, ΔFosB was shown to increase expression in the hippocampus after learning in 
the spatial Morris Water Maze (MM) compared to maze-naïve control rats and rats that 
experienced a non-spatial version of the MM (Eagle et al., 2015). This study also found 
the AAV- and HSV- mediated silencing of ΔFosB, as well as AAV-mediated 
overexpression of ΔfosB impaired learning and memory performance (Eagle et al., 2015). 
It was recently reported that in a ΔFosB knock-out mouse model confined to the 
subgranular zone of the dentate gyrus (NtsR2Cre/+FosBlox/lox mice) neurogenesis and 
learning were impaired compared to wildtype littermates (Manning et al., 2019), further 
suggesting an important role for ΔFosB in learning and memory processes.  
Evidence from the addiction literature suggests that ΔFosB can decrease the expression 
of an endogenous opioid neuropeptide called dynorphin (Nestler et al., 2001). Dynorphin-
producing neurons have diverse roles in the brain; of relevance to the work presented 
herein, 17b-estradiol has been shown to regulate dynorphin expression in the arcuate 
nucleus of the hypothalamus (Kanaya, Iwata, & Ozawa, 2017). Indeed, dynorphin-
producing neurons colocalize with other neuropeptides in the arcuate nucleus, which are 
collectively referred to as kisspeptin/neurokininB/dynorphin (KNDy) neurons that are 
abundantly expressed in the hypothalamus and play a key role not only in gonadotropin 
synthesis and release from the hypothalamus and pituitary, but are also thought to 
regulate the feedback loop of the hypothalamic-pituitary-ovarian axis and thus influence 
the female reproductive cycle (Lehman, Coolen, & Goodman, 2010). As such, it is 
plausible, and indeed likely, that alterations to the female reproductive tract, including 
surgical manipulations of the ovaries and uterus, interact with this system. Given the 
nature of ΔFosB expression, this IEG may be a candidate biomarker for long-term 
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changes in brain areas important to cognition following surgical menopause and hormone 
replacement, and merits further investigation into this novel area of research. 
 
Parameters for Understanding the Impact of Hormones on the Brain and 
Cognition: Evaluating Learning and Memory in the Rodent Model  
 
Mazes and Memory 
Since the early 20th century, a variety of innovative tasks have been implemented 
to study learning and memory in the rodent (Bimonte-Nelson, Daniel, & Koebele, 2015), 
and these maze tasks have been utilized to gain understanding of hormone effects on the 
brain and cognition. The radial-arm maze and Morris maze are two apparatuses often 
used to study estrogen effects on cognition; therefore, their histories and methods will be 
highlighted in brief here to set the backdrop for later discussion in the following chapters. 
In the 1940’s, Edward Tolman and colleagues created a “sunburst” maze, which was 
comprised of several arms radiating from a circular arena, to evaluate rodent navigation 
and formation of a cognitive map (Tolman, 1948; Tolman, Ritchie, & Kalish, 1946). 
These groundbreaking experiments sparked a revolution in the use of mazes to study 
learning and memory for spatial navigation in laboratory rodents. Spatial navigation is 
defined as utilizing distal or extra-maze cues to navigate in an environment. In the 
1970’s, David Olton pioneered an eight-armed radial arm maze, based on Tolman’s 
sunburst design, to test rodent cognition. Each arm was baited with a food reward, and 
once a food reward was obtained it was not replaced within a day, requiring the animals 
to remember and update which spatial locations they had already visited. Olton and 
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colleagues noted that animals most often relied on spatial cues to efficiently solve the 
radial-arm maze (Olton & Samuelson, 1976). The radial-arm maze continues to be one of 
the most utilized maze paradigms in animal models of learning and memory to evaluate 
reference memory, a form of long-term memory wherein information stays constant, and 
working memory, a form of short-term memory that is updated within a testing session 
(Bimonte-Nelson et al., 2015). Many studies using the land version of this task have 
contributed significantly to our understanding of ovarian hormone effects on cognition 
(e.g. Daniel et al., 1997, 1999; Fader et al., 1999; Gibbs and Johnson, 2008; Holmes et 
al., 2002; Witty et al., 2013), and the land version has also been used for notably 
translational working and reference memory assessments using Premarin, a widely used 
hormone therapy in women (Barha & Galea, 2013). One caveat to the land version of the 
radial-arm maze is that animals are typically food deprived, and food reward is given 
upon successful choices, to motivate rodents to perform in the maze. Using appetitive 
motivation can add complexity to interpretations of hormone research, as longer-term 
food restriction can impact cyclicity and alter circulating levels of LH, FSH, and estradiol 
(Ahmed et al., 2012) in the female rodent. As a solution to this concern, a water version 
of the radial-arm maze was developed in the Denenberg laboratory in the late 1990’s; of 
note, others were utilizing water escape in other maze tasks as well (for review see: 
Bimonte-Nelson et al., 2015). The water version of this task relieves the need for food 
deprivation by using hidden escape platforms (thereby removing the animal from the 
water, which is the negative reinforcer) and returning the animal to a warm, heated home 
cage as a positive reinforcer across all trials (Bimonte & Denenberg, 1999). Working 
memory load is taxed in the water version of the radial-arm maze by placing platforms in 
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the end of each arm, and removing each platform without replacement once the animal 
locates it within a day. A reference memory component can be added to this paradigm by 
placing escape platforms in a subset of the arms. In this maze testing protocol, the animal 
not only has to utilize working memory to remember where it has been within a day, but 
it also must use reference memory to remember where it should never go (i.e. arms that 
never contain a platform) (Bimonte-Nelson et al., 2015). Figure 9a provides a schematic 
of a common radial-arm maze setup. 
 Another invaluable task for studying spatial navigation and cognition in the 
rodent model is the Morris water maze, developed by Richard Morris in the early 1980’s. 
This simple, yet cleverly designed, water escape task involves a circular tub of water in 
which a hidden platform is submerged just beneath the surface of the water; rodents are 
tasked with navigating to the hidden escape platform, typically using spatial cues placed 
around the room (Figure 9b) (Morris, 1981, 1984, 2015; Morris, Garrud, Rawlins, & 
O’Keefe, 1982). This task often (and optimally, should) include a probe trial, where the 
platform is removed from the maze, and animals are allowed to swim freely for 60 
seconds. The probe trial is critical to evaluate the use of spatial localization to the hidden 
platform. The Morris water maze is traditionally a measure of spatial reference memory, 
but many laboratories have altered the paradigm to evaluate working memory, the use of 
distal and proximal cues, and room geometry and cue learning (Clark, Broadbent, & 
Squire, 2007; Pearce, Roberts, & Good, 1998). Other tasks including, but not limited to, 
the T maze, Y maze, delayed-match-to-sample, novel object recognition, and place 
recognition have also been used to quantify hormone effects on learning and memory 
performance in rodents (Bimonte-Nelson et al., 2015; Chisholm & Juraska, 2013; Daniel, 
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Hulst, & Lee, 2005; Foster et al., 2003; Frick & Gresack, 2003; Gibbs, 2002; Gibbs, 
Mauk, Nelson, & Johnson, 2009; D. A. Johnson, Zambon, & Gibbs, 2002; Nelson, Witty, 
Williamson, & Daniel, 2012; Orr, Lewis, & Frick, 2009). Many of the experiments 
discussed in this dissertation utilize a battery of these tasks to evaluate the effects of 
gonadal hormones on rodent cognition, and thus it is critical to provide a foundation to 
understand the history and utility of mazes in investigating rodent cognition in the 
context of menopause and aging.  
 
Summary and Dissertation Goals 
 The reproductive system is indisputably a fundamentally essential body system. 
Without it, a species fails to survive. This intricate and complex system is carefully 
regulated via the hypothalamic-pituitary-gonadal axis. In recent decades, it has become 
increasingly evident that the reproductive system influences the body far beyond 
reproduction itself. Ovarian hormones are essential to the health and function of many 
systems, including cardiovascular, gastrointestinal, and skeletal systems, and importantly, 
the brain. Reproductive hormone receptors are abundantly present throughout the 
mammalian brain and influence not only brain-mediated reproductive behaviors, but also 
have regulatory roles for mood, sleep, eating behavior, and, notably, cognition, including 
learning and memory processes. This dissertation explores how alterations to the 
reproductive system, including variations in surgical and transitional menopause, as well 
as exogenous hormone administration, impact cognition in adult and aging rats. 
Specifically, Chapter 2 and Chapter 3 describe an evaluation of longitudinal cognitive 
changes throughout follicular depletion using a transitional model of menopause (Chapter 
 
56 
2), with an exploration of relationships among endocrine, brain, and behavior factors in 
these subjects (Chapter 3). Chapter 4 and Chapter 5 detail investigations into exogenous 
hormone therapy following surgical menopause and subsequent cognitive effects, which 
were found to be dependent upon the hormone(s) administered, dose, and behavioral task 
order. Chapter 6 and Chapter 7 evaluate a novel rat model of hysterectomy and cognitive 
effects of variations in gynecological surgery both in the short-term time point after 
surgery (Chapter 6), as well as for extended time frames after surgery/during aging 
(Chapter 7). Chapter 8 evaluates a potential neurobiological mechanism underlying the 
cognitive changes noted in Chapters 6 and 7. The age at which these collective 
interventions occur is emphasized as a critical variable for cognitive outcomes, and 
highlights the necessity for investigating “re”-organizational events across the lifespan 
that influence longitudinal outcomes for the brain and behavior. 
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CHAPTER 2 
This chapter was published in Hormones and Behavior in 2017 and is titled: 
 
COGNITIVE CHANGES ACROSS THE MENOPAUSE TRANSITION: A 
LONGITUDINAL EVALUATION OF THE IMPACT OF AGE AND OVARIAN 
STATUS ON SPATIAL MEMORY 
 
 
Contribution: I was the first author on this manuscript and was the graduate student 
principal investigator for this experiment. This chapter encompasses my master’s thesis 
work under the mentorship of Dr. Heather Bimonte-Nelson. My co-authors are 
acknowledged for the invaluable contributions to carrying out the experimental data 
collection and manuscript preparation.  
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ABSTRACT 
Cognitive changes that occur during mid-life and beyond are linked to both aging 
and the menopause transition. Studies in women suggest that the age at menopause onset 
can impact cognitive status later in life; yet, little is known about memory changes that 
occur during the transitional period to the post-menopausal state. The 4-vinylcyclohexene 
diepoxide (VCD) model simulates transitional menopause in rodents by depleting the 
immature ovarian follicle reserve and allowing animals to retain their follicle-deplete 
ovarian tissue, resulting in a profile similar to the majority of perimenopausal women. 
Here, Vehicle or VCD treatment was administered to ovary-intact adult and middle-aged 
Fischer-344 rats to assess the trajectory of cognitive change across time with normal 
aging and aging with transitional menopause via VCD-induced follicular depletion, as 
well as to evaluate whether age at the onset of follicular depletion plays a role in 
cognitive outcomes. Animals experiencing the onset of menopause at a younger age 
exhibited impaired spatial memory early in the transition to a follicle-deplete state. 
Additionally, at the mid- and post- follicular depletion time points, VCD-induced 
follicular depletion amplified an age effect on memory. Overall, these findings suggest 
that the age at the onset of menopause is a critical parameter to consider when evaluating 
learning and memory across the transition to reproductive senescence. From a 
translational perspective, this study illustrates how age at menopause onset might impact 
cognition in menopausal women, and provides insight into time points to explore for the 
window of opportunity for hormone therapy during the menopause transition period. 
Hormone therapy during this critical juncture might be especially efficacious at 
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attenuating age- and menopause- related cognitive decline, producing healthy brain aging 
profiles in women who retain their ovaries throughout their lifespan.   
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Introduction 
Women typically begin to experience a natural transition to menopause, or the 
post-reproductive state, during the fifth decade of life (NAMS, 2014; Soules et al., 2001). 
This transitional stage, often referred to in the clinic as “perimenopause” or “climacteric,” 
is characterized by irregular menstrual cycles and erratic, fluctuating ovarian hormone 
levels that can last up to ten years before the final menstrual period (Hoffman et al., 2012; 
NAMS, 2014). Consequently, a range of physiological indicators often accompany the 
menopause transition, including vasomotor symptoms (e.g., hot flashes, night sweats), 
dyspareunia, genitourinary issues, sleep and mood alterations, and memory complaints 
(Al-Safi & Santoro, 2014; NAMS, 2014; Weber et al., 2014) Indeed, menopause and 
normal aging have each been associated with memory impairment (Mitchell & Woods, 
2001; Tulving & Craik, 2000). Both the type of menopause a woman experiences 
(transitional or surgical), and the age at which she experiences this climacteric change, 
may impact cognitive function later in life. Research in women suggests that 
oophorectomy, the surgical removal of the ovaries, detrimentally impacts cognition, and 
that this effect depends on the relationship to menopause status. Indeed, there is evidence 
that oophorectomy before the onset of the transition to menopause may result in a more 
negative impact on verbal memory and an increased risk of developing dementia than 
retaining the ovaries throughout the menopause transition, or compared to oophorectomy 
after the menopause transition is complete (Farrag, Khedr, Abdel-Aleem, & Rageh, 2002; 
Nappi et al., 1999; Rocca et al., 2007; Rocca, Grossardt, & Shuster, 2011; Rocca et al., 
2012). Thus, understanding the cognitive effects during and after transitional menopause 
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could be fundamentally important to women who may need to undergo surgical 
menopause.  
Menopause typically occurs around age 51; however, some women experience 
early-onset menopause, defined as the final menstrual period occurring before the age of 
45. In addition, spontaneous premature ovarian insufficiency, wherein the final menstrual 
period occurring before age 40, affects a small percentage of women (Pal & Santoro, 
2002; Shuster, Rhodes, Gostout, Grossardt, & Rocca, 2010; Simpson & Rajkovic, 1999). 
Evaluating whether age at the onset of premature, early, and normal menopause impacts 
cognition may provide insight into the divergent effects observed for memory and other 
age-related health factors associated with menopause and the post-reproductive life stage.  
In preclinical research, the gold standard for evaluating the impact of gonadal 
hormone loss and exogenous administration of hormone therapy on memory performance 
is ovariectomy (Ovx), or the surgical removal of the ovaries, which results in an abrupt 
loss of ovarian hormones. However, in the context of translational preclinical research, 
this classic technique only models a small percentage of women who undergo surgical 
menopause via bilateral oophorectomy (Centers for Disease Control and Prevention, 
2010; M. J. Hall, DeFrances, Williams, Golosinskiy, & Schwartzman, 2010). Most 
women experience a gradual, natural menopause transition and typically maintain their 
reproductive organs into the post-menopausal life stage. While rodents are animal models 
often utilized in hormone research, rats and mice do not experience menopause; they 
undergo estropause (Finch, 2014; Meites & Lu, 1994). In contrast to human menopause, 
whereby immature follicles in the ovaries are depleted via natural atresia, rodents do not 
experience follicular loss to the same extent as women. Rather, the driving mechanism 
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underlying reproductive senescence in rodents is a significant dysregulation of the 
hypothalamic-pituitary-gonadal (HPG) axis in middle age (for review, see: Downs & 
Wise, 2009; Finch, 2014; Wise et al., 1997, 1996, 1999, 2002, 1989). Thus, the 
introduction of 4-vinylcyclohexene diepoxide (VCD) as a rodent model of transitional 
menopause has given researchers another tool to model menopause in the preclinical 
laboratory (for review, see: Koebele & Bimonte-Nelson, 2016). VCD targets primordial 
and primary ovarian follicles by initiating accelerated atresia, or programmed cell death, 
in the ovary (Hoyer et al., 2001; L. N. Springer, McAsey, et al., 1996) resulting in 
follicular depletion and eventual ovarian failure in rodents (Borman et al., 1999; Flaws et 
al., 1994; Hirshfield, 1991; Hoyer et al., 2001; Hu, Christian, Thompson, et al., 2001; Hu, 
Christian, Sipes, et al., 2001; Kao et al., 1999; Mayer et al., 2004, 2005, 2002; L. N. 
Springer, Flaws, et al., 1996; L. N. Springer, McAsey, et al., 1996; L. N. Springer, Tilly, 
et al., 1996). As such, VCD provides a translational tool for evaluating ovarian and 
hormone changes that occur across the transition to a follicle-deplete state. Indeed, 
compared to Ovx animals, VCD-treated animals exhibit hormone profiles more similar to 
transitionally menopausal women, and allow for the retention of follicle-deplete ovarian 
tissue like most women who transition to menopause without surgical intervention 
(Burger, 2006; Frye et al., 2012; Timiras et al., 1995). In rats, VCD treatment uniquely 
models perimenopause, in which follicular depletion is accelerated and gonadal hormone 
levels fluctuate over time (Frye et al., 2012; Mayer et al., 2002). As such, the VCD-
induced menopause model is ideal for studying aging and the menopause transition, 
including the early stages of the transition when a multitude of physiological and 
affective symptoms begin to present in many women (Hale, Robertson, & Burger, 2014). 
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Our laboratory has previously shown that middle-aged rats that experienced VCD-
induced follicular depletion demonstrated impaired working and recent memory in the 
post-depletion time point compared to animals that did not have this VCD-induced 
accelerated follicular depletion, and compared to animals that underwent Ovx or VCD 
treatment followed by Ovx (Acosta et al., 2009). However, spatial memory performance 
has not yet been evaluated during the transition to a follicle-deplete state using a rat 
model. 
Here, we aimed to elucidate the longitudinal cognitive effects of transitional 
menopause via VCD-induced follicular depletion in ovary-intact Fischer-344 rats, and 
whether there were differences in cognition depending on the age at which accelerated 
follicular depletion was experimentally initiated, with VCD treatment beginning at either 
six or twelve months of age. In addition, we also longitudinally assessed performance in 
vehicle-treated ovary-intact rats at two age cohorts, evaluating the younger group as they 
aged from adulthood (6 months) to middle age (12 months), and the older group as they 
aged from middle age (12 months) to aged (18 months). Thus, the goals of evaluation for 
each age cohort were manifold: (1) to longitudinally investigate learning and memory as 
experimentally-induced follicular depletion ensues, (2) to longitudinally evaluate learning 
and memory in the normally aging rat, (3) to assess the hormonal and ovarian changes 
that occur during VCD-induced follicular depletion that may relate to behavioral 
outcomes, and (4) to evaluate the hormonal and ovarian changes that occur with normal 
aging that may relate to behavioral outcomes. Given that some research in women 
suggests that the loss of ovarian hormones earlier in life (including non-surgical, 
naturally premature or early transitional menopause, as well as surgical menopause) may 
 
64 
be detrimental to cognition (Rocca et al., 2007; J. Ryan et al., 2014), we hypothesize that 
if transitional menopause is induced at an earlier age, there will be a greater negative 
impact on cognition than if transitional menopause is induced at a later age. The VCD 
model affords us the opportunity to methodically test this hypothesis. Further, we predict 
that vehicle-treated, regularly aging animals will exhibit impaired memory performance 
as aging ensues; vehicle-treated controls were included to address this question. This 
inclusion of vehicle-treated, regularly aging animals also allows for a direct comparison 
to the VCD-treated animals with induced menopause across the transition to a follicle-
deplete state. 
Beginning at either six or twelve months of age, animals were trained on a water 
radial-arm maze, a complex spatial task requiring both working and reference memory. 
Of note, spatial memory necessitates the use of distal, extra-maze cues to solve a task, 
working memory is a type of short-term memory that needs to be updated, and reference 
memory is a form of long-term memory that stays constant (Bimonte-Nelson et al., 
2015). Following training, subjects were administered VCD or vehicle treatment, and 
then repeatedly tested on the same water radial-arm maze task over a four-month period 
during the VCD-induced menopause transition. We examined the impact of altered 
hormone profiles on memory, how memory ability changes across this transition, and 
whether the age at follicular-depletion initiation influences cognitive performance. 
Animals were also tested on a task requiring cognitive flexibility, as well as a reference 
memory task following the water radial-arm maze evaluations to assess performance on 
unfamiliar tasks in the post-follicular depletion time point prior to sacrifice. 
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Methods 
Animals 
Animals used for this study were 56 female virgin Fischer-344 rats obtained from 
the National Institute on Aging colony at Harlan Laboratories (Indianapolis, IN). At the 
beginning of the study, rats were either 6 months (n=28) or 12 months (n=28) of age. 
Upon arrival, rats were pair-housed, given food and water ad libitum, and maintained on 
a 12-hour light/dark cycle for the entirety of the study. Animals were given one week to 
acclimate in the vivarium prior to the commencement of the experiment. All procedures 
were approved by the Arizona State University Institutional Animal Care and Use 
Committee and adhered to National Institutes of Health standards. 
 
Experimental Timeline 
The following methods are described in chronological order of occurrence during 
the experiment. Prior to treatment, all animals were trained on the water radial-arm maze 
(WRAM), described in detail below. Pre-treatment training on the WRAM was 
conducted at six or twelve months of age and prior to VCD-induced menopause in order 
to obtain a baseline measure of learning and memory performance. Pre-treatment training 
also served to familiarize the animals with the task, allowing future evaluations of 
memory for a familiar task. Animals were randomly assigned to one of two treatments 
(balanced across age groups): Vehicle or VCD (to induce follicular depletion). After 
Vehicle or VCD treatment was administered, animals were subsequently given a two-day 
refresher session on the WRAM, followed by a two-day retest every other week for four 
months to obtain a behavioral profile across the early- , mid- , and post- follicular 
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depletion time points. A subset of animals (n=3/group) were randomly selected for 
sacrifice during early follicular depletion. Following the final WRAM retest, the 
remaining animals were evaluated on several other tasks (described below) prior to 
sacrifice, including a flexibility measure where parameters had to be relearned for a 
revised WRAM task, the Morris water maze task, and the Visible Platform task. An 
overview of the study timeline can be found in Figure 10. 
 
Water Radial-Arm Maze Training  
One week after arrival, and before any experimental hormonal manipulation, 
animals were trained for 12 days on the win-shift WRAM, evaluating spatial working and 
reference memory, as previously described (Figure 11A; Bimonte-Nelson, Hunter, 
Nelson, & Granholm, 2003; Bimonte-Nelson, Singleton, Hunter, et al., 2003; Bimonte-
Nelson, Singleton, Williams, & Granholm, 2004; Bimonte & Denenberg, 1999; Bimonte, 
Hyde, Hoplight, & Denenberg, 2000a; Bimonte, Nelson, & Granholm, 2003). Briefly, the 
WRAM is an eight-arm apparatus (each arm 39.37 x 13.97 cm) filled with room 
temperature water (18-20°C) tinted with non-toxic, powdered black tempera paint. Four 
out of eight arms contained a hidden platform (11 cm diameter) just beneath the surface 
of the water. Each subject was assigned to a set of unique platform locations that 
remained fixed across all days of testing, including the training period and all subsequent 
retests. The room contained salient extra-maze spatial cues to aid in spatial navigation. 
All animals received a total of four trials per day of testing. Each rat was released from 
the start arm and had three minutes to find a hidden platform. If the platform was not 
located within the allotted three-minute trial, the experimenter led the animal to the 
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nearest platform. Once the platform was located, the rat remained on the platform for 15 
seconds before the experimenter returned the animal to its heated testing cage for an 
inter-trial interval (ITI) of 30 seconds. During the ITI, the just-found platform was 
removed from the maze, and the experimenter cleaned the water to remove any debris 
and to interrupt potential olfactory cues. The rat was placed back into the start arm and 
given three minutes to locate the next platform. Because one platform was removed after 
each trial, the working memory system was increasingly taxed as trials progressed. The 
daily testing session ended when the animal had located all four hidden platforms. Errors 
were quantified as an entry into a non-platformed arm; an arm entry was counted when 
the tip of the rat’s snout crossed a mark delineated on the outside of the arm (not visible 
from inside the maze; 11 cm into the arm). 
 
VCD Injections 
Animals in each age cohort were randomly assigned to either the Vehicle or VCD 
group. Animals were classified as “Young Vehicle” (n=13), “Young VCD” (n=15), 
“Middle-Aged Vehicle” (n=13), or “Middle-Aged VCD” (n=15) to signify whether 
animals were young (6 mo) or middle-aged (12 mo) at the beginning of the experiment, 
and whether they underwent VCD-induced follicular depletion. VCD was administered 
for a total of 15 days via intraperitoneal injection at 160 mg/kg/day (Senestech Inc., 
Flagstaff, AZ) in 47% dimethyl sulfoxide (DMSO)/saline vehicle (Sigma-Aldrich, St. 
Louis, MO). The vehicle injection was 0.5 ml of 47% DMSO/saline solution. Daily VCD 
injection volume was determined by the animal’s weight. Animals were not injected if 
they decreased below 90% of their initial body weight; injections were resumed when 
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weight was regained. VCD injections were administered on Monday, Tuesday, Thursday, 
and Friday; injections were not administered Wednesday, Saturday, or Sunday to allow 
animals to recover any weight lost, and were completed over the course of one month. 
 
Water Radial-Arm Maze Refresher and Retests 
Following the initial training on the WRAM task and subsequent VCD or Vehicle 
administration, all animals were given a two-day refresher on the WRAM, with 
procedures and platform locations identical to the initial 12 days of training. Immediately 
following two days of refresher practice, the first WRAM retest took place. Each retest 
lasted two days. A total of nine retests occurred every other week for four months. 
Because ovarian follicular depletion via VCD takes approximately three months from the 
first injection (Lohff, Christian, Marion, Arrandale, & Hoyer, 2005; Mayer et al., 2004, 
2002), these retests captured behavioral snapshots throughout the transition to the 
follicle-deplete state, as well as throughout aging independent of VCD-induced follicular 
depletion in Vehicle-treated groups.  
 
Water Radial-Arm Maze Flexibility Task 
Following the final WRAM retest, the animals were evaluated for cognitive 
flexibility. That is, we tested cognitive flexibility by examining the animals’ ability to 
update previously learned information in the WRAM task. Specifically, we shifted the 
reward locations within the WRAM task so that the animals had to update formerly 
learned escape locations with new escape locations to successfully solve the task. 
Subjects were tested in the same room and apparatus as the previous WRAM retests, but 
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two of their four previously-assigned platform locations were changed to new platform 
locations for each animal, as schematically represented in Figure 11b. Altering two of the 
platform locations required animals to update previously learned information about 
navigating to a particular arm to find a platform and escape the maze. All other maze 
procedures were identical to previous WRAM testing. 
 
Morris Water Maze 
After one day of rest, all of the animals were evaluated for spatial reference 
memory using the win-stay Morris water maze (MM; Figure 11c). The apparatus was a 
large round tub (188 cm diameter) filled with black-tinted water maintained at 18-20°C. 
One platform (11 cm diameter) was hidden just below the surface of the water in the 
northeast quadrant of the maze. This platform location remained constant across all days 
and trials. Salient spatial cues were present around the room to aid in spatial navigation to 
the platform (Morris et al., 1982). Each animal received four trials per day for five days. 
At the beginning of each trial, animals were dropped off from one of four starting points 
(north, south, east, or west). Drop-off points varied semi-randomly across days. Animals 
had 60 seconds to locate the platform before the experimenter led them to it. Once the 
platform was found, the rat remained on the platform for 15 seconds to allow for spatial 
localization before the experimenter returned it to the heated testing cage for an ITI of 
five to eight minutes. On the final day of MM, animals were given an additional probe 
trial in which the submerged platform was removed from the maze and animals swam 
freely in the maze for 60 seconds. The probe trial was implemented to evaluate whether 
the animals had spatially localized to the platform by quantifying the swim distance in the 
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target quadrant versus the opposite quadrant. A video camera and tracking system 
(Ethovision; Noldus Instruments; Wageningen, The Netherlands) were utilized to 
measure each rat’s swim path (distance in cm) across all days and trials, as well as on the 
probe trial. 
 
Visible Platform 
Animals were tested on the Visible Platform (VP) task as a measure of visual and 
motor competency to solve a water-escape task at the end of the behavioral assay battery. 
This is a non-spatial adaptation of the cue-navigation version of the spatial MM, which 
has been used to dissociate visual and motor acuity from place memory (Morris et al., 
1982). The apparatus was a rectangular tub (100 x 60 cm) filled with clear water 
maintained at 18-20°C. A black platform (10 cm diameter) was placed 4 cm above the 
surface of the water. Opaque curtains were hung around the room to block out any 
potential spatial or geometric cues (Figure 11d). The rats were given six trials in one day. 
Animals were dropped off from a fixed location, while the platform location varied semi-
randomly in three possible locations across trials. Each subject had 90 seconds to locate 
the platform, and was allowed to remain on the platform for 15 seconds before being 
returned to its heated home cage for an ITI of five to eight minutes.  
 
Sacrifices 
Subset sacrifice. A subset of animals (n=3/group) was sacrificed on Day 52 of 
follicular depletion (i.e. approximately halfway to a follicle-deplete state). This subset is 
representative of the early menopause transition time point, wherein immature ovarian 
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follicles are undergoing extensive atresia leading to a follicle-deplete state (Mayer et al., 
2004, 2002). Procedures for the subset sacrifice and end sacrifice were identical and are 
described below. 
End sacrifice. Three additional animals died over the course of the study (one 
subject from the Middle-Aged-Vehicle group, one subject from Middle-Aged-VCD 
group, and one subject from the Young-VCD group). The remaining animals (N=41) 
were sacrificed one day after the final behavioral measure to obtain blood, ovaries, and 
uterine weights. Rats were deeply anesthetized with isoflurane anesthesia. Blood was 
collected via cardiocentesis prior to decapitation. Uterine horns and ovaries were 
dissected from the body cavity. Ovaries were removed from the tips of the uterine horn, 
trimmed of excess fat, and fixed in 4% paraformaldehyde until analysis. Uterine horns 
were trimmed of visible fat and wet weight was obtained as a marker of gonadal hormone 
stimulation.  
Serum hormone measurements. At sacrifice, blood was collected via 
cardiocentesis and allowed to clot at 4°C (Vacutainer 367986, Becton Dickinson and 
Company, Franklin Lakes, NJ, USA). Serum was collected after centrifugation for 20 
minutes at 2,000 rpm at 4°C and stored at -20°C until measurement by 
radioimmunoassay. Steroid hormone levels for 17b-estradiol, estrone, androstenedione, 
and progesterone were determined by radioimmunoassay using previously described 
methods (Acosta et al., 2010; Camp et al., 2012; Mennenga, Gerson, et al., 2015; 
Mennenga, Koebele, et al., 2015). Briefly, 17b-estradiol was determined using a double 
antibody liquid-phase radioimmunoassay purchased from Beckman Coulter (Brea, CA), 
which employs estradiol-specific antibodies along with an 125I-labeled estradiol as the 
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tracer. Interassay coefficients of variation for the assay average 8% at a mean value of 6 
pg/ml. Functional sensitivity of the assay is 4 pg/ml. Estrone was determined using a 
double antibody liquid-phase radioimmunoassay purchased from Beckman Coulter (Brea, 
CA), that employs estrone-specific antibodies along with an 125I-labeled estrone as the 
tracer. Interassay coefficients of variation for the assay average 11% at a mean value of 
90 pg/ml. Functional sensitivity of the assay is 16 pg/ml. Androstenedione was 
determined using a solid-phase radioimmunoassay purchased from Siemens (Los 
Angeles, CA), based on androstenedione-specific antibodies that are immobilized to the 
wall of polypropylene tubes and 125I-labeled androstenedione as the tracer. Interassay 
coefficients of variation for the assay average 3% at a mean value of 2.80 ng/ml. 
Functional sensitivity of the assay is 0.1 ng/ml. Progesterone was determined using a 
solid-phase radioimmunoassay, based on progesterone-specific antibodies that are 
immobilized to the wall of polypropylene tubes and 125I-labeled progesterone as the 
tracer. Interassay coefficients of variation for the assay average 4% at a mean value of 3.3 
ng/ml. Functional sensitivity of the assay is 0.1 ng/ml.  
Ovarian follicle counts. After post-fixing ovaries in 4% paraformaldehyde at 
sacrifice, one ovary from each subject was randomly selected for processing and 
quantification of primordial, primary, secondary, and antral follicles, as well as corpora 
lutea. Primordial follicles are considered to be non-growing, or resting-state, follicles 
within the ovary; these are the follicles targeted by VCD. Figure 12a provides a 
schematic of ovarian follicle types and corpora lutea, and 3b shows representative ovary 
micrographs from each group.  
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Ovarian tissues were processed for paraffin embedding, sectioned at 5 µm, 
mounted, and stained with hematoxylin and eosin Y-phloxine B. Primordial, primary, 
secondary, and antral follicles were counted for every 20th section. Corpora lutea were 
counted at a magnification of 10x (Spencer compound microscope; American Optical, 
Buffalo, NY). The total number of follicles was calculated using the following formula: 
Nt = (N0 x St x ts) / (S0 x d0), where Nt = total calculated number of follicles, N0 = 
number of follicles observed in the ovary, St = total number of sections in the ovary, ts = 
thickness of the section (µm) S0 = total number of sections observed, and d0 = mean 
diameter of the nucleus (Gougeon & Chainy, 1987). Ovarian follicle stage was 
determined using criteria from Haas et al., 2007. Briefly, primordial cells were denoted 
by the presence of a single layer of squamous granulosa cells surrounding an oocyte. 
Primary follicles presented with a single layer of cuboidal granulosa cells. Secondary 
follicle classification required several granulosa cell layers. Antral follicles were defined 
as having two or more layers of granulosa cells as well as a fluid-filled antral space 
within the follicle (Haas, Christian, & Hoyer, 2007).  
 
Statistical Analyses 
All data analyses were completed using SPSS 23 software. For all analyses 
following Vehicle or VCD treatment assessments, two group comparisons were set a 
priori to compare treatment effects within each age group to determine if younger 
animals respond differently than older animals to the onset of VCD-induced follicular 
depletion. That is, an effect of Follicular Depletion was determined by comparing VCD 
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and Vehicle treatments only in the young animals, as well as VCD and Vehicle 
treatments only in middle-aged animals.  
Additionally, planned comparisons were set to compare age effects within each 
treatment group to understand, in both young and middle-aged animals, the impact of 
menopause induction versus normal aging. Specifically, an Age effect was evaluated 
within the VCD-treated group only, as well as within the Vehicle-treated group only. 
Unless otherwise noted, two-tailed tests were used with an alpha level set at 0.05. The 
Huynh-Feldt correction was applied to repeated measures analyses to account for 
potential violations of sphericity by altering degrees of freedom (but not the F-ratio) to 
reduce Type I error rate as a result of repeated measures analysis (Huynh & Feldt, 1976). 
For all planned comparison repeated measures ANOVAs, effect sizes are reported as 
generalized eta squared (ηG2) (Bakeman, 2005; Olejnik & Algina, 2003). For all planned 
comparison ANOVAs with only one between-subjects independent variable (i.e., serum 
hormone levels and ovarian follicle counts), effect sizes are reported as eta squared (η2). 
These effect sizes are interpreted by standard guidelines for η2 outlined by Cohen, 
whereby 0.02 is a small effect, 0.13 is a medium effect, and 0.26 is a large effect 
(Bakeman, 2005; Cohen, 1988, 1992). Cohen’s d is reported for all pairwise comparisons 
as a measure of effect size, and is interpreted by the standard guidelines specified by 
Cohen, where 0.2 indicates a small effect, 0.5 indicates a medium effect, and 0.8 
indicates a large effect (Cohen, 1988, 1992). Four animals were excluded for health-
related concerns, and three animals were excluded from all analyses due to significant 
outlying scores that were greater than two standard deviations from the mean of the 
group’s performance when compared to other animals for WRAM performance.  
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Behavior data. 
Water radial-arm maze. Raw error scores from the WRAM were log transformed 
to account for extreme scores and the negative skew of error distribution as trials progress 
(Cohen, Cohen, West, & Aiken, 2003). WRAM training data prior to the Vehicle or VCD 
treatments were analyzed using a nested repeated-measures ANOVA design with Age as 
the independent variable, and Days and Trials as repeated measures. The dependent 
measure was Total Errors committed. WRAM refresher, retest, and flexibility data 
following Vehicle or VCD treatments were also analyzed for Total Errors. Each retest 
(averaged across the two-day block) was assessed separately utilizing a nested repeated-
measures ANOVA design. Days and Trials were repeated measures within each two-
group a priori comparison, with four trials per day within each of the two-day retests.  
Morris water maze. Data were analyzed using a nested repeated-measures 
ANOVA. Days and Trials were repeated measures in all comparisons, with four trials per 
day within each of the five days. The dependent measure assessed was Swim Distance 
(cm) to the platform. The probe analysis used percent of total Swim Distance (cm) in the 
Target versus Opposite Quadrant as the dependent measure.  
Visible platform task. Visible platform data were analyzed using repeated-
measures ANOVA with latency to platform (s) as the dependent measure and trials as the 
repeated measure. 
 
Ovarian follicle and serum hormone level data. Ovarian follicle and serum 
hormone level data were analyzed using ANOVA. Quantification and analysis of ovarian  
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follicles were divided into the following stages: primordial, primary, secondary, 
and antral follicles; corpora lutea were also assessed. Dependent variables for serum 
analyses included 17b-estradiol, androstenedione, progesterone, and estrone levels. Of 
note, for the estrone hormone assay, we did not collect a sufficient quantity of serum 
from seven animals at the end time point to complete the assay, and for the 
androstenedione hormone assay, we did not collect a sufficient quantity of serum from 
three animals at the end time point to complete the assay. Animals that were excluded for 
behavioral analyses were also excluded from serum and ovarian follicle analyses.  
 
Results 
Water Radial-Arm Maze Training 
Evaluating age effects: Do young and middle-aged ovary-intact rats differ in 
performance on the water radial-arm maze task? The ANOVA for Total Errors (ln) 
including all young and middle-aged animals prior to treatment administration across all 
days of training revealed a main effect of Age [F(1,44)=4.12, p<0.05, ηG2=0.003], wherein 
Middle-Aged animals made more errors than Young animals collapsed across all days of 
testing (Figure 13a). There was also a main effect of Day [F(10,445)=29.83, p<0.01, 
ηG2=0.14], such that animals decreased in errors across days of testing, and a main effect 
of Trial [F(3,129)=277.64, p<0.01, ηG2=0.35], wherein errors increased as trials progressed 
and working memory load increased.  
Previous studies examining the impact of gonadal hormones on spatial memory 
have observed marked effects on the WRAM when working memory load is taxed 
(Bimonte-Nelson et al., 2004; Bimonte & Denenberg, 1999; Bimonte et al., 2003; Braden 
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et al., 2010). Working memory load effects often present in the latter part of testing, or 
the asymptotic phase, after animals have learned the rules of the task (Bimonte & 
Denenberg, 1999; Bimonte et al., 2000, 2003; Hyde, Sherman, & Denenberg, 2000; 
Mennenga, Gerson, et al., 2015). Therefore, we assessed performance for the asymptotic 
phase, comprised of the last six days of testing (Days 7-12), based on previous WRAM 
findings from our laboratory (e.g., Bimonte & Denenberg, 1999; Braden et al., 2011; 
Mennenga, Gerson, et al., 2015); of note, asymptotic performance is operationally 
defined as animals approaching their optimal performance. For this block, there was a 
marginal main effect of Age [F(1,44)=3.88, p=0.06, ηG2=0.01]. Each trial for the Day 7-12 
block was assessed separately, and we found that there was a main effect of Age on Trial 
3 [F(1,44)=5.58, p<0.05, ηG2=0.04], where the Middle-Aged group made more errors than 
the Young group (Figure 13b). However, by Trial 4, there was no longer an Age effect 
[F(1,44)=1.354, p=NS, ηG2=0.01], indicating that the working memory load on Trial 4 was 
sufficiently difficult to challenge both young and middle-aged animals.  
 
Water Radial-Arm Refresher Practice 
Does forgetting occur for the water radial-arm maze task across a one-month 
interval? After initial WRAM training and then one month of Vehicle or VCD 
injections, animals in the Young group were eight months old, and animals in the Middle-
Aged group were fourteen months old (Figure 10). Animals received two days of 
refresher practice on the WRAM, utilizing the same respective platform locations each 
animal previously learned during training, one month prior to starting the retest sessions. 
Performance was evaluated within each treatment group from the last day of training 
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(prior to treatment administration) to the first day of the refresher practice block (after 
treatment) to assess forgetting over the one-month interim. For the Young Vehicle-treated 
group, there was no effect of Day [F(1,11)=2.72, p=NS, ηG2=0.05], suggesting that during 
the one-month interval where these animals received Vehicle injections and were not 
tested, they retained memory for their four assigned platform locations. However, the 
Young VCD-, Middle-Aged Vehicle-, and Middle-Aged VCD- treated groups had a main 
effect of Day (Young-VCD: [F(1,10)=8.76, p<0.05, ηG2=0.09; Middle-Aged Vehicle: 
[F(1,9)=15.72, p<0.01, ηG2=0.14]; Middle-Aged VCD: [F(1,12)=13.69, p<0.01, ηG2=0.11]) 
with errors increasing across the training to refresher interval, indicating forgetting across 
the month in which they received their VCD or Vehicle injections (Figure 14). The 
collected results from the refresher indicate that initiation of follicular depletion impacted 
the Young group’s ability to remember platform locations learned a month ago as 
compared to Vehicle-treated counterparts, and that Middle-Aged animals exhibited 
forgetting across the month delay regardless of treatment. 
 
Water Radial-Arm Maze Retests 
Evaluating follicular depletion effects: Does follicular depletion across the 
menopause transition impact young and middle-aged animals differently? To 
evaluate how each age group responded to VCD-induced follicular depletion compared to 
age-matched Vehicle-treated animals, planned comparisons between VCD and Vehicle-
treated animals were performed within the Young cohort and within the Middle-Aged 
cohort. Retests 1 and 2 were combined into a single block representing the early follicular 
depletion period. During this block, two group (Vehicle vs. VCD) planned comparisons 
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for Young animals revealed a main effect of Follicular Depletion [F(1,21)=10.32, p<0.01, 
ηG2=0.07], with Young-VCD animals making more errors than Young-Vehicle animals. 
We also found a Trial x Follicular Depletion interaction [F(3,63)=3.56, p<0.05, ηG2=0.05], 
with Young-VCD animals making disproportionately more errors as trials and, 
respectively, working memory load increased, as compared to Young-Vehicle animals. 
On Trial 4, the highest working memory load trial, the Young VCD-treated group made 
more errors than the Young Vehicle-treated group [F(1,21)=15.93, p<0.01, d=1.66] (Figure 
15a). Planned comparisons for the Middle-Aged cohort showed neither a main effect of 
Follicular Depletion [F(1,21)=0.61, p=NS, ηG2=0.004] nor a Trial x Follicular Depletion 
interaction [F(2,46)=0.07, p=NS, ηG2=0.002]. Moreover, Middle-Aged Vehicle- and 
Middle-Aged VCD-treated groups did not differ in performance on Trial 4 [F(1,21)=0.22, 
p=NS, d=0.196] (Figure 15b). 
 Following this initial early menopause transition block, no Follicular Depletion 
effects were observed in the planned comparisons within the Young cohort and within the 
Middle-Aged cohort on retests three through nine for Total Errors, indicating that VCD-
induced follicular depletion had a transient impairing effect on spatial memory for young 
animals, but not middle-aged animals, early in the menopause transition.  
Evaluating age effects: Does follicular depletion influence age effects on 
cognition? Another goal of the study was to evaluate whether menopause exacerbates 
age-related changes in spatial memory performance. Therefore, we compared Young and 
Middle-Aged animals within the Vehicle-treated cohort and within the VCD-treated 
cohort. During the early follicular depletion block (Retest 1 and 2), a marginal main 
effect of Age was observed for Vehicle-treated animals [F(1,20)=3.56, p=0.07, η2=0.02], 
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where Middle-Aged Vehicle-treated animals made marginally more errors than Young 
Vehicle-treated animals (Figure 15c). For VCD-treated animals, an age effect was not 
observed, indicating that Young VCD-treated animals performed similarly to Middle-
Aged VCD-treated animals (Figure 15d).  
No differences were observed on Retest 3. However, on Retest 4, as the VCD-
treated cohort transitioned to a mid-follicle deplete state, we observed that for VCD-
treated animals, there was a main effect of Age [F(1,16)=5.38, p<0.05, ηG2=0.04] and a 
marginal Age x Trial interaction [F(3,48)=2.77, p=0.05, ηG2=0.06]. On Trial 4, for animals 
that received VCD, Middle-Aged animals, which were 15 months old at this time point, 
made more errors than Young animals, which were 9 months old at this time point 
[F(1,16)=8.75, p<0.01, d=1.40], indicating that VCD-induced follicular depletion imparted 
an age effect (Figure 15f). On the other hand, for the Vehicle-treated cohort, there was 
neither a main effect of Age [F(1,14)=2.21, p=NS, ηG2=0.03] nor an Age x Trial interaction 
[F(2,23)=1.11, p=NS, ηG2=0.03]. On Trial 4, there was no Age effect for animals that 
received Vehicle treatment (Figure 15e). Thus, menopause induction revealed an age 
effect that was not seen in Vehicle-treated animals.  
 No age effects were observed on Retests 5, 6, 7, or 8 within each treatment 
cohort. On Retest 9 – a post-follicular depletion time point – for VCD-treated animals, 
there was a marginal main effect of Age [F(1,16)=4.34, p=0.05, ηG2==0.06]. On Trial 4, 
there was a marginal effect of Age for animals that received VCD-induced follicular 
depletion, whereby Middle-Aged animals, now 18 months old, trended toward making 
more errors than Young animals, now 12 months old [F(1,16)=3.42, p=0.08, d=0.88], 
indicating that VCD-induced follicular depletion marginally imparted an age effect in the 
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post-follicular depletion time point (Figure 15h). For Vehicle-treated animals, there was 
no main effect of Age [F(1,14)=1.27, p=NS, ηG2=0.02] and no observed differences in 
performance on Trial 4 (Figure 15g).  
 
Water Radial-Arm Maze Flexibility Task 
After Retest 9, platform location assignments were altered for all animals; two of 
their assigned locations remained the same, and two locations were changed to different 
arms, such that there were two familiar and two novel platform locations for this task 
(Figure 11b). Animals that were Young animals at VCD or Vehicle treatment were now 
12 months of age, and Middle-Aged animals were now 18 months of age at the flexibility 
task assessment. 
Evaluating follicular depletion effects: Does follicular depletion impact 
cognitive flexibility in young and middle-aged animals differently? From the last day 
of Retest 9 to the first day of the WRAM Flexibility task, there was a main effect of Day 
for the Young cohort [F(1,15)=80.14, p<0.01, ηG2=0.39] as well as for the Middle-Aged 
cohort [F(1,15)=30.97, p<0.01, ηG2=0.27] wherein all animals made more errors on the test 
day of the platform location flip as compared to the last day of WRAM testing with all 
platforms in the familiar spatial location; since there was no interaction with Follicular 
Depletion for either age group, the platform location flip impaired performance in both 
ages regardless of Vehicle or VCD treatment (Figure 16a). Across the five days of 
flipped testing, there was a main effect of Day within each age (Young: [F(3,52)=12.96, 
p<0.01, ηG2=0.15]; Middle-Aged: [F(4,60)=13.28, p<0.01, ηG2=0.13]), where errors 
decreased across days, indicating that all animals learned across the testing period (Figure 
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16b-c); again, a lack of interaction with Follicular Depletion within each age indicated 
that learning occurred similarly regardless of vehicle treatment or VCD-induced follicular 
depletion. On the final day of the flexibility task, for the Middle-Aged cohort, there was a 
marginal main effect of Follicular Depletion [F(1,15)=3.97, p=0.07, ηG2=0.06], where 
VCD-treated animals trended toward making more errors than Vehicle-treated 
counterparts, suggesting that follicular depletion in middle-aged animals results in poorer 
performance compared to Vehicle-treated counterparts for a flexibility measure (Figure 
16c); however, the Young cohort did not differ in performance, regardless of ovarian 
status. 
Evaluating age effects: Does follicular depletion influence age effects for 
cognitive flexibility? From the last day of Retest 9 to the first day of the WRAM 
Flexibility task, there was a main effect of Day for the Vehicle cohort [F(1,14)=50.28, 
p<0.01, ηG2=0.32] as well as for the VCD cohort [F(1,16)=51.64, p<0.01, ηG2=0.34], 
wherein all animals made more errors on the day of the flip, regardless of age (Figure 
16a). Across the five days of testing, there was a main effect of Day (Vehicle: 
[F(3,56)=14.55, p<0.01, ηG2=0.15]; VCD: [F(4,64)=10.54, p<0.01, ηG2=0.13]) indicating that 
all animals learned across the testing period. On the final day of the flexibility task, in the 
VCD cohort, there was a marginal main effect of Age [F(1,16)=3.52, p=0.08, ηG2=0.05] 
where older animals tended to make more errors than younger animals; of note, this age 
effect did not occur in the Vehicle cohort. Again, we see that follicular depletion 
exacerbated memory deficits in older, but not younger, animals, while there were no age 
effects in animals that did not undergo follicular depletion (Figure 16d-e).  
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Morris Water Maze 
Evaluating follicular depletion effects: Does follicular depletion impact young 
and middle-aged animals differently for a novel reference memory task? For the 
Young cohort, across the five days of MM testing, there were no Follicular Depletion 
effects. There was a main effect of Day [F(4,60)=74.85, p<0.01, ηG2=0.49] indicating 
learning across days for all Young animals (Figure 17a). Planned comparisons for 
Middle-Aged animals revealed a main effect of Follicular Depletion [F(1,15)=5.24, p<0.05, 
ηG2=0.04], where VCD-treated animals had a lower swim distance compared to Vehicle-
treated counterparts, indicating that ovarian follicle depletion occurring in middle-age 
may aid reference memory for a novel task as compared to non-follicle deplete animals of 
the same age. There was also a main effect of Day [F(4,60)=37.62, p<0.01, ηG2=0.44] 
demonstrating learning across days for all Middle-Aged animals (Figure 17b).  
Overnight forgetting was assessed as a measure of memory retention for a 
reference memory task across an overnight interval. We examined performance on the 
last trial of each day (Trial 4) and the first trial of each day (Trial 1). When collapsed 
across overnight intervals, for Middle-Aged animals, there was a marginal Trial x 
Follicular Depletion interaction [F(1,15)=3.52, p=0.08, ηG2=0.03], where on the first trial of 
the day, although it did not reach significance, Middle-Aged VCD-treated animals had a 
lower swim distance to the platform than Vehicle-treated counterparts [F(1,15)=4.32, 
p=0.06, d=1.02], suggesting better memory retention during the overnight interval for 
older follicle-deplete animals compared to their Vehicle-treated counterparts. There were 
no effects of follicular depletion between Young groups for overnight forgetting. 
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Evaluating age effects: Does follicular depletion influence age effects for a 
novel reference memory task? For the Vehicle-treated cohort, across the five days of 
MM testing, there were no Age effects. There was a main effect of Day [F(4,56)=41.98, 
p<0.01, ηG2=0.41] indicating learning across days for all Vehicle-treated animals (Figure 
17c). Planned comparisons for the VCD-treated cohort revealed a main effect of Age 
[F(1,16)=5.42, p<0.05, ηG2=0.02], where Young animals had less swim distance compared 
to Middle-Aged animals, indicating that older follicle-deplete animals were impaired 
compared to their younger counterparts. There was also a main effect of Day 
[F(4,64)=63.75, p<0.01, ηG2=0.53] indicating learning across days for all VCD-treated 
animals (Figure 17d). Overnight forgetting planned comparisons did not reveal effects of 
Age in either Vehicle- or VCD- treated cohorts.  
Probe trial performance. Each group was assessed separately for performance 
on the probe trial. Results indicated that there was a main effect of Quadrant for each 
group (Young-Vehicle: [F(1,8)=35.09, p<0.01, ηG2=0.77], Young-VCD: [F(1,7)=49.60, 
p<0.01, ηG2=0.85], Middle-Aged-Vehicle: [F(1,6)=29.43, p<0.01, ηG2=0.81], Middle-
Aged-VCD: [F(1,9)=79.64, p<0.01, ηG2=0.83]), indicating that all animals, regardless of 
follicular depletion status or age, had a greater percent of total swim distance in the target 
quadrant; that is, they all localized to the northeast quadrant where the platform was 
previously located versus the opposite, southwest quadrant (Figure 18).  
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Visible Platform 
Evaluating follicular depletion effects: Does follicular depletion impact young 
and middle-aged animals differently for visual and motor competency? Among 
Young animals as well as Middle-Aged animals, there were no main effects of Follicular 
Depletion. The mean escape latency for the last trial was 6.13±1.90 seconds for Young 
animals, and 5.31±1.15 seconds for Middle-Aged animals, indicating the ability to 
successfully perform the procedural components of a water escape task for both younger 
and aged cohorts (Figure 19). 
Evaluating age effects: Does follicular depletion influence age effects for 
visual and motor competency? There was no effect of Age within Vehicle-treated 
animals, or within VCD-treated animals. The mean escape latency for the last trial was 
4.88±0.92 seconds for Vehicle-treated animals, and 6.56±1.77 seconds for VCD-treated 
animals, indicating the ability to successfully perform the procedural components of a 
water escape task for both Vehicle- and VCD- treated cohorts (Figure 19). 
 
Serum Hormone Levels 
Serum hormone levels for 17b-estradiol, estrone, androstenedione, and 
progesterone were obtained for animals at the subset sacrifice time point and at the end 
sacrifice time point. Tables 1-4 include the mean ± SE, range, and median values for each 
hormone at each time point.  
Subset sacrifice. Young animals (VCD: n=3; Vehicle: n=3) were 8 months old 
and Middle-Aged animals (VCD: n=3; Vehicle: n=3) were 14 months old at the time of 
serum analysis for the subset sacrifice.  
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Evaluating follicular depletion effects for the subset sacrifice: Does follicular 
depletion impact circulating ovarian hormone levels differently in young and middle-
aged animals at the early follicular depletion time point? For the subset sacrifice, there 
were no Follicular Depletion effects within either age group for 17b-estradiol, estrone, or 
progesterone levels (Figures 20a, b, d, respectively), indicating that follicular depletion 
had no impact on these hormones within the Young cohort or within the Middle-Aged 
cohort early in the menopause transition (52 days after initiating VCD-induced follicular 
depletion). For androstenedione levels in the Young cohort, there was a marginal main 
effect of Follicular Depletion [F(1,4)=4.71, p=0.096, η2=0.53], where Vehicle-treated 
animals had marginally more androstenedione than VCD-treated animals. No differences 
in androstenedione levels were found in the Middle-Aged cohort at this time point 
(Figure 20c).   
Evaluating age effects for the subset sacrifice: Does follicular depletion 
influence age effects on circulating ovarian hormone levels at the early follicular 
depletion time point? There were no Age effects within either treatment group for 17b-
estradiol or estrone (Figures 20a, b, respectively), indicating that the age did not impact 
estrogen levels within the Vehicle cohort or within the VCD cohort early in the 
menopause transition. For androstenedione levels in the VCD-treated cohort, there was a 
marginal main effect of Age [F(1,4)=7.50, p=0.05, η2=0.65], wherein Middle-Aged 
animals had marginally higher androstenedione levels than Young animals (Figure 20c). 
For the Vehicle-treated cohort, there were no Age effects for androstenedione levels. For 
progesterone in the VCD-treated cohort, there was a main effect of Age [F(1,4)=11.24, 
p<0.05, η2=0.74], where Middle-Aged animals had more progesterone than Young 
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animals (Figure 20d); however, there were no differences in progesterone levels for the 
Vehicle cohort at the subset sacrifice time point.  
End sacrifice. Animals that were excluded for behavioral analyses were also 
excluded from serum analyses. Young animals (VCD: n=8; Vehicle: n=9) were 12 
months old, and Middle-Aged animals (VCD: n=10; Vehicle: n=7) were 18 months old, 
at the end sacrifice time of serum analysis.  
Evaluating follicular depletion effects for the end sacrifice:  Does follicular 
depletion impact circulating ovarian hormone levels differently in young and middle-
aged animals at the post-follicular depletion time point? There were no Follicular 
Depletion effects within either age group for 17b-estradiol or androstenedione levels at 
the end sacrifice (Figures 20e, g, respectively), indicating that follicular depletion did not 
impact these hormones within the Young cohort or within the Middle-Aged cohort in the 
post-follicular depletion time point. For estrone levels, within the Young cohort as well 
as within the Middle-Aged cohort, there was a marginal main effect of Follicular 
Depletion (Young: [F(1,11)=3.62, p=0.08, η2=0.25]; Middle-Aged: [F(1,12)=4.31, p=0.06, 
η2=0.26]; Figure 20f), whereby VCD-treated animals had marginally less estrone 
compared to Vehicle-treated animals within both age groups. For progesterone levels 
within the Young cohort as well as within the Middle-Aged cohort, there was a main 
effect of Follicular Depletion (Young: [F(1,15)=6.98, p<0.05, η2=0.32]; Middle-Aged: 
[F(1,15)=12.35, p<0.01, η2=0.45]; Figure 20h) wherein VCD-treated animals had less 
progesterone than Vehicle-treated animals within both age groups. Because the majority 
of progesterone is produced by the corpus luteum after ovulation, these latter results 
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suggest that the VCD-induced follicular depletion was effective in initiating ovarian 
failure.  
Evaluating age effects for the end sacrifice: Does follicular depletion influence 
age effects on circulating ovarian hormone levels at the post-follicular depletion time 
point? There were no Age effects within either treatment group for 17b-estradiol, 
estrone, or progesterone levels (Figures 20e, f, h, respectively) indicating that age did not 
impact these serum hormone levels within the Vehicle cohort or within the VCD cohort 
in the post-follicular depletion time point. For androstenedione levels within the Vehicle 
cohort, there was a marginal main effect of Age [F(1,12)=3.97, p=0.07, η2=0.25] wherein 
Middle-Aged animals had marginally more androstenedione than Young animals (Figure 
20g). However, within the VCD cohort, there were no age differences in androstenedione 
levels (Figure 20g), such that younger VCD-treated animals had similar androstenedione 
levels to older VCD-treated animals.  
 
Ovarian Follicle Counts 
Ovarian follicle counts were obtained for both subset and end sacrifices (Figure 
21).  
Subset sacrifice. 
Evaluating follicular depletion effects at the subset sacrifice:  Does follicular 
depletion impact ovarian follicle counts differently in young and middle-aged animals 
at the early follicular depletion time point? Within the Young cohort there was a main 
effect of Follicular Depletion for primordial follicles [F(1,4)=26.40, p<0.01, η2=0.87, 
Figure 21a], primary follicles [F(1,4)=14.30, p<0.05, η2=0.78, Figure 21b], secondary  
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follicles [F(1,4)=10.98, p<0.05, η2=0.73, Figure 21c], and antral follicles [F(1,4)=28.80, 
p<0.01, η2=0.88, Figure 21d], where VCD-treated animals had fewer ovarian follicles of 
each subtype than Vehicle-treated counterparts. Within the Middle-Aged cohort there 
was a main effect of Follicular Depletion for primordial follicles [F(1,4)=27.01, p<0.01, 
η2=0.87, Figure 21a] and a marginal main effect of Follicular Depletion [F(1,4)=6.42, 
p=0.06, η2=0.62, Figure 21b] for primary follicles, with VCD-treated animals tending to 
have fewer cells than Vehicle-treated counterparts. The Middle-Aged cohort did not have 
an observed difference in secondary or antral follicles at the subset time point (Figures 
21c, d respectively). There were no observed differences in the number of corpora lutea 
in either the Young cohort or the Middle-Aged cohort at this time point (Figure 21e). 
Evaluating Age effects at the subset sacrifice: Does follicular depletion 
influence age effects on ovarian follicle loss at the early follicular depletion time point? 
Within the Vehicle cohort, there was a marginal main effect of Age [F(1,4)=5.50, p=0.08, 
η2=0.58], where Young animals had more primordial follicles than Middle-Aged animals 
(Figure 21a). There were no differences in primary, secondary, or antral follicles for the 
Vehicle cohort (Figures 21b, c, d, respectively). Within the VCD cohort there were no 
differences in any ovarian follicle subtype (Figures 21a-d). Neither the Vehicle cohort 
nor the VCD cohort exhibited differences in corpora lutea at this time point (Figure 21e).  
 
End sacrifice. Animals that were excluded for behavioral analyses were also 
excluded from ovarian follicle count analyses. 
Evaluating follicular depletion effects at the end sacrifice: Does follicular 
depletion impact ovarian follicle counts differently in young and middle-aged animals 
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at the post-depletion time point?  Within the Young cohort, there was a main effect of 
Follicular Depletion for primordial follicles [F(1,15)=25.12, p<0.01, η2=0.63, Figure 21f], 
primary follicles [F(1,15)=34.72, p<0.01, η2=0.70, Figure 21g], secondary follicles 
[F(1,15)=27.44, p<0.01, η2=0.65, Figure 21h], antral follicles [F(1,15)=16.31, p<0.01, 
η2=0.52, Figure 21i], and corpora lutea [F(1,15)=200.89, p<0.01, η2=0.93, Figure 21j], 
where VCD-treated animals had fewer ovarian follicles and corpora lutea than Vehicle-
treated counterparts. Within the Middle-Aged cohort, there was also a Follicular 
Depletion effect observed for primordial follicles [F(1,15)=4.79, p<0.05, η2=0.24, Figure 
21f], primary follicles [F(1,15)=63.57, p<0.01, η2=0.81, Figure 21g], secondary follicles 
[F(1,15)=61.45, p<0.01, η2=0.80, Figure 21h], antral follicles [F(1,15)=41.36, p<0.01, 
η2=0.73, Figure 21i], and corpora lutea [F(1,15)=241.00, p<0.01, η2=0.94, Figure 21j], 
where VCD-treated animals had fewer ovarian follicles and corpora lutea than Vehicle-
treated counterparts. In sum, VCD treatment effectively reduced ovarian follicle number 
in both age groups compared to Vehicle treatment.  
Evaluating age effects at the end sacrifice: Does follicular depletion influence 
age effects on ovarian follicle loss at the post-depletion time point? Within the Vehicle 
cohort, there was a marginal effect of Age [F(1,14)=3.80, p=0.07, η2=0.21, Figure 21f] for 
primordial follicles, where Young animals had marginally more primordial follicles than 
Middle-Aged animals. In addition, for Vehicle-treated animals a main effect of Age was 
revealed for primary follicles [F(1,14)=10.00, p<0.01, η2=0.42, Figure 21g] and secondary 
follicles [F(1,14)=5.34, p<0.05, η2=0.28, Figure 21h], where Young animals had more of 
these follicle subtypes than Middle-Aged animals. However, there were no effects of Age 
for antral follicles or corpora lutea in the Vehicle cohort (Figures 21i, j, respectively). 
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Within the VCD cohort, there were no effects of Age on primordial follicles, primary 
follicles, secondary follicles, or antral follicles (Figures 21f, g, h, i, respectively), 
suggesting that VCD reduced the number of follicles in the ovary without interactions 
with age. It is of note that none of the VCD-treated animals had quantifiable antral 
follicles at this time point, suggesting that these animals were no longer experiencing a 
normal ovarian cycle. However, within the VCD-treated animals, there was a marginal 
main effect of Age for corpora lutea counts [F(1,16)=3.66, p=0.07, η2=0.19, Figure 21j] 
where Middle-Aged VCD-treated animals had marginally more corpora lutea than Young 
VCD-treated animals. These collective results provide evidence for age-related follicle 
decline in Vehicle-treated rats, as well as substantial atresia of ovarian follicles in VCD-
treated animals. 
 
Uterine Horn Weights 
There were no main effects of Age or Follicular Depletion on uterine horn wet 
weight (g) at either sacrifice time point. All uterine horns were similar in weight 
regardless of treatment. Given that estrogens have a well-known stimulatory effect on 
uterine tissue growth (Brody & Wiqvist, 1961; Yuan Hsu Kang, Anderson, & DeSombre, 
1975) and there were no differences in circulating 17b-estradiol levels, this result was 
expected. 
 
Discussion 
Here, we performed a longitudinal study systematically evaluating the effects of 
age and ovarian status on spatial memory performance across the transition to menopause 
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in a rodent model. The collective results indicate that: (1) age at the onset of transitional 
menopause impacts cognitive performance, with the onset of follicular depletion at a 
younger age negatively impacting spatial memory, and (2) follicular depletion 
exacerbates age-related memory changes later in the menopause transition. Furthermore, 
the impact of age and follicular depletion on spatial memory become evident when the 
working memory system was highly taxed, as demonstrated by the differences on trial 
four of the WRAM, when working memory load was the highest.  
 
Inducing Transitional Menopause at a Younger Age Impairs Spatial Memory Early 
in Follicular Depletion 
Early in the transition to menopause (Retests 1 and 2), VCD treatment impaired 
WRAM performance in the young animals, but not the middle-aged animals, compared to 
their respective age-matched Vehicle-treated controls (Figure 15a, b). In fact, at this time 
point, VCD-induced transitional menopause rendered younger animals' performance on 
the WRAM similar to that of middle-aged animals (Figure 15d). Because only the Young 
cohort was impaired with VCD treatment, this age-specific impairment suggests that 
undergoing the transition to menopause prior to middle-age is detrimental to memory 
performance, at least in the early stages of follicular depletion. This early stage of the 
VCD menopause model involves substantial ovarian follicle decline, particularly for the 
young animals, which is analogous to the beginning of the human menopause transition 
when women tend to report some memory complaints (Woods, Mitchell, & Adams, 
2000).  
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It is particularly interesting that these changes occur in adult animals undergoing 
follicular depletion, because advanced age is not a confounding factor for these animals 
due to the nature of our experimental design. Indeed, their age-matched Vehicle-treated 
counterparts performed better on the WRAM at the highest working memory load, 
indicating that follicular depletion and the associated hormonal and ovarian changes have 
a unique impact on adult animals that are not yet at the age that they would be naturally 
transitioning to a reproductively senescent state. Dissociating the effects of aging and 
follicular depletion is a tremendous benefit gained from using animal models. These 
variables are difficult to evaluate independently in women, because the onset of 
transitional menopause is typically concomitant with aging. Our results, if translated to 
women, suggest that an earlier onset of transitional menopause may result in disrupted 
cognition. It is notable that aging affects the functional connectivity and structure of brain 
areas important for learning and memory (Barnes, 1979; Poe et al., 2000) and these 
changes may impact strategy selection for solving behavioral tasks (Samson et al., 2015). 
As such, it is a possibility that younger animals relied more heavily on an allocentric 
spatial strategy to solve the WRAM compared to the strategies used by older animals. If 
induced transitional menopause impacted the capacity to use a hippocampal-dependent 
strategy or attend to the extramaze cues, this could, in part, explain their poor 
performance compared to age-matched counterparts. In addition, strategy selection for 
some spatial tasks has been shown to vary in female rats depending on estrous cycle 
phase (Korol, Malin, Borden, Busby, & Couper-Leo, 2004), which may also have 
influenced subjects’ performance and maze-solving strategy. 
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Currently, there are no definitive clinical markers that identify the onset of the 
menopause transition. Menopause is confirmed retrospectively following one year 
without a menstrual period, and its onset is difficult to determine prospectively. Research 
suggests that changes in hypothalamic-pituitary-gonadal (HPG) axis function are 
detectable prior to the onset of menstrual or estrous cycle irregularities (Downs & Wise, 
2009; Wise et al., 1997, 1996, 1999, 1989). It is possible that perturbations in HPG axis 
activity prior to the average onset of reproductive senescence — as is the case for early 
and premature onset of menopause — may result in unique cognitive and brain changes 
that ultimately impact the trajectory of cognitive and brain aging. Developing reliable 
measures to establish the impetus of the transition to reproductive senescence in women 
could provide the opportunity to intervene during a critical window early in the transition, 
which may be necessary to ascertain the beneficial effects of hormone therapy on 
menopause-related memory changes.  
 
For Transitionally Menopausal Animals, Detrimental Age Effects Present in Mid- 
and Post- Follicular Depletion 
The series of retests administered here throughout the transition into a follicle-
deplete state allowed us to capture memory performance at several key time points in the 
menopause transition as well as across normal aging. Following the early menopause 
time point, as the transition to menopause progressed, an age-related effect of follicular 
depletion became apparent. During Retest 4 on the WRAM, during mid-follicular 
depletion, this age-related deficit was only evident in animals undergoing VCD-induced 
follicular depletion; Middle-Aged VCD-treated animals made more errors than Young 
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VCD-treated animals, particularly at the highest working memory load trial. In contrast to 
the age-related change in the VCD cohort, there was no age-related change in the 
Vehicle-treated animals during Retest 4. Therefore, the detrimental cognitive effect of 
aging was only apparent in the transitional menopause model, but not in the naturally 
aging group. 
Post-follicular depletion, at Retest 9, we saw a similar age-related impairment 
only in the VCD-treated animals, although the effect reached only marginal significance 
at this time point. Thus, during (at Retest 4) and after (at Retest 9) the transition to 
follicular depletion, older animals tended to perform worse than younger animals 
undergoing accelerated follicular depletion. Perhaps repeated testing on the WRAM (i.e., 
cognitive practice) resulted in a beneficial effect for memory maintenance, albeit only for 
animals aging independently of accelerated follicular depletion — a finding which has 
previously been shown in our and other laboratories (Markowska & Savonenko, 2002b; 
Talboom et al., 2014). Given that age-related impairment remained in the VCD cohort, 
this result could indicate that undergoing follicular depletion in middle age may obviate 
the beneficial effects of cognitive practice for a task that taxes the working memory 
system. Translationally, because the average lifespan in women is increasing (Central 
Intelligence Agency, 2015; Murray et al., 2015; G. K. Singh, Kochanek, & MacDorman, 
1996; Xu, Kochanek, Murphy, & Arias, 2014), it is potentially of interest to slow the rate 
of ovarian follicle reserve loss in order to prolong the benefits of follicle-replete ovaries 
and normal circulating sex steroid hormone levels on memory as well as on a myriad of 
other body systems, such that age effects seen with follicular depletion would be delayed 
until later in life.  
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All Animals Showed Cognitive Flexibility to Learn a Revised Task, With Some 
Marginal Impairments of Transitional Menopause 
After initial training on the WRAM task, half of the reinforced locations were 
switched so that we could assess cognitive flexibility. All animals were able to update 
previously learned information by shifting to new escape locations for the altered WRAM 
task, as indicated by improved performance across the five days of this WRAM 
flexibility task. On the final day, older VCD-treated animals performed marginally worse 
than their age-matched Vehicle controls, indicating that in a later stage of follicular 
depletion, the loss of ovarian follicles had a minor impact on performance on a novel 
flexibility task. Within the VCD-treated cohort, a marginal age effect was observed, with 
older animals tending to make more errors than younger animals; this effect did not occur 
within the Vehicle-treated cohort, indicating that follicular depletion may initiate age-
related impairments for cognitive flexibility, similar to the impact of follicular depletion 
on the WRAM task in the mid- and post- menopausal time points.  
 
Follicular Depletion Improves Reference Memory Performance for Older Animals, 
but Impairs Performance Compared to Younger Transitionally Menopausal 
Animals 
Morris water maze results indicated that the younger animals learned the task 
similarly regardless of ovarian status. On the other hand, VCD treatment improved MM 
performance in middle-aged animals, as measured by decreased swim distance to the 
platform on the last day of testing. Ovarian follicular depletion in older animals bestowed 
a beneficial effect on learning and memory retention for a novel spatial reference 
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memory task, providing evidence that the negative memory effects often noted in the 
post-menopausal state may not extend to all learning and memory domains. It is 
noteworthy that the VCD-treated animals had been in a post-follicle deplete state for 
several months at this time point and likely had a more stable circulating hormone 
profile, including significantly lower progesterone levels that could benefit spatial 
reference memory performance (discussed below). Of note, within the VCD-treated 
cohort, middle-aged animals had a greater swim distance to the platform, interpreted as 
poorer performance, compared to younger animals. Since a concordant age-related 
difference was not seen in Vehicle-treated animals, this suggests again that VCD induced 
follicular depletion revealed age-related effects. It is noteworthy that all groups were 
effectively utilizing a spatial strategy to solve the MM, regardless of ovarian status or 
age, as indicated by the probe trial. Additionally, the Visible Platform task verified that, 
after six months of testing, the animals included in these analyses were still able to see as 
well as perform the motor-related components of the task, even with advanced age.  
 
Endocrine and Ovarian Markers 
VCD-Induced Follicular Depletion Alters Ovarian Hormone Profiles. A 
hallmark of the human transition into a post-menopausal state is a marked decrease in 
circulating ovarian hormone levels. During the transitional phase, serum hormone levels 
may be erratic due to irregular ovulation patterns and disrupted hypothalamic-pituitary-
ovarian communication. VCD treatment models this perimenopausal time point during 
which gonadal hormone levels are in a state of flux resulting from accelerated follicular 
depletion. Measurement of the four primary ovarian hormones, 17b-estradiol, estrone, 
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androstenedione, and progesterone at the subset sacrifice time point (that is, at the early 
follicular depletion time point), revealed that older VCD-treated animals had marginally 
increased androstenedione as well as significantly increased progesterone levels 
compared to younger VCD-treated animals. These results possibly indicate that the 
younger animals experienced a more rapid decline in ovarian follicle reserve, even 
though estrogen levels were not different at this time point. At the post-menopausal time 
point, both Young and Middle-Aged VCD-treated cohorts had less progesterone and 
marginally less estrone than Vehicle-treated counterparts. A key characteristic of 
menopause is the decline in circulating progesterone levels resulting from anovulation 
and, consequently, no formation of the corpora lutea to secrete progesterone. 
Furthermore, exogenous progesterone alone (Bimonte-Nelson et al., 2006, 2004), as well 
as exogenous estrone alone (Engler-Chiurazzi et al., 2012), have been implicated in 
impaired spatial memory performance in middle-aged Ovx rats. Perhaps the elevated 
progesterone levels, as well as the marginally elevated estrone levels, in the Vehicle-
treated animals observed at the end time point can partially explain the older VCD-
treated animals’ advantage over their Vehicle-treated counterparts in the MM task 
discussed above.  
The initial, foundational research using VCD-induced follicular depletion as a 
model of transitional menopause was completed in mice; VCD treatment was initiated 
early in life and resulted in a decline in progesterone and androstenedione, as well as 
undetectable 17b-estradiol levels, compared to age-matched controls (Mayer et al., 2004). 
Other VCD studies in both rats and mice have found no differences in 17b-estradiol 
levels at multiple time points compared to age-matched controls (Frye et al., 2012; Lohff 
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et al., 2005; Mayer et al., 2002). These experiments consistently report increased FSH 
levels, reduced ovarian follicle counts, and extended estrous cycles following VCD 
treatment. Mice tended to transition into persistent diestrus (acyclicity) following VCD 
treatment (Lohff et al., 2005; Mayer et al., 2004), while rats had extended periods of 
persistent estrous (and detectable 17b-estradiol levels) during VCD-induced disrupted 
cyclicity (Frye et al., 2012; Mayer et al., 2002). Thus, this suggests that in rats, VCD-
induced follicular depletion is a unique model of the perimenopause time point, during 
which ovarian cyclicity is disrupted and ovarian hormone levels may be fluctuating and 
at some time points elevated prior to the eventual decline of these circulating hormones. 
Indeed, our serum hormone levels with VCD-induced follicular depletion reported here 
are consistent with the observations reported in the Frye et al. (2012) and Mayer et al. 
(2002) publications using the same VCD dosing regimen. A limitation to this study is that 
we did not collect blood at multiple points across time within the same animal. It is 
possible that we may have observed fluctuating patterns of ovarian hormones that are 
similar to women’s circulating ovarian hormone patterns during the perimenopause. 
Human research suggests that it is not necessarily the final decline in circulating ovarian 
hormones, but the erratic fluctuations during the transition, in conjunction with changes 
in affect, stress, and physical health during midlife, that are associated with perceived 
cognitive changes as identified by self-reports (Mitchell & Woods, 2001; Weber et al., 
2014; Weber, Mapstone, Staskiewicz, & Maki, 2012; Weber, Rubin, & Maki, 2013). 
Indeed, within the time constraint of the experimental design, all subjects, regardless of 
ovarian status, showed stable 17b-estradiol levels. Had we continued our assessments 
until a later time point or completed blood draws to evaluate hormone fluctuations across 
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time, we may have observed altered 17b-estradiol profiles. Thus, this is an important 
future direction to pursue in order to fully understand the VCD model of transitional 
menopause in rats and its relationship to what is known about menopause in women.  
 
VCD Successfully Induced Follicular Depletion Across Time and Normally Aging 
Rats Experience Some Follicular Atresia in Midlife 
Recent clinical literature suggests that ovarian follicle counts are a contender as a 
reliable biomarker to determine reproductive status, over and above other measurements 
such as serum hormone levels alone. Indeed, serum hormone levels may not be a reliable 
measurement across the transition to menopause because they are in constant flux. More 
stable markers, such as antimüllerian hormone levels to estimate the non-growing follicle 
population (i.e., the ovarian follicle reserve), as well as antral follicle count, may be 
important in determining individual trajectories into the post-menopausal state 
(Anderson, Nelson, & Wallace, 2012; Broer et al., 2011; Fleming, Kelsey, Anderson, 
Wallace, & Nelson, 2012). Ovarian follicle counts quantified here were an excellent 
guide in determining the rats’ progression into reproductive senescence and verifying the 
effectiveness of VCD-induced follicular depletion. At the subset sacrifice during the early 
menopause transition, a snapshot of the progression into follicle depletion was obtained. 
For primordial (non-growing) follicles, the VCD-treated animals had fewer follicles than 
Vehicle-treated animals in both age cohorts; for primary follicle counts, Young VCD-
treated animals had fewer cells than age-matched counterparts, and Middle-Aged VCD-
treated animals had marginally fewer. These results verify that VCD treatment effectively 
targets the resting ovarian follicle pool by initiating accelerated depletion of the pool. 
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Interestingly, Young Vehicle-treated animals had marginally more primordial follicles 
than Middle-Aged Vehicle-treated counterparts, indicating that rats naturally experience 
some follicle depletion during aging; this loss of ovarian follicles is clearly not as 
extreme as is the case with VCD-induced ovarian changes, as evidenced by the fact that 
both VCD-treated age groups had significant follicular depletion of non-growing follicles 
at the time of the subset analysis. The antral follicle count, which is most often used in 
the clinical setting as a reliable marker of reproductive capacity, differed within the 
Young cohort, such that VCD-treated animals had fewer antral (pre-ovulatory) follicles 
compared to age-matched Vehicle-treated counterparts. The Middle-Aged cohort did not 
exhibit the same effect – VCD- and Vehicle- treated animals did not differ in antral 
follicle count at this subset snapshot. At the subset time point, within the Young and 
within the Middle-Aged cohorts, corpora lutea did not differ depending on treatment; this 
null effect was also seen within the VCD cohort and within the Vehicle cohort. Evidence 
of corpora lutea in the ovary at this early follicular depletion time point indicates that 
even animals undergoing accelerated follicular depletion still experience intermittent 
ovulatory cycles – akin to women’s irregular ovulatory cycles in the early menopause 
transition (O’Connor et al., 2009).  
At the end of the study, within the Young cohort and within the Middle-Aged 
cohort, there were main effects of VCD-induced follicular depletion for all ovarian 
follicle types, as well as for corpora lutea, wherein animals that had undergone VCD-
induced follicular depletion had fewer ovarian follicles and corpora lutea than Vehicle-
treated animals. Indeed, VCD-treated animals had no quantifiable antral follicles at 
analysis, indicating the termination of normal ovulatory cycles and follicle maturation in 
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these animals after the transition to a post-menopausal state. Although older VCD-treated 
animals had marginally more corpora lutea than younger VCD-treated counterparts, there 
was no difference in circulating progesterone levels between these groups at this time 
point. These results indicate that, despite VCD-treated animals experiencing intermittent 
ovulation, the few corpora lutea produced were not sufficient to generate a significant 
impact on resulting spatial memory performance. Similar to the results seen in the subset 
sacrifice, older Vehicle-treated animals had fewer primordial, primary, and secondary 
follicles than their younger counterparts, corroborating the idea that as aging ensues, 
rodents experience a natural decline in the ovarian follicle pool over time (for review, 
see: Finch, 2014), though not to the same extent as the profile of a VCD-induced follicle-
deplete rat, or that of a menopausal woman. Within the VCD cohort, ovarian follicle 
counts did not differ between the ages, suggesting that overall, follicular depletion was 
successfully induced in both age groups with VCD treatment.  
 
Broad Interpretations, Translational Implications, and Conclusions 
To our knowledge, this is the first study to perform a longitudinal, repeated 
measures evaluation of ovary intact female rats comparing animals with or without VCD-
induced follicular depletion at different ages to model human menopause. Several key 
findings are presented here: (1) undergoing the transition to menopause at a younger age 
is detrimental to memory performance compared to age-matched, reproductively 
competent subjects, at least during the early stages of the transition to reproductive 
senescence; (2) follicular depletion amplifies age-related differences in cognitive 
performance in the mid- and late- transitional menopause phases; and (3) in a post-
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follicle deplete state, ovarian follicular depletion in older animals may confer an 
enhanced capacity to solve a novel spatial memory task.  
Of note, other laboratories have conducted cross-sectional studies looking at age-
related memory decline in males (Bizon et al., 2009; Frick, Baxter, Markowska, Olton, & 
Price, 1995; Markowska, 1999b) and females (Markowska, 1999a; Markowska & 
Breckler, 1999). Ovx and sham female Fischer-344 rats have also been longitudinally 
evaluated for cognitive performance over a nine-month period, beginning in middle-age 
(Markowska & Savonenko, 2002a). Our laboratory recently demonstrated that cognitive 
practice can attenuate age-related decline in males and females by enhancing 
performance on the practiced task when tested at a later age compared to naïve, age-
matched animals; additionally, cognitive practice bestows a sex-specific benefit for 
females to transfer enhanced performance capacity to a novel cognitive task (Talboom et 
al., 2014). It is possible that the animals’ previous, repeated experience on the complex 
WRAM task (i.e. cognitive practice) improved performance on the MM later in life. 
Similar findings for cognitive practice in females have also been seen in non-human 
primates (Lacreuse et al., 2005). 
Many factors, including the appropriate timing, duration, hormone formulation, 
dose, and route of administration, are involved in developing hormone therapy regimens 
that will result in the attenuation of physiological menopause symptoms as well as 
provide potential beneficial effects for cognition. To add complexity to this puzzle, what 
is optimal for one woman may not have the same effect in another woman (for review, 
see: Koebele & Bimonte-Nelson, 2015). Our findings provide further insight into the 
window of opportunity for hormone therapy by revealing that the age at the onset of the 
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menopause transition matters for memory outcomes. The current study’s finding that 
early follicular depletion is detrimental to cognition corroborates clinical findings that 
younger women who experienced oophorectomy prior to the onset of natural menopause 
have poorer short-term verbal scores than those who experienced oophorectomy later in 
life (Nappi et al., 2009). Taken together, these findings indicate that age at menopause 
onset is an important parameter that impacts cognitive outcomes. Whether the age at 
onset of menopause, and further, the age at the onset of perimenopause, influences 
efficacy of hormone therapy is an important consideration as a next research step. Indeed, 
in the future, it will be important to experimentally evaluate whether the sensitive 
window(s) of follicular depletion and hormone loss map onto the sensitive window(s) for 
hormone therapy exposures to result in beneficial cognitive effects. Elucidating the 
impact of age, ovarian status, and hormone changes on spatial memory across the 
transition to a reproductively senescent state is key in developing personalized hormone 
therapy regimens that can be translated to the clinic for women experiencing the 
menopause transition. Understanding the dynamic nature of the menopausal hormone 
milieu and potential interactions with subsequent hormone therapy is key to deciphering 
parameters for optimal healthy brain aging profiles in women throughout their lifespans.   
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CHAPTER 3 
 
The data presented in this chapter are currently unpublished observations culminating 
from the brains acquired from the experiment described in Chapter 2. These data were, 
in part, presented with correlations to behavior findings at the Society for Neuroscience 
conference in 2016. 
 
EVALUATING RELATIONSHIPS AMONG NORMAL AGING, FOLLICULAR 
DEPLETION, AND OVARIAN HORMONE LEVELS WITH CHOLINE 
ACETYLTRANSFERASE-IMMUNOREACTIVE NEURONS IN THE BASAL 
FOREBRAIN AND GLUTAMIC ACID DECARBOXYLASE PROTEIN 
EXPRESSION IN THE HIPPOCAMPAL FORMATION 
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ABSTRACT 
During the menopause transition, ovarian hormones fluctuate irregularly prior to a 
chronic decline in serum levels. This altered hormonal milieu impacts many body 
systems, including the brain. Long-range cholinergic projections originating from the 
basal forebrain are the primary cholinergic input into the hippocampal formation, 
including connections to hippocampal GABAergic interneurons, which are important 
regulators for spatial learning and memory. These neuronal populations and their synaptic 
connections are each altered with age, endogenous ovarian hormone changes, and 
exogenous hormone treatment. The fluctuation in ovarian hormones levels during the 
menopause transition may also be related to midlife memory changes regulated by these 
systems. Here, the 4-vinylcyclohexene diepoxide (VCD) transitional menopause rat 
model, which accelerates ovarian follicular depletion, was utilized to explore menopause- 
and age- related changes in the cholinergic system and GABAergic systems, and 
relationships among these systems with serum hormone levels and cognitive outcomes. 
Specifically, stereology was used to quantify ChAT-immunoreactive (IR) neurons in the 
medial septum and vertical-diagonal bands of the basal forebrain in early- and late- 
middle-aged Fisher-344 rats tested on a behavioral battery for spatial working and 
reference memory. Western blot protein analysis was used to assess GAD65 and GAD67 
protein expression in the dorsal hippocampus, entorhinal cortex, perirhinal cortex, and 
ventral CA1/2 hippocampus of the right hemisphere. Correlations encompassing serum 
hormone levels, ovarian follicle reserve, ChAT-IR cell count estimates, GAD65/GAD67 
protein expression, and spatial memory are presented here. Overall, the relationships 
observed suggest that age and ovarian status are both important factors contributing to the 
 
108 
complex relationships among these systems, and provide insight into their influence on 
learning and memory during the menopause transition. 
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Introduction 
Neural systems are dynamic across the lifespan. The aging brain is susceptible to 
a number of alterations to important regulatory systems that can, in turn, influence health 
outcomes and determine whether an individual will have a normal cognitive and brain 
aging profile, or whether neuropathological aberrations will occur. A critical life stage 
during which alterations likely ensue is during the transition to menopause, or 
reproductive senescence, which ovary-intact women naturally undergo around the fifth 
decade of life. The finite ovarian follicle pool reaches a critical threshold of natural 
depletion, the menstrual cycle halts, and systemic estrogens and progesterone decline 
substantially, while androgens become the predominantly circulating ovarian hormones 
for the remainder of the post-menopausal lifespan. Natural menopause is not an abrupt 
event, but rather a transitional stage that can last up to ten years before the final menstrual 
period. The menopause transition is marked by irregular fluctuations in circulating 
ovarian hormone levels and variable menses resultant from dysregulation of the normal 
female reproductive cycle (Harlow et al., 2013; Soules et al., 2001). Symptoms 
associated with the menopause transition include hot flashes, night sweats, vaginal 
dryness, dyspareunia, and alterations in mood, sleep, and cognition (Al-Safi & Santoro, 
2014). Specifically, up to two-thirds of women report subjective changes in memory, 
especially within the domain of working memory (Im et al., 2019; K. N. Morgan, Derby, 
& Gleason, 2018; Unkenstein, Bryant, Judd, Ong, & Kinsella, 2016; Weber et al., 2014, 
2013; Weber & Mapstone, 2009; Woods et al., 2000). These symptoms can negatively 
impact quality of life for women and warrant further investigation.  
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It is well known that steroid hormone receptors are present in many brain regions, 
including those important for learning and memory. The irregular fluctuations in ovarian 
hormone levels during the menopause transition likely cause dysregulation within these 
neural circuits essential for cognition. It is challenging, however, to determine whether 
the fluctuation and eventual decline in ovarian hormone levels result in transient changes 
to these systems, or if the menopause transition initiates reorganization in neural circuitry 
with consequential long-term changes to the synthesis and release of neurotransmitters 
necessary for normal learning and memory. Exploring possible relationships among 
known neural systems important for cognition and serum hormone levels is one way to 
further understanding of the variables at play associated with cognitive changes during 
the menopause transition and aging in general.  
 One of the neurotransmitters that can be altered by aging and ovarian hormone 
levels is acetylcholine. Among acetylcholine’s diverse roles in the brain and periphery, 
this neurotransmitter is intricately linked to learning and memory. The basal forebrain is 
the primary synthesis site for acetylcholine in the mammalian brain, and long-range 
cholinergic projections exist from the medial septum and vertical/diagonal bands of the 
basal forebrain to the hippocampus and cortical regions, including the frontal cortex. 
Cholinergic neurons in the basal forebrain produce choline acetyltransferase (ChAT), the 
enzyme necessary for acetylcholine synthesis. Impairments in the cholinergic neuron 
function and loss of these neurons can occur with aging and neurodegenerative disease. 
Estrogens have also been heavily implicated in maintaining normal functioning of 
cholinergic neurons and activity (Gibbs, 2010; Luine, 1985). Furthermore, the cholinergic 
hypothesis suggests that the loss of estrogen with menopause at midlife could play a 
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crucial role in the degradation of the underlying neural circuitry, leading to subsequent 
cognitive decline, including the occurrence of neurodegenerative disease like 
Alzheimer’s disease (Bañuelos et al., 2013; Gibbs, 1997, 1998, 2000c, 2000a, 2000b; 
Gibbs & Aggarwal, 1998). 
Cholinergic neurons from the basal forebrain are the primary cholinergic input 
into the hippocampal formation; they project to many subtypes of hippocampal neurons, 
including inhibitory interneurons (Pelkey et al., 2017). The hippocampal formation 
includes several key structures beyond the hippocampus itself, including the surrounding 
entorhinal and perirhinal cortices, which act as gateways or hubs for information transfer 
related to temporal and object recognition components of memory, respectively 
(Kitamura, MacDonald, & Tonegawa, 2015; Suzuki & Naya, 2014). Receptors for 
acetylcholine can be found pre- and post- synaptically on hippocampal γ-aminobutyric 
acid-(GABA)ergic interneurons (Pelkey et al., 2017). Although GABAergic interneurons 
make up a small subpopulation of the total neural population in the hippocampus (10-
15%), they play a specific and critical role in regulating many critical brain functions and 
have a central role in regulating memory formation (Kalueff & Nutt, 1997; Katz & 
Liebler, 1978; Pelkey et al., 2017). Glutamic acid decarboxylase (GAD) is the rate-
limiting enzyme for GABA synthesis present in these neurons, and has two distinct 
isoforms, GAD65 and GAD67, which are products of two independent genes 
(Soghomonian & Martin, 1998). Although GAD65 and GAD67 are generally co-
expressed in GABAergic neurons and both work to synthesize the neurotransmitter 
GABA, each isoform has distinct biochemical features and thus the possibility of 
functionally different roles regarding synaptic transmission of GABA in the central 
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nervous system (Soghomonian & Martin, 1998). GAD67 has also been detected in 
excitatory granule cells in the rat hippocampus under normal conditions, further 
complicating the interpretation of the role of these isoforms in regulating 
neurotransmission (Sloviter et al., 1996). Like acetylcholine signaling, GABA signaling 
is altered with age (Shetty & Turner, 1998; Stanley & Shetty, 2004), and ovarian 
hormones have been implicated in regulating GAD65 and GAD67 production 
(McCarthy, Kaufman, Brooks, Pfaff, & Schwartz-Giblin, 1995; Wójtowicz & 
Mozrzymas, 2010). Furthermore, our laboratory has shown that the synthetic progestin 
medroxyprogesterone acetate (MPA) significantly decreased GAD65+GAD67 expression 
in the hippocampus and significantly increased GAD65+GAD67 expression in the 
entorhinal cortex of middle-aged Ovx rats compared to Ovx-Vehicle treated rats; Ovx 
rats treated with natural progesterone also tended to have lower GAD65+GAD67 in the 
hippocampus, and had significantly increased GAD65+GAD67 expression in the 
entorhinal cortex, compared to the Ovx-Vehicle group (Braden et al., 2010). 
Cholinergic and GABAergic signaling are tightly linked to one another 
(Lawrence, 2008) and are each independently altered with age and ovarian hormone 
levels (Koebele & Bimonte-Nelson, 2017). In order to explore some of the complex 
relationships among cholinergic and GABAergic neurons in the context of menopause 
and aging, we investigated ChAT-immunoreactive (IR) neuron counts in the basal 
forebrain, as well as GAD65 and GAD67 protein expression in the hippocampal 
formation (including Right Dorsal Hippocampus, Entorhinal Cortex, Perirhinal Cortex, 
and Ventral CA1/2 Hippocampus) in the brains of early- to late- middle-aged ovary-intact 
rats treated with 4-vinylcyclohexene diepoxide (VCD), a rodent model of transitional 
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menopause, or Vehicle control. These rats were longitudinally tested on cognitive tasks, 
detailed in Chapter 2 of this dissertation and published in Koebele et al., 2017. The brains 
of the subjects used in that behavioral experiment were analyzed, and correlations were 
performed with previously published serum, ovarian follicle count, and behavioral data to 
provide insight into the complex relationships among aging, menopause, and neural 
circuits important for learning and memory, and to inform future research directions on 
neurobiological factors involved in altered learning and memory with hormone changes 
and age. 
 
Methods 
Subjects 
Fifty-six female virgin Fischer-344 rats acquired from the National Institute on 
Aging colony at Harlan Laboratories (Indianapolis, IN) were utilized in this experiment. 
Rats were either Young (6 months, n = 28) or Middle-Aged (12 months, n = 28) upon 
arrival to the Arizona State University animal facility. Rats were pair-housed, provided 
with free access to food and water, and maintained on a 12-hour light/dark cycle for the 
entirety of the study. Half of the rats in each age cohort were assigned to Vehicle or VCD 
treatment to induce follicular depletion. Rats were periodically behaviorally tested on a 
series of water maze tasks testing spatial working and memory (for detailed procedures, 
see Chapter 2) across six months in order to encompass the menopause transition period 
in the VCD-treated rats. A subset of rats in each age and treatment group (n=3/group) 
were randomly selected for a subset sacrifice about half way through follicular depletion 
to obtain a snapshot of circulating serum hormone levels, ovarian follicle counts, and 
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corresponding brain changes at this time point. All procedures were approved by the 
Arizona State University Institutional Animal Care and Use Committee and adhered to 
National Institutes of Health standards. For the purpose of the data presented here, only 
rats included in the behavioral analyses of the published data were included in the brain 
analyses and correlations present in this chapter.  
 
Tissue Collection 
At the subset sacrifice and at the end of the experiment, rats were heavily 
anesthetized using inhaled isoflurane anesthesia. Following cardiocentesis, brains were 
rapidly removed. The anterior portion of the brain encompassing the basal forebrain was 
blocked and fixed in 4% paraformaldehyde for 48 hours. Then, post-fixed brain tissues 
were transferred to 0.1 M phosphate buffered solution until histological analysis. The 
posterior right hemisphere of the brain was rapidly raw dissected for the dorsal 
hippocampus, entorhinal cortex, perirhinal cortex, and ventral CA1/2 hippocampus. Wet 
weight was obtained for each region and then immediately frozen at -70°C until analysis. 
 
Immunohistochemistry 
All brains from the subset and end sacrifices were processed for 
immunohistochemistry. Two to three days prior to sectioning, post-fixed brains were 
transferred to a 30% sucrose solution until fully saturated. Using a freezing microtome 
(Leica SM 2010R), 40 µm coronal sections were obtained throughout the basal forebrain 
(plates 12-18, Paxinos and Watson) and transferred to 0.1 M phosphate buffered saline 
(PBS, pH 7.4). Every third section was selected for choline acetyltransferase (ChAT) 
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immunohistochemistry and stereology. Tissue sections were washed in PBS, incubated 
for 15 minutes in 0.03% Triton (Triton100X) in PBS (PBST), blocked for 30 minutes at 
room temperature using horse serum in PBST, and incubated on a shaker overnight at 
4°C with the primary antibody (1:1000 goat anti-ChAT, Sigma-Aldrich/Millipore 
#AB144P). The following day, sections were washed with PBS and incubated with the 
secondary antibody (1:200 donkey anti-goat IgG, JacksonImmuno Research, #705-065-
147) for 45 minutes at room temperature. Following secondary incubation, tissues were 
washed in PBS and incubated in quenching solution for 30 minutes at room temperature. 
Again tissues were washed with PBS and then transferred to ABC solution (Vector 
Laboratories, #PK-6100) for 45 minutes at room temperature. Tissues were washed with 
PBS and transferred to DAB solution (Vector Laboratories, #SK-4100) for several 
minutes until color was optimal. Tissues were removed from the DAB and transferred to 
PBS solution. Tissue sections were then mounted on subbed slides and allowed to dry 
overnight in a fume hood. Once dry, tissues were dehydrated and cover-slipped using 
DPX (VWR, #100503-834). Slides were allowed to dry for at least 48 hours prior to 
cleaning in preparation for stereology. Experimental treatment groups were 
counterbalanced and equally represented across plates, and two controls were included 
for each staining run; one control did not receive primary antibody (resulting in no 
cellular staining) and the second control did not receive secondary antibody (resulting in 
a lack of DAB reaction).  
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Stereology 
Unbiased stereology using the optical fractionator method in StereoInvestigator 
software (MBF Bioscience, Williston, VT) was completed to quantify ChAT-IR cells in 
the medial septum (MS) and vertical/diagonal bands (VDB) of the basal forebrain, as 
these regions innervate the hippocampus and frontal cortex. All subjects from the subset 
sacrifice (n=3/group) were counted; however, one Middle-Aged Vehicle subject from the 
subset sacrifice was excluded due to error in blocking the brain at sacrifice, and thus the 
whole basal forebrain was not collected. In addition, five subjects from each experimental 
group from the end sacrifice that were processed via immunohistochemistry were 
randomly selected for stereological analysis. One researcher who was blind to treatment 
groups completed all stereological cell counts. The optical fractionator method used 
allows for an accurate estimate of a particular cell population by uniformly randomly 
sampling within regions of interest and, using the known number of cells counted within 
the samples, mathematically estimates the total number of cells in that region (West, 
2002, 2012; West, Slomianka, & Gundersen, 1991), as previously done in our laboratory 
(Engler-Chiurazzi et al., 2012; Mennenga, Gerson, et al., 2015). 
 
Western Blot Protein Analysis 
All brains from the subset and end sacrifices were processed for western blot 
protein analysis. Dorsal Hippocampus, Entorhinal Cortex, Perirhinal Cortex, and Ventral 
(CA1/2) Hippocampus from the right hemisphere of each brain were analyzed for 
GAD65 expression and GAD67 expression via Western blots. Frozen raw tissue samples 
were suspended in a 1:50 weight-to-volume RIPA buffer solution (150 mM NaCl, 
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1%Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate, 50-mM Tris HCl, protease 
inhibitor (Millipore-Sigma, CAT#5892791001), and phosphatase inhibitor (Millipore-
Sigma, CAT#524625) and subsequently kept on ice at all times. Tissues were 
homogenized using a probe sonicator (Ultrasonic Processor, Cole Parmer, IL, USA), and 
then centrifuged at 10,000 rpm for 10 minutes at 4°C. Supernatant was collected, 
aliquoted, and frozen at 70°C until analysis. Protein concentration for each sample was 
determined using a bicinchoninic acid protein assay (Thermo-Fisher Scientific, Pittsburg, 
PA, USA).  
Treatment groups from both sacrifice time points were counterbalanced and 
equally represented on each gel run. The NuPAGE PowerEase electrophoresis system 
was utilized for tissue processing. Samples for each region were loaded at an equal 
protein concentration and were run on a 4-12% NuPAGE Bis-Tris gel in an XCell 
SureLock Mini-Cell (Invitrogen, Carlsbad, CA, USA) using MOPS running buffer. After 
transferring to an Immobilon polyvinylidene difluoride membrane, the blot was blocked 
in 5% nonfat milk for one hour at room temperature. Following blocking, the membrane 
was washed in 1xTBST and then incubated overnight with primary antibodies for anti-
GAD65 (1:5000; Abcam, ab26113), anti-GAD67 (1:10,000; Abcam 26116) and loading 
control primary antibody anti-beta-actin (1:20,000: Cell Signaling, #4970S) in 5% nonfat 
milk on a shaker at 4°C. The following day, the membrane was washed in 1xTBST and 
then incubated with secondary antibodies anti-mouse HRP (1:2000; Cell Signaling 
#7076S) for GAD65 and GAD67, and anti-rabbit HRP (1:2000; Cell Signaling #7074) 
for beta-actin for one hour at room temperature in 5% nonfat milk. The membrane was 
washed again, and developed using chemiluminescence (Lumiglo and peroxide, Cell 
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Signaling, #7003S) in a film developer (Konica SRX-101A Film Processor, Tokyo, 
Japan). Films were scanned in as JPEG files at 600 dpi. Densitometry analyses were 
completed using ImageJ software (Gallo-Oller, Ordoñez, & Dotor, 2018). GAD65 and 
GAD67 levels were normalized to beta-actin levels on each gel run. A total of four gels 
per region were run.  
 
Statistical Analyses 
All statistical analyses were performed using Statview software. ANOVA was 
utilized to analyze densitometry data, with Age and Follicular Depletion as independent 
variables, and GAD65 expression, GAD67 expression, or ChAT-IR cell count estimates 
as the dependent variables. Pearson r correlations were completed between densitometry 
and stereological cell counts with ovarian hormone levels, ovarian follicle counts, and 
cognitive scores, which have been reported in a prior publication (Koebele et al., 2017) 
and are detailed in Chapter 2 of this dissertation. Rats that received VCD treatment 
beginning at 6 months of age were referred to as “Young” groups, and rats that received 
VCD treatment beginning at 12 months of age were referred to as “Middle-Aged” groups. 
Brain evaluations took place when the Young groups were 8-12 months old (late 
adulthood to early middle-age), and the Middle-Aged groups were 14-18 months old 
(middle-age to aged). All analyses were two-tailed and had an alpha level set to 0.05. The 
correlations presented here were exploratory in nature to investigate whether associations 
existed between the examined variables; therefore, corrections for multiple comparisons 
were not made (Michael Edwards, personal communication, June 4, 2019). 
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As noted above, only rats included in published behavioral analyses (Koebele et 
al., 2017) were included in brain evaluations. Due to a processing error during tissue 
homogenization, 11 subjects were excluded from the Dorsal Hippocampus GAD65 and 
GAD67 western blot analyses and correlations (7 subjects from the subset sacrifice and 4 
subjects from the end sacrifice). One subject from the Middle-Aged Vehicle group was 
excluded from all 17b-estradiol (E2) analyses due to a significant outlying value for 
serum E2.  
 
Results 
GAD65 and GAD67 Western Blots 
For rats in the end sacrifice group, there was a marginal effect of Follicular 
Depletion [F(1,28)=3.21, p=0.08] for GAD65 expression in the Dorsal Hippocampus, such 
that VCD treatment tended to increase GAD65 expression compared to Vehicle-treated 
rats (Figure 22A). There was also a marginal effect of Follicular Depletion [F(1,32)=3.84, 
p=0.06] for GAD67 expression in the Entorhinal Cortex, where VCD tended to decrease 
GAD67 expression compared to Vehicle-treated rats (Figure 22B). No differences for 
Follicular Depletion or Age were found for GAD65 or GAD67 expression in the 
Perirhinal Cortex or Ventral Hippocampus. 
 
Basal Forebrain ChAT-IR Stereology 
For the subset sacrifice only, there was a marginal main effect of Follicular 
Depletion [F(1,9)=3.61, p=0.09], such that VCD-treated rats tended to have fewer ChAT-
IR cells in the VDB compared to Vehicle-treated rats, collapsed across age. Given the 
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low number of subjects per group in the subset sacrifice (n=2-3/group), these findings 
should be interpreted with caution. There were no Follicular Depletion or Age differences 
in ChAT-IR cells for the end sacrifice in the VDB or MS. 
 
Correlations 
Because there were no significant differences for stereology or western blot 
protein analyses, subjects from the subset and end sacrifices were combined for 
correlation analyses. Subjects within each treatment group that were part of the subset 
sacrifice are denoted in graphs with a triangle symbol. Only significant correlations are 
presented in graph form.  
 
Region-specific correlations between serum hormone levels and GAD65 and 
GAD67. Relationships between GAD65 expression and GAD67 expression were 
assessed with serum E2 (pg/mL), Progesterone (ng/mL), Androstenedione (ng/mL), and 
Estrone (pg/mL) levels. There was a marginal positive correlation between Estrone levels 
and GAD67 expression [r(9)=0.606, p=0.09] as well as with GAD65 expression 
[r(9)=0.600, p=0.09] in the Dorsal Hippocampus for Middle-Aged-Vehicle rats, where 
higher levels of Estrone tended to be associated with higher GAD67 expression and 
higher GAD65 expression in the Dorsal Hippocampus. The interclass correlation, which 
evaluated relationships collapsed across treatment and age, between Dorsal Hippocampus 
GAD67 expression and serum Estrone was also marginal [r(30)=0.353, p=0.06], where 
higher levels of Estrone tended to be associated with higher GAD67 expression in the 
Dorsal Hippocampus. There were no significant or marginal correlations between 
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GAD65 or GAD67 expression with E2, Androstenedione, or Progesterone in the Dorsal 
Hippocampus.  
In the Entorhinal Cortex, GAD67 expression negatively correlated with serum 
Estrone for the Young-VCD group, such that increased Estrone levels were associated 
with lower GAD67 expression [r(10)=-0.635, p<0.05] (Figure 23A). However, there was 
a marginal positive interclass correlation between GAD67 levels in the Entorhinal Cortex 
and Estrone levels [r(40)=-0.277, p=0.08]. There were no significant correlations 
between GAD65 expression or GAD67 expression with E2, Androstenedione, or 
Progesterone in the Entorhinal Cortex. 
Within the Ventral Hippocampus, there was a positive correlation between E2 and 
GAD65 expression [r(12)=0.705, p<0.01] as well as with GAD67 expression 
[r(12)=0.763, p<0.01] for Young-Vehicle treated rats, where higher serum E2 levels were 
associated with increased GAD65 and GAD67 expression in the Ventral Hippocampus 
(Figure 23B-C). There was also a marginal positive correlation between serum Estrone 
levels and GAD65 expression for the Middle-Aged VCD group in the Ventral 
Hippocampus [r(11)=0.538, p=0.09]. No significant or marginal correlations were found 
between GAD65 or GAD67 expression and Androstenedione or Progesterone in the 
Ventral Hippocampus. 
There were no significant or marginal correlations between any of the measures 
serum hormone levels and GAD65 expression or GAD67 expression in the Perirhinal 
Cortex (data not shown).  
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Region-specific correlations between serum hormone levels and ChAT-IR 
cell counts. Regarding ChAT-IR cell counts, within the MS, there was a marginal 
positive correlation between serum E2 levels and MS ChAT-IR cell counts for the 
Young-VCD group, such that higher serum E2 levels tended to be associated with a 
greater number of ChAT-IR cells in the MS [r(8)=0.672, p=0.07]. There was a significant 
positive correlation between serum Androstenedione levels and MS ChAT-IR cell counts 
for the Middle-Aged VCD group [r(7)=0.796, p<0.05] (Figure 24) and a marginal 
positive correlation between serum Androstenedione levels and MS ChAT-IR cell counts 
for the Young-Vehicle group [r(8)=0.671, p=0.06], such that higher Androstenedione 
levels were associated with more ChAT-IR cells in the MS.  
Within the VDB of the basal forebrain, there was a significant positive correlation 
between VDB ChAT-IR cell counts and Androstenedione levels [r(8)=0.851, p<0.01], 
Progesterone levels [r(8)=0.869, p<0.01], and Estrone levels [r(7)=0.798, p<0.05] for the 
Young-Vehicle group, such that higher VDB ChAT-IR cell counts were associated with 
higher levels of Androstenedione, Progesterone, and Estrone levels (Figure 25A-C). 
Interestingly, the associations between serum ovarian hormone levels and ChAT-IR cell 
counts were not present in the Young-VCD group, suggesting VCD alters the association 
between circulating serum hormone levels and cholinergic neurons in the VDB of the 
basal forebrain. There were no significant relationships among circulating ovarian 
hormone levels and ChAT-IR counts in the VDB for the middle-aged groups, regardless 
of follicular depletion status. 
It is notable that there were positive correlations between the number of ChAT-IR 
cells in the MS and ChAT-IR cells in the VDB for Young-Vehicle [r(8)=0.729, p<0.05], 
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Young-VCD [r(8)=0.961), p<0.0001] (Figure 26A), and Vehicle-Middle-Aged 
[r(6)=0.975, p<0.001] groups. Although this association did not reach significance in the 
VCD-Middle-Aged group [r(8)=0.283, p=NS] (Figure 26B), the interclass correlation 
between ChAT-IR cells in the two regions of interest was significant [r(30)=0.824, 
p<0.0001].  
Ovarian follicle counts correlate with ChAT-IR cell counts. There was a 
positive correlation between primordial ovarian follicles (considered a marker of ovarian 
reserve) and ChAT-IR cells in the VDB for the Young-Vehicle group [r(8)=0.903, 
p<0.001] (Figure 27); this association was not present in Young-VCD rats or Middle-
Aged groups. For growing follicle correlations, there was a marginal positive correlation 
between primary follicles and VDB ChAT-IR cell counts [r(7)=0.720, p=0.07] and MS 
ChAT-IR cell counts [r(7)=0.713, p=0.07] for the VCD-Young group.   
 
Correlations for spatial memory performance, ovarian hormone levels, and 
brain measures. Performance on the highest working memory load trial (Trial 4) on the 
last water radial-arm maze (WRAM) re-test completed before sacrifice as well as average 
swim distance to the platform on the last day of the Morris water maze (MM) were 
correlated with serum hormone levels, GAD65 expression, GAD67 expression, and 
ChAT-IR cell counts.  
High working memory load measures in the WRAM. There was a significant 
negative correlation for the Young-VCD group between serum E2 levels and WRAM 
performance, where higher levels of serum E2 were associated with fewer errors on the 
highest working memory load trial of the WRAM [r(11)=-0.694, p<0.05] (Figure 28A). 
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There was a marginal positive correlation between Dorsal Hippocampus GAD67 
expression and WRAM performance for the Young-VCD rats [r(10)=0.578, p=0.08], 
where higher GAD67 expression was associated with more errors on Trial 4, and a 
marginal negative correlation between Dorsal Hippocampus GAD67 expression and 
WRAM performance for the Young-Vehicle rats [r(10)=-0.574, p=0.08], where higher 
GAD67 expression was associated with fewer errors on Trial 4.  
Morris water maze performance. There was a marginal positive correlation 
between GAD67 expression in the Entorhinal Cortex and average swim distance on the 
last day of MM [r(9)=0.601, p=0.09] and a significant correlation between GAD65 
expression in the Entorhinal Cortex and average swim distance on the last day of MM 
[r(9)=0.764, p<0.01] (Figure 28B) for Young-Vehicle rats, where higher GAD67 
expression tended to be associated with greater swim distance, and higher GAD65 
expression was associated with a greater swim distance, and thus, poorer performance. A 
negative correlation was present for GAD67 expression in the Perirhinal Cortex and 
average swim distance on the last day of MM  within the Young-Vehicle group [r(9)=-
0.717, p<0.05] (Figure 28C), where higher GAD67 expression was associated with less 
average swim distance on the last day of MM. There were no significant correlations 
between ChAT-IR cell counts and behavioral outcomes.  
 
Discussion 
The menopause transition is a pivotal period that marks the end of the female 
reproductive life stage. The reproductive years are characterized by regular, cyclic 
fluctuations across the 28-day menstrual cycle in women. During the menopause 
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transition, however, these regular fluctuations become altered. Production and release of 
ovarian hormones becomes irregular and eventually declines to low, sometimes 
undetectable, levels. From early in life, the female brain is organized to respond to the 
presence of ovarian hormones; the brain and many peripheral body systems contain 
receptors for ovarian hormones and rely on their regular production for normal processes. 
The menopause transition and post-reproductive life stage can be thought of as a 
reorganizational event for the female, where the systems that utilize ovarian hormones 
must adapt to the post-menopausal hormone milieu (Koebele & Bimonte-Nelson, 2015).  
Ovarian hormones play a role in neuromodulation and cognitive processes. There 
is evidence that the cholinergic system and estrogens have a synergistic influence on 
normal learning and memory. For example, lesions to basal forebrain cholinergic neurons 
prevent estrogen from benefiting acquisition of a spatial memory task (D. A. Johnson et 
al., 2002), and dose and duration of estrogen treatment have short-term and long-term 
effects on basal forebrain cholinergic function in Ovx rats (Gibbs, 1997). Basal forebrain 
cholinergic neurons project to the hippocampal formation and surrounding cortical areas, 
including GAD-producing hippocampal interneurons, which also have a crucial role in 
memory formation and maintenance (McQuail et al., 2015). Normal neural circuitry that 
promotes GABAergic signaling within the hippocampus and between the basal forebrain 
and hippocampus becomes disrupted with age and ovarian hormone loss (Bañuelos et al., 
2013; Gibbs, 1998; McQuail et al., 2015) and can negatively impact cognitive outcomes. 
Thus, it is important to explore the complex relationships among ovarian hormones, 
cholinergic neurons in the basal forebrain, and GABAergic neurons in the hippocampus 
and surrounding structures to elucidate possible mechanisms underlying neural changes 
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in relation to menopause and aging. Until now, most pre-clinical evaluations have utilized 
an Ovx rodent model with or without ovarian hormone replacement to evaluate cognitive 
effects associated with menopause. The VCD model of transitional menopause allows us 
to better mimic the hormonal milieu during the transition to menopause, rather than the 
abrupt loss of ovarian hormones with the Ovx model (Koebele & Bimonte-Nelson, 2016). 
Additionally, few studies have explored interactions among these variables under 
endogenous conditions.  
In this evaluation herein, we discovered that the relationships of serum ovarian 
hormone levels, including estrogens, progesterone, and androstenedione with the 
cholinergic system and GABAergic system appear to be dependent upon follicular 
depletion status and age. Many of the observed relationships were marginal; the reason 
for this is likely two-fold. First, with this longitudinal study design, some natural attrition 
of subjects occurred, and thus the analyses may have been underpowered for correlations. 
Second, the experiment was designed to evaluate basal stereological cell estimates of 
cholinergic neurons and GAD expression in relationship to endogenous circulating 
ovarian hormone levels in normally aging and VCD-treated rats to best model the 
normally aging female; as such, there was no acute treatment that could result in a drastic 
change in brain chemistry, and the longitudinal nature of this experiment lends itself to 
the brain’s natural homeostatic processes of adaption to the hormonal milieu. However, 
some relationships were still evident, and provide insight into the complex relationships 
of ovarian hormones and basal forebrain-hippocampus circuitry in the context of learning 
and memory during normal aging. Although effects are subtle, these associations will 
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provide direction for designing future experiments to systematically evaluate, and 
potentially manipulate, these variables. 
When collapsing across age, VCD-induced follicular depletion tended to decrease 
GAD65 expression in the Dorsal Hippocampus and increase GAD67 expression in the 
Entorhinal Cortex, two crucial areas for normal memory processing, compared to Vehicle 
controls. It is possible that altered hormone profiles associated with VCD-induced 
follicular depletion cause a disruption in normal GABAergic processes. Although these 
effects did not reach statistical significance, it is notable that the direction of these effects 
is opposite from previously reported findings in our laboratory using an Ovx rat model 
given progestin treatment. In the previous report, Ovx rats exhibited higher hippocampal 
GAD65+GAD67 expression in the hippocampus and lower GAD65+67 expression in the 
entorhinal cortex compared to Ovx + progesterone and Ovx + medroxyprogesterone 
acetate-treated groups (Braden et al., 2010). As such, it is important to acknowledge that 
the menopause model used in a given experiment may differentially affect brain areas 
important to learning and memory.   
With regard to correlations, for the Young-VCD group, higher Estrone levels 
were associated with lower GAD67 expression in the Entorhinal Cortex. Our laboratory 
has previously shown that exogenous Estrone administration can impair spatial memory 
in middle-aged Ovx rats (Engler-Chiurazzi et al., 2012); the current findings point to the 
idea that higher Estrone levels are associated with disrupted GABAergic regulation in 
ovary-intact, follicular-deplete females as well. In Young-Vehicle rats, higher E2 levels 
were associated with higher GAD65 expression and GAD67 expression in the Ventral 
Hippocampus, suggesting that E2 may facilitate hippocampal GABAergic processes in 
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non-follicular-deplete middle-aged rats. Older, middle-aged rats (14-18 mo) did not 
exhibit correlations between serum ovarian hormone levels and GAD65 or GAD67 
expression, suggesting that relationships may shift after a particular time point in middle-
age.  
We demonstrate that the Young-Vehicle group (8-12 mo) showed positive 
correlations between ChAT-IR cells in the VDB of the basal forebrain with 
Androstenedione, Progesterone, and Estrone serum levels, where higher circulating 
ovarian hormone levels were associated with an increased number of ChAT-IR neurons 
in the VDB. A positive correlation was also observed between the ovarian follicle reserve 
and ChAT-IR VDB neuron counts. These associations were not observed within the 
Young-VCD group. These observations indicate that the relationships among ovarian 
hormone levels and ChAT-IR counts in the basal forebrain are altered with follicular 
depletion status in this age range. We previously reported (see Chapter 2) that 
Progesterone levels were significantly lower in Young-VCD rats compared to their 
Vehicle-treated counterparts, and Estrone levels tended to be decreased as well (Koebele 
et al., 2017). It is possible that the endogenous hormonal milieu associated with follicular 
depletion may alter the relationships between ChAT-producing cells in the basal 
forebrain compared to the hormonal milieu of a normally aging rat. Furthermore this 
relationship was not present in older rats regardless of follicular depletion status, again 
indicating that this middle-aged time point may be a critical reorganizational period for 
rats undergoing a menopause-like transition. Although the traditional cholinergic 
hypothesis emphasizes the role of E2 in altered cholinergic function with age and 
hormone loss (Gibbs, 1998, 2000d, 2010), these associations reported herein extend the 
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potential role for ovarian hormones to interact with normal cholinergic system function, 
and indicate that premature follicular depletion alters the relationship between cholinergic 
neurons and ovarian hormone levels in the transitionally menopausal rat.  
Lastly, brain measures were correlated with spatial working and reference 
memory performance, results of which are discussed in detail in Chapter 2. A significant 
negative correlation between E2 levels and errors on the highest working memory load 
trial of the water radial-arm maze, a task that measures spatial working and reference 
memory, was observed for the Young-VCD group, where higher serum E2 was 
associated with fewer total errors when working memory load was maximally taxed in 
follicle-deplete rats. These findings corroborate prior findings from our laboratory 
indicating that higher serum E2 levels from hormone therapy treatment were associated 
with enhanced performance on the MM in young and old Ovx rats (Talboom et al., 2008). 
Collectively, these findings provide support for the idea that E2, whether endogenous or 
exogenous in form, can benefit cognitive performance in the working and reference 
memory domains during the menopause transition when the hormonal milieu is changing 
during follicular depletion. Higher GAD65 expression in the Entorhinal Cortex was 
found to positively correlate with a greater swim distance to the platform on the final 
baseline testing day of the spatial reference memory MM for Young-Vehicle rats; 
however, higher GAD67 expression in the Perirhinal Cortex was associated with less 
swim distance to the platform in this group. These region- and GAD isoform- specific 
associations highlight the complexity of relationships between spatial memory, multiple 
memory-related neural circuits, and neurotransmitter systems working together to 
produce behavioral outcomes. Furthermore, this exploratory analysis provides insight for 
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systematic manipulation within these cortical regions and the GABAergic system to 
further parse out specific functions for these factors in cognition. 
Overall, this exploratory correlational investigation highlights the multifaceted 
relationships among circulating serum hormone levels during aging and follicular-
depletion with neural circuits important for spatial learning and memory, including the 
cholinergic system within the basal forebrain and the GABAergic system within the 
hippocampus and surrounding cortical areas. The reported associations between hormone 
levels and ChAT-IR neuron counts, as well as with GAD65 expression and GAD67 
expression, afford valuable insight into how these systems are affected by follicular-
depletion in the aging female, and point to middle-age as a critical time of influence for 
changing ovarian hormone levels for these circuits. The findings provide a foundation for 
understanding central factors in cognitive outcomes when investigating memory changes 
in the context of menopause and aging. Further, these results will aid in the development 
of novel experiments methodically evaluating these variables, and translationally, for 
developing ideal hormone therapy options for midlife women undergoing a natural 
transition to menopause. 
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ABSTRACT 
Aging and reproductive senescence in women have been linked to cognitive 
decline. Surgical menopause can induce or exacerbate menopause symptoms, including 
memory complaints. Estrogen-containing hormone therapy is commonly prescribed after 
surgical menopause to treat symptoms such as hot flashes, and may ameliorate reported 
memory changes. Clinical and preclinical research suggest that performing cognitive 
exercises are neuroprotective during aging. Cognitive task complexity and prior 
experience with cognitively-challenging tasks are important factors to consider when 
evaluating cognitive outcomes. Whether these outcomes interact with estrogen status is 
unknown. Using a rat model of surgical menopause, we systematically assessed whether 
the level of cognitive demand involved in performing maze tasks, and order of task 
presentation, impacted learning and memory when receiving Vehicle, Low-17b-estradiol 
(E2), or High-E2 treatment. Low-E2 treated rats with low cognitive demand experience 
made fewer high-working-memory-load errors during the latter half of the subsequent 
high cognitive demand task compared to Low-E2 treated rats that were naïve. Low-E2 
treated rats with high cognitive demand experience made fewer errors while learning the 
low cognitive demand task compared to Low-E2 treated rats that were naïve. High-E2 
treated rats with high cognitive demand experience had some learning enhancements for 
the low cognitive demand task compared to Naïve High-E2 treated rats; however, prior 
low cognitive demand experience did not impart benefits for the subsequent high demand 
task for this E2 treatment. Prior maze experience did not have a substantial effect on 
subsequent task performance for Vehicle treated rats regardless of task demand level 
during the first exposure to maze experience or final testing. Of the three treatment 
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regimens given mapped onto a surgically menopausal background, a lack of estrogen 
treatment yielded the least benefit from prior cognitive experience, the high-dose 
estrogen a variable benefit, and the low-dose estrogen the most benefit. Specifically, the 
low-dose estrogen treatment broadly enhanced learning and memory in rats that had prior 
experience on another task, regardless of task complexity level. These collective results 
highlight the importance of understanding how the complexity of cognitive experience 
impacts cognition, and indicate that estrogen milieu influences the impact of prior 
cognitive experience on cognition during aging. 
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Introduction 
Aging can be associated with a normal decline in cognitive function. A diverse 
number of variables, including genetic, epigenetic, and lifestyle factors contribute to the 
extent and severity of cognitive changes in an aging individual. Collectively, these factors 
can impact whether an individual undergoes normal healthy brain aging, or develops 
pathological and cognitive changes associated with neurodegenerative disease and 
dementia. While women typically live longer than men, this does not account for the 
disproportionate number of women affected by the most common form of dementia, 
Alzheimer’s disease (Alzheimer’s Association, 2018; Riedel, Thompson, & Brinton, 
2016). The significant decline in ovarian hormones all women experience by midlife with 
menopause is also associated with cognitive changes, especially those related to working 
memory and attention (Mitchell & Woods, 2001; Weber & Mapstone, 2009). In fact, up 
to two-thirds of women report subjective memory problems during the transition to 
menopause (Henderson, 2009; Weber et al., 2012). The mechanisms underlying these 
cognitive changes are an area of substantial interest and are still being investigated. It is 
now recognized that ovarian hormones, and estrogens in particular, impact a wide variety 
of peripheral body systems as well as the brain, and further exploration into the complex 
interplay between the endocrine system and cognition is necessary to elucidate a clearer 
understanding of how these factors work together to impact brain health outcomes during 
midlife and beyond.  
That estrogens are neuroprotective molecules remains a popular tenet that has 
received significant scientific support and attention in the past few decades. Basic science 
research utilizing animal models has shown that estrogen-containing hormone therapy 
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can enhance memory in surgically menopausal, or ovariectomized (Ovx), rodents 
(Bimonte & Denenberg, 1999; Heikkinen, Puoliväli, Liu, Rissanen, & Tanila, 2002; 
Heikkinen, Puoliväli, & Tanila, 2004; M. Singh et al., 1994; M. Wallace et al., 2006). The 
beneficial effects of exogenously administered estrogens are thought to be dependent 
upon a variety of factors, including dose, duration of treatment, administration route, and 
administration timing regarding time since ovarian hormone deprivation as well as age at 
onset of administration (Koebele & Bimonte-Nelson, 2015). The appropriate parameters 
for optimally efficacious estrogen treatment effects remain difficult to pinpoint in humans 
because menopause is retrospectively determined after one year without menses (Harlow 
et al., 2013). Initial findings from the Women’s Health Initiative Memory Study 
(WHIMS) suggested initiating exogenous estrogen-containing hormone therapy 
(conjugated equine estrogens, CEE) given with or without the progestin 
medroxyprogesterone acetate (a synthetic form of progesterone) in post-menopausal 
women aged 65 and older could be detrimental to cognition and increased the relative 
risk of developing dementia (Coker et al., 2010; Espeland et al., 2004; Shumaker et al., 
2003). However, more recent evaluations regarding variations in hormone therapy use 
have been underway, including: the Kronos Early Estrogen Prevention Study (KEEPS), 
the Early versus Late Intervention Trial with Estrogen (ELITE), the Women’s Health 
Initiative Memory Study-Younger (WHIMS-Y), the Women’s Health Initiative Study of 
Cognitive Aging (WHISCA), and the Study of Women’s Health Across the Nation 
(SWAN). This research has been undertaken to better understand cognitive aging, the use 
of estrogen-containing hormone therapy in perimenopausal or menopausal women, and 
the impact hormone therapy has on the body and brain acutely and longitudinally 
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(Gleason et al., 2015; Greendale et al., 2009; Kantarci et al., 2016; Maki & Henderson, 
2012; Vaughan et al., 2013; Wharton, Gleason, Miller, & Asthana, 2013). Indeed, there is 
evidence that initiating CEE-containing hormone therapy closer to menopause onset (age 
50-54) does not result in cognitive impairments or benefits when tested 6-7 years after the 
initial WHIMS study was terminated (Espeland et al., 2017, 2013). Furthermore, 
initiating hormone therapy earlier in the transition to menopause has been reported to 
enhance verbal memory, and increase hippocampal activation during task performance 
compared to women who never used hormone therapy (Greendale et al., 2009; Maki et 
al., 2011). Thus, estrogen-containing hormone therapy has merit for its capacity to 
alleviate many unfavorable symptoms associated with menopause, including vasomotor 
symptoms as well as vaginal dryness and atrophy (Pinkerton et al., 2017), and the 
possibility to delay cognitive changes in aging women given the optimal parameters.  
Even with the plethora of research indicating that estrogen can induce positive 
effects on the brain and its functioning, it is important to acknowledge that estrogen-
containing hormone therapy is not the golden ticket to ensure healthy brain aging. In fact, 
currently the clinical recommendation is to not prescribe hormone therapy for the primary 
indication of memory complaints (Pinkerton et al., 2017). There are conflicting reports 
that exist in the scientific literature regarding factors that impact the efficacy of hormone 
therapy for cognition (for review, see: Koebele & Bimonte-Nelson, 2017; Korol & Pisani, 
2015; Turgeon et al., 2006). Some lifestyle factors have been shown to impact cognitive 
aging outcomes, including diet, exercise, and cognitive practice. Both clinical and 
preclinical research suggest that performing complex cognitive tasks can be 
neuroprotective during aging. Basic science research indicates that neurogenesis occurs 
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throughout adulthood in many species (Kempermann, Hongjun, & Gage, 2015; Lim & 
Alvarez-Buylla, 2016; Paredes, Sorrells, Garcia-Verdugo, & Alvarez-Buylla, 2016), and 
that experience in complex environments can lead to enhanced dendritic complexity in 
rodents (Diamond, 2001; Green, Greenough, & Schlumpf, 1983), collectively implicating 
greater plasticity of the brain throughout the lifespan with enriching experiences. Several 
decades of research in humans also associates a higher educational attainment level with 
a decreased incidence of developing dementia (Crimmins et al., 2018; Mortimer & 
Graves, 1993; Schoenhofen Sharp & Gatz, 2011). Numerous reports in the literature 
indicate a significant relationship between education and dementia risk. It is important to 
acknowledge that there are many psychosocial and demographic factors that mediate and 
contribute to this association, including socioeconomic status, access to education and 
healthcare, nutrition, emotional wellbeing, and lifetime exposures to infections and other 
illnesses (Goveas et al., 2016; Schoenhofen Sharp & Gatz, 2011). Research from the Nun 
Studies have reported an increased incidence of dementia associated with lower 
education levels (Tyas et al., 2007), and a similar finding has been recently reported in a 
more heterogeneous population, representative of U.S. adults over age 50, as well 
(Crimmins et al., 2018). Indeed, higher educational attainment is associated with a greater 
life expectancy, as well as with good cognition while living longer lives (Crimmins & 
Saito, 2001; Crimmins et al., 2018). Whether these cognitive outcomes interact with 
estrogen status across the lifespan remains unknown and merits further investigation.  
Because of the inability to methodically control for many lifestyle, 
sociodemographic, and hormone exposure factors, there can be limitations to research in 
humans when attempting to systematically investigate the specific contributions of each 
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of these factors on cognitive outcomes. Rat models aid in elucidating key factors 
associated with exogenous estrogen exposures in conjunction with life factors including 
cognitive practice and reserve, which we propose may be roughly equated to educational 
attainment measures. Rodents are often tested on a battery of maze tasks to evaluate 
different memory types (Bimonte-Nelson et al., 2015). The complexity of these tasks 
vary, and the order in which animals experience or learn these tasks could impact 
performance as well as the ability to shift task rule learning from one task to another. 
Indeed, our laboratory has shown that cognitive practice earlier in life benefits memory 
for the familiar task longitudinally for both sexes, and that females in particular have the 
capacity to transfer the benefits of earlier cognitive practice to novel tasks, even when 
they are aged (Talboom et al., 2014). As such, it is critical to evaluate whether the order 
in which mazes of varying complexity are presented contributes to cognitive outcomes, 
and if so, to acknowledge how prior maze experience might influence the interpretation 
of behavioral data. 
The overarching goal of this experiment was to elucidate how prior cognitive 
demand experience alters subsequent learning and memory during aging, and whether 
17b-estradiol (E2) treatment influences the effects of cognitive experience. We utilized 
two spatial memory tasks of varying cognitive demand and complexity. The delayed 
match-to-sample water maze task (DMS) is considered a low cognitive demand task that 
requires animals to learn the new location of a single hidden platform within a day; the 
platform location changes each day, thus requiring the animals to update that platform 
location daily. The water radial-arm maze task (WRAM) is considered a high cognitive 
demand task because it involves an increasing working memory load within a day, such 
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that animals have to remember several items of information in order to effectively solve 
the task each day. We tested whether prior low- and/or high- cognitive demand 
experience using spatial maze learning and memory altered learning and memory 
performance for subsequent tasks with or without tonic E2 treatment in middle-aged, 
surgically menopausal rats. 
 
Methods 
Subjects 
Sixty female, virgin Fischer-344-CDF rats were obtained from the National 
Institute on Aging colony at Charles River Laboratories (Raleigh, NC, USA). Rats were 
11 months old upon arrival. All animals were pair-housed, had free access to food and 
water, and were maintained on a 12-hour light/dark cycle for the entirety of the 
experiment. Rats were given two weeks to acclimate in the vivarium prior to the 
commencement of the experiment. All procedures were approved by the Arizona State 
University Institutional Animal Care and Use Committee and adhered to National 
Institutes of Health standards. 
 
Ovariectomy and Hormone Replacement 
Surgeries were completed in two waves. Ovx occurred two weeks after arrival to 
the facility. Under inhaled isoflurane anesthesia, dorsolateral incisions were made in the 
skin and peritoneum. The ovaries and tips of the uterine horns were exposed, ligated, and 
excised. Muscle and skin incisions were sutured closed with dissolvable Vicryl suture. 
All subjects received a subcutaneous injection of 5 mg/mL/kg Rimadyl (carprofen, a 
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nonsteroidal anti-inflammatory drug) for pain management and 2 mL sterile saline for 
post-surgical hydration. Rats were single-housed for a 48-hour recovery period before 
being re-pair-housed with a cage mate.  
Two weeks after Ovx, Alzet osmotic pumps (2006 model with a constant release 
rate of 0.15 µl of solution per hour for six weeks) were implanted subcutaneously to 
deliver vehicle (polyethylene glycol; PEG) or E2 treatment. Rats were anesthetized using 
inhaled isoflurane anesthesia and a small incision was made in the skin of the scruff of 
the neck. A small pocket was made in the subcutaneous space and osmotic pumps were 
inserted. The skin incision was sutured closed with dissolvable Vicryl suture. Rats from 
each wave of surgery were randomly assigned to Vehicle (PEG), Low-E2 (2µg/day 
dissolved in PEG), or High-E2 (4µg/day dissolved in PEG) treatment groups. The E2 
doses were based on previous studies in our laboratory that produced cognitive-
behavioral effects of exogenous estrogen treatment when administered via osmotic 
pumps (Engler-Chiurazzi et al., 2011, 2012; unpublished observations). Rats were given 
a 48-hour recovery period before being re-pair-housed with their cage mate until 
sacrifice. 
Rats were randomly assigned to the high cognitive demand WRAM-first 
condition (Vehicle n = 10, Low-E2 = 10, High-E2 = 9) or the low cognitive demand 
DMS-first condition (Vehicle n = 11, Low-E2 = 10, High-E2 = 10). 
 
Vaginal Cytology 
Vaginal smears were obtained one day prior to osmotic pump insertion to confirm 
that Ovx was successful. One day of smears was also completed one week after pump 
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insertion to verify successful vehicle treatment or hormone replacement in the estrogen-
treated animals. Smears were classified as proestrus- , estrus- , metestrus- , or diestrus- 
like smears (Goldman et al., 2007; Koebele and Bimonte-Nelson, 2016). Prior to osmotic 
pump insertion, all rats exhibited diestrus-like smears characterized by leukocytes but 
with more scarcity of cells compared to an ovary-intact diestrus smear, indicating 
successful ovary removal. As anticipated after pump insertion, estrogen-treated rats 
exhibited estrus-like smears containing cornified cells, while vehicle-treated animals 
continued to display diestrus or blank vaginal smears. 
 
Behavior Testing 
Two weeks after osmotic pump surgeries, subjects began behavioral testing with 
either WRAM or DMS water mazes. Half of the rats were assigned to learn the high 
cognitive demand WRAM first, followed by the low cognitive demand DMS second. The 
other half were assigned to learn the low cognitive demand DMS first, followed by the 
high cognitive demand WRAM second. Rats were 12 months old at the start of behavior 
testing. 
Water radial-arm maze. The win-shift 8-arm WRAM was a water escape task 
that measured spatial working and reference memory (Bimonte-Nelson et al., 2015, 2004; 
Bimonte-Nelson, Singleton, Hunter, et al., 2003; Bimonte & Denenberg, 1999; Bimonte, 
Granholm, Seo, & Isacson, 2002; Bimonte et al., 2000, 2003). The WRAM was 
constructed with 8 evenly-spaced and equally-sized arms radiating out from the circular 
center (each arm 39.37 cm x 13.97 cm). Salient spatial cues were placed on the walls and 
around the room to aid in spatial navigation. The maze was filled with room temperature 
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water (maintained at 18-20°C) and made opaque with black non-toxic powdered paint. 
Each rat was assigned a pre-determined set of platform location combinations such that 
four of the eight arms contained a hidden escape platform at the end of the arm, 
submerged 2-3 cm beneath the water’s surface. Platform location combinations remained 
constant across days for each rat, but varied amongst rats. Each subject received four 
trials per day for 14 consecutive days. The first 12 days were considered baseline testing. 
At the beginning of each testing session, the rat was placed in the non-platformed start 
arm of the maze and was given a maximum of 3 minutes to locate a platform on each 
trial. If the rat did not find the platform within the allotted 3-minute time limit, the 
experimenter guided the rat to the nearest platform. Once a platform was located, the rat 
remained on it for 15 seconds before being returned to its heated testing cage for a 30 
second inter-trial-interval (ITI). During the ITI, the experimenter removed the just-found 
platform from the maze (not replaced with a daily testing session), removed any debris, 
and stirred the water to distribute potential olfactory cues. Following 12 days of baseline 
testing, on days 13 and 14, a four-hour delay was implemented between trials two and 
three to evaluate memory retention after a delay. Arm entry errors were recorded for each 
trial on the testing sheet by the experimenter, defined as the tip of the rat’s snout passing 
a line 11 cm into the arm (visible to the experimenter outside of the maze, but not visible 
to the rat). Three error types were recorded. Working memory correct (WMC) errors 
were entries into an arm that previously contained a platform within a day (trials 2-4). 
Reference memory (RM) errors were first entries into an arm that never contained a 
platform. Working memory incorrect (WMI) errors were subsequent entries within a day 
into an arm that never contained a platform. The WRAM is defined as a high cognitive 
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demand spatial working and reference memory task because the number of locations 
needed to be recalled increases as trials progress, thus progressively taxing working 
memory load capacity across trials each day. 
Delayed match-to-sample water maze. The DMS was a water escape task that 
evaluated spatial working and recent memory (Bimonte-Nelson et al., 2015). The 
apparatus had 4 equally sized and spaced arms (each arm 39.37 cm x 13.97 cm), 
configured as a plus shape, radiating out from a circular center. Salient spatial cues were 
placed on the walls and around the room to aid spatial navigation. A single platform was 
submerged 2-3 cm below the surface of the water in 1 of the 4 arms. The platform 
remained in the same location within a day for all rats, but the platform location changed 
across days. With this protocol, rats must update their working memory to go to the 
newly-learned location within each day, thus breaking the association with the previous 
day’s rewarded place in space. However, working memory was not increasingly taxed in 
DMS because there was only 1 item of information (i.e., the constant daily location of the 
one platform) to retain in a given testing session. Each rat experienced 6 trials per day for 
10 days. The first 8 days were considered baseline testing. The first trial of each day was 
operationally defined as an information trial in which the rats learn the new platform 
location. Trial 2 was considered the working memory trial, and trials 3 through 6 were 
recent memory trials, where rats must retain information about the current platform 
escape location. Rats were dropped off in 1 of 2 alternating non-platformed start arms 
that were not directly across from the platform location, such that the rat must make a 
series of left and right turns to locate the platform. The order in which drop-off location 
points occurred was semi-random so that there was no consistent pattern of left and right 
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turns within a day or across days. Each trial had a maximum 90-second swim time before 
the experimenter led the rat to the platform. Once found, the rat remained on the platform 
for 15 seconds before being returned to its heated testing cage for a 30 second ITI, during 
which the experimenter removed any debris from the maze and stirred the water to 
obscure potential olfactory cues. After 8 days of baseline training was completed, a four-
hour delay was implemented between trials 1 and 2 for days 9 and 10 to test delayed 
memory retention for the new platform location each day. An arm entry was recorded 
when the tip of rat’s snout passed the 11 cm mark into a given arm. Total entry errors into 
non-platformed arms on each trial prior to locating the platform were calculated. The 
DMS is defined as a low cognitive demand spatial memory task because, while 
information needs to be updated across days (requiring working memory), the task does 
not involve an increasing working memory load component within or across days. 
 
Body Weights 
Body weights (grams) were recorded at baseline (i.e., prior to Ovx surgery), at 
pump insertion surgery (i.e., 2 weeks after Ovx), prior to behavior (i.e., 2 weeks after 
pump insertion), and at euthanization. 
 
Euthanization 
Rats were euthanized 1 day after the completion of their respective maze tasks, 
and were approximately 13 months of age at this time point. Subjects were deeply 
anesthetized using inhaled isoflurane anesthesia. After confirming successful Ovx, the 
uterine horns were removed from the body cavity, trimmed of excess fat, and wet weight 
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was collected for each subject. Osmotic pumps were removed from the dorsal 
subcutaneous space and inspected for pump integrity.  
 
Statistical Analyses 
All data analyses were completed using Statview statistical software. Separate 
analyses were completed for Vehicle, Low-E2, and High-E2 treatment groups. Repeated 
measures ANOVAs were utilized for WRAM and DMS data. The independent variable 
within each analysis was Low- or High- Demand Experience. For WRAM data analyses, 
“Low-Demand-Experience” refers to prior testing on the DMS before exposure to 
WRAM testing, and “Naïve” refers to the respective groups’ first exposure to a maze 
task. For DMS data analyses, “High-Demand-Experience” refers to prior testing on the 
WRAM before exposure to DMS testing, and “Naïve” refers to the respective groups’ 
first exposure to a maze task. The repeated measures were Trials nested within Days. The 
dependent variable was Errors; for WRAM, this included analyses for WMC, WMI, and 
RM errors, and for DMS this comprised a Total error analysis. ANOVAs were utilized to 
assess body weights and uterine weights, with Treatment as the independent variable and 
Body Weight or Uterine Weight as the dependent variable, respectively. All analyses 
were two-tailed and the alpha level was set at 0.05. Results were deemed marginal if the 
p value was between 0.05 and 0.10.  
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Results 
Water Radial-Arm Maze 
WRAM data were divided into two blocks: Days 1-6 were considered the 
Learning Phase of the task wherein the rats were learning the rules of the task, and Days 
7-12 were considered the Asymptotic Phase of the task, wherein rats were performing to 
the best of their ability. These blocks were chosen based on the trajectory of the subjects’ 
learning curves in this experiment; additionally, we have previously reported cognitive 
effects when WRAM data were evaluated using these blocks with rats of the same age 
(Koebele et al., 2017). Furthermore, this data blocking was the optimal way to indirectly 
compare WRAM and DMS data in this experiment. That is, in DMS, Day 1 was analyzed 
separately, whereby each rat had 6 exposures to the same platform location. Because 
WRAM requires that subjects find a combination of four platform locations per day, 
assessing performance on Days 1-6 for WRAM provides a comparable six-exposures to 
each platform location as was completed on Day 1 of DMS. Similarly, the latter half of 
testing (Days 7-12) was blocked after rats learned the rules of the task, similar to the 
Days 2-8 blocking structure in the DMS. There were no main effects or interactions of 
Low-Demand-Experience for the Vehicle treated rats, the Low-E2 treated rats, or the 
High-E2 treated rats for WMC, WMI, or RM errors during the Learning Phase of WRAM 
(Days 1-6, data not shown).  
 For the Asymptotic Phase (Days 7-12), there was a marginal main effect of Low-
Demand-Experience for WMC for the Vehicle rats [F(1,19) = 3.23, p = 0.09] (Figure 29A) 
and the High-E2 rats [F(1,17) = 3.69, p = 0.07] (Figure 29C), whereby the animals with 
prior Low-Demand-Experience tended to make more errors than their naïve counterparts. 
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There was no main effect or interaction for WMC errors for the Low-E2 treated rats 
during the Asymptotic Phase collapsed across all trials (Figure 29B). Prior findings in our 
laboratory have shown that group differences often become evident on the WRAM when 
working memory load is highly taxed, during moderate and high working memory load 
trials. Therefore, we evaluated WMC errors on Trials 3 and 4 alone, the moderate and 
highest working memory load trials respectively, as done previously (Braden et al., 2015; 
Camp et al., 2012; Koebele et al., 2017, 2019; Mennenga, Gerson, et al., 2015; 
Prakapenka et al., 2018). There was no difference between Naïve rats and Low-Demand-
Experience rats within the Vehicle treated rats for WMC errors on Trial 3 (Figure 29D). 
However, there was a main effect of Low-Demand-Experience for the Low-E2 treated 
rats on Trial 3 [F(1,18) = 10.69, p < 0.01], whereby Low-Demand-Experience Low-E2 
treated rats made fewer WMC errors than Naïve Low-E2 treated rats, indicating that 
Low-E2 treatment enhanced memory performance on the moderate working memory 
load trial, only when subjects had prior Low-Demand-Experience (Figure 29E). 
Interestingly, for the High-E2 treated rats, there was a marginal main effect of Low-
Demand-Experience on Trial 3 [F(1,17) = 3.59, p = 0.08]; Low-Demand-Experience High-
E2 treated rats tended to make more WMC errors than Naïve High-E2 treated rats, such 
that High-E2 treatment tended to have an impairing effect on the moderate working 
memory load trial when subjects had Low-Demand-Experience, suggesting a dose-
dependent effect of estrogen when prior experience is taken into account (Figure 29F). 
There were no main effects for Trial 4 alone, indicating the WRAM task was sufficiently 
difficult on the highest working memory load trial to impair all groups, an effect we have 
previously observed with middle-aged rats (Koebele et al., 2017). There were no main 
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effects or interactions across all trials for WMI errors, nor were there high-working 
memory load trial-specific effects for WMI. Likewise, there were no main effects of 
Low-Demand-Experience for RM errors in any treatment group. 
 On days 13 and 14 of WRAM testing, rats were given a four-hour delay between 
trials 2 and 3. Each treatment group was assessed separately to evaluate individual group 
performance on Trial 3 of day 12 (the last day of baseline WRAM testing) versus the 
average of Trial 3 following both four-hour delays (days 13 and 14). For WMC errors, 
there was a main effect of Delay Day for the Naïve Vehicle group [F(9,1) = 12.86, p < 
0.01], the Low-Demand-Experience Vehicle group [F(10,1) = 23.07, p < 0.001], the Naïve 
Low-E2 group [F(9,1) = 7.11, p < 0.05], the Low-Demand-Experience Low-E2 group 
[F(9,1) = 14.23, p < 0.01], the Naïve High-E2 group [F(8,1) = 18.18, p < 0.01], and the Low-
Demand-Experience High-E2 group [F(9,1) = 16.20, p < 0.01], such that all subjects, 
regardless of treatment or prior low cognitive demand maze experience, made more 
WMC errors on trial 3 after a four-hour delay in the WRAM (Figure 30A-F).  
 
Delayed Match-to-Sample Water Maze 
As noted above, Day 1 of DMS was analyzed separately so that we could evaluate 
the effect of High-Demand-Experience (that is, prior testing experience on the WRAM) 
on the first exposure to the DMS, a low cognitive demand working memory task, within 
each treatment group. For each treatment group, performance on the recent memory 
trials, Trials 3-6, were analyzed on Day 1, in order to assess performance after 2 
exposures to reinforcement at the same location in space (i.e., the rat is removed from the 
water and placed into the heated testing cage as a result of locating the platform). For the 
 
150 
Vehicle treated rats, there was no difference between Naïve rats and High-Demand-
Experience rats on Trials 3-6 [F(1,19) = 3.00, p = NS] (Figure 31A). There was a main 
effect of High-Demand-Experience for Low-E2-treated rats [F(1,18) = 11.12, p < 0.01] 
(Figure 31B) as well as for High-E2-treated rats [F(1,17) = 4.49, p = 0.049] (Figure 31C), 
with Low- or High- E2 treated High-Demand-Experience rats making fewer errors than 
their Naïve counterparts on Trials 3-6 of Day 1 of DMS testing. It is notable that upon 
visualizing errors on each trial (Figure 31D-F), Vehicle treated rats with high demand 
experience did appear to perform better than Vehicle treated naïve rats on Trials 4-6. 
Therefore, we made a post-hoc decision to evaluate Trials 4-6 on Day 1 for the Vehicle 
treated group; there was a significant effect of High-Demand-Experience [F(1,19)=4.65, p 
<0.05], where High-Demand-Experience Vehicle treated rats made fewer errors than 
Naïve Vehicle treated rats on Trials 4-6 (Figure 31G).  
 Days 2-8 of DMS were analyzed within each vehicle or hormone treated group 
for Trials 2-6 (working plus recent memory trials). Performance of Vehicle treated rats 
with High-Demand-Experience did not differ from Naïve Vehicle treated rats for the 
remainder of the baseline days, indicating that High-Demand-Experience did not impact 
performance in Ovx rats administered Vehicle treatment [F(1,19) = 0.55, p = NS] (Figure 
32A,D). There was a main effect of High-Demand-Experience for the Low-E2 treated 
rats [F(1,18) = 6.00, p < 0.05]; a Fisher’s PLSD post hoc test indicated that High-Demand-
Experience rats treated with Low-E2 made fewer errors than Naïve rats treated with Low-
E2 (p < 0.05, Figure 32B,E), suggesting that prior high demand experience enhanced 
performance on the DMS when Low-E2 treatment was administered. There was a 
marginal main effect of High-Demand-Experience for the High-E2 group [F(1,17) = 3.69, p 
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= 0.07], where High-Demand-Experience rats treated with High-E2 tended to make fewer 
errors than Naïve rats treated with High-E2, suggesting a subtle enhancement in 
performance on the DMS for High-E2 treated rats with prior high demand cognitive 
experience (Figure 32C). Furthermore, there was a significant High-Demand-Experience 
x Trial interaction for the E2-High group [F(4,68) = 2.93, p < 0.05] (Figure 32F), where the 
benefit of high demand experience appeared to be most prominent on Trial 2, when the 
platform location is being updated using working memory. Collectively, these results 
indicate that high demand cognitive experience was most beneficial to subsequent DMS 
performance when E2 was present after Ovx, particularly with the Low-E2 dose. Of note, 
we separately evaluated Trials 3-6 on for Days 2-8 to assess whether these effects were 
carried by Trial 2, the working memory trial. When Trial 2 was excluded from the 
analysis, the same effects remained for each group, concluding that the effects were not 
specifically carried by the working memory trial (data not shown).  
 On Days 9 and 10 of DMS testing, rats were given a four-hour delay between the 
information trial (Trial 1) and the working memory trial (Trial 2). Each treatment group 
was analyzed separately to assess performance on Trial 2 of day 8 (the last day of 
baseline testing) as compared to the average of trial 2 following both four-hour delays 
(days 9 and 10). There were no differences between baseline and delay days for the Naïve 
Vehicle group, the High-Demand-Experience Vehicle group, the Naïve Low-E2 group, or 
the High-Demand-Experience Low-E2 group (Figures 33A-D). However, there was a 
main effect of Delay Day for the Naïve High-E2 rats [F(9,1) = 11.25, p < 0.01] and for the 
High-Demand-Experience High-E2 rats [F(8,1) = 10.67, p < 0.01], such that number of 
total errors committed in the DMS task by High-E2 treated rats increased with this 
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elevated four-hour long temporal retention requirement; this impairment was apparent 
regardless of whether rats had prior high demand cognitive experience (Figure 33E-F).  
 
Body Weights 
Across time, there was a main effect of Measurement Time Point [F(3,171) = 83.38, 
p < 0.0001], as well as a Measurement Time Point x Treatment interaction [F(6,171) = 
30.04, p < 0.0001]. At baseline, prior to Ovx surgery, there were no group differences in 
weight [F(2,58) = 0.18, p = NS], nor were there group differences prior to pump insertion 
[F(2,58) = 0.35, p = NS]. However, body weight increased in all rats between Ovx and 
Pump Insertion time points [F(1, 58) = 161.18, p < 0.0001]. Prior to commencement of 
behavior testing, 2 weeks after pump insertion, there was a main effect of Treatment 
[F(2,58) = 9.72, p < 0.001]; a Fisher’s PLSD post hoc test revealed that the Low-E2 group 
(p < 0.0001) and the High-E2 group (p < 0.0001) weighed less than the Vehicle-treated 
group. Body weights in the Low-E2 and High-E2 groups did not differ from each other. 
At sacrifice, there was also a main effect of Treatment [F(2,57) = 9.93, p < 0.001]; a 
Fisher’s PLSD post hoc test revealed that the Low-E2 group (p < 0.0001) and the High-
E2 group (p < 0.0001) weighed less than the Vehicle-treated group, but the estrogen-
treated groups did not differ from each other (Figure 34).  
 
Uterine Weights 
Uterine wet weights were collected at sacrifice. As expected, there was a main 
effect of Treatment [F(2,54) = 26.28, p < 0.0001]. Fisher’s PLSD post hoc tests indicated 
that uteri from the Vehicle-treated group weighed significantly less than the Low-E2 
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group (p < 0.0001) and the High-E2 group (p < 0.0001) (Figure 35). Uterine weight did 
not differ between Low- and High- E2 treated groups.  
 
Discussion 
 Cognitive practice is considered neuroprotective and can impart benefits for 
acquiring and remembering novel information. Whether estrogen milieu interacts with 
prior cognitive experience to influence outcomes is an area of substantial interest from 
both basic science and translational clinical perspectives. In the current study, we 
evaluated whether prior experience on a low- or high- cognitive demand maze task 
impacted the ability to learn a subsequent cognitive task, and whether these effects were 
influenced by circulating E2 milieu, during middle age. We utilized a model of surgical 
menopause and hormone therapy administration in middle-aged rats, evaluating whether 
E2 administration impacted learning and memory on a series of mazes. We used two 
mazes of varying complexity: the water radial-arm maze, a high cognitive demand task 
that tests spatial working and reference memory and requires the maintenance of an 
increasing working memory load, and the delayed match-to-sample water maze, a low 
cognitive demand task that tests spatial working memory without a memory load 
component. Overall, we found that prior experience on tasks of varying complexity can 
alter learning and/or memory for the subsequent maze task, and these effects appear to be 
moderated, at least in part, by exogenous E2 treatment.  
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Low Demand Experience Impacts Subsequent High Demand Working Memory 
Performance Only with Estrogen Supplementation 
We report here that prior experience on a low complexity maze task does not 
impart benefits while subsequently learning a more cognitively demanding task, 
regardless of hormone milieu. Specifically, the experience of learning the low cognitive 
demand task, DMS, first did not alter performance during the learning phase of a high 
cognitive demand task, WRAM, regardless of Vehicle or E2 treatment. However, after 
experiencing the low cognitive demand task, the presence of Low-E2 did enhance 
memory performance for the more complex task after task rules had been learned. This is 
evidenced by the observation that during the asymptotic phase of the WRAM, the Low-
E2 treated rats with prior low demand task experience made significantly fewer errors 
than the naïve Low-E2 treated rats when working memory load was taxed. When E2 was 
not present, prior low demand experience on the DMS somewhat impaired memory 
performance on the high demand task in control rats given vehicle. Specifically, Vehicle 
treated rats with prior low demand experience trended toward worse performance across 
all trials during the asymptotic phase of the WRAM compared to Vehicle treated rats 
naïve to the current task. However, when working memory load was taxed, both the 
Naïve-Vehicle rats and Low-Demand-Experience Vehicle rats performed similarly, 
indicating that prior low demand experience had no effect on WRAM performance for 
Ovx vehicle-treated rats when the current task became demanding. Of note, the High-E2 
treated rats with prior low demand experience on the DMS also showed a trend toward 
impaired performance compared to the High-E2 treated rats that were naïve to the task 
when working memory load was taxed on the WRAM, indicating that low demand 
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experience had a somewhat negative impact on the subsequent ability to handle an 
increased working memory load for rats with a hormone milieu of high dose E2 
supplementation. Collectively, these findings suggest that the presence of a low dose of 
E2 in the hormonal milieu of rats with prior experience on a low cognitive demand task 
can impart beneficial effects on a subsequent more complex task after the initial learning 
period of this subsequent task. It is notable that there may be a dose-dependent estrogen 
response for this enhanced spatial working memory performance on the high demand 
task, whereby too high of a dose of E2, perhaps resulting in supraphysiological 
circulating levels of the hormone, can impair cognitive performance, an effect that has 
been previously reported (Barha, Dalton, & Galea, 2010; Holmes et al., 2002; Korol & 
Pisani, 2015).  
When delayed working memory retention was evaluated with a four-hour delay 
between trials 2 and 3 in the WRAM, all rats made more errors in the post-delay trials 
compared to baseline performance. These results suggest that the four-hour delay was 
sufficiently difficult to disrupt working memory in middle-aged Ovx rats, regardless of 
whether E2 was present in the hormonal milieu or whether rats had prior low cognitive 
demand task experience.  
 
High Demand Experience Enhances Subsequent Low Demand Learning and Recent 
Memory Performance with Estrogen Supplementation 
Here, we showed that prior experience on a cognitively challenging task can 
bestow beneficial effects for learning and memory on a subsequent low demand cognitive 
task, and that these performance benefits were particularly evident when E2 was present. 
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First, we evaluated Day 1 of DMS separately as a measure of learning for Naïve versus 
High-Demand-Experience rats within each hormone treatment group. An analysis of 
DMS performance on Day 1 only was completed because on this task the rats have 6 
exposures to the single daily platform location across trials within a day; thus, daily 
platform location learning can be observed within a day. For Day 1, Trials 3-6 were 
evaluated, such that both the information trial and working memory trial were considered 
training. Rats treated with Low-E2 or with High-E2 with prior high demand experience 
on the WRAM performed significantly better than Low- and High- E2 treated rats naïve 
to the DMS task on Day 1. While High-Demand-Experience and Naïve Vehicle-treated 
rats did not differ in error scores when assessed on Trials 3-6, the pattern of performance 
across trials indicated that the Vehicle-treated groups did learn the rules of the task within 
the first day, and this was confirmed via statistical analysis. Indeed, an analysis of Trials 
4-6 on Day 1 for the Vehicle-treated groups revealed enhanced performance for the 
Vehicle treated rats with high demand experience group compared to Vehicle treated rats 
that were naïve. It is notable that for High-Demand-Experience rats treated with low or 
high doses of E2, enhanced performance on the DMS was apparent at an earlier trial 
within the first training day than for Vehicle treated rats, suggesting that E2 treatment 
after Ovx may aid in acquiring new task rules faster, or after fewer exposures, than if 
circulating E2 is not present in measurable quantities, as in the Ovx-Vehicle rats. The 
beneficial effects of prior high demand experience in the Low-E2 treated rats continued 
to be present throughout the remainder of DMS testing, where Low-E2 treated rats with 
prior high demand task experience made fewer total errors across Days 2-8 of DMS than 
their naïve counterparts. The High-E2 treated rats with prior High-Demand-Experience 
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also tended to make fewer total errors than their naïve counterparts for Days 2-8, 
although this effect did not reach statistical significance. On the other hand, both the 
Naïve Vehicle treated rats and the High-Demand-Experience Vehicle treated rats 
performed similarly to each other across Days 2-8 of DMS, regardless of experience 
profile. Overall, rats that had prior experience on a high cognitive demand task and were 
also given E2 treatment, particularly at a low dose, exhibited enhanced learning and 
memory for a subsequent low cognitive demand task. When a four-hour memory 
retention delay was implemented between trials 1 and 2 on the low cognitive demand 
task, only the rats receiving High-E2-treatment  — both naïve and those that had high 
cognitive demand task experience — made more errors, again suggesting that there are 
dose-dependent effects of E2 for the impact of prior cognitive experience on subsequent 
cognitive performance. Specifically, low E2 dose treatment yielded beneficial effects for 
learning and memory on a low cognitive demand task and intact memory retention 
following a delay when there was a background of prior high demand experience. On the 
other hand, high E2 dose treatment imparted learning and memory benefits on the low 
demand task, but impaired memory retention following a delay, even with a background 
of prior high demand experience. Overall, the benefits of prior cognitive task experience 
were most pronounced with low dose E2 administration; indeed, the low E2 dose 
treatment utilized in this experiment yielded the broadest beneficial cognitive effects for 
subsequent learning and memory performance on mazes of varying complexity.  
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Body and Uterine Weights 
As expected, body weights decreased in E2-treated rats, regardless of test 
experience order, following E2 supplementation after Ovx, an effect consistently 
observed in our (Mennenga & Bimonte-Nelson, 2013; Prakapenka et al., 2018), and other 
(Diz-Chaves et al., 2012; Geary, Trace, McEwen, & Smith, 1994; McLaughlin et al., 
2008) laboratories. Vehicle-treated rats gained weight following Ovx (Kakolewski, Cox, 
& Valenstein, 1968; Rogers, Li, Strissel, Obin, & Greenberg, 2009) and maintained a 
higher average weight than both E2-treated groups at sacrifice.  
 Uterine weights were increased in both the Low-E2 treated rats and the High-E2 
treated rats compared to the Vehicle treated rats. This confirms that the currently utilized 
E2 treatment via Alzet osmotic pumps was successful through the duration of the study, 
as estrogen stimulation of uterine tissue results in growth and therefore increased weight, 
whereas Vehicle-treated rats without E2 experienced uterine atrophy following Ovx 
surgery (Engler-Chiurazzi et al., 2012; Prakapenka et al., 2018; Westerlind, Gibson, 
Malone, Evans, & Turner, 1998).  
 
Conclusions 
Estrogen-containing hormone therapy administration following surgical 
menopause in middle-age has been reported to have mixed effects in the literature, 
including beneficial, detrimental, or null effects for cognition in both animal and human 
studies. There are likely many factors contributing to these outcomes, including the dose, 
route of administration, timing of treatment initiation, and duration of hormone treatment. 
Hormone milieu does not impact cognitive outcomes in isolation, but undoubtedly 
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interacts with a number of environmental factors, including exposure to novel task 
learning and cognitive reserve capacity. This current study highlights variables related to 
these factors, including maze task complexity and maze order presentation, to consider 
when assessing the cognitive effects of E2 on learning and memory in rodent models. 
Many laboratories, including our own, implement a battery of tasks to evaluate various 
types of learning and memory, as well as other behaviors, such as measures of anxiety-
like, depressive-like, and exploratory behaviors. While one resolution could be to 
counterbalance the order in which rats in each group experience the tasks, our findings 
indicate that, depending on the treatment administered, prior experience on maze tasks of 
varying complexity alters performance on subsequent tasks, and counterbalancing task 
order may therefore actually muddle treatment effects if task counterbalancing is 
implemented. Our laboratory has shown that for gonadally intact rats, prior experience on 
a simple cognitive task can confer benefits to learning future, novel tasks. Specifically, 
benefits of prior experience were especially notable for female rats compared to male 
rats, as the females with prior cognitive practice showed enhanced performance on a task 
assessing a different type of memory, even a year after the first behavioral experience 
(Talboom et al., 2014). In addition, this effect was not accounted for by the procedural 
components of testing, but was only noted when cognitive demand was utilized (Talboom 
et al., 2014). These prior findings, in conjunction with the current report, indicates that it 
is crucial to describe any previous experience animals may have on tasks prior to 
reporting experimental results, as previous cognitive experience can be a significant 
factor in performance on a given task. 
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 Furthermore, the current experiment demonstrates a potential dose-dependent 
effect of E2 that interacts with prior maze experience, highlighting the importance of 
estrogen dose in the context of investigating cognition. Here, low and high doses of E2 
were administered tonically via Alzet osmotic pumps, such that rats received a steady rate 
of E2 (0.15 µl of solution per hour, resulting in 2µg or 4µg of E2 per day for Low and 
High groups, respectively) and treatment was initiated 2 weeks after Ovx surgery and 
continued until the study’s end. This regimen compliments the current standard 
recommendations for estrogen-containing menopausal hormone therapy in women, which 
is the lowest effective dose of estrogen possible, often in a non-oral administration route 
(such as a hormone-containing transdermal patch, vaginal applications, or intrauterine 
devices) to produce physiologically relevant circulating levels of E2 that concomitantly 
minimizes health risks (Pinkerton et al., 2017). It is also notable that the E2 used in the 
current study is considered a bioidentical hormone, rather than a synthetic substrate such 
as ethinyl estradiol, or a natural but non-bioidentical, non-human derived compound such 
as conjugated equine estrogens (CEE, tradename Premarin), which are commonly used in 
hormonal contraceptives and menopausal hormone therapy, respectively. The use of 
endogenously available E2, conferring beneficial effects herein, may yield different 
effects than CEE or ethinyl estradiol, which have been shown to have mixed cognitive 
outcomes (Acosta et al., 2010; Mennenga, Gerson, et al., 2015). 
 Collectively, this experiment found that prior cognitive experience of varying 
complexity can alter subsequent learning and memory prowess, and that the beneficial 
effects of prior cognitive experience are, in part, dependent upon the presence of 
circulating estrogen milieu when in a surgically menopausal aging background. These 
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results provide important insight into the role of estrogen and cognitive practice during 
aging. Our findings underscore that acknowledgement and careful consideration of task 
order are critical when testing a behavioral battery and when interpreting the often mixed 
results of basic science evaluations of hormone efficacy. As the behavioral endocrinology 
field moves forward with the goal to translate preclinical data outcomes to better the 
cognitive health of women during aging, it is crucial to consider these types of effects as 
putative mediating factors for determining the efficacy of estrogen treatments, rather than 
secondary nuances that arise from the idiosyncrasies of preclinical rodent behavioral 
testing. Taking such considerations into account when interpreting outcomes will yield 
clarity and help dictate new pathways to discovery of how factors such as enrichment, 
educational attainment, cognitive status, and cognitive reserve histories influence 
outcomes of hormone therapies and healthy brain aging in menopausal women. 
  
 
162 
Acknowledgments 
Funding: Dr. Heather Bimonte-Nelson is funded by the following grant awards: 
NIA (AG028084), state of Arizona, Arizona Department of Health Services (ADHS14-
052688), NIH Alzheimer’s Disease Core Center (P30AG019610), Arizona State 
University Office of Knowledge Enterprise Development, College of Liberal Arts and 
Sciences, and Department of Psychology. Stephanie Koebele is funded by the following 
grant awards: NIA (1F31AG056110-01A1). 
Alicia M. Quihuis, Courtney N. Lavery, Zachary M.T. Plumley, and Arthur J. 
Castaneda, are thanked for their assistance with data collection. 
  
 
163 
CHAPTER 5 
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ABSTRACT 
Oral contraceptives and hormone therapies administered to uterus-intact women 
require a progestogen component to prevent estrogen-induced uterine hyperplasia and 
reduce the risk of gynecological cancers. Because natural progesterone is not readily 
orally bioavailable, there are diverse classes of synthetic progestogens, called progestins, 
that can be used in these formulations as an alternative to natural progesterone. Although 
progestins have similar efficacy peripherally, prior research has found that many 
progestins have a negative impact on cognition and can reverse neuroprotective effects of 
estrogen. Give that most women need a progestin component with estrogen-containing 
oral contraceptives and hormone therapies, it is important to discover a progestin that 
does not detrimentally affect cognition. Here, we investigate drospirenone, a fourth-
generation progestin derived from spironolactone. Currently, drospirenone is the 
progestin component in several FDA-approved oral contraceptives (e.g. Yaz®) and 
hormone therapies for menopausal women (e.g. Angeliq®). Unlike other progestins, 
drospirenone is comparatively similar in its pharmacological profile to natural 
progesterone, and, notably, has anti-androgenic and anti-mineralocorticoid properties 
without concomitant glucocorticoid activity, making this a unique progestin of interest to 
investigate for its effects on cognition, including spatial memory and anxiety-like 
behaviors. Study 1 assessed several doses of drospirenone in young adult, ovariectomized 
(Ovx) rats, and found that a moderate dose of drospirenone had a beneficial effect on 
spatial working memory. To investigate potential neural mechanisms underlying this 
observed effect, brains were probed for GAD65, GAD67, and IGF1-R expression in the 
hippocampus, entorhinal cortex, and perirhinal cortex using western blot. Study 2 
 
165 
investigated this optimal drospirenone dose with and without concomitant ethinyl 
estradiol (EE) treatment, the most common synthetic estrogen prescribed in oral 
contraceptives. Results suggest that the addition of EE to drospirenone administration 
reversed the beneficial effects of drospirenone on cognition. It is essential to better 
understand how these hormones work in concert with one another, and why they produce 
unique cognitive profiles when administered together compared to those observed when 
each hormone is administered separately.  
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Introduction 
 Most women use some form of contraception in their lifetime (Daniels & Abma, 
2018). There has been a rise in the popularity of hormone-containing methods, including 
oral contraceptives, intrauterine devices, vaginal rings, and subcutaneous implants due to 
their reliability not only in preventing pregnancy, but also for their value in treating a 
range of other health-related indications such as endometriosis, acne, and premenstrual 
dysphoric disorder (PMDD; Dayal and Barnhart, 2001). It is currently estimated that 
79.3% of women have used the oral contraceptive pill at some point during their life, and 
13.9% of U.S. women ages 15-44 report current use of the pill between 2015 and 2017; 
this percentage increases to 19.5% for users in the 20-29 year old age range (Centers for 
Disease Control and Prevention, 2019). Likewise, some women undergoing the 
menopause transition opt to take hormone therapy to alleviate unwanted symptoms 
including hot flashes, dyspareunia, and vaginal dryness (Pinkerton et al., 2017). Although 
the reported rates of hormone therapy use have declined substantially in the last 15 years 
(Crawford et al., 2018; Sprague, Trentham-Dietz, & Cronin, 2012), it is important to 
understand the long-term effects hormone-containing contraceptives and menopausal 
hormone therapy have on health outcomes in women.  
 Women who have a uterus and utilize-estrogen containing formulations require a 
progestin component to prevent endometrial hyperplasia and alleviate gynecological 
cancer risk, making combined oral contraceptives (COC) the most popular form of oral 
contraceptive use (K. S. Hall & Trussell, 2012). Given the low oral bioavailability of 
natural 17b-estradiol and progesterone, synthetic forms of estrogen and progesterone are 
most often utilized in contraceptives and hormone therapies. Ethinyl estradiol (EE) is the 
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synthetic estrogen used in nearly all COC formulations. However, there is a wide range 
of synthetic forms of progesterone, called progestins. Progestins are derived from a 
variety of parent molecules structurally related to either testosterone (derivatives of 19-
nortestosterone, called estranes and gonanes), or to progesterone (17α-
hydroxyprogesterone [pregnanes]; 17α-hydroxynorprogesterone or 19-norprogesterone 
[norpregnanes]), thus resulting in different pharmacological and pharmacokinetic 
profiles, including variable affinities to receptors for progesterone, androgens, estrogens, 
as well as to glucocorticoids receptors and mineralocorticoid receptors (Schindler et al., 
2003; Sitruk-Ware & Nath, 2010). Progestins are often referred to by generation (i.e., 
first through fourth), although these designations can be arbitrary and refer to when the 
drugs were introduced to the market, or to their structure or pharmacological actions 
(Apgar & Greenberg, 2000; Davtyan, 2012; Petitti, 2003). Although progestins have 
similar efficacy peripherally, prior research has found that many of the earlier generation 
progestins have a negative impact on cognition and can reverse neuroprotective effects of 
estrogen (Bimonte-Nelson et al., 2006, 2004; Braden et al., 2011, 2015, 2010; Chesler & 
Juraska, 2000; Harburger, Bennett, & Frick, 2007; Harburger, Saadi, & Frick, 2009; 
Lowry, Pardon, Yates, & Juraska, 2010; Rosario, Ramsden, & Pike, 2006), while others 
have beneficial or neutral effects when administered alone (Braden et al., 2016; 
Prakapenka et al., 2018). Given the prevalence of progestin use in COCs and hormone 
therapies, it is of critical importance to better understand how these synthetic hormones 
impact the brain and behavior beyond their prescribed use. 
 While most progestins on the market are chemically similar to testosterone and 
progesterone, the fourth-generation progestin drospirenone is derived from a novel 
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source: spironolactone, an anti-androgenic aldosterone antagonist (Archer, Ahrendt, & 
Drouin, 2015; Krattenmacher, 2000). This makes the molecular structure and function of 
drospirenone unique. Aldosterone is an adrenal-derived hormone that regulates water 
retention and blood pressure; thus, beyond drospirenone's capacity to bind to the 
progesterone receptor with high affinity and its molecular structure more similar to 
natural progesterone than other clinically-available progestins (Fuhrmann, 
Krattenmacher, Slater, & Fritzemeier, 1996; Muhn, Krattenmacher, Beier, Elger, & 
Schillinger, 1995), it may also better modulate fluid retention (i.e. bloating) that naturally 
occurs during the menstrual cycle (Bitzer & Paoletti, 2009; Fenton, Wellington, Moen, & 
Robinson, 2007; Foidart, 2005). Drospirenone possesses these spironolactone-derived 
anti-androgenic and anti-mineralocorticoid receptor properties without concomitant 
glucocorticoid receptor activity (Schindler et al., 2003). As such, drospirenone-containing 
COCs are the only COCs approved by the Food and Drug Administration to treat acne 
vulgaris and PMDD, a mood disorder different from premenstrual syndrome (PMS) that 
affects approximately 5% of women (Fenton et al., 2007; Hofmeister & Bodden, 2016). 
Furthermore, drospirenone-containing COCs are a popular choice for younger women, 
making up 17% of all COC prescriptions in 2010 (K. S. Hall & Trussell, 2012). Although 
drospirenone was reported to increase deep vein thrombosis, this finding has since been 
refuted, and its safety profile is similar to other clinically-used progestins (Larivée et al., 
2016).  
Ovarian hormones have a well-established impact on cognition. Little attention 
has been dedicated to methodically understanding drospirenone’s impact on spatial 
learning and memory and anxiety-like behaviors. Given drospirenone’s unique 
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pharmacological properties and potential for alleviating cognitive symptoms associated 
with PMDD, it is of significant interest to evaluate its effects on cognition alone and in 
combination with the synthetic estrogen EE. Our laboratory has demonstrated unique 
cognitive effects of progestins and estrogens depending on whether the drugs are 
administered alone or in combination with each other. Specifically, when levonorgestrel, 
a second-generation progestin that has null or beneficial effects on spatial working 
memory in rodent models when administered alone (Braden et al., 2016; Prakapenka et 
al., 2018), was paired with 17b-estradiol in middle-aged ovariectomized rats, its 
beneficial effect was attenuated compared to levonorgestrel alone (Prakapenka et al., 
2018). Furthermore, the presence of progesterone and synthetic progestins can impact 
multiple neural systems to influence learning and memory processes. Our laboratory has 
reported that the synthetic progestin medroxyprogesterone acetate (MPA), a first-
generation pregnane-derived progestin, had detrimental effects on spatial memory, even 
after drug cessation, when it was no longer detectable in blood serum (Braden et al., 
2011, 2010). Furthermore, MPA impacted the GABAergic system, which is the primary 
inhibitory neurotransmitter system in the brain and a critical modulator of normal 
learning and memory. This was evidenced by altered GAD65+GAD67 expression in the 
hippocampus and surrounding cortical areas of Ovx rats treated with MPA (Braden et al., 
2010), which could point to an underlying mechanism for the observed cognitive effects 
with MPA treatment. Another recent study showed that the norpregnane-derived 
progestin segesterone acetate increased expression of insulin-like growth factor-1 
receptor (IGF1-R), which is known to be important for neurogenesis, in the frontal cortex 
of mice (S. Chen, Kumar, Mao, Sitruk-Ware, & Brinton, 2018). The frontal cortex is 
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heavily involved in working memory, and thus these recent findings implicating 
progestins in the neurogenesis process provides an interesting route to explore for 
understanding neural correlates of progestin-induced behavioral changes. Additionally, 
our laboratory showed that there are dose-dependent effects of EE on memory, where a 
higher dose impaired memory (Mennenga, Gerson, et al., 2015), so evaluating these 
commonly prescribed hormones is imperative to parse out cognitive effects of the drugs 
alone and in combination with one another.  
Elucidating whether drospirenone may differentially impact cognition in contrast 
to earlier generation progestins is an important step toward discovering novel 
pharmacotherapies that can provide long-term health benefits, including neuroprotective 
properties. In order to assess the cognitive impact of drospirenone on cognition, two 
experiments were performed. Using adult, ovariectomized (Ovx) Fischer-344-CDF rats, 
Study 1 evaluated a range of doses of drospirenone to determine an optimal dosing 
regimen that impacted cognition. Study 2 incorporated the optimal dose determined from 
Study 1 and combined this dose with EE to investigate cumulative effects of the drugs on 
cognitive performance.  
 
Methods 
Subjects: Study 1 
Forty three-month-old Fischer-344 (F344-CDF) rats were obtained from Charles-
River Laboratories (Raleigh, NC). Upon arrival to the animal facility, all rats were pair-
housed, provided with free access to food and water for the duration of the experiment, 
and were maintained on a 12-hour light/dark cycle for the entirety of the study. 
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Procedures were approved by the Arizona State University Institutional Animal Care and 
Use Committee and adhered to National Institutes of Health standards.  
 
Subjects: Study 2 
Sixty three-month-old F344-CDF rats were obtained from Charles-River 
Laboratories (Raleigh, NC). Upon arrival to the animal facility, all rats were pair-housed, 
provided with free access to food and water for the duration of the experiment, and were 
maintained on a 12-hour light/dark cycle for the entirety of the study. Procedures were 
approved by the Arizona State University Institutional Animal Care and Use Committee 
and adhered to National Institutes of Health standards.  
 
Ovariectomy 
Procedures were identical for Study 1 and Study 2. After 9-10 days of acclimation 
to vivarium, all rats underwent Ovx, or surgical removal of the ovaries. Ovx results in a 
“blank ovarian hormone slate” that allows us to evaluate the specific effect of the 
hormone treatment given without interactions with endogenously-circulating hormones. 
Rats were anesthetized via inhaled isoflurane anesthesia. Five mg/mL/kg of the NSAID 
Rimadyl (carprofen) was administered to prevent post-surgical pain. Following 
sterilization of the surgical area, all rats received bilateral dorsolateral incisions through 
the skin, muscle, and peritoneal cavity. Ovaries and tips of the uterine horns were ligated 
and excised on each side. Muscle was sutured with dissolvable Vicryl suture and a local 
anesthetic, bupivacaine (Marcaine; Pfizer Pharmaceutical, Hospira Inc., Lake Forest, IL) 
was applied topically to the incision site. Skin was sutured with dissolvable Vicryl suture. 
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All rats received 2 mL of sterile saline subcutaneously to prevent post-surgical 
dehydration. 
  
Hormone Treatment: Study 1 
 Drospirenone will be abbreviated as DRSP in reference to treatment groups. Rats 
were randomly assigned to one of the following treatment groups (n=10/group): Vehicle 
(sesame oil, control), DRSP-Low (12.5 µg/day), DRSP-Medium (30 µg/day), or DRSP-
High (300 µg/day). Forty-eight to 72 hours after Ovx surgery, daily subcutaneous 
treatment injections began. Each treatment was administered in a 0.1 mL volume in the 
scruff of the neck, and continued throughout the entirety of the experiment until 
euthanasia. Each treatment was dissolved into sesame oil and sonicated for 2.5 hours at 
50°C. The DRSP-High dose was sonicated for an additional 2.5 hours at 50°C. 
Sonication of the drug vials continued weekly for 2 hours throughout the experiment to 
ensure that the drug stayed in solution. All treatments were stored at room temperature. 
The low dose was based on the most common dose prescribed to women in a COC (3 
mg/day), adjusted for an average weight (250 g) Ovx rat. Clinically, the ratio of DRSP to 
EE in a typical COC is 100:1, so the medium dose reflected this ratio when considering 
the range of EE doses used in Study 2. The high dose was a replication of the dose used 
in a prior study outside of our laboratory (Muhn et al., 1995) that resulted in ovulation 
inhibition in ovary-intact adult rats.  
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Hormone Treatment: Study 2 
Rats were randomly assigned to one of the following treatment groups 
(n=10/group): Vehicle (control, sesame oil); DRSP (30 µg/day); EE-Low (0.125 µg/day), 
EE-High (0.3 µg/day), EE-Low + DRSP (0.125 µg/day EE + 30 µg/day DRSP), or EE-
High + DRSP (0.3 µg/day EE + 30 µg/day DRSP). All treatments were administered 
daily in 0.1 mL of sesame oil in the scruff of the neck beginning 2-3 days after Ovx and 
continued throughout the experiment until euthanasia. The EE doses utilized here were 
based on prior research from our laboratory; the Low-EE dose represented a typical dose 
of EE in a modern-day oral contraceptive (30-35 µg/day), and the High-EE dose 
represented the higher doses of EE prescribed in earlier generations of oral contraceptives 
(75-80 µg/day), each adjusted for rat body weight (Mennenga, Gerson, et al., 2015). The 
DRSP-Medium dose (30 µg/day) was chosen for use in Study 2 based on Study 1 results. 
 
Vaginal Smears  
 Eighteen days after the first hormone injection, vaginal smears were performed 
for three consecutive days. Vaginal cytology was assessed to confirm successful Ovx and 
understand how DRSP treatment could impact vaginal epithelial cells. Cytology was 
defined based on specifications in Goldman et al., 2007 and Koebele and Bimonte-
Nelson, 2016, where diestrus smears contained leukocytes with or without the presence 
of cornified cells, proestrus smears contained round, nucleated epithelial cells and 
cornified cells present in clusters, estrous was defined by the presence of cornified cells, 
and metestrus contained a combination of cornified cells, leukocytes, round cells, and 
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keratonized, needle-like cells (Goldman et al., 2007; Koebele & Bimonte-Nelson, 2016). 
Procedures were identical for Study 1 and Study 2. 
 
Body Weights 
 Beginning at Ovx surgery, weekly weights (grams) were recorded for all rats in 
Study 1 and Study 2 until the end of the experiment.   
 
Cognitive Behavioral Battery 
One month after daily hormone treatment initiation, rats were administered a 
battery of cognitive tasks evaluating spatial working and reference memory, including the 
water radial-arm maze (WRAM) and Morris water maze (MM). Additionally, rats were 
tested on the open field task (OFT) to assess locomotor activity and anxiety-like 
behavior. Procedures were identical for Study 1 and Study 2. 
Water Radial-Arm Maze. The water radial-arm maze was an eight arm 
apparatus used to test spatial working and reference memory in rodents, as previously 
described (Bimonte-Nelson et al., 2015; Bimonte & Denenberg, 1999; Bimonte et al., 
2000). Working memory was defined as memory that required updating within a session. 
Reference memory was defined as memory that remained constant through the entirety of 
the task. Each arm was identical in size (39.37 cm long x 13.97 cm wide) and evenly 
spaced, radiating out from the circular center of the maze. Water was maintained at 18-
20°C. Black non-toxic powdered paint was used to make the water opaque. Four out of 
the eight arms contained hidden platforms, 2 cm below the water’s surface, at the 
beginning of each daily testing session. The specific locations of the platforms were 
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constant within a rat, but varied across rats and were counterbalanced across treatment 
groups. Salient spatial cues were placed on the walls around the testing room to assist the 
rats with learning to spatially navigate to the hidden platforms.  
 Rats underwent baseline WRAM testing for 12 consecutive days, with four trials 
administered per daily testing session (one for each hidden platform). Once the rat was 
placed in the non-platformed start arm, it had 3 minutes to locate a hidden platform. If the 
rat did not locate a platform in the maximum allotted time of 3 minutes, the experimenter 
led the rat to the nearest hidden platform. Once a platform was located, the rat was 
permitted to stay on it for 15 seconds, and then the experimenter removed the rat from the 
maze and placed it back into a heated testing cage for a 30 second inter-trial-interval 
(ITI). During those 30 seconds, the experimenter removed the just-found platform from 
the maze for the remainder of the daily testing session and gently stirred the water using a 
net to obscure potential olfactory cues and remove any debris from the water. The rat was 
placed back into the maze for the remaining three trials in an identical fashion. Following 
12 days of baseline testing, a six-hour delay was implemented between trials 2 and 3 to 
test delayed memory retention. Cognitive performance on the WRAM was quantified by 
the number of non-platformed arm entries—called errors—committed prior to locating a 
platform on each trial. An arm entry was quantified when the rat’s nose passed a 
designation mark 11 cm into the arm that was visible to the experimenter but not visible 
to the rat. Errors were defined in 1 of 3 categories: working memory correct (WMC) 
errors were entries into a previously platformed arm on trials 2-4, reference memory 
(RM) errors were entries into a never-platformed arm for the first time within a daily 
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testing session, and working memory incorrect (WMI) errors were defined as repeat 
entries into never-platformed arms within a daily testing session. 
Morris Water Maze. The MM was a large round tub (diameter = 188 cm) filled 
with 18-20°C black-painted water used to assess spatial reference memory (Bimonte-
Nelson et al., 2015; Morris, 2015; Morris et al., 1982). One hidden platform was 
submerged within the northeast quadrant of the maze, where it remained for all days and 
trials. Salient spatial cues were placed on the walls in the testing room to aid in spatial 
navigation. Each rat received four trials per day for five days. On each trial, a rat was 
dropped off from one of the four cardinal directions (north, east, south, and west). The 
order of drop-off locations was the same for all rats within a day, but changed across 
days. The maximum trial time was 60 seconds. If a rat did not locate the hidden platform 
within the maximum allotted time, the experimenter led the rat to the platform. Once the 
rat found the platform it remained on it for 15 seconds prior to being returned to its 
heated testing cage for an ITI of approximately 10 minutes. The rats’ swim paths and 
latency to platform were recorded using Ethovision software (Noldus Instruments, 
Wageningen, The Netherlands). On the fifth testing day, an additional trial was 
implemented following the four baseline trials. During this probe trial, the platform was 
removed from the maze and the rats were allowed to swim freely for 60 seconds.  
Open Field Task. The OFT measured locomotor activity and anxiety-like 
behavior. This task has been shown to be sensitive to the presence and absence of ovarian 
hormones (Hiroi & Neumaier, 2006). The OFT was a 100 cm x 100 cm x 30 cm black 
Plexiglas arena. Although some paradigms use a bright light in the center of the maze, 
this assay was completed in red light (i.e., darkness for rats), as rats with significant 
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anxiety-like phenotypes tend not to move at all if the center of the arena is lit. Rats were 
acclimated to the anteroom of the testing area for at least 30 minutes. Each rat was placed 
in the arena on the north wall. The experimenter quietly exited the room while the rat was 
allowed to explore the arena freely for a 10 minute trial. The rat was then placed back in 
its testing cage and removed from the room. The experimenter counted and removed any 
fecal boli from the area, cleaned the arena with water, and dried it with paper towel prior 
to the next subject’s trial. Dependent variables assessed in the OFT were total distance 
moved, distance moved and time spent in the arena center, small center, and arena 
corners.  
 
Euthanasia 
One day following behavioral assay completion, all rats were deeply anesthetized 
with inhaled isoflurane anesthesia. Brains were removed and blocked posterior to the 
basal forebrain. This anterior portion was post-fixed in 4% paraformaldehyde for 48 
hours and then transferred to 0.1 M phosphate buffered solution for storage. The dorsal 
hippocampus, entorhinal cortex, and perirhinal cortex of the right hemisphere were 
rapidly raw dissected, weighed, and frozen until western blot analysis. Ovx status was 
verified at necropsy and the uterine horns were removed from the body cavity, trimmed 
of visible fat, and wet weight was recorded. Procedures were identical for Study 1 and 
Study 2. 
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Western Blot Protein Analysis 
Right hemisphere dorsal hippocampus, entorhinal cortex, and perirhinal cortex 
from Study 1 were analyzed for GAD65 expression, GAD67 expression, and IGF1-R 
expression via Western blots. Frozen raw tissue samples were suspended in a 1:25 
weight-to-volume RIPA buffer solution (150 mM NaCl, 1%Triton X-100, 0.1% SDS, 
0.5% sodium deoxycholate, 50-mM Tris HCl, protease inhibitor (Millipore-Sigma, 
CAT#5892791001), and phosphatase inhibitor (Millipore-Sigma, CAT#524625) and 
subsequently kept on ice at all times. Tissues were homogenized using a probe sonicator 
(Ultrasonic Processor, Cole Parmer, IL, USA), and then centrifuged at 10,000 rpm for 10 
minutes at 4°C. Supernatant was collected, aliquoted, and frozen at 70°C until analysis. 
Protein concentration for each sample was determined using a bicinchoninic acid protein 
assay (Thermo-Fisher Scientific, Pittsburg, PA, USA).  
Treatment groups were counterbalanced and equally represented on each gel run. 
The NuPAGE PowerEase electrophoresis system was utilized for tissue processing. 
Samples for each region were loaded at an equal protein concentration and were run on a 
4-12% NuPAGE Bis-Tris gel in an XCell SureLock Mini-Cell (Invitrogen, Carlsbad, CA, 
USA) using MOPS running buffer. After transferring to an Immobilon polyvinylidene 
difluoride membrane, the blot was blocked in 5% nonfat milk for one hour at room 
temperature. Following blocking, the membrane was washed in 1xTBST and then 
incubated overnight with primary antibodies for anti-GAD65 (1:5000; Abcam, ab26113), 
anti-GAD67 (1:10,000; Abcam 26116), IGF1-R (1:1000; Cell Signaling, 9750S) loading 
control primary antibody anti-beta-actin (1:20,000: Cell Signaling, 4970S) in 5% nonfat 
milk on a shaker at 4°C. The following day, the membrane was washed in 1xTBST and 
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then incubated with secondary antibodies anti-mouse HRP (1:2000; Cell Signaling 
#7076S) for GAD65 and GAD67, and anti-rabbit HRP (1:2000; Cell Signaling #7074) 
for beta-actin for one hour at room temperature in 5% nonfat milk. The membrane was 
washed again, and developed using chemiluminescence (Lumiglo and peroxide, Cell 
Signaling #7003S) in a film developer (Konica SRX-101A Film Processor, Tokyo, 
Japan). Films were scanned in as JPEG files at 600 dpi. Densitometry analyses were 
completed using ImageJ software (Gallo-Oller et al., 2018). GAD65, GAD67, and IGF1-
R expression was normalized to beta-actin expression on each gel run. A total of 3 gels 
per region were run for Study 1.  
 
Statistical Analyses 
Behavior analyses were identical in Study 1 and Study 2. A priori two-group 
comparisons between each DRSP group and Vehicle were completed using repeated 
measures ANOVA for Study I. For Study II, each DRSP, EE, and DRSP+EE group was 
compared to Vehicle using two-group comparisons. Additionally, we planned to compare 
EE-Low and EE-High groups to each other to assess dose-dependent effects, as well as 
EE-Low, EE-High, and DRSP groups to the combinations of EE+DRSP to evaluate 
effects of the hormones alone versus in combination on spatial working memory. Alpha 
level was set to 0.05 and all comparisons were two-tailed.  
WRAM data were separated into 3 separate blocks based on the learning curve. 
Day 1 was considered training and was excluded from the analysis. Block 1 (Days 2-5) 
was considered the Early Acquisition Phase, Block 2 (Days 6-9) was considered the Late 
Acquisition Phase, and Block 3 (Days 10-12) was considered the Asymptotic Phase. 
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WMC, RM, and WMI errors were analyzed separately for each of the blocks. Treatment 
group was the independent variable, and trials nested within days were the repeated 
measures. Prior research from our laboratory indicates that hormone treatment 
differences become evident when working memory load is taxed, so a priori analyses of 
Trial 3 alone and Trial 4 alone were completed, as previously done (Braden et al., 2010; 
Koebele et al., 2017, 2019; Mennenga, Gerson, et al., 2015; Prakapenka et al., 2018).  
MM data were analyzed using repeated measures ANOVA, with Treatment as the 
independent variable and Swim Distance to Platform (cm) as the dependent variable for 
baseline trials within each planned comparison. Performance on the probe trial was 
analyzed separately for each treatment group with Quadrant (%NE, %SW) as the 
dependent variable. 
OFT data were analyzed using ANOVA, with Treatment group as the independent 
variable, and Total Distance Moved (cm), Center Distance, Center Time, Small Center 
Distance, Small Center Time, Corner Distance, and Corner Time as dependent variables 
for each planned comparison.  
Western blot protein analyses for Study 1 were completed using ANOVA, with 
Treatment as the independent variable and normalized GAD65, GAD67, and IGF1-R 
expression as the dependent variable for each planned comparison. 
Body weight and uterine weight data were also analyzed using ANOVA, with 
Treatment as the independent variable and Weight (g) as a dependent variable for each 
planned comparison. 
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Results 
Study 1: Water Radial-Arm Maze 
Early Acquisition Phase. There was a main effect of Treatment for WMC errors 
on Trial 3 for each planned comparison (Vehicle versus DRSP-Low: F(1,18) = 5.69, p < 
0.05; Vehicle versus DRSP-Medium: F(1,18) = 10.50, p < 0.01; and Vehicle versus DRSP-
High: F(1,18) = 7.57, p < 0.05), indicating that all DRSP-treated rats made fewer errors 
than Vehicle controls on the moderate working memory load trial (Figure 36A). A main 
of effect of Treatment was also present for WMI on Trial 3 for the Vehicle group 
compared to the DRSP-Low group (F(1,18) = 7.83, p < 0.05) and compared to the DRSP-
Medium (F(1,18) = 5.13, p < 0.05) group, where DRSP-treated groups made fewer WMI 
errors compared to Vehicle-treated rats (Figure 36B). There were no effects of RM for 
the Early Acquisition Block. 
Late Acquisition Phase. There were no main effects of Treatment during the 
Late Acquisition Phase for WMC, WMI, or RM errors. 
Asymptotic Phase. There was a main effect of Treatment for WMI errors on 
Trial 4 for the Vehicle versus DRSP-Medium comparison [F(1,18)=4.47, p < 0.05], such 
that the DRSP-Medium rats made fewer WMI errors on the maximum working memory 
load trial compared to the Vehicle treated rats (Figure 36C). There were no effects of RM 
in the Asymptotic Phase.   
Delayed Memory Retention. WMC errors on Trial 3 from the last day of 
baseline testing (day 12) were compared to Trial 3 after the 6 hour delay (first post-delay 
trial) for each treatment group. Post-delay errors on Trial 3 were increased for Vehicle 
rats [F(9,1)=5.44, p < 0.05] and DRSP-Low rats [F(9,1)=10.79, p < 0.01] compared to the 
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previous day’s performance (Figure 37A,B). DRSP-Medium rats [F(9,1)=3.65, p = 0.09] 
and DRSP-High rats [F(9,1)=4.37, p = 0.07] tended to make more WMC errors on Trial 3 
after a delay, although these analyses did not reach statistical significance (Figure 
37C,D).  
 
Study 1: Morris Water Maze  
Day 1 was considered a training day and was not included in the analyses. For 
Days 2-5, the Learning Curve can be seen in Figure 38A. There was a main effect of 
Treatment for the Vehicle versus DRSP-Medium comparison [F(1,18) = 8.03, p < 0.01], 
where DRSP-Medium rats swam less distance to the platform compared to Vehicle-
treated rats (Figure 38C). Each treatment group was analyzed separately on the probe 
trial. There was a main effect of Quadrant for each group (Vehicle: [F(9,1) = 60.17, p < 
0.0001]; DRSP-Low: [F(9,1) = 174.65, p < 0.0001]; DRSP-Medium: [F(9,1) = 78.85, p < 
0.0001]; DRSP-High: [F(9,1) = 56.32, p < 0.0001]). All rats had a greater percent of total 
swim distance in the target quadrant that previously contained the platform compared to 
the opposite quadrant (Figure 38E).  
 
Study 1: Open Field Task 
 There was no main effect of Treatment for Total Distance in any planned 
comparison, indicating that DRSP treatment did not impact overall locomotor activity. 
Although there were no significant effects of Treatment, the Vehicle versus DRSP-
Medium comparison revealed that for Small Center Distance [F(1,18) = 3.59, p = 0.07] and 
Time [F(1,18) = 4.12, p = 0.06], a marker of anxiolytic behavior, there was a marginal main 
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effect of Treatment, where the DRSP-Medium-treated rats tended to have increased 
distance covered and time spent in the Small Center of the OFT compared to Vehicle-
treated rats. There was also a marginal effect of Corner Time for the DRSP-High rats 
versus Vehicle rats [F(1,18) = 3.14, p = 0.09], where DRSP-High rats tended to spend more 
time in the Corners than Vehicle rats.  
 
Study 1: Peripheral Markers of Hormone Stimulation 
Body Weight. There was no main effect of Treatment on body weight at sacrifice 
for any two-group comparison, indicating the drospirenone administration did not 
influence body weight after Ovx compared to Vehicle treatment in this experiment 
(Figure 39A). 
Vaginal Smears. All vaginal smears were diestrus-like or blank, regardless of 
treatment group, indicating that daily drospirenone at any dose did not impact vaginal 
cytology following Ovx.  
Uterine Weights. There were no main effects of Treatment for uterine weights 
for any two-group comparison, such that daily drospirenone administration at Low, 
Medium, or High doses did not alter uterine weight compared to Vehicle-treated rats 
(Figure 39B).  
 
Study 1: Western Blot Protein Analysis 
 There were no main effects of Treatment present for GAD65 expression, GAD67 
expression, or IGF1-R expression in the dorsal hippocampus, entorhinal cortex, or 
perirhinal cortex for any two-group comparison (Figure 40A-C).  
 
184 
Study 2: Water Radial-Arm Maze 
Early Acquisition Phase. For the Vehicle versus DRSP comparison, there was a 
main effect of Treatment for WMI errors on Trial 3 [F(1,18) = 7.03, p < 0.05] where DRSP-
treated rats made fewer errors than Vehicle-treated counterparts, replicating findings 
from Study 1 (Figure 41A). DRSP alone versus combination treatment comparisons 
revealed that on Trial 3, DRSP+EE-Low rats [F(1,18) = 7.79, p < 0.05]  and DRSP+EE-
High rats [F(1,18) = 10.23, p < 0.01] each made more WMI errors than DRSP-treated rats, 
indicating that the addition of EE at either dose impaired working memory during the 
Early Acquisition block of testing (Figure 41A). No significant Treatment effects were 
detected for WMC errors or RM errors for the planned comparisons during the Early 
Acquisition Phase.  
Late Acquisition Phase. For Trial 3, there was a main effect of Treatment for 
WMI errors between the EE-High versus EE-High+DRSP groups [F(1,18) = 5.65, p < 
0.05], where EE-High+DRSP made fewer WMI errors on Trial 3 compared to EE-High 
alone (Figure 41B). For Trial 4 (the maximum working memory load trial), there was a 
main effect of Treatment for WMC errors between the EE-Low versus EE-Low+DRSP 
groups, where the EE-Low+DRSP-treated rats made more WMC errors than the DRSP 
alone group [F(1,18) = 5.17, p < 0.05; Figure 41C].  
Asymptotic Phase. There were no main effects of Treatment during the 
Asymptotic Phase for WMC, WMI, or RM errors for any planned comparison.  
Delayed Memory Retention. WMC errors on Trial 3 from the last day of 
baseline testing (day 12) were compared to Trial 3 after the 6 hour delay (first post-delay 
trial) for each treatment group. Post-delay errors on Trial 3 were increased for the EE-
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Low group [F(9,1)=19.29, p < 0.01; Figure 42B], the EE-High group [F(9,1)=16.20, p < 
0.01; Figure 42C],  and the EE-Low+DRSP group [F(9,1)=12.52, p < 0.01; Figure 42E] 
compared to the previous day’s performance. The Vehicle group tended to make more 
WMC errors on Trial 3 after a delay, although these analyses did not reach statistical 
significance [F(9,1)=4.97, p = 0.05; Figure 42A]. The DRSP group [F(9,1)=0.43, p = NS; 
Figure 42D] and the EE-High+DRSP group [F(9,1)=2.44, p = NS; Figure 42F] did not 
exhibit a significant increase in WMC errors on the post-delay trial compared to Trial 3 
performance on the last day of baseline testing. 
 
Study 2: Morris Water Maze 
Day 1 was considered a training day and was excluded from the analysis. For 
Days 2-5, there were no main effects of Treatment for any two-group planned 
comparisons (Figure 43A).  
Each treatment group was analyzed separately on the probe trial. There was a 
main effect of Quadrant for each group (Vehicle: [F(9,1) = 63.43, p < 0.0001]; DRSP: 
[F(9,1) = 40.74, p < 0.0001]; EE-Low: [F(9,1) = 191.53, p < 0.0001]; EE-High: [F(9,1) = 
76.74, p < 0.0001]; EE-Low+DRSP: [F(9,1) = 92.29, p < 0.0001]; EE-High+DRSP: [F(9,1) 
= 63.36, p < 0.0001]). In other words, all rats had a greater percent of total swim distance 
in the target quadrant that previously contained the platform compared to the opposite 
quadrant (Figure 43B).  
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Study 2: Open Field Task 
Two-group comparisons were completed for OFT data. Total Distance moved 
(cm) in the arena was a marker of locomotor activity (Figure 44A); main effects of 
Treatment were observed for the EE-Low versus EE-High comparison [F(1,18) = 10.77, p 
< 0.01], with EE-High rats having a greater distance covered in the 10 minute trial. 
Additionally the DRSP versus EE-High+DRSP groups differed in Total Distance moved 
[F(1,18) = 4.96, p < 0.05], where DRSP+EE-High rats covered a greater distance than 
DRSP-treated rats. Center Distance (cm), an indicator of anxiolytic behavior (Figure 
44B), showed that a main effect of Treatment between the Vehicle group and the EE-
High group [F(1,18) = 5.92, p < 0.05], where EE-High rats covered more distance in the 
center of the arena compared to Vehicle treated rats. Additionally there was a main effect 
of Treatment for EE-Low versus EE-High groups [F(1,18) = 9.14, p < 0.01], where EE-
High-treated rats moved more in the Center. Small Center Distance (cm) was distance 
traveled in the immediate center of the arena, and can be an additional marker of 
anxiolytic behavior (Figure 44C). There was a main effect of Treatment for EE-Low 
versus EE-High groups [F(1,18) = 4.71, p < 0.05], where EE-High treated rats traveled 
more distance in the Small Center, although this may be an artifact of this group covering 
overall greater distance across the 10-minute trial. Corner Distance analyses, a measure 
of anxiety-like behavior (Figure 44D), revealed a main effect of Treatment for the 
Vehicle versus EE-Low comparison [F(1,18) = 5.41, p < 0.05], as well as for the Vehicle 
versus EE-Low + DRSP comparison [F(1,18) = 6.99, p < 0.05], where the Vehicle group 
traveled more distance in the corner than the EE-Low group and the EE-Low+ DRSP 
group, respectively, for Corner Distance.  
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In addition to distance, time measures were evaluated for the OFT. For Time 
Spent in the Center (s; Figure 44E), there was a main effect of Treatment for the planned 
comparison between Vehicle versus EE-High groups F(1,18) = 7.02, p < 0.05], EE-Low 
versus EE-High groups [F(1,18) = 8.40, p < 0.01], and EE-High versus EE-High+DRSP 
[F(1,18) = 4.69, p < 0.05] groups, where the EE-High group spent more time in the Center 
than each respective group. Small Center time did not differ for any comparison (Figure 
44F). Corner Time measures of anxiety-like behavior were also evaluated (Figure 44G); 
there was a main effect of Treatment for the Vehicle versus EE-High comparison [F(1,18) = 
9.05, p < 0.01] and the Vehicle versus EE-Low+DRSP comparison [F(1,18) = 10.42, p < 
0.01], where Vehicle-treated rats spent more time in the corner in each case. There was 
also a main effect of Treatment for the EE-Low versus EE-Low+DRSP comparison 
[F(1,18) = 5.21, p < 0.05], where EE-Low spent more time in the corner than rats receiving 
the combination of EE-Low+DRSP.  
 
Study 2: Peripheral Markers of Hormone Stimulation 
Body Weights. Two-group comparisons were completed for body weight at 
euthanasia (Figure 45A). The Vehicle group weighed more than the EE-Low group 
[F(1,18) = 36.26, p < 0.0001], EE-High group [F(1,18) = 26.24, p < 0.0001], EE-Low+DRSP 
group [F(1,18) = 40.02, p < 0.0001], and EE-High+DRSP group [F(1,18) = 36.61, p < 
0.0001]. The Vehicle group tended to weigh less than the DRSP group [F(1,18) = 3.69, p 
=0.07], although this effect did not reach statistical significance. EE-Low and EE-High 
groups did not differ from one another. Additionally, the EE-Low group did not differ 
from the EE-Low+DRSP group, nor did the EE-High group differ from the EE-
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High+DRSP group. However, the DRSP group weighed more than the EE-Low+DRSP 
group [F(1,18) = 53.94, p < 0.0001] and the EE-High+DRSP group [F(1,18) = 51.22, p < 
0.0001]. Collectively, EE-treated groups, with and without concomitant DRSP 
administration, did not differ from one another, suggesting that EE administration 
decreased body weight in Ovx rats compared to Vehicle-treated Ovx rats, and DRSP 
treatment did not further alter body weight when combined with EE, at least at this time 
point and the doses given.  
Vaginal Smears. The Vehicle group and the DRSP group exhibited blank or 
diestrus-like smears for all 3 days evaluated, indicating successful Ovx and a lack of 
stimulation from daily drospirenone treatment alone, replicating results from Study 1. For 
rats treated with EE-Low, EE-High, EE-Low+DRSP, and EE-High+DRSP, all animals 
exhibited cornified cells in vaginal smears across all days, indicating EE-induced 
stimulation of the vaginal epithelium.  
Uterine Weights. Two-group comparisons were completed for uterine weights at 
euthanasia (Figure 45B). Wet uterine weight (g) was lower in the Vehicle group 
compared to the EE-Low group [F(1,18) = 246.14, p < 0.0001], EE-High group [F(1,18) = 
153.73, p < 0.0001], EE-Low+DRSP group [F(1,18) = 351.73, p < 0.0001], and EE-
High+DRSP group [F(1,18) = 114.6, p < 0.0001]. Uterine weights from the Vehicle group 
and DRSP group did not differ from one another, replicating findings from Study 1. The 
DRSP group also had significantly lower uterine weights compared to the EE-
Low+DRSP group [F(1,18) = 386.84, p < 0.0001] and the EE-High+DRSP group [F(1,18) = 
118.16, p < 0.0001]. Uterine weights from the EE-High group weighed more than the EE-
Low group [F(1,18) = 7.60, p < 0.01]. The EE-Low group did not differ from the EE-
 
189 
Low+DRSP group, nor did the EE-High group differ from the EE-High+DRSP group. 
Overall this indicated that unopposed EE-High treatment significantly increased uterine 
weights, while drospirenone treatment did not have a significant influence on uterine 
weights compared to Vehicle or when combined with EE. 
 
Discussion 
 Hormone containing contraceptives —including COCs— are commonly utilized 
by women of reproductive age for a variety of indications including not only 
contraceptive use, but also as management of other hormone-related conditions such as 
endometriosis, severe acne, and PMDD. Although the estrogen component, EE, is 
consistent across most preparations, the progestin component of COCs varies widely. 
Progestins in these formulations are derived from a variety of parent molecules that result 
in variable pharmacokinetic profiles and biological activity. Drospirenone, a fourth-
generation progestin derived from spironolactone, has a unique pharmacological profile 
and is structurally more similar to natural progesterone than other earlier-generation 
progestins. Ovarian hormones are known modulators of the brain and cognition, and it is 
crucial to understand how this commonly-prescribed progestin influences learning and 
memory processes alone and in combination with EE, especially given that progestins 
evaluated in our laboratory and others often result in detrimental cognitive effects. 
Drospirenone’s unique properties merited investigation into its potential impact on 
cognition. 
 In Study 1, a range of drospirenone doses were evaluated in a young adult, Ovx 
rat model to determine if there was a dose-dependent response to drospirenone for spatial 
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learning and memory compared to Vehicle-treated rats. We found that the Medium dose 
of drospirenone, which most closely models the typical ratio of drospirenone to EE used 
in COC formulations, had beneficial effects on spatial working memory when memory 
load was taxed compared to Vehicle-treated rats. The Low and High doses of 
drospirenone also showed benefits for working memory performance during the Early 
Acquisition Phase, but the Medium dose was the only dose of drospirenone that 
continued to exhibit benefits to spatial working memory in the Asymptotic Phase of the 
WRAM on the maximum working memory load trial. A six-hour delay on the WRAM 
significantly impaired working memory performance for Vehicle and DRSP-Low treated 
groups, but only marginally impaired DRSP-Medium and DRSP-High doses on the post-
delay trial, suggesting the potential for a dose-dependent effect for delayed memory 
retention. In the MM, a test of spatial reference memory, again the DRSP-Medium dose 
showed benefits for reference memory performance compared to Vehicle-treated rats, 
such the DRSP-Medium group swam less distance, on average, to the platform than 
Vehicle-treated rats across days 2-5 of the MM. The probe trial indicated that each 
treatment group spatially localized to the quadrant where the platform was previously 
located. Although several proteins of interest associated with spatial learning and 
memory, including GAD65, GAD67, and IGF1-R were evaluated in the dorsal 
hippocampus as well as the entorhinal and perirhinal cortices, no differences in protein 
expression were revealed for any two-group comparison. It is possible that the behavioral 
effects observed in this experiment are regulated by different neural systems. 
Alternatively, the chronic nature of Ovx and daily hormone administration could have led 
to reorganizational processes in the systems of interest by the time brains were evaluated; 
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another possibility is that alterations to these neural systems are not evident at the level of 
protein expression, at least at the time point assessed. Evaluations for other proteins and 
signaling cascades known to change with ovarian hormone loss and replacement, as well 
as other brain regions involved in spatial working memory, should be investigated to 
establish a possible underlying neurobiological mechanism for the cognitive effects 
observed here. 
 In Study 2, the Medium dose of drospirenone was administered alone and in 
combination with two doses of EE. The ratios of drospirenone to EE reflected commonly 
prescribed doses of hormone in COCs. In the Early Acquisition phase of the WRAM, we 
replicated the finding that drospirenone enhanced spatial working memory when memory 
load was taxed compared to Vehicle-treated rats. DRSP-treated rats also had enhanced 
performance during the Early Acquisition Phase compared to both combinations of 
DRSP + EE, suggesting that concomitant EE administration attenuated the beneficial 
effects of drospirenone alone. This result supports and extends prior findings in our 
laboratory using another progestin, levonorgestrel, wherein the progestin was beneficial 
when administered alone, but resulted in spatial working memory impairments when 
administered in combination with the endogenous estrogen, 17b-estradiol, in middle-aged 
Ovx rats (Prakapenka et al., 2018). During Late Acquisition, the EE-High dose impaired 
working memory compared to EE-High+DRSP treatment, indicating a potential benefit 
of combined hormone treatment in relation to estrogen-only treatment, at least at a high 
dose. However, Low-EE treated rats made fewer working memory errors than combined 
Low-EE+DRSP treated rats during Late Acquisition, suggesting that working memory 
outcomes could be dependent on both dose and combination of hormones in this Ovx 
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model. A six-hour delay impaired working memory performance for EE-Low, EE-High, 
and EE-Low+DRSP groups. The Vehicle group trended toward a delay-induced 
impairment, while the DRSP group and the EE-High+DRSP group did not exhibit poorer 
performance following the delay. These findings points to a potential protective effect of 
drospirenone on delayed memory retention alone and in combination with EE-High 
treatment. There were no differences on the MM task in Study 2; each treatment group 
swam more distance in the previously-platformed quadrant versus the opposite quadrant 
during the probe trial, indicating that all subjects spatially localized to the platform 
location. Differences in the OFT were evident in Study II, with the EE-High group 
having overall increased locomotor activity compared to Vehicle and EE-Low groups. 
Differences between EE-High and other treatment groups for other measures in the OFT 
may have been due to an overall change in locomotor activity, making these findings 
difficult to interpret clearly in the context of anxiety-like behaviors. EE treatment also 
affected body weight, where all rats treated with EE, alone and in combination with 
drospirenone, weighed less than Vehicle-treated rats at euthanasia. In addition, the DRSP 
group weighed more than the EE-Low+DRSP and EE-High+DRSP groups, and tended to 
weigh more than the Vehicle group. This was surprising, given drospirenone’s anti-
mineralocorticoid receptor properties as it pertains to water retention and metabolic 
effects. However, it is important to note that all rats in this experiment were Ovx, and 
therefore it is possible that the metabolic effects of Ovx impacted body weight over and 
above any potential effect drospirenone could have on body weight. To this end, an 
evaluation of drospirenone administration on weight maintenance or gain in ovary-intact 
rats would be informative in the future. Uterine weight was increased for all EE-treated 
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rats at sacrifice, supporting the idea that EE stimulates uterine tissue growth, a finding we 
have previously reported (Mennenga, Gerson, et al., 2015). The dose of drospirenone 
given in combination with EE treatments did not attenuate uterine weight at sacrifice, 
suggesting the dose given was insufficient to counter EE-induced uterine stimulation in 
this Ovx model. This is a primary role of progestins in COCs, and thus different ratios of 
drospirenone to EE will be important to investigate in the future. 
 Overall, this series of experiments found that the fourth-generation progestin 
drospirenone had beneficial effects for spatial working memory performance in a young 
adult Ovx rat model. The Medium dose of drospirenone, which is a dose modeled after 
the ratio of drospirenone to EE prescribed in COCs, was consistently beneficial for 
working memory performance across early and late phases of the WRAM, as well as for 
reference memory in the MM in Study 1, compared to Vehicle-treated rats. When this 
dose of drospirenone was combined with low and high doses of EE in Study 2, the 
combination treatment attenuated the beneficial cognitive effects of drospirenone 
compared to drospirenone treatment alone during learning. Because drospirenone did not 
decrease uterine weights for the combination treatment groups, it is possible that a higher 
dose of drospirenone would be necessary to counteract the proliferative effects of EE, 
especially at the high estrogen dose. It is notable that our laboratory has previously 
reported that High-EE treatment impaired spatial working memory (Mennenga, Gerson, 
et al., 2015); again, a higher dose of drospirenone could be necessary to result in 
beneficial cognitive effects when combined with EE. Future investigations using an 
ovary-intact rat model with these combination therapies would be beneficial to 
understand how combination treatment impacts cognitive function in a normally-cycling 
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reproductive system, as the majority of women prescribed COCs have an intact uterus 
and ovaries. Additionally, further investigations into neurobiological mechanisms 
underlying these cognitive changes are necessary to aid our understanding of how 
different progestins affect spatial learning and memory. While drospirenone treatment 
alone has promise for beneficial cognitive effects, the search continues for an estrogen-
progestin combination therapy that results in null or even beneficial cognitive outcomes. 
Discovering these optimal hormone combinations are necessary to provide information to 
the millions of women taking hormone-containing COCs and hormone therapy in order 
for individuals to have an informed understanding of the risks and benefits of utilizing 
hormone-containing drugs for contraceptive use and other hormone-related health 
conditions that impact quality of life.  
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ABSTRACT 
Approximately one-third of women experience hysterectomy, or the surgical 
removal of the uterus, by age 60, with most surgeries occurring prior to the onset of 
natural menopause. The ovaries are retained in about half of these surgeries while, for the 
other half, hysterectomy occurs concurrently with oophorectomy. The dogma is that the 
non-pregnant uterus is dormant. There have been no preclinical assessments of surgical 
variations in menopause including hysterectomy, with and without ovarian conservation, 
on potential endocrine and cognitive changes. We present a novel rat model of 
Hysterectomy alongside Sham, Ovariectomy (Ovx), and Ovx-Hysterectomy groups to 
assess effects of surgical menopause variations. Rats without ovaries learned the working 
memory domain of a complex cognitive task faster than those with ovaries. Moreover, 
uterus removal alone had a unique detrimental impact on the ability to handle a high-
demand working memory load. The addition of Ovx, that is, Ovx-Hysterectomy, 
prevented this hysterectomy-induced memory deficit. Performance did not differ amongst 
groups in reference memory-only tasks, suggesting that the working memory domain is 
particularly sensitive to variations in surgical menopause. Following uterus removal, 
ovarian histology and estrous cycle monitoring demonstrated that ovaries continued to 
function, and serum assays indicated altered ovarian hormone and gonadotropin profiles 
by two months post-surgery. These results underscore the critical need to further study 
the contribution of the uterus to the female phenotype, including effects of hysterectomy 
with and without ovarian conservation, on the trajectory of brain and endocrine aging to 
decipher the impact of common variations in gynecological surgery in women. Moreover, 
findings demonstrate that the nonpregnant uterus is not dormant, and indicate that there is 
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an ovarian-uterus-brain system that becomes interrupted when the reproductive tract has 
been disrupted, leading to alterations in brain functioning. 
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Introduction 
One of the most common gynecological surgical interventions in women, second 
only to cesarean section, is hysterectomy, or the surgical removal of the uterus (Carlson 
et al., 1993; United States Center for Disease Control and Prevention, 2010). 
Approximately half of the women who undergo hysterectomy retain their ovaries. This 
approach is taken to alleviate adverse symptoms associated with benign uterine 
conditions prompting hysterectomy while maintaining the ovarian tissue, thus preventing 
an abrupt menopause onset and other deleterious health effects if the woman is of 
reproductive age at the time of surgery (Whiteman et al., 2008). Despite the number of 
hysterectomy surgeries declining in recent years, it is estimated that currently, by age 60, 
one-third of women have undergone hysterectomy, with most women undergoing 
hysterectomy before age 50 (J. D. Wright et al., 2013). Thus, the majority of 
hysterectomies are performed before the average onset of natural menopause, which 
typically occurs between ages 51-52 (Hoffman et al., 2012; NAMS, 2014). Some 
research in premenopausal women suggests that hysterectomy disrupts normal ovarian 
function and initiates ovarian failure earlier than transitionally menopausal women who 
maintain their uterus, potentially due to localized ovarian blood flow disruption (Chan, 
Ng, & Ho, 2005; Kaiser, Kusche, & Würz, 1989; Kritz-Silverstein, Goldani Von Muhlen, 
& Barrett-Connor, 2000; Moorman et al., 2011; Read, Edey, Hapeshi, & Foy, 2010), 
while others report little to no change in ovarian function following hysterectomy 
(Beavis, Brown, & Smith, 1969; Chalmers et al., 2002; Findley et al., 2013). Of note, the 
measures used to operationally define normal ovarian function versus ovarian failure are 
not always consistent. Within the primary operational definition of menopause— 
 
200 
amenorrhea for twelve consecutive months (Hoffman et al., 2012; NAMS, 2014) — 
women who undergo hysterectomy with ovarian conservation could be considered 
menopausal in clinical practice despite continued ovarian function following surgery. 
Thus, determining the onset of the menopause transition in women who have undergone 
hysterectomy can be challenging, and may be defined as the onset of menopausal 
symptoms (e.g., hot flashes) rather than menstrual irregularity (for discussion, see 
Chalmers et al., 2002), both of which may not occur simultaneously, or may not occur in 
a sequential fashion where one precedes the other, in reproductively-intact women (Wise 
et al., 1999). The timing and etiology of menopause may prove to be critical to aging 
outcomes, and for determining an optimal time point for initiating individualized 
hormone therapy intervention to obtain the most favorable quality of life outcomes.  
Pre- and post- menopausal circulating reproductive hormone profiles are 
significantly different from one another. There is abundant evidence that endogenous 
ovarian hormones — particularly estrogens — have neuroprotective properties and 
beneficial effects on the health and functioning of several body systems, including 
cardiovascular, skin, bone, and urogenital systems (Hoffman et al., 2012). Disruptions to 
the reproductive hormone feedback loop via gynecological surgery likely have 
differential effects on the function of these systems depending on age and menopause 
status at the time of surgery, as well as whether or not the ovaries are retained. Both 
human and pre-clinical animal research indicate that an abrupt loss of circulating ovarian 
hormones from oophorectomy (the surgical removal of the ovaries; in non-human 
animals, termed ovariectomy [Ovx]) prior to natural reproductive senescence can be 
detrimental to many aspects of health, including cognition (Bimonte & Denenberg, 1999; 
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Farrag et al., 2002; Gibbs & Johnson, 2008; Nappi et al., 1999; Rocca et al., 2007, 2011, 
2012, 2009; Talboom et al., 2008; M. Wallace et al., 2006). Animal model studies of 
surgical menopause via Ovx confirm a significant decrease in serum ovarian steroid 
hormones and an increase in gonadotropin levels following surgical ovary removal 
(Acosta et al., 2010; Gibbs & Johnson, 2008). When ovaries are conserved during 
hysterectomy, they have the potential to function normally following hysterectomy if the 
surgery occurs during the pre-menopausal years. Although there has been limited study 
of ovarian structure and function following hysterectomy in women, some reports 
indicate that hysterectomy with ovarian conservation does not result in similar drastic 
changes in circulating ovarian hormones and gonadotropins as occurs with 
oophorectomy, because the steroid-producing ovaries remain intact (Chalmers et al., 
2002; Corson, Levison, Batzer, & Otis, 1981). Nonetheless, whether ovarian structure 
and function are altered following hysterectomy, particularly when the surgery occurs 
during reproductive years, has been understudied. There is evidence that transient post-
hysterectomy steroid hormone changes can occur. Vuorento and colleagues assessed 
daily salivary progesterone levels pre- and post- operatively in pre-menopausal women 
who underwent hysterectomy with ovarian conservation, and reported that 39% of the 
women had decreased progesterone levels during the luteal phase in at least one 
menstrual cycle within six months of the surgery. Of these women, most irregular serum 
progesterone levels occurred one month after hysterectomy; the majority of these women 
returned to preoperative progesterone levels by six months post-surgery, suggesting that 
alterations in ovulatory function and steroidogenesis following hysterectomy could be 
transient (Vuorento, Mäenpää, & Huhtaniemi, 1992). Other clinical studies have reported 
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no changes in circulating ovarian hormone levels up to 21 years post-hysterectomy when 
the ovaries were conserved (Beavis et al., 1969; Souza, Fonseca, Izzo, Clauset, & 
Salvatore, 1986), or variable estrogen levels up to 10 years after hysterectomy which 
result in inconclusive evidence for altered hormone profiles following the surgical 
removal of the uterus alone (Kaiser et al., 1989).  Collectively, there remains a lack of 
comprehensive, longitudinal assessments in the clinical literature to conclusively 
determine the short- or long- term impact of hysterectomy on ovarian structure and 
function.  
The uterus and ovaries are part of an intricately connected system including the 
hypothalamus, pituitary, and female reproductive tract. Over the past few decades, it has 
become clear that this system —and the hormone milieu produced by it— influences 
domains reaching far beyond reproduction alone with actions on many body systems, 
including the brain (for review, see Dubal & Wise, 2002; Turgeon, Carr, Maki, 
Mendelsohn, & Wise, 2006). For example, research in animal models shows that 
experimental manipulations to the endogenous ovarian hormone milieu impacts cognition 
(Daniel, 2013; Frick, 2015; Koebele & Bimonte-Nelson, 2015; Korol & Pisani, 2015; 
Luine, 2014). While the steroid-producing ovaries have been the main focus of these and 
the majority of related basic science investigations, the uterus is also tightly linked to the 
hypothalamic-pituitary-ovarian axis loop and the potentially wide-reaching effects of this 
system. Indeed, despite the long-held dogma that the non-pregnant uterus is a dormant 
and “useless organ” (p. 294) (Navot & Williams, 1991), there is evidence that the uterus 
contains gonadotropin and steroid hormone receptors (Lessey et al., 1988; Reshef et al., 
1990; Stilley et al., 2014), as well as direct sensory and autonomic innervation from the 
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central and peripheral nervous systems (Aguado & Ojeda, 1984; Dyer & Erickson, 1985; 
Gnanamanickam & Llewellyn-Smith, 2011), even in a non-pregnant state. Thus, it is 
biologically plausible, and in fact likely, that hysterectomy itself, with or without ovarian 
conservation, sufficiently alters the hypothalamic-pituitary-female reproductive tract 
system and, as a result, plays a role in altering the brain and cognition. Along these lines, 
several recent retrospective clinical studies have reported an increased relative risk of 
early-onset dementia for women who underwent hysterectomy compared to women with 
no history of hysterectomy, particularly when the surgery occurred prior to menopause 
onset (Phung et al., 2010; Rocca et al., 2007, 2012). In contrast, another group reported a 
small decrease in the relative risk for developing Alzheimer’s disease associated with 
oophorectomy, hysterectomy, and oophorectomy with hysterectomy; notably, the 
majority of the women in this study were >51 at the time of surgery, and were therefore 
likely post-menopausal (Imtiaz et al., 2014), with studies collectively suggesting that 
menopause status at the time of gynecological surgery could impact cognitive outcomes. 
In order to elucidate the impact of variations in surgical menopause on the brain and 
cognition during aging, we must acknowledge and appreciate the complexity of this 
multifaceted system and include the examination of the influence of uterine tissues into 
experimental models. 
Few studies have assessed hysterectomy in a pre-clinical animal model. A handful 
of endocrine studies using hysterectomy in a rodent model demonstrated that 
hysterectomy with ovarian conservation resulted in unique endocrine changes, such as 
increased ovarian aromatase activity, elevated follicle stimulating hormone (FSH) levels, 
and potentially accelerated ovarian failure via follicle atresia (Biró et al., 1984; Özdamar 
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et al., 2005; Tanaka et al., 1994; Tapisiz et al., 2008). Hysterectomy provides a novel 
model for investigating variations in surgical menopause in the context of studying 
cognition. Specifically, the additional factor of the presence or absence of uterine tissue 
provides an ancillary perspective to Ovx menopause models by more closely modeling 
the surgical procedures that occur most often in clinical practice. Indeed, it is not 
common practice to remove only the ovaries in women, as does the classic Ovx model 
used in basic science research.  
The cognitive effects of hysterectomy with and without ovarian conservation have 
not yet been fully explored in a systematic experimental context. Given the large number 
of women who undergo variations in gynecological surgeries, it is essential to understand 
how ovarian morphology and function may be altered following hysterectomy, as well as 
to elucidate how hysterectomy with and without ovarian preservation relates to the 
trajectory of brain aging and cognitive decline. For a truly translational approach, it is 
crucial to establish and methodically assess a pre-clinical rodent model of the most 
common surgical practices performed in women to obtain a complete understanding of 
how these surgical manipulations affect endocrine as well as cognitive and brain aging. 
Additionally, using a rodent model allows for a controlled manipulation of the type of 
surgical procedures and the age at which they occur, which is one of the primary 
complexities in interpreting outcomes when evaluating these phenomena in humans. The 
rodent reproductive system is well-defined and is in many ways functionally similar to 
the human; as such, the rat provides an excellent pre-clinical model to investigate the 
impact of hysterectomy on the brain and cognition. Of note, the uterine body of the rat 
bifurcates into two uterine horns, which will collectively be referred to as the uterus 
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hereafter. We herein aimed to methodically investigate how hysterectomy in adulthood 
(i.e., prior to the onset of reproductive senescence), with and without ovarian 
conservation, impacts cognition using a rat model. Utilizing this novel surgical model of 
hysterectomy, we evaluated spatial learning and memory performance in adult rats that 
received variations in surgical menopause, including ovariectomy, hysterectomy, 
ovariectomy plus hysterectomy and sham operations (Figure 46). Our systematic 
experimental design also allowed for simultaneous evaluation of endocrine and ovarian 
profiles known to change following variations in gynecological surgery, including 
putative biomarkers of menopause. Specifically, we assessed serum hormone levels of 
ovarian-derived hormones and the gonadotropins and ovarian follicle morphology, as 
well as monitored estrous cyclicity and body weight changes, in order to gain a 
comprehensive understanding of the far-reaching impact variations in gynecological 
surgeries have on the body’s reproductive anatomy, physiology, and function, and how 
these factors ultimately may lead to cognitive changes.  
 
Methods 
Subjects 
Sixty virgin, reproductively-intact female Fischer-344-CDF rats were obtained 
from the National Institute on Aging colony at Charles Rivers Laboratories (Raleigh, NC, 
USA). Subjects arrived at the animal facility at 5 months of age, were provided food and 
water ad libitum, and were maintained on a 12-hour light/dark cycle for the duration of 
the study. Rats were given 1 week to acclimate to the vivarium prior to beginning the 
experiment. All procedures in this experiment were approved by the Arizona State 
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University Institutional Animal Care and Use Committee and adhered to National 
Institutes of Health standards. 
 
Surgical Procedures 
Rats were randomly assigned to 1 of 4 treatment groups: Sham, Ovariectomy 
(Ovx), Hysterectomy, or Ovx plus Hysterectomy (Ovx-Hysterectomy). Surgeries were 
performed 1 week after arrival. All rats were anesthetized with inhaled isoflurane 
anesthesia and received 1.0 mg/kg meloxicam (NSAID), 1.2 mg/kg buprenorphine-SR-
LAB, and 5.0 mL of an isotonic solution used to ensure post-surgical hydration. All 
subjects received a ventral midline incision through the skin and peritoneum. The sham 
surgery group received skin and peritoneum incisions only. In the Ovx group, both 
ovaries were exposed, ligated along with the oviducts and tips of the uterine horns, and 
excised. In the Hysterectomy group, each uterine horn was ligated and cut below the 
ovary and oviduct. The uterus was then separated from the adjacent fat, and the 
uterocervical junction was ligated and cut above the cervix, at the base of the uterine 
body. In the Ovx-Hysterectomy group, the ovaries and uterus were separated from the 
internal fat, and the uterocervical junction was ligated and cut above the cervix. All 
groups’ muscle incisions were sutured with dissolvable Vicryl suture, and bupivacaine 
(Marcaine, Pfizer Pharmaceutical, Hospira Inc., Lake Forest, IL) was applied to the 
muscle incision prior to skin closure for all subjects. The skin incision was closed with 
surgical staples. Rats were allowed to recover under a heat lamp and were single-housed 
for 7 days following the surgery. Two rats died after surgery. As a result, 1 Hysterectomy 
rat and 1 Ovx rat were single-housed; the remaining subjects were pair-housed for the 
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entirety of the study. The final n’s per group used in the statistical analyses are the 
following, unless otherwise noted: Sham n = 15, Hysterectomy n = 14, Ovx n = 14, and 
Ovx-Hysterectomy n = 15. 
 
Weights and Vaginal Cytology 
Baseline weights were recorded at surgery, and weekly weights were recorded 
until behavior testing began. Two weeks after surgery, daily vaginal smears were 
evaluated for eight consecutive days to monitor estrous cyclicity following surgery. 
Smears were classified according to Goldman et al. (Goldman et al., 2007) and 
Mennenga and Bimonte-Nelson (Mennenga & Bimonte-Nelson, 2015), as proestrus, 
estrus, metestrus, or diestrus phases. Proestrus was characterized by the presence of 
round epithelial cells and some cornified cells. Estrus was classified by the presence of 
primarily cornified cells. Metestrus included the presence of cornified cells, round cells, 
needle-like cells, and leukocytes. Diestrus was characterized by leukocytes with or 
without cornified cells.  
 
Behavioral Testing 
Figure 47 illustrates the timeline for the experiment. 
Water radial-arm maze. Behavior testing began 6 weeks after surgery. The 
water radial-arm maze (WRAM) is a win-shift, 8-arm water escape task that tests spatial 
working and reference memory in rodents (Bimonte-Nelson et al., 2015, 2004; Bimonte-
Nelson, Singleton, Hunter, et al., 2003; Bimonte & Denenberg, 1999; Bimonte et al., 
2002, 2000, 2003) The maze had 8 evenly spaced arms radiating out from the circular 
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center (each arm 39.37 cm x 13.97 cm). Salient spatial cues were located around the 
room to assist in spatial navigation. Room temperature water (maintained at 18-20°C) 
was made opaque with black non-toxic powdered paint. Platforms were hidden in the 
ends of four of the eight arms, submerged just beneath the water surface. Each subject 
was assigned a unique set of platform locations, which remained constant for that animal 
across all days of testing. Platform combinations varied between subjects and treatment 
groups. Each subject had four trials per day. At the beginning of each trial, the rat was 
placed in the platform-free start arm of the maze and had 3 minutes to locate a platform. 
Once the rat climbed onto a platform, the rat remained on it for 15 seconds to localize to 
its spatial location before being returned to a heated testing cage for a 30-second inter-
trial-interval (ITI). During the ITI, the experimenter removed the just-located platform 
from the WRAM. Once found, platforms were not replaced within a daily testing session. 
The experimenter then removed any debris and stirred the water to distribute olfactory 
cues prior to the start of the next trial. If the rat did not find the platform within the 
allotted 3-minute trial time, the experimenter guided the rat to the nearest platform. Rats 
received four trials per day for 12 days. On day 13, a six-hour delay was implemented 
between trials 2 and 3 to evaluate delayed memory retention. Errors, defined as an entry 
into an arm that did not contain a platform, were recorded for each trial; an arm entry was 
defined as the rat’s snout passing a line 11 cm into the arm (only visible on the outside of 
the maze, but not visible to the rat). Three error types were quantified. Working memory 
correct (WMC) errors were entries into an arm on trials 2-4 that previously contained a 
platform within a day. Reference memory (RM) errors were first entries into an arm that 
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never contained a platform. Working memory incorrect (WMI) errors were repeated 
entries within a day into an arm that never contained a platform. 
Morris water maze. After 1 day of rest following the WRAM delay day, a subset 
of subjects began testing on the Morris water maze (MM), a task that assesses spatial 
reference memory. The apparatus was a large round tub (188 cm diameter) filled with 
water maintained at 18-20°C and made opaque with non-toxic black powdered paint. One 
platform (11 cm diameter) was hidden just below the surface of the water in the northeast 
quadrant of the maze. The location of the platform remained constant across all days and 
trials. Salient spatial cues were present around the room to aid in spatial navigation to the 
platform (Morris et al., 1982). Rats received four trials per day for five consecutive days. 
At the beginning of each trial, rats were dropped off from one of four starting points 
(north, south, east, or west). The order in which the rats were exposed to the drop off 
points changed across days, but was the same for all rats within a day. Rats were given a 
maximum trial time of 60 seconds to locate the platform before the experimenter 
terminated the trial and led the rat to the platform. Once the platform was found, the rat 
remained on it for 15 seconds to allow for spatial localization before the experimenter 
returned the rat to its heated testing cage for an ITI of approximately 8-10 minutes. On 
the last day of MM, a probe trial was given. Following the four regular trials, rats were 
administered a fifth trial in which the hidden platform was completely removed from the 
maze, and rats swam freely for the standard allotted trial time of 60 seconds. The probe 
trial was implemented to evaluate whether the rats had spatially localized to the platform 
by quantifying the percent of total swim distance in the target quadrant versus the 
opposite quadrant. A video camera and tracking system (Ethovision; Noldus Instruments; 
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Wageningen, The Netherlands) were utilized to measure each rat’s swim path (distance in 
cm) across all days and trials, including the probe trial. 
Delayed match-to-sample win-stay task. The remaining subset of rats was 
tested on a delayed match-to-sample (DMS) win-stay task that evaluated spatial reference 
memory. The WRAM apparatus was utilized for this task, but rats were tested in different 
rooms and with novel spatial cues compared to the WRAM task. One platform was 
placed in an arm of the WRAM, where it remained across all days and trials. Rats 
received 6 trials per day for 4 days. For each trial, subjects were dropped off from 1 of 
the 6 different start arm locations (excluding the platform-containing arm and the arm 
directly across from the platform). The order in which the drop-off locations occurred 
varied across days, but stayed the same within a day for all rats. There was no consistent 
pattern of left or right turns from the start arm to the platform within or across days. Once 
the rat found the platform, it was allowed to remain on it and spatially localize for 15 
seconds before being returned to its heated testing cage for a 30-second ITI. There was a 
90-second maximum trial time; if the rat did not find the platform within the allotted 
time, the experimenter led the rat to the platform. An arm entry was quantified when the 
snout of the rat passed an 11 cm mark denoted on each arm of the maze that was visible 
to the experimenter, but not to the rat. The dependent variable for this task was the total 
number of errors committed on each trial. Total errors were defined as any entry into a 
non-platformed arm within a trial prior to locating the platform.  
Visible platform. Following the last day of the reference memory tasks, all 
subjects were tested on the Visible Platform (VP) task to confirm that rats could perform 
the visual and motoric components of water maze tasks. The apparatus was a rectangular 
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tub (100 x 60 cm) filled with clear water (18-20°C). A black platform (10 cm diameter) 
was placed in the tub and protruded about 4 cm above the water’s surface. Opaque 
curtains were hung in a circular fashion around the room to block potential spatial or 
geometric cues. All rats received 6 trials in 1 day. For each trial, the rat was dropped off 
from a fixed start location. The visible platform escape location varied semi-randomly in 
3 possible locations across trials. The maximum trial time was 90 seconds, and, once the 
rat located the visible platform, it was allowed to remain on it for 15 seconds before 
being returned to its heated testing cage for an ITI of 8-10 minutes. Latency (in seconds) 
from drop off to the platform was recorded for each trial. 
 
Euthanasia 
Rats were euthanized 1 week after the completion of the behavioral battery. 
Subjects were approximately 7 months old at euthanization. Rats were deeply 
anesthetized with inhaled isoflurane anesthesia. Blood was collected via cardiocentesis 
and allowed to clot at 4°C (Vacutainer 367986, Becton Dickinson and Company, 
Franklin Lakes, NJ, USA). Blood samples were then centrifuged at 2,000 rpm at 4°C for 
20 minutes. Serum was collected and stored at -20°C until analysis. Ovaries from the 
Sham and Hysterectomy groups were collected, trimmed of excess fat, and fixed in 10% 
buffered formalin for 48 hours before being transferred to 70% ethanol until analysis. 
Uteri were collected from the Sham and Ovx groups, trimmed of excess fat, and wet 
weight was obtained. 
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Serum Hormone Assays 
A double antibody liquid-phase RIA (Beckman Coulter; Brea, CA, USA) was 
used to determine 17b-estradiol levels. This RIA utilized estradiol-specific antibodies 
with an 125I-labeled estradiol as the tracer. Interassay coefficients of variation for this 
assay averaged 10% at a mean value of 28 pg/ml. Functional sensitivity for this assay was 
5 pg/ml. Androstenedione was assessed using an ELISA assay (ALPCO, Salem, NH, 
USA), based on the typical competitive binding scenario between unlabeled antigen 
(present in standards, controls, and unknowns) and the enzyme-labeled antigen 
(conjugate) for a limited number of antibody binding sites on the microwell plate. 
Interassay coefficients of variation for this assay averaged 9% at a mean value of 0.5 
ng/ml. Functional sensitivity of the assay was 0.1 ng/ml. Progesterone levels were 
determined using an ELISA assay (ALPCO, Salem, NH, USA). Interassay coefficients of 
variation for the progesterone assay averaged 13% at a mean value of 2.6 ng/ml. 
Functional sensitivity of this assay was 0.3 ng/ml.  
A sensitive two-site sandwich immunoassay was utilized to measure serum LH 
(Fallest, Trader, Darrow, & Shupnik, 1995; Haavisto et al., 1993) using monoclonal 
antibodies against bovine LH (no. 581B7; RRID:AB_2665514) and against the human 
LH-beta subunit (no. 5303: Medix, Kauniainen, Finland; RRID:AB_2665513) as 
previously described (Haavisto et al., 1993). The tracer antibody (no. 518B7) was kindly 
provided by Dr. Janet Roser (Department of Animal Science, University of California, 
Davis) (Matteri, Roser, Baldwin, Lipovetsky, & Papkoff, 1987), iodinated by the 
chloramine T method, and purified on Sephadex G-50 columns. The capture antibody 
(no. 5303) was biotinylated and immobilized on avidin-coated polystyrene beads (7mm; 
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Epitope Diagnostics, Inc., San Diego, CA). The standard was a Mouse LH reference prep 
(AFP5306A; provided by Dr. A.F. Parlow and the National Hormone and Peptide 
program). The assay had a sensitivity of 0.04 ng/ml. 
RIA was used to assay serum FSH levels utilizing reagents provided by Dr. A.F. 
Parlow and the National Hormone and Peptide Program, as described previously (Gay, 
Midgley, & Niswender, 1970). Mouse FSH reference prep AFP5308D was used for assay 
standards. The primary antibody was a Mouse FSH antiserum (guinea pig; AFP-1760191; 
RRID:AB_2665512) diluted to a final concentration of 1:400,000. The secondary 
antibody was purchased from Equitech-Bio, Inc. and diluted to a final concentration of 
1:25. The assay had a sensitivity of 2.0 ng/ml, and less than 0.5% cross-reactivity with 
other pituitary hormones. 
A commercially available ELISA kit (ANSH Labs, Webster, TX, AL-113) was 
used to determine Anti-Müllerian Hormone (AMH) levels. The sensitivity of this assay 
was 0.011 ng/ml, and the reportable range spanned between 3.36 – 215.0 ng/ml. 
 
Ovarian Follicle Counts 
One ovary from each Sham and Hysterectomy subject (i.e., all rats that had 
ovaries at the end of the experiment) was randomly selected for histological evaluation 
and quantification of healthy primordial, primary, secondary, and antral follicles, as well 
as corpora lutea. Following fixation, ovarian tissues were paraffin embedded and 
sectioned at 5 µm. Every 10th section was mounted on a slide and stained with 
hematoxylin and eosin Y-phloxine B. Primordial, primary, secondary, and antral follicles 
were counted at 20x magnification for every 20th section. Corpora lutea were counted at 
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a lower magnification (Pannoramic DESK; 3D Histech, Budapoest, Hungary). The 
following formula was used to calculate the total number of follicles in the ovary: Nt = 
(N0 x St x ts) / (S0 x d0), where Nt = total calculated number of follicles, N0 = number of 
follicles observed in the ovary, St = total number of sections in the ovary, ts = thickness of 
the section (µm), S0 = total number of sections observed, and d0 = mean diameter of the 
nucleus (Gougeon & Chainy, 1987). Ovarian follicles were classified using criteria from 
Haas et al., 2007 (Haas et al., 2007). Primordial cells were counted when there was a 
single layer of squamous granulosa cells surrounding the oocyte. Primary follicles 
contained a single layer of cuboidal granulosa cells. Secondary follicles required several 
granulosa cell layers surrounding the oocyte. Antral follicles were counted when the 
follicle contained two or more layers of granulosa cells and had a fluid-filled antral space 
in the follicle (Haas et al., 2007).  
 
Statistical Analyses 
Data analyses were completed using Statview software. The independent variable 
for all analyses was Surgery type (Sham, Ovx, Hysterectomy, Ovx-Hysterectomy). 
Repeated measures ANOVAs were utilized for WRAM data, with Errors as the 
dependent variable, and Trials within Days as the repeated measures. Separate repeated 
measures analyses were completed for each error type (WMC, WMI, and RM errors). 
WRAM data were blocked into 3, 4-day blocks, as we have previously published 
(Mennenga, Koebele, et al., 2015). Block 1, Days 1-4, was the Early Acquisition Phase; 
Block 2, Days 5-8, was the Late Acquisition Phase; Block 3, Days 9-12, was the 
Asymptotic Phase. For MM data, Swim Distance to Platform (cm) across repeated Days 
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and Trials was evaluated. In the DMS win-stay task, Total errors were evaluated, 
repeated across Days and Trials. Visible platform data was evaluated for Latency to 
platform (seconds), repeated across Trials. Serum hormone, ovarian follicle, body weight, 
and uterine weight data were analyzed using ANOVA, with Surgery as the independent 
variable and Serum Hormone Concentration, Follicle Estimate, Body Weight, and 
Uterine Weight as the dependent variables, respectively. All analyses were two-tailed 
with an alpha level set to 0.05; results were deemed marginal if the p value fell between 
0.05 and 0.10. Effect size for repeated measures ANOVA analyses were reported as 
generalized eta squared (ηG2) (Bakeman, 2005; Olejnik & Algina, 2003). For all other 
ANOVAs (non-repeated measures), effect sizes were reported as eta squared (η2). Effect 
sizes were interpreted using Cohen’s general guidelines for η2, where 0.02 is a small 
effect, 0.13 is a medium effect, and 0.26 is a large effect (Bakeman, 2005; Cohen, 1992). 
All effect sizes for post hoc tests were reported using Cohen’s d and are interpreted by 
Cohen’s standard guidelines, where 0.2 indicates a small effect, 0.5 indicates a medium 
effect, and 0.8 indicates a large effect (Cohen, 1992). 
 
Results 
Vaginal Cytology 
Vaginal smears were performed for eight consecutive days, beginning two weeks 
after surgery. Rats that received Ovx or Ovx-Hysterectomy showed blank or diestrus-like 
smears, indicating a lack of estrogen stimulation of the vaginal epithelium and therefore 
successful surgical removal of the ovaries. Sham and Hysterectomy groups showed 
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normal 4-5 day estrous cycles, suggesting continued ovarian function and ovulatory 
patterns following surgery (Figure 48). 
 
Water Radial-Arm Maze 
Early acquisition phase (days 1-4). The Early Acquisition Phase best captures 
initial task-rule acquisition and learning, and its associated exploratory behavior in the 
WRAM. During the Early Acquisition Phase, a main effect of Surgery [F(3,54)=2.90, p < 
0.05, ηG2=0.02] was observed for WMC errors. Fischer’s PLSD indicated that Ovx rats 
made fewer WMC errors than did Sham rats (p < 0.01, d=0.33), and Ovx-Hysterectomy 
rats tended to make fewer WMC errors than did Sham rats (p = 0.06, d=0.20) (Figure 
49A). For this block of testing, there was also a Surgery x Trial interaction [F(6,108)=2.84, 
p < 0.01, ηG2=0.03]. Given that previous studies in our laboratory have shown age- , 
hormone- , and menopause- mediated differences in memory when working memory load 
is taxed (Acosta et al., 2010; Bimonte-Nelson, Hunter, Nelson, et al., 2003; Bimonte-
Nelson, Singleton, Hunter, et al., 2003; Bimonte-Nelson et al., 2004; Bimonte & 
Denenberg, 1999; Bimonte et al., 2003; Koebele et al., 2017; Mennenga, Gerson, et al., 
2015; Mennenga, Koebele, et al., 2015), we further probed this effect and assessed WMC 
errors for Trials 3 and 4 only, which are the high working memory load trials. There was 
a main effect of Surgery [F(3,54)=2.84, p < 0.05, ηG2=0.03] such that Sham rats made more 
errors than Ovx rats (p < 0.01, d=0.42) and Ovx-Hysterectomy rats (p < 0.05, d=0.28) on 
the high working memory load trials (Figure 49B). There was also a Surgery x Trial 
interaction for WMC errors on high working memory load trials (F(3,54)=3.15, p < 0.05, 
ηG2=0.03) (Figure 49C). Thus, we further probed this interaction. There were no 
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differences amongst groups on Trial 3. However, there was a main effect of Surgery on 
Trial 4, the maximum working memory load trial [F(3,54)=3.76, p < 0.05, ηG2=0.07], with 
the post hoc again indicating the same effect wherein Sham rats made more errors than 
did Ovx rats (p < 0.01, d=0.70) and Ovx-Hysterectomy rats (p < 0.05, d=0.45) (Figure 
49D). For WMI errors, there was a Surgery x Trial interaction [F(9,162)=3.10, p < 0.01, 
ηG2=0.03] (Figure 50A). Upon probing the high working memory load trials (Trials 3 and 
4), a marginal main effect of Surgery [F(3,54)=2.51, p = 0.07, ηG2=0.02] and a significant 
Surgery x Trial interaction [F(3,54)=3.02, p < 0.05, ηG2=0.02], (Figure 50B) were revealed. 
Post hoc analyses indicated that Sham rats made more errors than Ovx (p < 0.05, d=0.26), 
Hysterectomy (p < 0.05, d=0.27), and Ovx-Hysterectomy (p < 0.05, d=0.30) groups. 
Because there was a significant Surgery x Trial interaction for the high working memory 
load trials, we further investigated these effects. There were no differences amongst 
groups during Trial 3, but there was a main effect of Surgery during Trial 4 [F(3,54)=3.45, 
p < 0.05, ηG2=0.05], with Sham-treated rats making more errors than Ovx (p < 0.01, 
d=0.47), Hysterectomy (p < 0.05, d=0.38) and Ovx-Hysterectomy (p < 0.01, d=0.54) 
groups (Figure 50C). There were no main effects or interactions with Surgery for RM 
errors during the Early Acquisition phase (data not shown).  
Late acquisition phase (days 5-8). The Late Acquisition Phase captures mid-task 
learning when rats tend to decrease in errors compared to the Early Acquisition Phase, 
but continue to exhibit variable performance as they learn to handle the working memory 
load associated with the WRAM task. There were no main effects or interactions with 
Surgery during the Late Acquisition phase. However, there was a marginal main effect of 
Day for WMC errors [F(3,162)=2.30, p = 0.08, ηG2=0.01] and a main effect of Day for 
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WMI [F(3,162)=5.66, p < 0.001, ηG2=0.02] and RM errors [F(3,162)=3.25, p < 0.05, 
ηG2=0.01] such that errors decreased across days, suggesting learning of the task (data not 
shown). 
Asymptotic phase (days 9-12). The Asymptotic Phase of the WRAM is most 
crucial to understanding spatial working memory performance, as this phase occurs when 
the rats have learned the rules of this win-shift task and are approaching peak memory 
performance, where errors are decreased compared to earlier phases and remain at a 
consistent level of performance within the block of days, here 9-12. For WMC errors in 
the Asymptotic Phase, there was a marginal Surgery x Trial interaction [F(6,108)=1.93, p = 
0.08, ηG2=0.02] (Figure 51). For WMI errors, there was a main effect of Surgery 
[F(3,54)=3.06, p < 0.05, ηG2=0.03]. Fisher’s PLSD indicated that the Hysterectomy group 
made significantly more WMI errors than did the Sham (p < 0.05, d=0.27), Ovx (p < 
0.05, d=0.28), and Ovx-Hysterectomy groups (p < 0.01, d=0.40) (Figure 52A). There was 
also a marginal Surgery x Trial interaction for WMI errors [F(9,162)=1.75, p = 0.08, 
ηG2=0.02] (Figure 52B). When only high working memory load trials (Trials 3 and 4) 
were probed, a main effect of Surgery [F(3,54)=2.93, p < 0.05, ηG2=0.05] was again shown. 
Fisher’s PLSD showed that the Hysterectomy group made significantly more WMI errors 
than did the Sham group (p < 0.05, d=0.37), such that hysterectomy alone (i.e. with 
ovarian conservation) impaired memory compared to reproductively unaltered rats. Rats 
that had only their uterus removed made more WMI errors than any group of rats that had 
their ovaries removed, whether or not that ovarian removal was concomitant with uterus 
removal, as indicated by the Hysterectomy group making more errors than the Ovx group 
(p < 0.05, d=0.39) and the Ovx-Hysterectomy group (p < 0.01, d=0.56) when working 
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memory load was taxed in the Asymptotic Phase of WRAM (Figure 52C). Notably, once 
the ovaries were removed, the additional removal of the uterus had no further impact on 
cognitive effects (Fisher’s PLSD Ovx vs. Ovx-Hysterectomy: p = 0.64). There was no 
interaction between Surgery and Trial for this analysis; thus, effects were not further 
probed. These findings suggest that, 6 weeks after surgery, the surgical removal of the 
uterus alone, conserving the ovaries, impairs memory when working memory load is 
taxed in the latter half of testing. In addition, this detrimental impact of hysterectomy 
with ovarian conservation appears to be prevented if Ovx accompanies the hysterectomy. 
There were no main effects or interactions with Surgery for RM errors during the 
Asymptotic Phase, indicating that the spatial memory deficit observed for the 
Hysterectomy group is likely specific to working memory.  
Six hour delay. On day 13 of WRAM testing, a six-hour delay was given 
between trials 2 and 3 to test delayed memory retention. Each treatment group’s 
performance was assessed separately using a repeated measures ANOVA to evaluate 
group performance on trial 3 of the last day of baseline testing (day 12) compared to trial 
3 following the six-hour delay on day 13. Sham-treated rats did not show impaired 
performance between baseline and delay testing, suggesting that there was not a delay-
induced impairment (Figure 53A). There was a main effect of Delay Day for WMC 
errors on trial 3 for Ovx rats [F(1,13)=7.00, p < 0.05, ηG2=0.35] (Figure 53B). For 
Hysterectomy-treated rats, there was a marginal main effect of Delay Day for WMC 
errors on trial 3 [F(1,13)=3.96, p = 0.07, ηG2=0.23], such that WMC errors somewhat 
increased as a result of a six-hour memory retention delay (Figure 53C). There was also a 
main effect of Delay Day for WMC errors on trial 3 for Ovx-Hysterectomy rats 
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[F(1,14)=47.25, p < 0.0001, ηG2=0.77] (Figure 53D). Thus, both groups without ovaries 
showed significantly impaired delayed memory retention following a delay in WRAM 
trials, an effect our laboratory has previously reported (Hiroi et al., 2016; Prakapenka et 
al., 2018). 
 
Reference Memory Tasks 
A subset of rats (n=5/group) underwent training in the spatial reference memory 
MM task. All rats learned across days [F(4,64)=33.48, p < 0.0001, ηG2=0.38], with no 
differences in learning among surgery types. Furthermore, there was a main effect of 
Quadrant on the Probe trial [F(1,16)=129.08, p < 0.0001, ηG2=0.87] and no interaction with 
surgery type, suggesting that all rats successfully spatially localized to the target 
(previously platformed) quadrant (data not shown).  
 All other subjects were trained on a win-stay version of the DMS spatial reference 
memory task. Again, there was a main effect of Day [F(3,102)=69.25, p < 0.0001, 
ηG2=0.16] and no interaction with Surgery, such that all rats learned to navigate to the 
platform and decreased in the total number of errors committed across the 4 days of the 
task (data not shown). Given that no differences in reference memory performance were 
found on either of these reference memory-only tasks, nor the reference memory measure 
of the WRAM, findings support the tenet that the memory impairment induced by 
Hysterectomy is specific to the working memory domain. 
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Visible Platform 
There was a main effect of Trial [F(5,270)=5.53, p < 0.0001, ηG2=0.07] that did not 
interact with Surgery type, such that all rats decreased escape latency to the visible 
platform across six trials. The average escape latency on Trial 1 was 13.55s, and 
averaged 6.91s on Trial 6 (data not shown). This control task verifies that all subjects 
could perform the procedural components of the water maze tasks, including visual and 
motoric capacities. 
 
Body Weights 
Two weeks after surgery, there was a main effect of Surgery on body weight 
[F(3,54)=11.92, p < 0.0001, η2=0.40]. Fischer’s post-hoc analyses revealed that Ovx-
treated rats weighed more than Sham (p < 0.0001, d=1.88) and Hysterectomy (p < 
0.0001, d=1.61) rats; Ovx-Hysterectomy rats also weighed more than Sham (p < 0.0001 
d=1.48) and Hysterectomy (p < 0.0001, d=1.25) rats. This indicates that surgical removal 
of the ovaries increased body weight compared to rats that retained their ovaries. This 
difference in body weight between subjects with and without their ovaries continued to 
diverge across week 3 [F(3,54)=21.37, p < 0.0001, η2=0.54], week 4 [F(3,54)=37.35, p < 
0.0001, η2=0.68], week 5 [F(3,54)=44.02, p < 0.0001, η2=0.71], and through the 
euthanization time point, [F(3,54)=43.77, p < 0.0001, η2=0.71]. At euthanization, Ovx and 
Ovx-Hysterectomy rats weighed more than Sham (Ovx vs Sham: p < 0.0001, d=3.62; 
Ovx-Hysterectomy vs Sham: p < 0.0001, d=2.47). Ovx and Ovx-Hysterectomy rats also 
weighed more than Hysterectomy rats (Ovx vs Hysterectomy: p < 0.0001, d=3.82; Ovx-
Hysterectomy vs Hysterectomy: p < 0.0001, d=2.61) rats (Figure 54).  
 
222 
 
Uterine Weights 
Uterine weights of Sham and Ovx rats (i.e., subjects with uterine conservation) 
were assessed at euthanasia. Ovx rats had decreased uterine weight compared to Sham-
operated rats [F(1,27)=72.61, p < 0.0001, η2=0.73] (Figure 55). This confirms that Ovx was 
successful, and that the uteri of Sham rats continued to receive stimulation from 
endogenously circulating estrogen. 
 
Ovarian Follicle Counts 
Ovaries were analyzed in rats within the Sham and Hysterectomy groups; that is, 
the rats that retained their ovaries throughout the experiment. Figure 11 depicts ovary 
micrographs of representative subjects from the Sham (56A) and Hysterectomy (56B) 
groups. No differences in early-stage follicles were found between Sham and 
Hysterectomy groups (Primordials: F(1,25)=0.39, p = NS, η2=0.03, Figure 57A; Primaries: 
F(1,25)=0.80, p = NS, η2=0.003, Figure 57B; Secondaries: F(1,25)=0.38, p = NS, η2=0.03, 
Figure 57C). While there was a trend toward Hysterectomy subjects having fewer antral 
follicles as compared to Sham-treated counterparts, this analysis did not reach 
significance [F(1,25)=3.12, p = 0.09, η2=0.11] (Figure 57D). Furthermore, corpora lutea 
counts were not different from each other [F(1,25)=0.63, p = NS, η2=0.01] (Figure 57E), 
suggesting that following Hysterectomy surgery, the ovaries of Hysterectomy rats did not 
exhibit morphological changes in healthy follicle counts compared to Sham rats, at least 
up to 2 months after surgical intervention. Two subjects were excluded from the follicle 
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and corpora lutea analyses due to comprised tissue quality after processing (Sham n = 13, 
Hysterectomy n = 14). 
 
Serum Hormone Levels 
The 17b-estradiol analysis revealed a main effect of Surgery [F(3,53)=15.30, p < 
0.0001, η2=0.46]. Fisher’s PLSD indicated that the Ovx group had lower 17b-estradiol 
levels than the Sham group (p < 0.0001, d=2.85) and the Hysterectomy group (p < 0.001, 
d=1.74); the Ovx-Hysterectomy group also had lower 17b-estradiol levels than the Sham 
group (p < 0.0001, d=2.79) and the Hysterectomy group (p < 0.001, d=1.70), indicating 
successful surgical removal of the ovaries in rats that were Ovx. Additionally, the 
Hysterectomy group trended toward having lower 17b-estradiol levels compared to the 
Sham group (p = 0.06, d=0.52) (Figure 58A). One serum sample was excluded from the 
17b-estradiol analysis due to an issue with the sample during processing (Sham n = 15, 
Ovx n = 14, Hysterectomy n = 14, Ovx-Hysterectomy = 14) .  
For androstenedione, there was a main effect of Surgery [F(3,54)=94.23, p < 
0.0001, η2=0.84]. Fisher’s PLSD revealed that Sham rats had higher androstenedione 
levels than Ovx (p < 0.0001, d=6.08) and Ovx-Hysterectomy groups (p < 0.0001, 
d=6.08). Hysterectomy rats also had higher androstenedione levels than Ovx (p < 0.001, 
d=6.42) and Ovx-Hysterectomy groups (p <0.0001, d=6.42); indeed, neither Ovx nor 
Ovx-Hysterectomy rats had detectable levels of androstenedione at euthanization. The 
Hysterectomy group had lower androstenedione levels compared to the Sham-operated 
group (p < 0.01, d=0.70). (Figure 58B).  
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Progesterone analyses revealed a main effect of Surgery [F(3,54)=8.79, p < 0.0001, 
η2=0.33], and Fisher’s PLSD indicated that Sham rats had higher progesterone levels 
compared to Ovx rats (p < 0.05, d=1.09) and Ovx-Hysterectomy rats (p < 0.05, d=1.23). 
The Hysterectomy group had higher progesterone levels compared to the Ovx group (p < 
0.05, d=1.37) and the Ovx-Hysterectomy group (p < 0.05, d=1.45). Additionally, the 
Hysterectomy group had elevated progesterone levels compared to the Sham group (p < 
0.05; d=0.68) (Figure 58C).  
Analysis of AMH, which is produced by ovarian granulosa cells and is considered 
to be a correlate of ovarian follicle reserve (Hansen, 2013; Hansen et al., 2011), revealed 
a main effect of Surgery [F(3,53)=93.61, p <0.0001, η2=0.84]. Fischer’s PLSD showed that 
Sham rats had higher AMH levels than Ovx rats (p < 0.0001, d=5.26) and Ovx-
Hysterectomy rats (p < 0.0001, d=5.26). Hysterectomy rats also had higher AMH levels 
than Ovx rats (p < 0.0001, d=10.01) and Ovx-Hysterectomy rats (p < 0.0001, d=10.01). 
Indeed, AMH levels were undetectable in both the Ovx and Ovx-Hysterectomy groups. 
Because AMH is produced by the ovarian follicles, the ovary-intact groups (i.e. Sham 
and Hysterectomy groups) were compared to each other in an additional analysis. No 
statistical difference was seen for AMH levels between Sham and Hysterectomy rats, 
corroborating ovarian follicle count results wherein there were no differences in 
primordial follicle count, the ovarian follicle reserve (58D).  
LH analyses showed a main effect of Surgery [F(3,53)=27.51, p < 0.0001, η2=0.61], 
with Fischer’s PLSD indicating that Ovx rats had higher LH levels than Sham rats (p < 
0.0001, d=2.50) and Hysterectomy rats (p < 0.0001, d=2.42). Ovx-Hysterectomy rats also 
had higher LH levels than Sham rats (p < 0.0001, d=7.09) and Hysterectomy rats (p < 
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0.0001, d=6.39). These results indicate that surgical removal of the ovaries resulted in 
higher circulating LH levels, as has been previously observed in rodents (Gay & 
Midgley, 1969; Wise & Ratner, 1980) and women (Yen & Tsai, 1971). LH levels were 
compared between ovary-intact groups only (Sham and Hysterectomy rats) separately; no 
differences were observed between ovary-intact groups, suggesting that hysterectomy 
with ovarian conservation does not alter serum LH levels, at least up to 2 months post-
surgery as tested here (58E).  
FSH analyses also revealed a main effect of Surgery [F(3,53)=535.57, p <0.0001, 
η2=0.97], with Fischer’s PLSD indicating that Ovx rats had higher FSH levels than Sham 
rats (p < 0.0001, d=14.16) and Hysterectomy rats (p < 0.0001, d=12.92); Ovx-
Hysterectomy rats had higher FSH levels than Sham rats (p < 0.0001, d=11.372) and 
Hysterectomy rats (p < 0.0001, d=10.49) as well, corresponding with LH results 
suggesting that Ovx increases circulating FSH levels, an effect previously observed in 
rats (Elias & Blake, 1983; Wise & Ratner, 1980) and women (Yen & Tsai, 1971). FSH 
levels were compared between ovary-intact groups only; there was a main effect of 
Surgery for ovary-intact groups [F(1,27)=4.97, p < 0.05, η2=0.16], such that FSH levels 
were increased in Hysterectomy rats compared to Sham-operated rats, suggesting a 
response by the hypothalamus-pituitary axis induced by uterus removal (58F). 
 
Discussion 
To the best of our knowledge, the current report is the first systematic 
investigation of variations in surgical menopause including hysterectomy in an adult rat 
model testing relationships amongst reproductive profiles and cognition. A multi-systems 
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approach simultaneously evaluated ovarian morphology, endocrine physiology, and 
cognition within the same subjects. Collectively, results showed that common variations 
in surgical menopause yield distinct effects on spatial working memory performance 
across early acquisition to asymptotic phases, and that hysterectomy with ovarian 
conservation – a novel surgical model—has unique, detrimental effects on spatial 
working memory 2 months after surgery.  
 During the Early Acquisition phase of the WRAM, wherein animals were 
acquiring task rules through maze exploration, rats with Ovx alone made fewer WMC 
errors compared to Sham rats across all trials. Ovx-Hysterectomy rats also made fewer 
errors than Sham rats on high working memory load trials. For WMI errors, the Sham 
group made more errors during the Early Acquisition Phase compared to all other 
experimental groups. These findings may be interpreted as enhanced WRAM task rule 
acquisition for subjects without their ovaries. This enhancement during acquisition could 
be related to maze solving strategy or attentional processes. For example, estrogen milieu 
can impact learning strategies, as shown with exogenous ovarian hormone administration 
(Korol & Kolo, 2002), and across estrous cycle phases (Korol et al., 2004). In accordance 
with these findings, our laboratory has reported Ovx-induced spatial memory 
enhancements for aged rats tested on the WRAM as compared to Sham-operated rats 
(Bimonte-Nelson, Singleton, Hunter, et al., 2003; Bimonte-Nelson et al., 2004), and other 
laboratories have concordant findings showing long-term Ovx yields benefits for spatial 
memory compared to age-matched reproductively-intact controls in rhesus macaques 
(Lacreuse, Herndon, & Moss, 2000) and mice (Heikkinen et al., 2004). Of note, there are 
reports of no effects of Ovx in middle-aged rats, and some work has shown memory 
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impairments after Ovx in young adult and middle-aged rats, effects which occurred after 
animals had learned the task or after extended temporal delays to evaluate high-demand 
mnemonic retention, indicating that task phase and difficulty impacts outcomes of Ovx 
(Bimonte-Nelson, Acosta, & Talboom, 2010). Another interpretation of the increased 
errors in the Sham group during the early acquisition phase is related to an increase in 
exploratory behavior or activity levels in this group, rather than a relative learning 
impairment per se. Indeed, previous studies have found that Ovx decreases activity levels 
(Blizard, Lippman, & Chen, 1975) and increases anxiogenic behaviors (Hiroi and 
Neumaier, 2006) in the open field, and that that presence of ovarian hormones restores 
these activity levels and decreases anxiogenic behavior (Blizard et al., 1975; Hiroi & 
Neumaier, 2006). Thus, it is possible that the rats without ovaries are making fewer arm 
entries during the first several days of the task, which is operationally defined as better 
performance, due to an artifact of decreased exploratory or locomotor activity during task 
acquisition. 
 During the Asymptotic Phase of the WRAM (Days 9-12) when rats have learned 
the task rules, Hysterectomy with ovarian conservation had a unique, detrimental effect 
on spatial memory when working memory load was taxed compared to all other 
variations in surgical menopause tested here, as well as compared to Sham-operated rats. 
Interestingly, concomitant surgical removal of the ovaries with the uterus (i.e., Ovx-
Hysterectomy) prevented the detrimental memory effects of Hysterectomy alone on 
spatial working memory. Rats that received Sham surgery or Ovx surgery with uterine 
conservation did not show cognitive impairments at a high working memory load, 
suggesting that the presence or absence of ovaries alone does not dictate the observed 
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working memory effects. Taken together, these results indicate that during the 
Asymptotic Phase of WRAM, when subjects are performing to the best of their ability, 
there is a unique impact of uterus removal alone that detrimentally impacts the spatial 
working memory domain.  
 Following the WRAM, all subjects were exposed to 1 of 2 win-stay reference 
memory tasks: the MM or the DMS win-stay maze. Compared to the WRAM, these are 
both lower cognitive demand tasks that do not involve a working memory load 
component. In each reference memory task, all subjects learned the task, effectively 
decreasing swim distance to the platform in the MM or decreasing errors committed 
across days in the DMS task, regardless of surgery condition. This lack of difference 
among surgery conditions is notable in that the effects of these variations in surgical 
menopause are likely a domain-specific, rather than a global, change in cognitive 
function. Translationally, this is a crucial factor to keep in mind, as deficits in a particular 
cognitive area may not lead to an overall global decline in cognitive function. 
Furthermore, the order in which the rats were exposed to the task is likely important 
when interpreting cognitive outcomes. Specifically, following a high cognitive demand 
task like the WRAM, lower cognitive demand tasks may be easier to acquire since the 
subjects has experienced a taxing spatial memory task first. In the future, it will be 
important to explore whether maze task order matters for spatial learning and memory in 
the context of hormones and aging.  
It remains controversial whether the ovaries continue to function normally long-
term following hysterectomy in the premenopausal state. Some evidence from human 
literature where women in their reproductive years underwent hysterectomy with ovarian 
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conservation implies that the ovaries continue to function normally for many years 
(Beavis et al., 1969; Chalmers et al., 2002; Findley et al., 2013); this is evidenced in that 
these women are not prescribed estrogen-containing hormone therapy following their 
surgery until they may opt to take it in midlife, around the average age of natural 
menopause onset, when circulating ovarian hormone levels become erratic and symptoms 
of menopause, such as hot flashes, begin to present (Kritz-Silverstein et al., 2000). 
However, other clinical literature reports that women who undergo hysterectomy with 
ovarian conservation during reproductive years may transition to menopause earlier in 
life than women who have an intact uterus and ovaries throughout the menopause 
transition (Kaiser et al., 1989; Moorman et al., 2011; Read et al., 2010). Whether this is 
directly related to the hysterectomy procedure, or whether these women may be 
predisposed to an earlier menopause related to a comorbid condition, remains uncertain. 
Furthermore, recent evidence suggesting that a younger age at hysterectomy is associated 
with an increased relative risk of developing dementia compared to age-matched intact 
women (Phung et al., 2010; Rocca et al., 2007, 2012) points to a crucial role for uterine 
tissue in a trajectory of healthy aging. The data presented in the current study reveal that 
rats that received a hysterectomy with ovarian conservation had normal estrous cyclicity 
2 weeks after surgery, gained body mass at a rate similar to that of sham-operated 
controls, and did not show alterations in ovarian follicle morphology 2 months post-
surgery. However, alterations in circulating ovarian steroid hormones and gonadotropin 
levels were apparent two months after surgery. Whether changes in ovarian function and 
steroidogenesis are a transient effect of hysterectomy, or whether these are long-term 
changes in ovarian function remains an open, but critical, question.  
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Altered ovarian- and pituitary- derived hormone synthesis and release following 
hysterectomy are likely key factors to understanding the progression of morphological, 
physiological, and cognitive changes associated with hysterectomy surgery. It is notable, 
however, that serum AMH, a putative marker of ovarian follicle reserve, is not different 
between Sham and Hysterectomy rats, suggesting that hysterectomy with ovarian 
conservation did not significantly impact ovarian follicle reserve, at least in this short-
term 2 month time point after surgery. Furthermore, serum LH levels, the gonadotropin 
that regulates ovulation and corpus luteum function, were not different between 
Hysterectomy rats and ovary-intact Sham rats; indeed, low LH levels in the 
Hysterectomy group indicate continued ovarian function following surgery, supporting 
the idea that localized ovarian dysfunction is not the primary contributing factor to the 
cognitive detriments seen in the Hysterectomy rats 6 weeks after surgery, and that uterus 
itself likely has a unique impact on cognition, with or without additional impacts or 
interactions from other factors not yet determined. Notably, 2 months after surgery, FSH 
levels were significantly increased in Hysterectomy rats compared to ovary-intact Sham 
rats. Given that FSH is currently the gold standard in clinical settings to determine a 
woman’s menopause status and has been previously reported to increase following 
hysterectomy with ovarian conservation in women (Chan et al., 2005; Kaiser et al., 
1989), it is of particular interest to further investigate this increase in FSH in 
Hysterectomy rats in relation to hypothalamic-pituitary-reproductive tract communication 
and dysfunction. That FSH was one of the hormones altered two months after 
hysterectomy with ovarian conservation in our study implicates a potential accelerated 
disruption of hypothalamic-pituitary-reproductive tract communication when the uterus 
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alone is removed, which, when considering translational implications, could yield an 
earlier menopause in women who undergo hysterectomy. One potential contributing 
factor to this specific change in FSH is altered secretion of inhibins, which are peptide 
hormones belonging to the transforming growth factor-b family produced by growing 
ovarian follicles. FSH stimulates inhibin production, and in turn, inhibins selectively 
regulate FSH release and feedback from the pituitary gland across the female 
reproductive cycle (Norris & Lopez, 2011; Welt, Sidis, Keutmann, & Schneyer, 2002). 
The only ovarian change we found in our current evaluations was a marginal decrease in 
antral follicles, which are one of the primary sources of inhibin-B secretion (Nahás et al., 
2003). Indeed, declines in inhibins have been proposed as an early marker of ovarian 
follicular depletion following hysterectomy in women (Nahás et al., 2003). The role of 
inhibins is of interest to explore in future studies. In our current study, hysterectomy 
alone yielded changes in several circulating hormone levels produced by the ovaries and 
pituitary, which could be a result of altered hormone biosynthesis processes, changes in 
bioenergetics metabolism, and/or steroid release from the ovary prior to any gross 
morphological changes in the ovarian follicle structure or onset of follicular atresia, 
which may occur following a longer period after surgical intervention. We would be 
remiss if we did not also acknowledge that sex steroid hormones can be derived in non-
negligible quantities from extra-ovarian sources, including adipose tissue, skin, hair 
follicles, liver, and the adrenal glands (Rosen & Cedars, 2007), and that changes in these 
non-reproductive systems could also be induced by the surgical removal of the uterus. As 
such, the observed reproductive hormone changes following surgery can currently be 
interpreted as a potential mediating factor of cognitive change, rather than the primary 
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cause. Overall, it is crucial to evaluate the long-term effects of hysterectomy with ovarian 
conservation on ovary structure and function to better understand how a local change 
such as removing the uterus can ultimately result in a systemic alteration of 
neurobiological factors important for learning and memory. Given recent findings 
indicating autonomic and sensory innervation to the non-pregnant rat uterus 
(Gnanamanickam & Llewellyn-Smith, 2011), one possibility is that disturbance to this 
uterine innervation via hysterectomy is sufficient to alter neuroendocrine and 
neurotransmitter signaling in the central and peripheral nervous systems, in turn 
disrupting hormone production and secretion involved in brain-ovary-uterine 
communication. Furthermore, there is evidence that adrenergic innervation of the ovaries 
can influence ovarian hormone secretion during the estrous cycle in the rat (Aguado & 
Ojeda, 1984), and several neurotransmitters within the catecholamine class have been 
shown to induce androgen production in cultured ovarian theca-interstitial cells (Dyer & 
Erickson, 1985). These collected findings implicate a direct role of central and peripheral 
nervous system regulation of the non-pregnant uterus and the ovaries, and provide a 
starting point to investigate neurobiological mechanisms associated with the observed 
cognitive changes in future studies. Additionally, it is imperative to investigate how 
exogenous estrogen therapy affects this variant of surgical menopause in a rat model, as 
researchers in the field have historically investigated cognitive effects of estrogen-
containing hormone therapy in an Ovx model, where ovaries are removed, but the uterus 
remains intact. In sum, these findings are a fundamental next step in elucidating how 
variations in surgical menopause can impact cognitive and brain aging. Specifically, this 
is the first preclinical study to methodically investigate the impact of hysterectomy with 
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and without ovarian conservation on learning and memory. Furthermore, using this novel 
experimental design, we report that the nonpregnant uterus itself is not a quiescent organ. 
Rather, uterus removal with or without concomitant ovarian removal can have significant 
effects on physiology and cognition, opening new doors for future investigations into the 
role of the uterus in behavioral outcomes across the lifespan. In the future, it will be 
critical to experimentally evaluate the role of age at surgery and time since surgical 
manipulation to systematically decipher how variations in surgical menopause impact 
brain aging. Translationally, these findings are impactful in that they can inform clinical 
understandings of, and lead to additional human studies testing, the intricate connections 
between the brain and the female reproductive system. This will provide fundamental 
stepping stones to initiate further exploration into how common variations in 
gynecological surgery impact quality of life, as well as cognitive and brain aging, in 
women throughout their lifetimes. 
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ABSTRACT 
A significant number of women undergo gynecological surgery for benign 
reasons during their lifetime. A majority of these surgeries occur during a woman’s 
reproductive years, prior to the onset of natural menopause in midlife. Hysterectomy, or 
the surgical removal of the uterus, is a common gynecological surgery. If a woman is pre-
menopausal at the time of surgery and has a low cancer risk, ovaries are typically retained 
in order to prevent an abrupt surgical menopause; however, surgical ovary removal 
occurs alongside hysterectomy in about 50% of total cases. Thus, a woman can live a 
substantial proportion of her life without a uterus and/or ovaries. A premature loss of 
ovarian hormones negatively impacts cognition in women and animal models. 
Interestingly, hysterectomy with and without ovary removal is associated with a 
relatively higher risk of developing dementia, and this risk increases with a younger age 
at surgery. Our laboratory recently reported that two months after surgery, hysterectomy 
with ovarian conservation resulted in a unique, detrimental working memory impairment 
compared to other variations in gynecological surgery and to control subjects. Here, we 
aimed to determine whether this observed cognitive impairment was transient after 
surgery, or whether it was the onset of a long-term, and possibly global, impairment that 
persisted throughout aging. Three cohorts of rats received sham, ovariectomy, 
hysterectomy, or ovariectomy-hysterectomy in adulthood and were tested on a battery of 
behavior tasks evaluating spatial working memory, spatial reference memory, and 
anxiety-like behavior. The first cohort was tested six weeks after surgery based on the 
timing of our initial study, in adulthood; the second cohort was tested seven months after 
surgery, in middle-age; the third cohort was tested twelve months after surgery, in old 
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age. Findings revealed that spatial working memory deficits with hysterectomy were 
present at all time points, suggesting that hysterectomy in adulthood results in a long-
term detrimental impact on working memory compared to other variations in 
gynecological surgery and intact controls. Serum progesterone levels were decreased in 
Ovx groups compared to ovary-intact groups at all time points. Androstenedione, 
progesterone, and 17b-estradiol serum levels did not differ between Sham and 
Hysterectomy rats at any time point. Furthermore, ovarian follicle counts were not 
different between Sham and Hysterectomy rats at any time point, indicating that the 
ovaries did not undergo divergent morphological changes following hysterectomy 
compared to age-matched controls. Collectively, findings point to a primary role for the 
uterus itself in regulating cognition that is not secondary to ovarian changes. This is the 
first report of long-term effects of hysterectomy with and without ovarian conservation 
on cognition, as well as endocrine and ovarian profiles associated with variations in 
gynecological surgery in a rat model. Translationally, these findings highlight the critical 
need to better understand how variations in gynecological surgery that occur in adulthood 
impact the trajectory of cognitive aging in women in order to develop strategies to 
prevent or postpone cognitive decline in at-risk women.  
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Introduction 
 Rates of hysterectomy have been decreasing worldwide during the last several 
decades as alternative therapies have become available for benign uterine conditions, 
such as uterine leiomyomas, endometriosis, persistent abnormal bleeding, or pelvic organ 
prolapse (Corona et al., 2015; J. D. Wright et al., 2013). Yet, hysterectomy remains the 
most common non-obstetrical gynecological surgical procedure (Carlson et al., 1993; 
Centers for Disease Control and Prevention, 2010; McPherson, Gon, & Scott, 2013). By 
age 60, an estimated one-third of US women will have experienced hysterectomy (J. D. 
Wright et al., 2013), and in 2008, it was projected that lifetime prevalence of 
hysterectomy neared 48% (Merrill, 2008). This surgery is often performed in adulthood 
prior to age 52, which is the average age of natural menopause onset (Hoffman et al., 
2012; NAMS, 2014). Although some women undergo a complete ovariohysterectomy in 
adulthood, to avoid premature surgical menopause, the ovaries are retained in about half 
of hysterectomy cases, especially when women are at a low-risk for certain cancers 
(Asante et al., 2010; Lowder et al., 2010; Pocobelli et al., 2012; The American College of 
Obstetrics and Gynecology, 2008; Whiteman et al., 2008). The ovaries are thought to 
continue to function normally following hysterectomy if the surgery occurs when a 
woman is still of reproductive age (Beavis et al., 1969; Chalmers et al., 2002; Corson et 
al., 1981; Findley et al., 2013). This idea has been contested, however, given clinical 
reports that women who undergo hysterectomy with ovarian conservation tend to 
experience the transition to menopause three to four years earlier than uterus-intact 
women, possibly due to compromised ovarian blood flow following the hysterectomy 
procedure (Chan et al., 2005; Gallicchio et al., 2006; Kaiser et al., 1989; Kritz-Silverstein 
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et al., 2000; Moorman et al., 2011; Read et al., 2010). Operationally defining the onset of 
the menopause transition in women with hysterectomy is challenging, as vasomotor 
symptoms or elevated follicle stimulating hormone (FSH) levels are the primary 
indicators for menopause in women with hysterectomy, while irregular menstrual 
patterns are often the first indication of the menopause transition in uterus-intact women. 
Further methodical evaluation of menopause symptomology is needed to understand 
whether hysterectomy impacts the trajectory of reproductive system aging. Indeed, given 
that the average onset of menopause occurs around age 52—and potentially at a younger 
age in women with hysterectomy—and the average lifespan in the US for females is 82, 
women who undergo variations in gynecological surgery in adulthood may live many 
decades in a post-surgical, and eventually post-menopausal state. How hysterectomy with 
or without ovarian conservation impacts health risk factors longitudinally remains an 
open, yet imperative, question that necessitates further exploration. 
Ovarian hormones are intricately linked with the normal function and regulation 
of many peripheral body systems, including cardiovascular, skeletal, muscular, 
integumentary, and gastrointestinal systems, as well as with the central nervous system. 
A premature loss of ovarian hormones, as is the case with surgical ovary removal, is 
known to negatively impact cognition in women and animal models (Bimonte & 
Denenberg, 1999; Bove et al., 2014; Farrag et al., 2002; Gibbs & Johnson, 2008; Nappi et 
al., 1999; Rocca et al., 2007, 2011, 2012, 2010, 2009; Talboom et al., 2008; M. Wallace 
et al., 2006). The dogma in the field is that any cognitive changes that present following 
gynecological surgery are resultant of alterations in the ovaries because the non-pregnant 
uterus is thought to be a quiescent organ as an independent structure. However, research 
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from the Mayo Clinic and other laboratories has suggested that hysterectomy –with and 
without ovarian conservation– can increase the relative risk of developing 
neurodegenerative diseases such as dementia (Phung et al., 2010; Rocca et al., 2007, 
2012) and Parkinson’s disease (Benedetti et al., 2001) compared to reproductive-tract-
intact women of a similar age. The magnitude of this increased relative risk of dementia 
rises with a younger age at the time of surgery (Phung et al., 2010).  
The association between hysterectomy and neurodegenerative disease has piqued 
interest into how the non-pregnant uterus —which is typically considered an endocrine 
target but otherwise dormant without direct communication the ovaries— may influence 
non-reproductive functions, including cognitive processes. The standard model for 
evaluating effects of surgical menopause in rodents is the ovariectomy (Ovx) model, a 
procedure which surgically removes the ovaries but retains the uterine tissue (Koebele & 
Bimonte-Nelson, 2016). However, in clinical practice, this type of procedure is rarely 
performed; rather, women either undergo a hysterectomy with ovarian conservation or a 
complete ovariohysterectomy. Thus, a significant gap in the basic science literature 
existed regarding the effects of hysterectomy in the context of gynecological surgery, 
menopause, and cognition. A few investigations using rodent models to evaluate the 
physiological effects of hysterectomy on the ovaries and serum hormone levels do exist. 
For example, a series of early experiments using crude uterine extracts in rats suggested 
that the uterus may alter pituitary RNA activity as well as regulate hormone and 
gonadotropin synthesis and release from the hypothalamus and anterior pituitary (Biró, 
1979; Biró & Eneroth, 1989; Biró et al., 1983, 1988, 1984, 1987; H. G. Spies, Hilliard, & 
Sawyer, 1968). Another experiment where six-week-old rats underwent hysterectomy 
 
241 
found increased ovulatory activity approximately three weeks later, as well as increased 
ovarian homogenate-derived 17b-estradiol levels and aromatase activity during diestrus, 
but no change in plasma FSH or ovarian testosterone levels (Tanaka et al., 1994). More 
recent reports demonstrated that up to four months after hysterectomy, no changes were 
observed in serum FSH levels, but there was evidence of accelerated ovarian follicular 
atresia (Tapisiz et al., 2008); a longer interval after hysterectomy surgery indicated higher 
serum FSH levels in the hysterectomy rats in addition to increased follicular atresia 
compared to controls (Özdamar, Ülger, Sorkun, & Müderris, 2005). Despite these 
cumulative findings, no systematic evaluations of the role of hysterectomy on cognition 
existed. To address this knowledge gap, our laboratory recently developed a novel model 
of hysterectomy to systematically evaluate effects of variations in gynecological surgery 
on cognition. Surgery manipulations included Sham (intact control), Ovx, Hysterectomy, 
and Ovx-Hysterectomy surgeries in the adult rat. Six weeks after surgery, rats were 
cognitively tested on a battery of spatial memory tasks assessing working and reference 
memory. We reported that hysterectomy with ovarian conservation resulted in a unique, 
detrimental effect on spatial working memory two months after surgery (Koebele et al., 
2019). These findings should be interpreted in the context of a short-term time point after 
surgery. The goal of the current experiment was to extend these findings by investigating 
whether the cognitive effects following hysterectomy in adulthood were transient and 
reverse with time, or if the observed cognitive changes were the beginning of a long-
term, possibly global, cognitive impairment. Three cohorts of rats received Sham, Ovx, 
Hysterectomy, or Ovx-hysterectomy at 5 months of age. The first cohort was tested 6 
weeks after surgery, in adulthood; the second cohort was tested 7 months after surgery, in 
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middle age; the third cohort was tested 12 months after surgery, in old age. Rats 
underwent cognitive testing on a series of behavior tasks evaluating spatial working 
memory, spatial reference memory, and anxiety-like behavior to elucidate the long-term 
impact of variations in gynecological surgery on cognition. Serum hormone levels and 
ovarian follicle estimates were also assessed to understand how ovarian steroidogenesis 
and follicular development could be impacted by gynecological surgery manipulations. 
 
Methods 
Subjects 
Three cohorts of forty 5-month-old female, virgin, reproductively-intact Fischer-
344-CDF rats from the National Institute on Aging colony at Charles Rivers Laboratories 
(Raleigh, NC) were utilized in this experiment (N=120). Upon arrival to the Arizona 
State University animal facility, rats were pair-housed, provided free access to food and 
water, and were maintained in a temperature- and humidity- controlled environment on a 
12-hour light/dark cycle (lights on at 7 am, lights off at 7 pm). Experimental procedures 
commenced after allowing 1 week of acclimation to the facility. All experimental 
procedures were approved by the Arizona State University Institutional Animal Care and 
Use Committee and adhered to National Institutes of Health standards.  
All rats were 5 months old at the beginning of the experiment. The Adult cohort 
was tested 6 weeks after surgery, when rats were approximately 7 months of age. The 
Middle-Aged cohort was tested 7 months after surgery, when rats were approximately 12 
months of age. The Aged cohort was tested 12 months after surgery, when rats were 
approximately 18 months of age.  
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Surgical Procedures 
For each cohort of rats (N=40/cohort), 10 subjects were randomly assigned to one 
of the following surgical conditions: Sham, Ovx, Hysterectomy, or Ovx-Hysterectomy. 
Surgeries were performed one week (±1 day) after arriving to the animal facility. 
Isoflurane, a vaporized inhaled anesthetic was used. Each rat received subcutaneous 
injections of 1.0 mg/kg meloxicam (a non-steroidal anti-inflammatory drug), 1.2 mg/kg 
buprenorphine SR-LAB (an extended-release opioid analgesic), and 5.0 mL of Lactated 
Ringer’s Solution to maintain hydration post-surgery. Following sterilization of the 
surgical field, all rats received a ventral midline incision through the skin and muscle to 
expose the peritoneal cavity. The Sham group only underwent these incisions; abdominal 
viscera was not further manipulated. For the Ovx group, each ovary was exposed, ligated 
with dissolvable Vicryl suture along with the oviduct and tip of the uterine horn, and 
removed. For the Hysterectomy group, each uterine horn was exposed, ligated, and cut 
below the ovary and oviduct. Then, the uterine body was separated from the abdominal 
fat and ligated at the utero-cervical junction prior to excision. For the Ovx-Hysterectomy 
group, the ovaries, oviducts, and uterus were separated from the abdominal fat, and the 
uterine body was ligated at the utero-cervical junction, which was then removed. 
Following each surgical procedure, the muscle incision was sutured with dissolvable 
Vicryl suture. Topical 0.25% bupivicane (Marcaine, Pfizer Pharmaceutical, Hospira Inc., 
Lake Forest, IL), was applied to the incision prior to closing the skin with surgical 
staples. Rats recovered under an escapable heat lamp following surgery. All subjects 
were single-housed for one week after surgery prior to being re-pair-housed with a cage 
mate for the remainder of the study. Two rats died following surgery from the Middle-
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Aged Cohort (2 Ovx-Hysterectomy rats), and 3 rats died following surgery from the 
Aged Cohort (2 Ovx rats and 1 Hysterectomy rat). Over the course of this year-long 
experimental design, some natural attrition occurred in the Middle-Aged and Aged 
cohorts as well. The final n/group for each cohort was as follows: Adult (6 week cohort): 
Sham = 10, Ovx = 10, Hysterectomy = 10, Ovx-Hysterectomy = 10; Middle-Aged (7 
month cohort): Sham = 10, Ovx = 10, Hysterectomy = 9, Ovx-Hysterectomy = 8; Aged 
(12 month cohort): Sham = 10, Ovx = 8, Hysterectomy = 7, Ovx-Hysterectomy = 9. 
 
Weekly Weights and Vaginal Cytology Monitoring 
Baseline weight was recorded for each rat at the time of surgery. Body weights 
were then recorded by an experimenter weekly for the entirety of the experiment, as well 
as on the day of euthanization for each cohort.  
Rats in each cohort underwent vaginal cytology monitoring two weeks after 
surgery for eight consecutive days. The Adult (6 week) cohort was smeared 24 hours 
prior to euthanization and on the day of euthanization. The Middle-Aged and Aged 
cohorts were smeared again for eight consecutive days six months after surgery, prior to 
the Middle-Aged cohort’s behavior testing. The Middle-Aged (7 month) cohort was then 
smeared 24 hours prior to euthanization and on the day of euthanization. Finally, the 
Aged cohort was smeared 12 months after surgery for eight consecutive days, prior to 
starting behavior testing. Finally, the Aged cohort was smeared 24 hours prior to 
euthanization and on the day of euthanization. 
Vaginal cytology classification was completed in order to assess normal estrous  
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cyclicity in rats with intact ovaries (i.e. the Sham and Hysterectomy groups) as well as 
confirm Ovx status in rats without intact ovaries (i.e. the Ovx and Ovx-Hysterectomy 
groups). Smear cytology was classified as proestrus, estrus, metestrus, or diestrus, 
according to Goldman et al. (2007) and Koebele and Bimonte-Nelson (2016). Proestrus 
smears were characterized by round nucleated epithelial cells with or without some 
cornified cells. Estrus was classified as cornified cells. Metestrus was considered a 
combination of cornified, needle-like, leukocytes, and round epithelial cells. Diestrus 
consisted of the presence of leukocytes, with or without cornified cells (Goldman et al., 
2007; Koebele & Bimonte-Nelson, 2016).  
 
Behavioral Tasks 
Water Radial-Arm Maze. The water radial-arm maze (WRAM) was a water-
escape, win-shift task that evaluated spatial working and reference memory, as previously 
described (Bimonte-Nelson et al., 2015; Bimonte & Denenberg, 1999; Koebele et al., 
2019). The maze apparatus had a circular center with eight evenly-sized arms (38.1 cm 
long x 12.7 cm wide) radiating from the center arena in a circular fashion. The maze was 
filled with room temperature water maintained at 18-20°C throughout the testing period. 
Water was made opaque with black nontoxic powdered paint. Four out the eight arms had 
platforms submerged ~2 cm below the surface of the water. The pattern of arm locations 
for the hidden platforms stayed the same within a rat across all testing days, but varied 
among rats, and platform location patterns were counterbalanced across treatment groups. 
The testing rooms had clear spatial cues placed around the room to facilitate spatial 
navigation to the platforms. Rats were given four trials per day for 12 baseline days. 
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During each daily testing session, at the beginning of the first trial, the rat was released 
into the non-platformed start arm and allotted 3 minutes to locate a platform. If a platform 
was not discovered after the maximum allotted trial time, the experimenter gently guided 
the rat to the nearest platform. Once the rat found or was led to the platform, it was 
allowed to remain on it for 15 seconds before the experimenter gently removed the rat 
from the maze and placed it back into its testing cage for a 30 second inter-trial-interval 
(ITI). During those 30 seconds, the experimenter removed the just-found platform from 
the maze and used a net to stir the water to distribute potential olfactory cues and remove 
any debris from the water. The rat was then placed back in the water for trial 2 with the 3 
remaining platforms remaining. This procedure was repeated until all four platforms were 
located within the daily testing session. The experimenter manually recorded arm entries 
during all testing trials. An arm entry was quantified when the rat’s snout passed an 11 
cm mark on the outside of a given arm, which was only visible to the experimenter and 
not visible the rat. On the thirteenth day of testing, a six-hour delay was incorporated 
between trials 2 and 3 in order to assess delayed working memory retention. Across all 
days of testing, arm entries made prior to locating a platform on a given trial were 
considered errors and were further classified into three error subtypes. Working memory 
correct (WMC) errors were arm entries made on trials 2-4 into arms that previously 
contained a platform during the daily testing session. Reference memory (RM) errors 
were the first entries into a never-platformed arm within a day. Working Memory 
Incorrect (WMI) errors were quantified when a rat subsequently re-entered a never-
platformed arm within the daily testing.  
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Morris Water Maze. Following one day of rest after the WRAM, all rats were 
tested on the spatial reference memory Morris water maze (MM) task as previously 
described (Bimonte-Nelson et al., 2015; Morris, 2015; Morris et al., 1982). The apparatus 
was a circular tub (188 cm in diameter). The tub was filled with 18-20°C water made 
opaque with nontoxic powdered black paint. One platform (11 cm in diameter) was 
submerged ~2 cm below the water’s surface in the northeast quadrant of the maze, where 
it remained constant across all days and trials. Obvious spatial cues were placed around 
the room to aid in spatial navigation. The rats received four trials per day for five days. 
For each trial within a daily testing session, the rats were each dropped off from one of 
four possible starting points (north, south, east, or west). The trial drop-off location order 
varied across days, but was the same for all rats within a day. The rat was allotted a 
maximum of 60 seconds to locate the submerged platform. If the rat was unable to find 
the platform after 60 seconds, the experimenter gently guided the rat to the platform with 
a lead stick, where it remained for 15 seconds before being returned to its heated testing 
cage for an ITI of approximately 10 minutes. Between each trial the water was stirred and 
cleared of any debris. On day five of the task, after the four baseline trials were complete, 
an additional probe trial was administered. During the probe trial, the tester completely 
removed the platform from the maze, and each rat was allowed to swim for 60 seconds to 
test whether the rats had successfully spatially localized to the fixed platform location in 
this maze. A digital video camera and Ethovision tracking system (Ethovision; Noldus 
Instruments, Wageningen, Netherlands) were utilized to track the rat’s swim distance and 
path (cm) to the platform during each trial.  
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Visible Platform. The day following the completion of the MM task, all rats were 
tested on the control Visible Platform task. This task evaluates the motoric and visual 
competency of the rats to successfully solve a water maze task. The apparatus was a 
small, rectangular tub (100 cm x 60 cm) filled with 18-20°C clear water. A visible black 
platform (10 cm in diameter) protruded about 4 cm above the surface of the water. The 
tub was surrounded by opaque curtains to block any potential extra-maze cues. Each rat 
underwent six trials within one day. The visible platform location varied across trials 
(left, middle, or center of the north wall of the tub), but the location within a given trial 
was the same for all rats. Each rat was dropped off from a fixed start location in the 
middle of the south wall of the tub and had a maximum of 90 seconds to locate the visible 
platform. Once located, the rat remained on it for 15 seconds before the experimenter 
returned the rat to its heated testing cage for an ITI of approximately 10 minutes while 
the other rats were being tested. The experimenter recorded latency (seconds) to reach the 
visible platform for each subject and trial.  
Open Field Task. After two days of rest following the Visible Platform task, all 
rats underwent testing in the open field task (OFT), a measure of locomotor activity and 
anxiety-like behavior. Task performance has been reported to be sensitive to the presence 
and absence of hormones (Hiroi & Neumaier, 2006). The open field apparatus was a 100 
x 100 square arena made of black Plexiglas. Twenty-four hours prior to the task, the 
arena was thoroughly cleaned with Odormute, an enzyme cleaner used to eliminate odors. 
A red light visible to the experimenter was used in the room, such that the task was run in 
darkness for the rats, as has been previously done (Hiroi & Neumaier, 2006). Rats were 
allowed to acclimate in the anteroom of the testing area for at least 30 minutes in their 
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individual testing cages prior to OFT testing. Each rat was brought into the testing room 
individually. The experimenter gently placed the rat in the arena from the center of the 
north wall and quietly exited the room. The rat was allowed to explore the box freely for 
a 10-minute trial. Ethovision was used to record and track the rat’s movements in the 
OFT. Twenty-five equally spaced squared were digitally overlaid onto the arena in order 
to track distance moved and time spent in the small center, center, and corners of the 
arena. Following the 10-minute trial, the rat was removed from the arena. Any fecal boli 
were removed from the arena; the experimenter wiped the arena with water and then 
dried it prior to starting the next rat’s trial. This was completed in order to evenly 
distribute any odors left by a previously tested rat throughout the arena.   
 
Euthanasia 
One week following the OFT, rats were euthanized. The Adult cohort was 
approximately 7 months old, the Middle-Aged cohort was approximately 12 months old, 
and the Aged cohort was approximately 18 months old at sacrifice. All rats were deeply 
anesthetized using inhaled isoflurane anesthesia. Blood was obtained via cardiocentesis, 
and allowed to clot at 4°C for a minimum of 30 minutes (Vacutainer 367986, Becton 
Dickinson and Company, Franklin Lakes, NJ) prior to centrifugation at 2000 rpm at 4°C 
for 20 minutes. Serum was extracted and stored at -20°C until analysis. Rats were 
decapitated and brains were rapidly removed. The right hemisphere of the brain was 
rapidly raw dissected for frontal cortex, dorsal hippocampus, entorhinal cortex, perirhinal 
cortex, and ventral CA1/2 areas. The raw dissected tissues were then weighed, snap 
frozen, and stored at -70°C until analysis. The left hemisphere was post-fixed in 4% 
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paraformaldehyde for 48 hours and then transferred to 0.1M phosphate buffered solution 
until analysis. Ovaries were collected from ovary-intact groups (i.e. the Sham and 
Hysterectomy groups), trimmed of excess fat, weighed, and transferred to 10% buffered 
formalin for 48 hours prior to being stored in 70% ethanol until analysis. Uteri were 
collected from uterus-intact groups (i.e. the Sham and Ovx groups), trimmed of excess 
fat, and wet weight was obtained.  
 
Serum Hormone Assays 
All serum hormone assays were completed by the Center for Research in 
Reproduction Ligand Assay and Analysis Core Laboratory at the University of Virginia. 
Samples were run in duplicate unless otherwise noted. 17b-Estradiol (E2) levels were 
determined with a commercially-available ELISA kit (CAT# ES180S-100, 
CALBIOTECH, Spring Valley, CA). E2 inter-assay coefficients of variation averaged 
9.7% (intra-assay 6.7%) with a functional sensitivity of 3 pg/mL and a reportable range 
of 3 – 300 pg/mL. Progesterone levels were determined with a commercially-available 
ELISA kit (CAT# IB79105, Immuno-Biological Laboratories Inc., Minneapolis, MN). 
Inter-assay coefficients of variation averaged 10.5% (intra-assay 6.6%) with a functional 
sensitivity of 0.045 ng/mL and a reportable range of 0.150 – 40.00 ng/mL. 
Androstenedione levels were determined with a commercially available ELISA kit 
(CAT# 11-ANRHU-E01, ALPCO, Salem, NH). Inter-assay coefficients of variation 
averaged 9.1% (intra-assay 5.9%) with a functional sensitivity of 0.04 ng/mL and a 
reportable range of 0.1- 10.0 ng/mL. E2 and androstenedione levels were measures for 
ovary-intact rats only. Progesterone levels were obtained for all subjects.  
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Ovarian Follicle Counts 
 All ovarian histology and quantification was completed by Senestech, Inc 
(Flagstaff, AZ) with methods previously described (Koebele et al., 2017, 2019). For each 
cohort, one ovary from each Sham and Hysterectomy subject (i.e., all rats that had 
ovaries at the end of the experiment) was randomly selected for histological evaluation 
and quantification of healthy primordial, primary, secondary, and antral follicles, as well 
as corpora lutea. Following fixation, ovarian tissues were paraffin embedded and 
sectioned at 5 µm.  Every 10th section was mounted on a slide and stained with 
hematoxylin and eosin Y-phloxine B. Primordial, primary, secondary, and antral follicles 
were counted at 20x magnification for every 20th section. Corpora lutea were counted at 
a lower magnification (Pannoramic DESK; 3D Histech, Budapoest, Hungary). The 
following formula was used to calculate the total number of follicles in the ovary: Nt = 
(N0 x St x ts) / (S0 x d0), where Nt = total calculated number of follicles, N0 = number of 
follicles observed in the ovary, St = total number of sections in the ovary, ts = thickness of 
the section (µm), S0 = total number of sections observed, and d0 = mean diameter of the 
nucleus (Gougeon & Chainy, 1987). Ovarian follicles were classified using criteria from 
Haas et al., 2007 (Haas et al., 2007). Primordial cells were counted when there was a 
single layer of squamous granulosa cells surrounding the oocyte. Primary follicles 
contained a single layer of cuboidal granulosa cells. Secondary follicles required several 
granulosa cell layers surrounding the oocyte. Antral follicles were counted when the 
follicle contained two or more layers of granulosa cells and had a fluid-filled antral space 
in the follicle (Haas et al., 2007). Atretic/unhealthy follicles were not counted.  
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Statistical Analyses 
Statview software was utilized to complete all statistical analyses. The 
independent variable for all analyses was Surgery type (Sham, Ovx, Hysterectomy, and 
Ovx-Hysterectomy). All analyses were two-tailed tests with an alpha level set to 0.05 
unless otherwise noted. Two-group planned comparisons were completed between 
Hysterectomy and each other surgery group for all analyses. Results were deemed 
significant if the p value was < 0.05, and marginal if the p value fell between 0.05 and 
0.10.  
WRAM data were analyzed using repeated measures, with trials within days as 
the repeated measures, and the dependent variable as Errors. WRAM data were divided 
into two blocks, similarly to how our laboratory has previously reported (Bimonte & 
Denenberg, 1999; Bimonte et al., 2000; Braden et al., 2016; Koebele et al., 2017; 
Mennenga, Gerson, et al., 2015; Prakapenka et al., 2018). For all cohorts, Day 1 was 
considered training and was not included in the analyses. Days 2-7 were considered the 
Learning Phase and Days 8-12 were considered the Asymptotic Phase. Planned two-
group comparisons were completed for high working memory load trials, Trial 3 and 
Trial 4, for each error type within the Learning Phase and Asymptotic Phase, as 
previously published (Koebele et al., 2019; Prakapenka et al., 2018). Separate analyses 
were run for each error type quantified in the WRAM (i.e., WMC, WMI, RM). 
MM data were also evaluated using two-group planned comparison repeated 
measures ANOVA, with trials within days as repeated measures, and the dependent 
variable as Swim Distance (cm) to Platform for all baseline trials. For the probe trial, 
Percent Total Swim Distance (cm) was evaluated in the target versus the opposite 
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quadrant for each treatment group. Visible Platform data were assessed using repeated 
measures, with trial as the repeated measure and Latency (sec) as the dependent variable.  
OFT distance and time measures were analyzed using ANOVA for all planned 
comparisons. Serum ovarian hormone levels, ovarian follicle counts, body weights, ovary 
weights, and uterine weights were also analyzed using ANOVA with each of those 
respective measurements as the dependent variable for all planned comparisons. 
 Three rats were excluded from all analyses within the Middle-Aged cohort due to 
consistent floating behavior, and thus failure to perform in the WRAM task. Two rats 
were excluded from all analyses within the Aged cohort due to deteriorated health. 
Unless otherwise noted, the final n/group for each cohort was as follows: Adult (6-week 
cohort): Sham = 10, Ovx = 10, Hysterectomy = 10, Ovx-Hysterectomy = 10; Middle-
Aged (7-month cohort): Sham = 10, Ovx = 9, Hysterectomy = 9, Ovx-Hysterectomy = 6; 
Aged (12-month cohort): Sham = 9, Ovx = 8, Hysterectomy = 6, Ovx-Hysterectomy = 9. 
 
Results 
Adult (6 Week) Cohort WRAM 
Learning Phase (Days 2-7). Based on recent findings regarding hysterectomy-
induced working memory deficits 6 weeks post-surgery (Koebele et al., 2019) and other 
reports revealing working memory deficits when working memory load becomes taxed in 
rats, we planned to evaluate working memory performance on Trial 3, the moderate 
working memory load trial, and Trial 4, the maximum working memory load trial, using 
two-group comparisons between the Hysterectomy group and each other surgery group.  
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Performance across trials for WMC errors is demonstrated in Figure 59A and for WMI 
errors in 59B. For WMC errors on Trial 3, Hysterectomy and Ovx-Hysterectomy groups 
were significantly different from each other [F(1,18)=6.82, p < 0.05], such that 
Hysterectomy rats made more WMC errors than Ovx-Hysterectomy rats (Figure 59C). 
Furthermore, for WMI errors, two-group comparisons revealed that Hysterectomy rats 
made more WMI errors on Trial 3 compared to Sham rats [F(1,18)=8.82, p < 0.01] and 
trended toward making more WMI errors when compared to Ovx-Hysterectomy rats 
[F(1,18)=3.17, p = 0.09], although this latter two-group comparison was marginal (Figure 
59D). That Hysterectomy rats made more WMI errors compared to Sham rats six weeks 
after surgery is a replication of our prior work (Koebele et al., 2019). There were no main 
effects of Surgery for Trial 4 alone during this block for any planned comparison (Figure 
59E-F). There were no effects for RM errors (data not shown), pointing to a working-
memory specific impairment in the Hysterectomy group.  
Asymptotic Phase (Days 8-12). There were no significant differences in 
performance for WMC or WMI in the Asymptotic Phase of testing for any planned 
comparison, suggesting that all surgery groups successfully learned the WRAM task by 
the latter portion of testing and were able to similarly handle a working memory load, 
regardless of surgery type (Figure 60A-F). There were no effects for RM errors in the 
Asymptotic Phase (data not shown).  
Delayed Memory Retention. Following the last day of baseline testing on the 
WRAM, a six-hour delay was introduced between trials 2 and 3 on Day 13. Performance 
was evaluated on Trial 3 (the first post-delay trial) compared to Trial 3 performance on 
the last baseline day for each surgery group. A main effect of Delay Day was present for 
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Ovx rats [F(9,1)=15.00, p < 0.01], Hysterectomy rats [F(9,1)=6.43, p < 0.05], and Ovx-
Hysterectomy rats [F(9,1)=14.23, p < 0.01], where more WMC errors were committed in 
the post-delay trial compared to the previous day’s performance. Sham rats did not show 
a significant delay-induced working memory impairment (Figure 61).  
 
Adult (6 Week) Cohort Morris Water Maze 
Learning curves for the MM task are visualized in Figure 62A. Within each 
planned group comparison, there were no main effects of Surgery. There was a main 
effect of Day within each comparison (Hysterectomy versus Sham: [F(4,72)=37.22, p < 
0.0001]; Hysterectomy versus Ovx: [F(4,72)=30.23, p < 0.0001]; Hysterectomy versus 
Ovx-Hysterectomy: [F(4,72)=18.05, p < 0.0001]), indicating learning across the five days 
of baseline testing. Each Surgery group was evaluated independently for probe trial 
performance. There was a main effect of Quadrant for all groups (Sham: [F(9,1)=80.79, p 
< 0.0001]; Ovx: [F(9,1)=103.59, p < 0.0001]; Hysterectomy: [F(9,1)=118.30, p < 0.0001]; 
Ovx-Hysterectomy: [F(9,1)=125.63, p < 0.0001]), where all subjects spent a greater 
proportion of total swim distance in the previously platformed quadrant compared to the 
opposite quadrant, indicating spatial localization to the platform location (Figure B).  
 
Adult (6 Week) Cohort Visible Platform 
Each group was evaluated individually for performance on the Visible Platform. 
The average latency to platform for the Sham group on Trial 1 was 10.62 ± 1.80 seconds, 
and the average latency to platform on Trial 6 was 4.08 ± 1.06 seconds. For Ovx rats, the  
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average latency to platform for Trial 1 was 10.16  ± 2.72 seconds, and the average 
latency to platform on Trial 6 was 6.33 ± 1.73 seconds. For Hysterectomy rats, the 
average latency to platform on Trial 1 was 10.42  ± 2.87 seconds, and the average latency 
to platform on Trial 6 was 5.55  ± 1.32 seconds. Ovx-Hysterectomy rats had an average 
latency to platform of 10.85 ± 2.93 seconds on Trial 1, and an average latency to platform 
on Trial 6 of 5.94 ± 1.50 seconds. Overall, all groups’ average latency to platform was 
lower by the last trial of Visible Platform testing. By Trial 6, all rats located the visible 
platform in 20 seconds or less, indicating that all subjects had intact visual and motor 
procedural skills to perform a water maze task. 
 
Adult (6 Week) Cohort Open Field Task 
There was a marginal main effect of Total Distance for the Ovx versus 
Hysterectomy comparison  [F(1,18)=3.86, p = 0.06], where Ovx rats tended to move less 
than Hysterectomy rats overall (data not shown). There were no other significant or 
marginal main effects in any of the measured variables for any comparison at this time 
point.  
 
Adult (6 Week) Cohort Vaginal Smears  
Vaginal smears were collected beginning two weeks after surgery for eight 
consecutive days. Ovx and Ovx-Hysterectomy rats all displayed diestrus-like or blank 
smears, indicating successful ovary removal and a lack uterine stimulation. Sham and 
Hysterectomy groups exhibited normal cyclic estrous activity consisting of 4-5 day  
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estrous cycles. Vaginal smears were also collected one day prior to euthanization and on 
the day of euthanization. Ovx and Ovx-Hysterectomy groups continued to display 
diestrus-like or blank smears, and Sham and Hysterectomy rats were in various phases of 
the estrous cycle, such that all phases (proestrus, estrus, metestrus, and diestrus) were 
each represented in both ovary-intact groups on the day of euthanization.  
 
Adult (6 Week) Cohort Body Weights 
Two-group comparisons were made between all Surgery conditions at the 
euthanasia time point. There was a main effect of Surgery for Body Weight for the Ovx 
versus Hysterectomy comparison [F(1,18)=96.35, p < 0.0001], where Ovx rats weighed 
more than Hysterectomy rats. There was also a main effect of Body Weight for the Ovx-
Hysterectomy versus Hysterectomy comparison [F(1,18)=72.35, p < 0.0001], where Ovx-
Hysterectomy rats weighed more than Hysterectomy rats. Sham rats weighed less 
compared to Ovx rats [F(1,18)=47.82, p < 0.0001] and compared to Ovx-Hysterectomy rats 
[F(1,18)=37.36, p < 0.0001] (Figure 63A).  
 
Adult (6 Week) Cohort Uterine Weights 
Only rats that retained their uterus throughout the experiment (i.e., Sham and Ovx 
rats) were compared. As expected, there was a main effect of uterine weight between 
Sham and Ovx rats [F(1,18)=58.56, p < 0.0001], such that uterine weights for Ovx rats 
were lower than Sham rats due to a lack of estrogen stimulation from the ovaries (Engler-
Chiurazzi et al., 2012; Koebele et al., 2019; Mennenga, Gerson, et al., 2015; Prakapenka 
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et al., 2018; Westerlind et al., 1998). When uterine weights were corrected for body 
weight, the main effect of Surgery persisted [F(1,18)=53.12, p < 0.0001] (Figure 63B). 
 
Adult (6 Week) Cohort Ovary Weights and Ovarian Follicle Estimates 
Only rats that retained their ovaries throughout the experiment (i.e., Sham and 
Hysterectomy rats) were compared. When ovary weight was summed, there was no 
difference in weight between groups at this time point (Figure 63C). 
 There were no main effects of Surgery for Primordial Follicles [F(1,18)=0.06, p = 
NS], Primary Follicles [F(1,18)=0.33, p = NS], Secondary Follicles [F(1,18)=0.28, p = NS], 
Antral Follicles [F(1,18)=2.07, p = NS], or Corpora Lutea Counts [F(1,18)=0.64, p = NS] at 
this time point (Figure 64A-E).  
 
Adult (6 Week) Cohort Serum Hormone Levels 
 One Sham subject and one Hysterectomy subject were excluded for Progesterone 
analyses due to serum values outside the detectable range of the assay. There were no 
differences between Sham and Hysterectomy groups [F(1,16)=0.50, p = NS]. However, 
Hysterectomy rats had higher Progesterone levels compared to Ovx rats [F(1,17)=11.19, p 
< 0.01] and compared to Ovx-Hysterectomy rats [F(1,17)=10.04, p < 0.01]. Sham rats also 
had higher Progesterone levels compared to Ovx rats [F(1,17)=10.38, p < 0.01] and 
compared to Ovx-Hysterectomy rats [F(1,17)=9.58, p < 0.01] (Figure 65A). Ovx groups 
did not differ from each other. 
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 Three Sham subjects and two Hysterectomy subjects were excluded for 
Androstenedione analyses due to serum values outside the detectable range of the assay. 
One value in the Sham group was based on a singlet value, as the other singlet was 
outside the detectable range. There were no differences in Androstenedione levels 
between Sham and Hysterectomy rats [F(1,13)=0.161, p = NS; Figure 65B]. 
One Sham subject and one Hysterectomy subject were excluded for E2 analyses 
due to serum values outside the detectable range of the assay. One value in the 
Hysterectomy group was based on a singlet value, as the other singlet was outside the 
detectable range. There were no differences in E2 levels between Sham and 
Hysterectomy rats [F(1,16)=1.20, p = NS; Figure 65C]. 
 
Middle-Aged (7 month) Cohort WRAM 
Learning Phase (Days 2-7). Performance by Trial during the Learning Phase, 
averaged across days, is shown in Figure 66A (WMC errors) and Figure 66B (WMI 
errors). For Trial 3, there was a main effect of Surgery for WMC errors between 
Hysterectomy and Ovx rats [F(1,16)=4.83, p < 0.05] and between Hysterectomy and Ovx-
Hysterectomy rats [F(1,13)=9.49, p < 0.01]. There was also a marginal main effect of 
Surgery on Trial 3 WMC errors between Sham and Hysterectomy rats [F(1,17)=3.25, p = 
0.09], where Hysterectomy rats made more WMC errors on Trial 3 than each group 
(Figure 66C). For WMI errors on Trial 3, there was a main effect of Surgery between 
Sham and Hysterectomy rats [F(1,17)=4.62, p < 0.05], as well as between Ovx and 
Hysterectomy rats [F(1,16)=11.80, p < 0.01] with Hysterectomy rats making more errors 
than Sham and Ovx rats, respectively (Figure 66D).  
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There were no effects of Surgery for WMC errors on Trial 4 (Figure 66E). 
However, for WMI errors on Trial 4, Hysterectomy and Ovx-Hysterectomy rats differed 
[F(1,13)=5.27, p < 0.05], with Hysterectomy rats making more errors than Ovx-
Hysterectomy rats (Figure 66F). There were no main effects of RM for any comparison 
(data not shown).  
Asymptotic Phase (Days 8-12). Performance by Trial during the Asymptotic 
Phase, averaged across days, is shown in Figure 67A for WMC errors and Figure 67B for 
WMI errors. There were no main effects or interactions with Surgery for WMC and WMI 
errors during the Asymptotic Phase for this cohort, indicating that by the end of WRAM 
testing, all subjects could similarly handle the working memory load, regardless of 
Surgery condition (Figure 67C-F). There were no effects for RM for any comparison at 
this time point (data not shown). 
Delayed Memory Retention. Following the last day of baseline testing on the 
WRAM, a 6 hour delay was introduced between trials 2 and 3 on Day 13. Performance 
was evaluated on Trial 3 (the first post-delay trial) compared to Trial 3 performance on 
the last baseline day for each surgery group. A main effect of Delay Day was present for 
Ovx-Hysterectomy rats [F(5,1)=7.35, p < 0.05; Figure 68D], where more WMC errors 
were made on Trial 3 following the six-hour delay. A marginal effect of Delay Day was 
present for Sham rats [F(9,1)=4.37, p = 0.07; Figure 68A] and for Hysterectomy rats 
[F(8,1)=5.26, p = 0.05; Figure 68C], with the six-hour delay resulting in increased WMC 
errors on Trial 3 for each group. Ovx rats did not exhibit increased WMC errors on the 
post-delay trial at this time point (Figure 68B). 
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Middle-Aged (7 month) Cohort Morris Water Maze 
Within each planned comparison, there were no main effects of Surgery. There 
was a main effect of Day within each comparison (Hysterectomy versus Sham: 
[F(4,68)=12.64, p < 0.0001]; Hysterectomy versus Ovx: [F(4,64)=8.73, p < 0.0001]; 
Hysterectomy versus Ovx-Hysterectomy: [F(4,52)=17.20, p < 0.0001]), indicating learning 
across the five days of baseline testing (Figure 69A). Each Surgery group was evaluated 
independently for probe trial performance. There was a main effect of Quadrant for all 
groups (Sham: [F(9,1)=29.12, p < 0.001]; Ovx: [F(8,1)=67.11, p < 0.0001]; Hysterectomy: 
[F(8,1)=38.59, p < 0.001]; Ovx-Hysterectomy: [F(5,1)=14.10, p < 0.05]), where all rats 
spent a greater proportion of total swim distance in the previously platformed quadrant 
compared to the opposite quadrant, indicating spatial localization to the platform location 
(Figure 69B).  
 
Middle-Aged (7 month) Cohort Visible Platform 
Each group was evaluated individually for performance on the Visible Platform. 
The average latency to platform for the Sham group on Trial 1 was 9.71 ± 2.19 seconds, 
and the average latency to platform on Trial 6 was 6.15 ± 0.94 seconds. For Ovx rats, the 
average latency to platform for Trial 1 was 12.16  ± 4.05 seconds, and the average 
latency to platform on Trial 6 was 3.12 ± 0.51 seconds. For Hysterectomy rats, the 
average latency to platform on Trial 1 was 9.99  ± 2.78 seconds, and the average latency 
to platform on Trial 6 was 3.81  ± 1.24 seconds. Ovx-Hysterectomy rats had an average 
latency to platform of 10.50 ± 2.44 seconds on Trial 1, and an average latency to platform 
on Trial 6 of 5.83 ± 2.92 seconds. Overall, all groups average latency to platform was 
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lower by the last trial of testing. By Trial 6, all rats located the visible platform in 20 
seconds or less, indicating that all subjects had intact visual and motor procedural skills 
to perform a water maze task. 
 
Middle-Aged (7 month) Cohort Open Field Task 
 There was a marginal main effect of Total Distance Moved [F(1,13)=3.79, p = 0.08] 
and Center Distance [F(1,13)=3.61, p = 0.08] for the Ovx-Hysterectomy versus 
Hysterectomy comparison, where Hysterectomy rats tended to move more overall; the 
trend toward greater distance traveled in the center is likely an artifact of overall 
increased movement. There were no other marginal or significant effects for any OFT 
measure at this time point (data not shown).  
 
Middle-Aged (7 month) Cohort Vaginal Smears 
Vaginal smears were collected beginning two weeks after surgery for eight 
consecutive days, when rats were approximately 6 months of age. All Ovx and Ovx-
Hysterectomy rats displayed diestrus-like or blank smears, indicating successful ovary 
removal and a lack uterine stimulation. Sham and Hysterectomy groups exhibited normal 
cyclic estrous activity consisting of 4-5 day estrous cycles. Eight consecutive days prior 
to behavior testing, vaginal smears were collected again for this cohort, when rats were 
approximately 12 months of age. All Ovx and Ovx-Hysterectomy rats continued to 
display diestrus-like or blank vaginal smears. All Sham and Hysterectomy rats displayed 
regular estrous cycle activity at this time point as well. Lastly, after behavior testing was  
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complete, vaginal smears were also collected one day prior to euthanization and on the 
day of euthanization. Ovx and Ovx-Hysterectomy groups continued to display diestrus-
like or blank smears, and Sham and Hysterectomy rats were in various phases of the 
estrous cycle, such that all phases (proestrus, estrus, metestrus, and diestrus) were each 
represented in both ovary-intact groups within 24 hours of euthanization.  
 
Middle-Aged (7 month) Cohort Body Weights 
 Hysterectomy rats weighed less than Ovx rats [F(1,16)=23.13, p < 0.001] and Ovx-
Hysterectomy rats [F(1,13)=31.50, p < 0.0001]. Sham rats also weighed less than Ovx rats 
[F(1,17)=28.39 p < 0.0001] and Ovx-Hysterectomy rats [F(1,14)=45.25, p < 0.0001]. Ovx 
and Ovx-Hysterectomy rats marginally differed from each other at the euthanasia time 
point [F(1,13)=4.13, p = 0.06], where Ovx-Hysterectomy rats tended to weigh more than 
Ovx rats (Figure 70A).  
 
Middle-Aged (7 month) Cohort Uterine Weights 
Only rats that retained their uterus throughout the experiment (i.e., Sham and Ovx 
rats) were compared. As expected, there was a main effect of uterine weight between 
Sham and Ovx rats [F(1,17)=51.76, p < 0.0001], such that uterine weights for Ovx rats 
were lower than Sham rats due to a lack of estrogen stimulation from the ovaries (Engler-
Chiurazzi et al., 2012; Koebele et al., 2019; Mennenga, Gerson, et al., 2015; Prakapenka 
et al., 2018; Westerlind et al., 1998). When uterine weights were corrected for body 
weight, the main effect of Surgery persisted [F(1,17)=51.53, p < 0.0001] (Figure 70B). 
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Middle-Aged (7 month) Cohort Ovary Weights and Ovarian Follicle Estimates 
Only rats that retained their ovaries throughout the experiment (i.e., Sham and 
Hysterectomy rats) were compared. There was no effect of Surgery on ovary weight at 
this time point (Figure 70C).  
There were no main effects of Surgery for Primordial Follicles [F(1,17)=0.03, p = 
NS], Primary Follicles [F(1,17)=0.04, p = NS], Secondary Follicles [F(1,17)=1.23, p = NS], 
Antral Follicles [F(1,17)=0.68, p = NS], or Corpora Lutea Counts [F(1,17)=2.67, p = NS] at 
this time point (Figure 71A-E).  
 
Middle-Aged (7 month) Cohort Serum Hormone Levels 
Only subjects included in behavioral analyses were included in serum 
assessments. Additionally, two Sham subjects, two Hysterectomy subjects, and one Ovx 
subject were excluded for Progesterone analyses due to serum values outside the 
detectable range of the assay. There were no differences in Progesterone levels between 
Sham and Hysterectomy rats [F(1,13)=0.43, p = NS]. However, Hysterectomy rats had 
more Progesterone compared to Ovx rats [F(1,13)=10.62, p < 0.01] and compared to Ovx-
Hysterectomy rats [F(1,11)=12.24, p < 0.01]. Sham rats also had more Progesterone 
compared to Ovx rats [F(1,14)=9.62, p < 0.01] and compared to Ovx-Hysterectomy rats 
[F(1,12)=8.79, p < 0.05] (Figure 72A). Ovx groups did not differ from each other. 
 One Hysterectomy subject was excluded for Androstenedione analyses due to 
serum values outside the detectable range of the assay. Two values in the Sham group 
and one value in the Hysterectomy group were based on a singlet value, as the other 
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singlet was outside the detectable range. There were no differences in Androstenedione 
levels between Sham and Hysterectomy rats [F(1,16)=0.23, p = NS; Figure 72B]. 
 Six Sham subjects and four Hysterectomy subjects were excluded for E2 analyses 
due to serum values outside the detectable range of the assay. Additionally, one value in 
the Hysterectomy group was based on a singlet value, as the other singlet was outside the 
detectable range. There were no differences in E2 levels between Sham and 
Hysterectomy rats [F(1,7)=0.89, p = NS; Figure 72C]. 
 
Aged (12 month) Cohort WRAM 
Learning Phase (Days 2-7). Performance by Trial on the Learning Phase, 
averaged across days, can be seen in Figure 73A (WMC errors) and Figure 73B (WMI 
errors). For Trial 3, there were no differences in WMC or WMI errors committed in any 
two-group comparison (Figure 73C,D). For Trial 4, marginal main effects of Surgery for 
WMC errors were present for the Sham versus Hysterectomy comparison [F(1,13)=4.11, p 
= 0.06] and Ovx versus Hysterectomy comparison [F(1,12)=4.20, p = 0.06], where 
Hysterectomy rats tended to make more WMC errors than each comparison group on 
Trial 3 (Figure 73E). For WMI errors on Trial 4, there was a main effect of Surgery for  
the Sham versus Hysterectomy comparison [F(1,13)=7.11, p < 0.05] and Ovx versus 
Hysterectomy comparison [F(1,12)=14.36, p < 0.01], where Hysterectomy rats made more 
WMI errors on the maximum working memory load trial than Sham and Ovx rats, 
respectively. There was also a marginal main effect of Surgery on WMI errors on Trial 4 
for the Ovx-Hysterectomy versus Hysterectomy comparison [F(1,13)=4.41, p = 0.06], 
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where Hysterectomy rats tended to make more errors than Ovx-Hysterectomy rats 
(Figure 73F). There were no RM effects for any planned comparison (data not shown). 
Asymptotic Phase (Days 8-12). Performance by Trial on the Asymptotic Phase, 
averaged across days, can be seen in Figure 74A (WMC errors) and Figure 74B (WMI 
errors). There were no main effects or interactions with Surgery for any two group 
comparison for WMC, WMI, or RM errors during the Asymptotic Phase for this cohort. 
However, there was a marginal effect of Surgery for the Ovx versus Hysterectomy 
comparison for Trial 4 [F(1,12)=3.78, p = 0.08], where Ovx rats tended to make more 
errors on this high load trial (Figure 74E).   
Delayed Memory Retention. When a six-hour delay was implemented between 
trials 2 and 3 on Day 13 of WRAM, Sham rats made more WMC errors on the post-delay 
Trial 3 compared to performance on Trial 3 on the last day of baseline testing  
[F(8,1)=16.00, p < 0.01l Figure 75A]. Ovx, Hysterectomy, and Ovx-Hysterectomy rats 
performed similarly on the post-delay trial, suggesting a delay did not result in 
significantly impaired working memory for these subjects at this time point (Figure 75B-
D). 
 
Aged (12 month) Cohort Morris Water Maze 
Within each planned comparison, there were no main effects of Surgery. There 
was a main effect of Day within each comparison (Hysterectomy versus Sham: 
[F(4,52)=15.77, p < 0.0001]; Hysterectomy versus Ovx: [F(4,48)=24.34, p < 0.0001]; 
Hysterectomy versus Ovx-Hysterectomy: [F(4,52)=18.85, p < 0.0001]), indicating learning  
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across the five days of baseline testing (Figure 76A). Each Surgery group was evaluated 
independently for probe trial performance. There was a main effect of Quadrant for all 
groups (Sham: [F(8,1)=11.75, p < 0.01]; Ovx: [F(7,1)=7.52, p < 0.05]; Hysterectomy: 
[F(5,1)=11.25, p < 0.05]; Ovx-Hysterectomy: [F(8,1)=30.49, p < 0.001]), where all subjects 
spent a greater proportion of total swim distance in the previously platformed quadrant 
compared to the opposite quadrant, indicating spatial localization to the platform location 
(Figure 76B).  
 
Aged (12 month) Cohort Visible Platform 
Each group was evaluated individually for performance on the Visible Platform. 
The average latency to platform for the Sham group on Trial 1 was 8.31 ± 1.17 seconds, 
and the average latency to platform on Trial 6 was 4.62 ± 1.13 seconds. For Ovx rats, the 
average latency to platform for Trial 1 was 17.92 ± 4.26 seconds, and the average latency 
to platform on Trial 6 was 5.56  ± 1.57 seconds. For Hysterectomy rats, the average 
latency to platform on Trial 1 was 12.25 ± 2.66 seconds, and the average latency to 
platform on Trial 6 was 5.25  ± 1.31 seconds. Ovx-Hysterectomy rats had an average 
latency to platform of 8.24 ± 0.93 seconds on Trial 1, and an average latency to platform 
on Trial 6 of 4.94 ± 0.97 seconds. Overall, all groups average latency to platform was 
lower by the last trial of testing. By Trial 6, all rats located the visible platform in 20 
seconds or less, indicating that all subjects had intact visual and motor procedural skills 
to perform a water maze task. 
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Aged (12 month) Cohort Open Field Task 
 There was a marginal effect of Surgery in the Ovx versus Hysterectomy 
comparison for Time Spent in the Corner [F(1,12)=3.64, p = 0.08], where Ovx rats tended 
to spend more time in the corner than Hysterectomy rats. There was a main effect of 
Total Distance Moved for the Ovx-Hysterectomy versus Hysterectomy rats [F(1,13)=5.14, 
p < 0.05], where Hysterectomy rats moved move total distance than Ovx-Hysterectomy 
rats. There was also a marginal effect of Surgery between Ovx-Hysterectomy and 
Hysterectomy rats for Center Distance [F(1,13)=4.00, p = 0.07], where Hysterectomy rats 
traveled more distance in the center than Ovx-Hysterectomy rats, although this may be an 
artifact of overall increased distance moved for Hysterectomy rats because there was a 
trend toward Hysterectomy rats having a greater distance traveled in the corners 
compared to Ovx-Hysterectomy rats as well [F(1,13)=3.87, p = 0.07] (data not shown).  
 
Aged (12 month) Cohort Vaginal Smears 
Vaginal smears were collected beginning two weeks after surgery for eight 
consecutive days, when rats were approximately 6 months of age. All Ovx and Ovx-
Hysterectomy rats displayed diestrus-like or blank smears, indicating successful ovary 
removal and a lack uterine stimulation. Sham and Hysterectomy groups exhibited normal 
cyclic estrous activity consisting of 4-5 day estrous cycles. Vaginal smears were collected 
for this cohort when rats were approximately 12 months of age for eight consecutive 
days. All Ovx and Ovx-Hysterectomy rats continued to display diestrus-like or blank 
vaginal smears. All Sham rats displayed regular estrous cycle activity at this time point. 
Seven out of nine Hysterectomy rats displayed estrous cyclicity; the remaining two 
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Hysterectomy rats were observed to be in persistent diestrus across all eight days of 
vaginal smear collection at this middle-aged time point. Eight consecutive days prior to 
behavior testing, vaginal smears were collected for this cohort, when they were 
approximately 18 months of age. Seven out of eight Ovx rats displayed diestrus or blank 
smears; one Ovx rat displayed a persistent estrous phenotype across all eight days of 
evaluation. All Ovx-Hysterectomy rats displayed blank or diestrus-like smears. While 
two Sham rats displayed persistent diestrous smears across all eight days of evaluation, 
the remaining eight subjects displayed elongated estrous cycles with most days in diestrus 
and variable/intermittent cycling. Three out of seven Hysterectomy rats displayed 
persistent diestrus smears; the remaining four exhibited elongated estrous cycling, with 
most days in diestrus and variable/intermittent cycling. Lastly, after behavior testing was 
complete, vaginal smears were also collected one day prior to euthanization and on the 
day of euthanization. Ovx-Hysterectomy groups displayed diestrus-like or blank smears. 
Seven out of eight Ovx displayed blank or diestrus-like smears, and one Ovx rat (the 
same rat) remained in persistent estrous. All Sham rats were in diestrus prior to 
euthanization. Five out of seven Hysterectomy rats were in diestrous, and two 
Hysterectomy rats displayed estrus or metestrus-like cytology within 24 hours of 
euthanization. 
 
Aged (12 month) Cohort Body Weights 
 Ovx rats weighed more than Sham rats at euthanasia [F(1,15)=4.78, p < 0.05; 
Figure 77A]. There were no other differences in body weight for any two-group 
comparison at this time point.  
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Aged (12 month) Cohort Uterine Weights 
Only rats that retained their uterus throughout the experiment (i.e., Sham and Ovx 
rats) were compared. As expected, there was a main effect of uterine weight between 
Sham and Ovx rats [F(1,15)=68.15, p < 0.0001], such that uterine weights for Ovx rats 
were lower than Sham rats due to a lack of estrogen stimulation from the ovaries (Engler-
Chiurazzi et al., 2012; Koebele et al., 2019; Mennenga, Gerson, et al., 2015; Prakapenka 
et al., 2018; Westerlind et al., 1998). When uterine weights were corrected for body 
weight, the main effect of Surgery persisted [F(1,15)=52.49, p < 0.0001] (Figure 77B). 
 
Aged (12 month) Cohort Ovary Weights and Ovarian Follicle Estimates 
Only rats that retained their ovaries throughout the experiment (i.e., Sham and 
Hysterectomy rats) were compared. There was a main effect of Surgery for summed 
ovary weight [F(1,13)=7.35, p < 0.05], such that Hysterectomy rats’ ovaries weighed more 
than Sham rats’ ovaries at this time point. However, when ovary weight was corrected for 
body weight, this effect became marginal [F(1,13)=3.76, p = 0.08] (Figure 77C). 
There were no main effects of Surgery for Primordial Follicles [F(1,13)=0.11, p = 
NS], Primary Follicles [F(1,17)=0.93, p = NS], Antral Follicles [F(1,13)=0.51, p = NS], or 
Corpora Lutea Counts [F(1,13)=1.07, p = NS] at this time point (Figure 78A,B,D,E). There 
was a marginal main effect of Surgery for Secondary Follicles [F(1,13)=3.57, p = 0.08; 
Figure 78C], where Hysterectomy rats tended to have fewer secondary follicles than 
Sham rats, although this effect did not reach statistical significance.  
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Aged (12 month) Cohort Serum Hormone Levels 
Only subjects included in behavioral analyses were included in serum 
assessments. Unfortunately, 7/9 Sham rats and 4/6 Hysterectomy rats had values outside 
of the detectable range of the Progesterone assay. These results should be interpreted with 
caution, given that n=2 for Sham and Hysterectomy groups. No differences in 
Progesterone levels between Sham and Hysterectomy rats [F(1,2)=1.85, p = NS]. Despite 
the low n, Hysterectomy rats had higher Progesterone levels than Ovx rats [F(1,8)=54.00, p 
< 0.0001] and tended to have higher Progesterone levels compared to Ovx-Hysterectomy 
rats [F(1,9)=5.05, p = 0.05]. Sham rats also had higher Progesterone levels than Ovx rats 
[F(1,8)=40.09, p < 0.001]. Sham rats did not differ from Ovx-Hysterectomy rats, but this is 
likely due to the unequal and low n in the Sham group. Ovx groups did not differ from 
each other [F(1,15)=1.14, p = NS] (Figure 79A). 
 There were no significant differences in serum Androstenedione levels at this 
time point [F(1,13)=2.60, p = NS; Figure 79B].  
 Three Sham subjects and three Hysterectomy subjects were excluded from the E2 
assay due to levels outside of the detectable range. Additionally, three values from the 
Sham group and three values from the Hysterectomy group were based on a singlet value, 
as the other singlet value registered outside the detectable range of the assay. There were 
no significant differences in serum E2 levels at this time point [F(1,8)=0.60, p = NS; 
Figure 79C]. 
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Discussion 
 Women may undergo gynecological surgery at any point in their lives. A younger 
age at surgery can increase the risk of developing a multitude of diseases later on, 
including dementia, coronary heart disease, diabetes, depression, Parkinson’s disease, and 
some cancers (Adelman & Sharp, 2018; Benedetti et al., 2001; Bove et al., 2014; Gierach 
et al., 2014; Rocca et al., 2011, 2012; Wilson, Pandeya, Byles, & Mishra, 2018a). If a 
woman is under 35 when oophorectomy occurs, or under 40 when hysterectomy occurs, 
these surgeries increase the risk of all-cause mortality (for review, see: Adelman and 
Sharp, 2018; Gierach et al., 2014), although this risk may be mitigated with hormone 
therapy use (Wilson, Pandeya, Byles, & Mishra, 2018b). Given that women can live a 
substantial proportion of their lives post-surgery, it is important to elucidate how 
variations in gynecological surgery, including hysterectomy with and without ovarian 
conservation, impact cognition longitudinally. There is a significant gap in the basic 
science literature regarding the cognitive effects of hysterectomy and corresponding 
neurobiological factors. Chapter 6 of this dissertation was the first methodical evaluation 
of variations in gynecological surgery using a novel rat model of hysterectomy. Findings 
suggested that hysterectomy in adulthood resulted in a unique, detrimental impact on 
spatial working memory compared to reproductively-intact Sham rats, as well as 
compared to Ovx rats and Ovx-Hysterectomy rats. We also reported altered serum 
hormone level profiles between Sham and Hysterectomy groups, with no changes to 
ovarian morphology at the time point assessed. However, it is important to keep in mind 
that the cognitive evaluation for this experiment occurred six weeks after surgery, making 
it a relatively short-term time point after surgery. Evidence from human literature 
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suggests potential short-term effects of hysterectomy on serum hormone levels that return 
to baseline in longer time frames after surgery (Kaiser et al., 1989; Vuorento et al., 1992). 
Therefore, it was crucial to understand whether the cognitive and physiological effects of 
hysterectomy on cognition were transient after surgery, or whether they were indicative 
of a long-term impairment associated with the procedure. Thus, to address this, the 
current experiment investigated the longitudinal effects of hysterectomy and other 
variations of surgical menopause on spatial learning and memory. 
 
Spatial Memory 
 Three cohorts of rats underwent Sham, Ovx, Hysterectomy, or Ovx-Hysterectomy 
surgery at 5 months old (adulthood). The first cohort was cognitively tested six weeks 
after surgery, a replication of experimental methods on Chapter 6; rats were 
approximately 7 months old (Adult) at euthanasia. The second cohort was assessed 7 
months after surgery, when rats were 12 months old (Middle-Aged). The third cohort was 
assessed 12 months after surgery, when rats were 18 months old (Aged). All cohorts 
experienced an identical behavioral battery, including the WRAM, MM, and OFT tasks, 
as well as the control VP task to assess visual and motor skills needed to successfully 
complete a water maze task. Remarkably, at all three time points assessed, Hysterectomy 
rats exhibited impaired spatial working memory performance on the WRAM when 
memory load was taxed. Specifically, during the Learning Phase, Hysterectomy rats in 
the Adult cohort made more WMC errors on Trial 3 compared to Ovx-Hysterectomy rats; 
furthermore Hysterectomy rats made more WMI errors compared to Sham rats, and 
tended to make more errors than Ovx-Hysterectomy rats on Trial 3– a replication of 
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findings in Chapter 6 (Koebele et al., 2019). Following a test of delayed memory 
retention in the WRAM, all surgery groups were relatively impaired on the post delay-
trial compared to individual group performance on the last baseline day of testing, again 
replicating prior findings. For the Middle-Aged cohort, which was tested 7 months after 
surgery, when rats were 12 months old, Hysterectomy rats made more WMC errors on 
Trial 3 compared to the other groups, and more WMI errors on Trial 3 compared to Sham 
and Ovx groups during the Learning Phase. Furthermore, on the maximum working 
memory load trial, Trial 4, Hysterectomy rats made more WMI errors than Ovx-
Hysterectomy rats. Delayed memory retention results were more variable for this time 
point. Ovary-intact groups tended to show impaired memory performance in the post-
delay trial. Ovx-Hysterectomy rats were significantly impaired, but interestingly, Ovx 
rats did not exhibit a significant increase in WMC errors following a six-hour delay. 
When Ovx surgery is performed in adulthood and animals are tested in old age, null 
effects of Ovx on working memory have been reported in mice (Heikkinen et al., 2004), 
and beneficial effects of Ovx on spatial delayed recognition-span task have been shown 
in rhesus macaques compared to age-matched intact controls (Lacreuse et al., 2000), 
corroborating our current findings in rats. Furthermore, our laboratory has reported 
benefits of long-term Ovx when surgery is performed in aged animals compared to age-
matched Sham controls; as such, Ovx may enhance spatial working memory in some 
instances (Bimonte-Nelson, Singleton, Hunter, et al., 2003; Bimonte-Nelson et al., 2004). 
Similarly to the Middle-Aged time point, spatial working memory impairments were 
evident during the Learning Phase for the Aged cohort, tested one year after initial 
surgery, when rats were 18 months old. Impairments became evident on the maximum 
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working memory load trial for this cohort. Specifically, WMC errors tended to increase 
in Hysterectomy rats compared to Sham and Ovx rats on Trial 4. WMI errors were 
significantly increased in Hysterectomy rats compared to Sham and Ovx rats, and 
marginally increased compared to Ovx-Hysterectomy rats on Trial 4. Although 
Hysterectomy rats trended toward decreased WMC errors during the asymptotic phase 
compared to Ovx rats, this effect did not reach statistical significant. In this Aged time 
point, Sham rats were impaired on the test of delayed memory retention, while surgical 
groups were not, indicating a potential interaction of delayed memory impairments with 
age dependent upon surgery status. Collectively, these results provide convincing 
evidence that Hysterectomy with ovarian conservation results in long-term cognitive 
detriments for spatial working memory. These findings have significant translational 
implications for the role of hysterectomy and its effect on cognition and quality of life 
during aging, particularly when the surgery occurs during a woman’s reproductive years.  
 
Physiological Measures 
At the Adult and Middle-Aged time points, ovary-intact rats (i.e., Sham and 
Hysterectomy groups) had lower body weights compared to Ovx rats (i.e., Ovx and Ovx-
Hysterectomy groups) at euthanasia. At the Aged time point, all rats had progressively 
gained weight with age, such that only Sham rats weighed less than Ovx rats. 
Hysterectomy rats weighed similarly to Ovx and Ovx-Hysterectomy rats. This is 
particularly interesting, as a prospective research study in women reported greater weight 
gain in women with hysterectomy one year after surgery (Moorman et al., 2009, but see 
also: Fitzgerald et al., 2009), indicating uterus removal with ovarian conservation may 
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have a unique effect on metabolism and/or the microbiome. This association is of interest 
to systematically investigate in future research.   
Uterine weights were increased in Sham rats compared to Ovx rats at all time 
points, indicating estrogen stimulation of the uterus in ovary-intact rats, an effect that has 
been consistently reported in the literature (Engler-Chiurazzi et al., 2012; Koebele et al., 
2019; Mennenga, Gerson, et al., 2015; Prakapenka et al., 2018; Westerlind et al., 1998). 
At the 12 month time point, ovaries from Hysterectomy rats tended to weigh more than 
Sham ovaries after correcting for body weight, although this was not a statistically 
significant effect.  
Ovarian follicle counts estimate the number of healthy follicles present in the 
ovaries, including non-growing ovarian follicle reserve (Primordial Follicle counts), as 
well as growing follicles (Primary, Secondary, and Antral Follicles) that are 
steroidogenic. Corpora Lutea were also quantified as a measure of ovulatory activity. 
There were no differences between Sham and Hysterectomy groups for any ovarian 
follicle type or corpora lutea counts at the Adult and Middle-Aged time points. There 
were no differences in Primordial, Primary, or Antral Follicles at the Aged time point. 
Hysterectomy rats tended to have fewer Secondary follicles compared to Sham rats at this 
time point, although the difference did not reach statistical significance. Corpora Lutea 
counts did not differ at the Aged time point. Overall, this suggests that the ovaries did not 
undergo divergent morphological changes following hysterectomy compared to age-
matched controls at any time point. These findings challenge the notion that ovarian 
dysfunction or accelerated ovarian aging occurs after hysterectomy in adulthood and 
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collectively point to a primary role for the uterus itself in regulating cognition that is not 
secondary to ovarian changes. 
Serum progesterone, androstenedione, and E2 levels did not differ between ovary-
intact groups at any time point. That ovarian-derived steroid hormone serum levels did 
not differ between Sham and Hysterectomy groups suggests that the ovaries continue to 
function in a similar fashion to reproductive-tract-intact ovaries following hysterectomy, 
at least at the time points assessed. In each cohort assessed, Progesterone was 
significantly decreased in Ovx groups compared to ovary-intact groups. It is notable that 
the serum results reported in this current experiment show a different pattern of effects 
from those reported in Chapter 6. Specifically, we had previously detected a marginal 
decrease in E2, a decrease in androstenedione, and an increase in progesterone levels 
between Sham and Hysterectomy rats. In the current report, endogenous E2 levels were 
overall substantially lower in values compared to the data presented in Chapter 6. Here, 
samples were analyzed with a commercially available ELISA kit (CAT# ES180S-100, 
CALBIOTECH, Spring Valley, CA). In Chapter 6, RIA was used to determine E2 levels. 
However, RIA measurements of E2 may unreliably produce E2 results several fold 
higher than values obtained via ELISA- or gas chromatography/tandem mass 
spectrometry (GC/MSMS)- based measurements of E2, which both produce similar 
results (Haisenleder, Schoenfelder, Marcinko, Geddis, & Marshall, 2011; Nilsson et al., 
2015). Androstenedione and progesterone were measured by ELISA kits in both cases, 
however, kit-to-kit variability (in the case of androstenedione) and different kit use (in the 
case of progesterone) may be responsible for the variation in serum hormone levels. 
Serum hormone analyses for luteinizing hormone (LH) and follicle stimulating hormone 
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(FSH) levels for this experiment are currently underway. It is important to note that 
steroid hormone levels vary across the normal estrous cycle, and fluctuate irregularly as 
aging ensues, and are therefore not the best indicator of a given hormonal milieu. This is 
also true of the erratic fluctuations of serum steroid hormone levels in women undergoing 
the transition to menopause. In both species, LH and FSH levels rise at a much steadier 
rate, and may be a better measure overall of ovarian status during the transition to 
reproductive senescence. Indeed, FSH is the gold standard serum marker for menopause 
status in clinical settings (Chan et al., 2005; Kaiser et al., 1989). These data will provide 
meaningful information to the interpretation of the current data set.  
 
Conclusions and Future Directions 
 This is the first report of long-term cognitive impairments associated with 
hysterectomy in a rodent model. Hysterectomy with ovarian conservation had a unique, 
negative impact on spatial working memory 6 weeks after surgery, in adulthood; 7 
months after surgery, in middle-age; and 12 months after surgery, in old age. It is well-
accepted that intricate feedback loops exist between the reproductive system and the 
brain. Variations in gynecological surgery likely result in reorganizational processes of 
important neural circuits, including those associated with learning and memory. 
Determining specific brain regions impacted by age and gynecological surgery 
manipulations will aid in developing novel and targeted therapies with the goal of 
delaying or preventing the onset of deleterious cognitive effects associated with 
hysterectomy and other variations in surgical menopause. In order to develop these novel 
interventions for associated cognitive detriments, it is necessary to identify prospective 
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biomarkers in the brain that are indicative of long-term neural reorganization (see 
Chapter 8). 
In the future it will also be critically important to investigate whether the age at 
which hysterectomy occurs differentially impacts cognitive outcomes. For example, one 
study reported that hysterectomy after the natural menopause transition did not affect the 
relative risk of developing dementia, and may in fact be neuroprotective (Imtiaz et al., 
2014). We have previously reported that the age at the onset of follicular depletion (i.e., a 
model of transitional menopause) is a paramount factor in cognitive outcomes (Koebele 
et al., 2017); thus, it is of particular interest to evaluate age as a central variable in 
hysterectomy model outcomes. Furthermore, given that ovarian follicle count estimates 
and ovarian-derived hormone levels were similar between Sham and Hysterectomy rats at 
each time point, systematic evaluation into the direct role of the uterus on cognition is a 
critical next step. There is clear, direct sensory and autonomic nervous system 
innervation of the nonpregnant rat uterus (Brauer & Smith, 2015; Gnanamanickam & 
Llewellyn-Smith, 2011). Although this may be unsurprising given the intricate neural 
control associated with parturition, the collective evidence described herein alludes to a 
significant role of the uterus-brain connection in addition to factors related solely to 
pregnancy and birth. Nervous system plasticity occurs naturally throughout the 
reproductive cycle and is mediated, in large part, by reproductive hormones; this 
plasticity is undoubtedly interrupted following gynecological surgery. It is plausible, and 
rather likely, that neural signaling is impacted by hysterectomy, even when ovaries are 
preserved, resulting in longitudinal effects on the trajectory of brain aging. This novel 
model of hysterectomy affords significant advancement in the field of behavioral 
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neuroendocrinology by highlighting the importance of the nonpregnant uterus, opening 
new doors to many more questions revolving around the ovary-uterus-brain connection, 
through which we will better our understanding of reproductive hormones, aging, and 
cognition as a whole.  
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ABSTRACT 
Gynecological surgery can alter a woman’s relative risk of developing cognitive 
impairment or dementia later in life. Premature menopause following surgical ovary 
removal (oophorectomy) in adulthood likely results in some neural circuit reorganization, 
including that related to cognition, and in particular, learning and memory modulation. 
Hysterectomy with ovarian conservation does not result in a similar drastic drop in 
ovarian hormones immediately after surgery like oophorectomy, but is nonetheless also 
associated with a greater relative risk of dementia in women, and has recently been 
shown to impair working memory in rats. Given the brain’s impressive capacity for rapid 
changes as well as long-term plasticity, adaptation, and reorganization, it is challenging 
to identify how neural circuitry and signaling become dysregulated and/or acclimate to a 
long-term environmental change in a given system. Delta (Δ) FosB, an immediate-early 
gene-derived transcription factor, has been proposed as a long-term marker of change 
within the brain. Here, FosB and ΔFosB protein expression were evaluated in regions 
intricately involved in spatial working memory, including the Dorsal Hippocampus, 
Frontal Cortex, and Entorhinal Cortex, in the brains of rats that received variations of 
gynecological surgery, including Sham, Ovariectomy, Hysterectomy, or Ovariectomy-
Hysterectomy in adulthood. Rats were 7 mo old (Adult), 12 mo old (Middle-Aged), or 18 
mo old (Aged) at the time of behavioral testing and subsequent brain analysis. Data 
revealed that within the Entorhinal Cortex, FosB expression and ΔFosB expression were 
altered at Middle-Aged and Aged time points in rats that underwent ovary removal in 
adulthood. When evaluating the brain regions of interest within each group across the 
three age cohorts, age- and surgery- dependent alterations in FosB and ΔFosB protein 
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expression were detected in the Dorsal Hippocampus and the Entorhinal Cortex during 
aging. This is the first systematic evaluation of a prospective marker of long-term change 
(ΔFosB) in the brains of aging rodents that have undergone variations in gynecological 
surgery including hysterectomy. Overall, results provide insight into possible ΔFosB-
related neural pathways that may be altered with age and following gynecological surgery 
in brain regions vital to normal learning and memory processes.  
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Introduction 
It is estimated that up to nearly half of women experience some form of 
gynecological surgery in their lifetime (Merrill, 2008). Approximately one-third of 
women in the United States will undergo hysterectomy, or surgical removal of the uterus, 
by age 60 (J. D. Wright et al., 2013). While surgery rates continue to be on the decline as 
alternative treatment options become available for benign uterine conditions (Corona et 
al., 2015), hysterectomy remains a common gynecological surgery, second only to 
cesarean section (Carlson et al., 1993; Centers for Disease Control and Prevention, 2010). 
Women undergo hysterectomy for a variety of benign indications, including leiomyomas, 
abnormal bleeding, endometriosis, chronic pain, or uterine prolapse (Carlson et al., 
1993). Prophylactic oophorectomy, or the surgical removal of the ovaries, is performed in 
conjunction with hysterectomy in about half of cases, especially when women are at 
high-risk for gynecological cancers (Asante et al., 2010; Lowder et al., 2010; Pocobelli et 
al., 2012; The American College of Obstetrics and Gynecology, 2008; Whiteman et al., 
2008). Although it is generally recommended to avoid oophorectomy in reproductive-age 
women without genetic risk factors (The American College of Obstetrics and 
Gynecology, 2008), if the surgery occurs prior to the natural onset of menopause, 
oophorectomy results in surgical menopause, meaning there is an abrupt, drastic drop in 
serum ovarian hormone levels (NAMS, 2014). The premature loss of ovarian hormones 
in adulthood can have manifold repercussions on the health and quality of life of women 
(Faubion, Kuhle, Shuster, & Rocca, 2015; Matthews, 2013; Parker, Jacoby, Shoupe, & 
Rocca, 2009; Rodriguez & Shoupe, 2015). Given that the majority of hysterectomy 
procedures occur before age 52, the average age of natural menopause, it is imperative to 
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understand the full range of long-term health risks associated with variations in 
gynecological surgery. Indeed, women who experience surgical menopause self-report 
more severe menopausal symptoms, such as hot flashes, sexual dysfunction, mood, and 
memory changes compared to women who undergo a natural transition to menopause 
(Benshushan et al., 2009; Gallicchio et al., 2006; Rodriguez & Shoupe, 2015). As well, 
observational data suggest that there is an increased relative risk of developing 
neurodegenerative diseases, including Parkinson’s disease (Benedetti et al., 2001) and 
dementia in women who undergo oophorectomy, hysterectomy, and compete 
oophorectomy-hysterectomy; this relative risk increases with a younger age at surgery 
(Phung et al., 2010; Rocca et al., 2011, 2012).  
 It is challenging to determine specific neurobiological underpinnings of the 
increased dementia risk in women. Many neural circuits are influenced by ovarian 
hormones and become disrupted when hormones are no longer present; many of the same 
circuits are also impacted by aging (for review, see: Koebele & Bimonte-Nelson, 2017). 
Given the remarkable life-long plasticity of the brain, it is plausible that reorganizational 
processes ensue to promote continued functionality of these circuits, especially those 
related to learning and memory. Because the brain likely utilizes homeostatic 
mechanisms to adapt to changing conditions, and due to the chronic nature of aging and 
hormone loss following variations in surgical menopause, it is difficult to pinpoint the 
time course of specific changes within a given neural system; nonetheless, it is imperative 
to find a prospective indicator of long-term change in the brain.  
One candidate marker to evaluate is Delta (Δ) FosB. Delta FosB is a transcription 
factor encoded by the immediate early gene (IEG) fosB. FosB can undergo alternative 
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splicing to produce full-length FosB and a truncated form called ΔFosB, which has 
unusual stability compared to other IEG transcription factors. This is because ΔFosB 
lacks proteasomal degradation sites (called degron domains) present on the C-terminus of 
full-length FosB, consequently preventing rapid protein breakdown (Carle et al., 2007). 
In general, IEGs are rapidly and transiently activated genes following various 
extracellular activity or stimulation. IEGs are unique in that they do not require new 
protein synthesis to exert meaningful effects on the brain and periphery (J. I. Morgan & 
Curran, 1989; Sheng & Greenberg, 1990). While IEGs are not limited to activity in the 
brain, they have been found to play important roles in many neurobiological processes, 
including synaptic plasticity and memory (Minatohara et al., 2016; Sheng & Greenberg, 
1990). There are several different families of IEGs with distinctive properties. IEGs in 
the fos family hetereodimerize with jun family IEGs to form a complex called the 
activator protein 1 (AP-1) complex, through which it eventually up- and down- regulates 
gene expression (Carle et al., 2007; Nestler et al., 2001; Ruffle, 2014). Though c-fos is 
one of the best-characterized IEGs, it has a short half-life of approximately 60 minutes, 
after which its expression rapidly declines, making it difficult to evaluate for long-term 
effects in the brain (Carle et al., 2007). Because of the stability associated with ΔFosB 
expression, it has been described as a “sustained molecular switch,” as it can be 
maintained at detectable levels in neurons for weeks to months following initial 
activation; in fact, ΔFosB has been touted as the “longest-lived adaptation known to 
occur in [sic] adult brain” (Nestler et al., 2001) and has an extended half-life compared to 
other transcription factors (Carle et al., 2007; J. Chen et al., 1997; Ulery-Reynolds et al., 
2009). 
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What we know of ΔFosB primarily comes from research on addiction. 
Specifically, ΔFosB expression becomes upregulated in the nucleus accumbens with 
repeated drug exposures (e.g. cocaine) and remains elevated even after drug cessation, 
implicating ΔFosB in mechanisms of drug dependency (Nestler et al., 2001; Ruffle, 
2014). This work furthermore suggests that ΔFosB activation and/or expression can have 
long-term behavioral effects. For example, ΔFosB has been shown to become 
upregulated with stress, indicating a potential role for ΔFosB in hypothalamic-pituitary-
adrenal axis function (Ruffle, 2014). Sustained ΔFosB expression also increases 
hippocampal gene expression of cyclin-dependent protein kinase 5 (cdk5), a gene related 
to phosphorylation of synaptic proteins that has many crucial functions in the central 
nervous system, including acting as a mediator of synaptic plasticity (Ruffle, 2014). Cdk5 
also plays a role in regulating extracellular signal-regulated kinase (ERK1/2) signaling 
(Sharma et al., 2002), an important signaling cascade with a multitude of downstream 
effects, including on learning and memory processes. When dysregulated, cdk5 increases 
tau hyperphosphorylation and is associated with neurodegenerative disease, such as 
Alzheimer’s and Parkinson’s diseases (Cortés, Guzmán-Martínez, Andrade, González, & 
Maccioni, 2019). Overexpression of ΔFosB in mice has been shown to result in an 
upregulation of genes within the nucleus accumbens that also become upregulated with 
cAMP response element binding protein (CREB) expression (McClung & Nestler, 2003), 
a transcription factor implicated in many neural processes, including its crucial role in 
memory formation (Kandel, 2012) as well as a downstream target of ERK1/2 signaling. 
Interestingly, an extended overexpression of ΔFosB in mice results in opposing up- and 
down- regulation of gene expression compared to short-term ΔFosB overexpression, at 
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least in the context of drug reward pathways (McClung & Nestler, 2003). More recently, 
overexpression of ΔFosB was found to transiently increase CREB protein levels in the 
striatum of male mice and in vitro (Enwright et al., 2010). As such, it is plausible that 
CREB and ΔFosB work in concert to produce long-term changes in gene expression and 
behavior not only in the context of addiction and reward, but also in brain regions that 
regulate learning and memory. Recently, the number of FosB/ΔFosB-immunoreactive 
(IR) cells was shown to increase in the CA1 region of the hippocampus after spatial 
Morris water maze (MM) learning compared to maze-naïve control rats and compared to 
rats that experienced a non-spatial version of the MM (Eagle et al., 2015). Additionally, 
FosB/ΔFosB-IR cells increased in the dentate gyrus of all mice and rats that experienced 
behavior testing. AAV- and HSV- mediated silencing of ΔFosB, as well as AAV-
mediated overexpression of ΔFosB, impaired learning and memory performance in this 
experiment (Eagle et al., 2015). Furthermore, it was recently reported that a ΔFosB 
knock-out mouse model confined to the subgranular zone of the dentate gyrus 
(NtsR2Cre/+FosBlox/lox mice) exhibited neurogenesis and learning impairments compared 
to wildtype littermates (Manning et al., 2019), further signifying a role for ΔFosB in 
learning and memory.  
Additional evidence from literature on the neuroscience of addiction suggests that 
ΔFosB can decrease the expression of an endogenous opioid neuropeptide called 
dynorphin (Nestler et al., 2001). Dynorphin-producing neurons have diverse roles in the 
brain; of relevance to menopause and aging, 17b-estradiol—the most potent endogenous 
estrogen primarily produced by the ovaries—has been shown to regulate dynorphin 
expression in the arcuate nucleus of the hypothalamus (Kanaya et al., 2017). Indeed, 
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dynorphin-producing neurons colocalize with other neuropeptides in the arcuate nucleus, 
which are collectively referred to as kisspeptin/neurokininB/dynorphin (KNDy) neurons. 
KNDy neurons are abundant in the hypothalamus and play a key role not only in 
gonadotropin synthesis and release from the hypothalamus and pituitary, but are also 
thought to regulate the hypothalamic-pituitary-ovarian axis feedback loop, and thus 
influence the female reproductive cycle (Lehman et al., 2010). Early research into the 
physiological alterations that occur with hysterectomy and oophorectomy point to an 
inhibitory role of the uterus on pituitary function, including the synthesis and release of 
gonadotropins and other hormones (Biró, 1979; Biró & Eneroth, 1989; Biró et al., 1988, 
1984, 1987). It is conceivable that alterations to the female reproductive tract, including 
surgical manipulations of the ovaries and/or uterus, interact with these regulatory neural 
systems and signaling cascades in order to influence behavioral outcomes, such as those 
observed in Chapters 6 and 7 of this dissertation.  
Given its prolonged nature, ΔFosB expression may be a candidate biomarker for 
long-term changes in brain areas important to cognition following variations in surgical 
menopause and with age. To explore this hypothesis, we evaluated full-length FosB and 
ΔFosB protein expression in the Frontal Cortex, Dorsal Hippocampus, and Entorhinal 
Cortex of rats that had undergone variations in gynecological surgery, including Sham, 
Ovariectomy (Ovx), Hysterectomy, or Ovx-Hysterectomy surgery in adulthood. The rats 
were then aged and were behaviorally evaluated 6 weeks after surgery (Adult time point), 
7 months after surgery (Middle-Aged time point) or 12 months after surgery (Aged time 
point). Following a battery of behavioral tasks evaluating spatial learning and memory, 
the results of which are described in detail in Chapter 7 of this dissertation, brains were 
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collected for analysis. We hypothesized that these variations in gynecological surgery 
would result in long-term changes in areas of the brain important for spatial working and 
reference memory, as measured by FosB and ΔFosB protein expression. 
 
Methods 
Subjects 
Three cohorts of 40 female, virgin, reproductively-intact Fischer-344-CDF rats 
from the National Institute on Aging colony at Charles Rivers Laboratories (Raleigh, NC) 
were utilized in this experiment (N=120). All rats were 5 months of age upon arrival to 
the Arizona State University animal facility. Rats were pair-housed, provided free access 
to food and water, and were maintained in a temperature- and humidity- controlled 
environment on a 12-hour light/dark cycle (lights on at 7 am, lights off at 7 pm). 
Experimental procedures commenced after 1 week of acclimation to the facility. All 
experimental procedures were approved by the Arizona State University Institutional 
Animal Care and Use Committee and adhered to National Institutes of Health standards.  
 
Surgical Procedures 
For each cohort of rats (N=40/cohort), 10 subjects were randomly assigned to one 
of the following surgical conditions: Sham, Ovx, Hysterectomy, or Ovx-Hysterectomy. 
Surgeries were performed 1 week (±1 day) after arriving to the animal facility. Surgical 
procedures and behavior testing protocols are detailed in Chapter 7 of this dissertation.  
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Euthanization and Tissue Collection 
At the end of the experiment, rats were heavily anesthetized using inhaled 
isoflurane anesthesia. Following cardiocentesis, brains were rapidly removed. The right 
hemisphere of the brain was rapidly raw dissected for the Frontal Cortex, Dorsal 
Hippocampus, and Entorhinal Cortex. Wet weight was obtained for each region and then 
tissues were immediately frozen at -70°C until analysis. 
 
Western Blot Protein Analysis 
Frontal Cortex, Dorsal Hippocampus, and Entorhinal Cortex from the right 
hemisphere were processed for FosB expression and ΔFosB expression via western blot 
protein analysis for all subjects that survived until the end of the experiment. Frozen raw 
tissue samples were suspended in a 1:25 weight-to-volume RIPA buffer solution (150 
mM NaCl, 1%Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate, 50-mM Tris HCl, 
protease inhibitor (Millipore-Sigma, CAT#5892791001), and phosphatase inhibitor 
(Millipore-Sigma, CAT#524625) and subsequently kept on ice at all times. Tissues were 
homogenized using a probe sonicator (Ultrasonic Processor, Cole Parmer, IL, USA), and 
then centrifuged at 10,000 rpm for 10 minutes at 4°C. Supernatant was collected, 
aliquoted, and frozen at -70°C until analysis. Protein concentration for each sample was 
determined using a bicinchoninic acid protein assay (Thermo-Fisher Scientific, Pittsburg, 
PA, USA).  
Treatment groups were counterbalanced and equally represented on each gel run. 
The NuPAGE PowerEase electrophoresis system was utilized for tissue processing. 
Samples for each region were loaded at an equal protein concentration and run on a 4-
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12% NuPAGE Bis-Tris gel in an XCell SureLock Mini-Cell (Invitrogen, Carlsbad, CA, 
USA) using MOPS running buffer. After transferring to an Immobilon polyvinylidene 
difluoride membrane, the blot was blocked in 5% nonfat milk for 1 hour at room 
temperature. Following blocking, the membrane was washed in 1xTBST and then 
incubated with the primary antibody for anti-FosB (1:1000; Abcam, ab184938) in 5% 
nonfat milk on a shaker at 4°C overnight. The following day, the membrane was washed 
in 1xTBST and then incubated with secondary antibody anti-rabbit HRP (1:500; Cell 
Signaling #7074) for 1 hour at room temperature in 5% nonfat milk. The membrane was 
washed again, and developed using chemiluminescence (Lumiglo and peroxide, Cell 
Signaling, #7003S) in a film developer (Konica SRX-101A Film Processor, Tokyo, 
Japan). The membrane was washed again in 1xTBST 3 times for 5 minutes each, and 
then incubated with the primary antibody for anti-beta-tubulin (1:20,000; Cell Signaling, 
#2128S) in 5% nonfat milk on a shaker at 4°C overnight. The following day, the 
membrane was washed in 1xTBST and then incubated with secondary antibody anti-
rabbit HRP (1:2000; Cell Signaling #7074) for 1 hour at room temperature in 5% nonfat 
milk. The membrane was washed again, and developed using chemiluminescence 
(Lumiglo and peroxide, Cell Signaling, #7003S) in a film developer (Konica SRX-101A 
Film Processor, Tokyo, Japan). Films were scanned in as JPEG files at 600 dpi. 
Densitometry analyses were completed using ImageJ software (Gallo-Oller et al., 2018). 
FosB expression and ΔFosB expression were normalized to beta-tubulin expression on 
each gel run. A total of 9 gels per region (3 per age cohort) were completed.  
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Statistical Analyses 
All statistical analyses were completed using Statview software. Data were 
assessed using an omnibus ANOVA test. Surgery type was the independent variable and 
normalized FosB expression and ΔFosB expression were the dependent variables. All 
tests were two-tailed and set at an alpha level of 0.05. Results were deemed marginal if 
the p value fell between 0.05 and 0.10.  
 
Results 
Right Dorsal Hippocampus 
 There were no main effects of Surgery for FosB expression or ΔFosB expression 
at any time point in the Dorsal Hippocampus. 
 
Right Frontal Cortex 
 There were no main effects of Surgery for FosB expression or ΔFosB expression 
at any time point in the Frontal Cortex. 
 
Right Entorhinal Cortex 
 There were no main effects of Surgery for FosB expression or ΔFosB expression 
in rats tested 6 weeks after surgery, at the Adult time point when rats were 7 months old 
(Figure 80A-B). At the Middle-Aged time point, 7 months after surgery when rats were 
12 months old, there was a main effect of Surgery for FosB expression [F(3,33)=4.15, p < 
0.05]. Fisher’s PLSD post hoc test revealed that Ovx rats had lower FosB expression 
compared to Sham rats (p < 0.05) and Hysterectomy rats (p < 0.01) at the 7 month post-
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surgery time point. Ovx-Hysterectomy rats also had lower FosB expression compared to 
Hysterectomy rats (p < 0.05), and tended to have lower FosB expression compared to 
Sham rats (p = 0.06), at this time point, while ovary intact groups did not differ from one 
another, nor did Ovx groups (Figure 80C). There was a marginal main effect of Surgery 
for ΔFosB expression [F(3,33)=2.82, p = 0.05]. Fisher’s PLSD post hoc test indicated that 
Hysterectomy rats had higher ΔFosB expression compared to Ovx rats (p < 0.05) and 
Ovx-Hysterectomy rats (p < 0.05; Figure 80D) at this time point. 
 At the Aged time point, 12 months after surgery when rats were 18 months old, 
there were no Surgery differences in FosB expression in the Entorhinal Cortex (Figure 
80E). Although there was no main effect of Surgery for ΔFosB expression, an 
exploratory two-group comparison between Sham and Ovx rats based on findings at the 7 
month post-surgery time point indicated that Ovx rats had lower ΔFosB expression 
compared to Sham rats at the 12 month post-surgery time point (p < 0.05; Figure 80F).  
 
Exploratory Analysis of Age Effects 
 Acknowledging that each age cohort was behaviorally tested at separate times, we 
evaluated whether Age impacted FosB expression and ΔFosB expression within each 
Surgery group. Each brain region was assessed separately using an ANOVA with Age 
(Adult, Middle-Aged, and Aged at test) as the independent variable. Normalized FosB 
expression and normalized ΔFosB expression were the dependent variables. 
 
Frontal Cortex. There were no main effects of Age on FosB expression or 
ΔFosB expression within the Frontal Cortex for any surgery group. (Figure81A-H).  
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Dorsal Hippocampus. For Sham rats, there was a main effect of Age for ΔFosB 
expression in the Dorsal Hippocampus [F(2,27)=8.97, p < 0.001]. Fisher’s PLSD post hoc 
tests indicated that Aged rats had significantly lower ΔFosB expression than Adult rats (p 
< 0.001) and Middle-Aged rats (p < 0.01) (Figure 82B). Ovx rats showed a significant 
effect of Age for ΔFosB expression [F(2,25)=4.70, p < 0.05], with post hoc analyses 
indicating that Aged rats had lower ΔFosB expression than Adult rats (p < 0.05) and 
Middle-Aged rats (p < 0.01) (Figure 82D). There was a main effect of Age for ΔFosB 
expression in Hysterectomy rats [F(2,23)=8.99, p < 0.001], where Fisher’s PLSD post hoc 
analyses indicated that Aged rats had lower ΔFosB expression in the Dorsal 
Hippocampus compared to Adult rats (p < 0.001) as well as compared to Middle-Aged 
rats (p < 0.01) (Figure 82F). For Ovx-Hysterectomy rats, there was a marginal main 
effect of Age for ΔFosB expression [F(2,24)=3.28, p = 0.06]. Fisher’s PLSD post hoc tests 
indicated that Aged rats had lower ΔFosB expression than Adult rats (p < 0.05) and 
Middle-Aged rats (p < 0.05) (Figure 82H). There were no main effects of Age for FosB 
expression within any surgery group (Figure 82A,C,E,G). 
 
Entorhinal Cortex. For Sham rats, there was a main effect of Age for FosB 
expression [F(2,27)=5.52, p < 0.01] and for ΔFosB expression [F(2,27)=7.02, p < 0.01]. 
Fisher’s PLSD post hoc tests showed that FosB expression increased from Adult to 
Middle-Aged rats (p < 0.05), and decreased from Middle-Aged to Aged rats (p < 0.01), 
suggesting a transient increase in Entorhinal Cortex FosB expression in midlife (Figure 
83A). Delta FosB in the Entorhinal Cortex increased from Adult to Middle-Aged rats (p 
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< 0.01), and remained elevated in Aged rats compared to Adult rats (p < 0.01) (Figure 
83B). For Ovx rats, there was a marginal effect of Age for ΔFosB expression 
[F(2,25)=2.66, p = 0.09]; Fisher’s PLSD post hoc for this analysis indicated that there was 
an increase in ΔFosB expression from Adult to Middle-Aged rats (p < 0.05) (Figure 
83D). For Hysterectomy rats, there was a main effect of Age for FosB expression 
[F(2,21)=4.42, p < 0.05] as well as for ΔFosB expression [F(2,21)=7.01, p < 0.01] in the 
Entorhinal Cortex. Fisher’s PLSD post hoc indicated there was a marginal increase in 
FosB expression from Adult to Middle-Aged time points (p = 0.07), and that Aged rats 
had lower FosB expression compared to Middle-Aged rats (p < 0.01) (Figure 83E). Delta 
FosB expression, on the other hand, significantly increased from Adult to Middle-Aged 
rats (p < 0.001). Aged Hysterectomy rats also tended to have higher ΔFosB expression 
compared to Adult rats, although this effect was marginal (p = 0.07) (Figure 83F). There 
were no significant Age effects in Entorhinal Cortex FosB expression (Figure 83G) or 
ΔFosB expression (Figure 83H) in Ovx-Hysterectomy rats.  
 
Discussion 
The brain is a highly plastic organ throughout life; it is ever-adapting to changing 
conditions. Ovarian hormones act as modulators for many neural systems, including 
those that regulate normal learning and memory processes (Koebele & Bimonte-Nelson, 
2017). When systems are disrupted, such as with surgical menopause or with aging, there 
are likely a number of reorganizational events that occur in order to maintain the function 
of critical neural communication in a new hormonal milieu (Koebele & Bimonte-Nelson, 
2015). It has been established that women who undergo variations in gynecological 
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surgery, including the removal of the ovaries and uterus, are at a greater risk for 
neurodegenerative diseases, including dementia and Parkinson’s disease, and this risk 
increases with a younger age at surgery (Benedetti et al., 2001; Phung et al., 2010; Rocca 
et al., 2007, 2011; Rocca, Grossardt, & Shuster, 2014; Rocca et al., 2012, 2009). Even 
women who undergo hysterectomy with ovarian conservation, which does not involve an 
abrupt loss of circulating hormones, are at a greater relative risk of dementia compared to 
ovary intact women (Benedetti et al., 2001; Phung et al., 2010; Rocca et al., 2012). Given 
the frequency of gynecological surgery in women, it is of critical importance to form an 
understanding of the neurobiological underpinnings of this increased risk of 
neurodegenerative disease in order to potentially prevent or postpone the onset of 
cognitive changes. These observational findings in women have recently been supported 
by experimentally randomized and controlled basic science research indicating that 
hysterectomy with ovarian conservation impairs spatial working memory in adult rats 
compared to other variations in menopause, at least 6 weeks after surgery (Koebele et al., 
2019); these findings were recently extended to show that cognitive impairments 
observed with hysterectomy are present at long-term time points after surgery, when rats 
are middle-aged and aged (unpublished observations, Chapter 7).  
In this chapter, ΔFosB protein expression was evaluated as a prospective indicator 
of long-term change in the brains of rats that underwent gynecological surgery in 
adulthood. Full-length FosB protein expression was also measured. When comparing 
across Surgery type, results indicated that there were differences in FosB expression and 
ΔFosB expression within the Entorhinal Cortex 7 months and 12 months after surgery. 
Specifically, 7 months after surgery, when rats were 12 months old (Middle-Aged), Ovx 
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rats had less FosB expression compared to ovary-intact groups. Ovx-Hysterectomy rats 
had less FosB expression compared to Hysterectomy rats, and trended toward having less 
FosB expression compared to Sham rats. Delta FosB expression tended to be lower in 
Ovx and Ovx-Hysterectomy rats compared to Hysterectomy rats at this time point as 
well. One year after surgery, when rats were 18 months old (Aged), ΔFosB expression 
tended to be lower in Ovx rats compared to Sham rats. There were no significant or 
marginal differences in FosB expression or ΔFosB expression in the Dorsal Hippocampus 
or Frontal Cortex at these time points when comparing effects by Surgery type. Given 
that the Entorhinal Cortex acts as an information gateway between the hippocampus and 
other cortical areas, the observation that a marker of long-term change such as ΔFosB is 
decreased in animals that had their ovaries removed indicates a potential role for ovarian 
hormones in regulating neuronal activity, including FosB and ΔFosB expression, thus 
subsequently impacting information transfer during spatial learning and memory. 
It was also of interest to evaluate FosB expression and ΔFosB expression within 
each surgical group to understand how protein expression varies with age. There were no 
changes in expression in the Frontal Cortex for any surgery group at any age time point. 
However, in the Dorsal Hippocampus, significantly lower ΔFosB expression in Aged rats 
was observed for Sham, Ovx, and Hysterectomy groups; there was also a marginal 
decrease with age for the Ovx-Hysterectomy group. FosB was unaltered by age in all 
groups. Collectively, these results indicate that lower ΔFosB expression in the Dorsal 
Hippocampus of Aged rats appears to be age-mediated, regardless of surgery type.  
Within the Entorhinal Cortex, a different pattern of FosB expression was present 
across ages in a surgery-dependent manner compared to that observed in the Dorsal 
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Hippocampus. In ovary-intact groups (i.e. Sham and Hysterectomy groups), there was a 
transient increase in FosB expression during the Middle-Aged time point that was not 
present in groups without ovaries. Although full-length FosB undergoes proteasomal 
degradation after activation much faster than ΔFosB, it continues to be produced at basal 
levels by the fosB gene to some extent, and may provide meaningful information about 
alternative splicing mechanisms of the gene with age and hormone changes. For example, 
this transient increase in full-length FosB may be associated with reorganizational factors 
related to changing ovarian hormone levels as rats approach estropause, or rodent 
reproductive senescence, in middle-age. Furthermore, ovary-intact groups exhibited 
greater ΔFosB expression in Middle-Age compared to the Adult time point. This 
increased expression was sustained at the Aged time point, despite lower expression of 
full-length FosB at the Aged time point. One possible explanation for this is that fosB 
gene splicing preferentially generates the truncated, long-lasting ΔFosB variant with age 
in ovary-intact rats. Recent reports that both aging and 17b-estradiol alter alternative 
gene splicing mechanisms lends credence to this idea (Shults, Pinceti, Rao, & Pak, 2015; 
Tollervey et al., 2011). Ovx rats also displayed an increase in ΔFosB expression in 
Middle-Age compared to Adult rats, but this effect did not persist at a statistically 
significant level into the Aged time point. Ovx-Hysterectomy rats did not have significant 
changes in Entorhinal Cortex ΔFosB expression with age, suggesting that removal of the 
entire reproductive tract during adulthood could differentially influence patterns of 
reorganizational processes in relation to removal of the ovaries alone.  
This is the first observation of a prospective biomarker of long-term change in the 
brain during aging following variations in gynecological surgery including hysterectomy. 
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The mechanisms underlying these changes that, in turn, regulate behavioral output are 
complex and multifaceted. Age was the primary factor for altered ΔFosB expression over 
and above the influence of gynecological surgery when analyzed within a surgery group. 
It is notable that opposite patterns of age-related ΔFosB expression exist for the Dorsal 
Hippocampus and Entorhinal Cortex. Specifically, ΔFosB expression declines with age in 
the Dorsal Hippocampus, but increases with age in the Entorhinal Cortex. This 
differential pattern of expression across brain regions with aging could indicate a 
compensatory mechanism that occurs with aging and the transition to reproductive 
senescence. Alternatively, ΔFosB expression in either region may be dynamic with age; 
observations at later time points, in advanced age, will be important in future 
investigations. It is also essential to note that ovary-intact rats undergo estropause, which 
is characterized by a different hormone profile than menopause in women; because 
female rats do not experience follicular depletion to the extent that humans do, 
reproductively senescent rats typically display tonically increased estrogen and/or 
progesterone levels instead of experiencing a significant decline in these hormones with 
age (Koebele & Bimonte-Nelson, 2016). Therefore, these age-related findings should be 
interpreted with caution, and evaluations in follicle-deplete rats with a hormone profile 
more similar to human menopause will be informative in future research. 
It is important to keep in mind that FosB expression and ΔFosB expression do not 
operate in a vacuum, and are intricately linked to many complex neural systems with both 
up- and down- stream effectors working together to produce changes in gene expression 
as well as behavioral outcomes. A premature deprivation of ovarian hormones in 
adulthood likely alters neural systems shortly after hormone loss occurs, and the 
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mechanisms by which they reorganize may vary due to the absence of ovarian hormones. 
In the future it will be necessary to investigate other key regulators, including ERK1/2 
and CREB activation, in these rats in order to parse out a more cohesive understanding of 
the complex regulatory processes that can alter behavioral outcomes. Evaluating the role 
of ΔFosB expression in relation to KNDy neurons is also of interest to elucidate whether 
altered ΔFosB expression influences hypothalamic-pituitary-reproductive tract axis 
regulation and function throughout aging. 
Regardless of surgery status, women have an increased risk of developing 
cognitive impairment and dementia with age compared to men (Alzheimer’s Association, 
2018; Riedel et al., 2016). Changes in ovarian hormone levels with reproductive 
senescence may influence this risk. Within the Entorhinal Cortex, which is thought to be 
the first brain region affected by tauopathy in Alzheimer’s disease pathology in humans 
(Braak & Braak, 1991; Kaufman, Del Tredici, Thomas, Braak, & Diamond, 2018), both 
ovary intact groups showed a transient increase in full-length FosB expression in middle-
age, as well as a sustained increase in ΔFosB expression at the Aged time point that was 
not seen in groups without their ovaries. Prior research using transgenic mice has shown 
that ΔFosB expression upregulates cdk5 in the hippocampus (J. Chen et al., 2000). Cdk5 
is implicated in increased phosphorylation and inhibition of activated MEK1, leading to a 
decrease in ERK1/2 phosphorylation, possibly resultant of a negative feedback 
mechanism (Sharma et al., 2002). Although cdk5 has many important regulatory roles in 
the normally functioning system, cdk5 dysregulation can have pathological 
consequences, including a significant role in tau hyperphosphorylation and consequential 
neurodegenerative disease, including Alzheimer’s and Parkinson’s diseases, among 
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others (Cortés et al., 2019). Perhaps the sustained increase in Entorhinal Cortex ΔFosB 
expression in ovary-intact rats is an early indicator of a disrupted system that could lead 
to eventual pathological brain aging. Given that ERK1/2 activation and signaling also 
regulates IEG expression, a disruption to this feedback loop could result in altered 
behavioral outcomes in the aging female. In the future it will be informative to 
investigate these other molecular targets to determine if altered expression of ΔFosB with 
age could initiate downstream changes that alter susceptibility to cognitive decline in 
ovary-intact animals. This hypothesis, however, does not explain the relative increased 
risk of cognitive impairment when ovaries are removed in humans. Given that our 
laboratory has reported beneficial effects of aged Ovx for rats compared to aged intact 
rats (Bimonte-Nelson, Singleton, Hunter, et al., 2003; Bimonte-Nelson et al., 2004), and 
other laboratories have shown protective effects of long-term Ovx on spatial memory in 
rhesus macaques (Lacreuse et al., 2000) and mice (Heikkinen et al., 2004), it is necessary 
to investigate alternative pathways influencing susceptibility to cognitive impairment 
following Ovx in the future as well.  
Lastly, correlations between brain and behavioral measures will afford 
meaningful information regarding the relationships among neural signaling, age, and 
ovarian hormones in the context of variations in gynecological surgery. Translationally, 
better understanding how neural systems important for regulating learning and memory 
are impacted by aging and variations in gynecological surgery will provide insight into 
the increased susceptibility for age-related cognitive changes and risk for 
neurodegenerative disease in women, as well as possible novel targets for intervention 
therapies in order to improve quality of life and cognitive health throughout the lifespan.  
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CHAPTER 9 
 
GENERAL SUMMARY AND DISCUSSION 
 
Aging can be thought of as a lifelong process. From early development, to 
puberty, to menopause and beyond, each life stage is comprised of critical events that 
shape an individual’s future responses and health outcomes. Throughout every life stage, 
the endocrine system—and in particular, reproductive hormones—play an integral role in 
shaping and shifting an organism’s responses. Reproductive hormones are now 
recognized for their integral role in the functionality of many critical body systems 
beyond reproduction, including cardiovascular, skeletal, muscular, integumentary, and 
gastrointestinal health. Perhaps most critically, reproductive hormones are a paramount 
regulatory factor in the brain, and thus, in cognitive function. The collective research 
presented in this dissertation expounds upon the influence of endogenous and exogenous 
hormone exposures across the lifespan in the context of reproductive senescence and 
cognitive aging. Noteworthy discoveries include the influence of age at the onset of 
reproductive senescence and how the etiology of reproductive senescence affects 
cognition and brain aging.  
 Females are born with a finite pool of immature ovarian follicles that, throughout 
life, undergoes a normal process of depletion, called follicular atresia (Hsueh et al., 1994; 
W. H. B. Wallace & Kelsey, 2010). At puberty, the hypothalamic-pituitary-ovarian axis 
becomes active, and ovarian follicles begin to grow and produce sex steroid hormones 
including estrogens, progesterone, and androgens. The growth and maturation of ovarian 
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follicles is stimulated by the release of gonadotropin releasing hormone from the 
hypothalamus, as well as follicle stimulating hormone (FSH) and luteinizing hormone 
(LH) from the anterior pituitary gland. This intricate feedback system carefully regulates 
the female reproductive cycle (in women, the menstrual cycle; in rats, the estrous cycle). 
The reproductive years –from puberty to menopause– are characterized by monthly 
cyclic fluctuations in circulating estrogens, progesterone, androgens, and the 
gonadotropins. As such, this cyclicity is inherent to the female for much of her life. Of 
the thousands of immature follicles present at birth, only about 400 are selected to 
become fully mature eggs for ovulation during the reproductive lifespan (Gougeon, 
2010). The vast majority of immature follicles become atretic. By midlife, it is thought 
that the finite ovarian follicle reserve reaches a critical threshold of depletion, in turn 
initiating the transition to reproductive senescence, or menopause (Hansen et al., 2008; 
W. H. B. Wallace & Kelsey, 2010). In women, menopause is a natural event that 
typically happens in a transitional fashion around the fifth decade of life. Ovarian 
hormone levels —particularly estrogens and progesterone—fluctuate irregularly 
throughout this transition, which can last up to ten years, and eventually decline to low or 
undetectable levels for the remainder of the lifespan, while gonadotropins become 
chronically elevated due to disrupted feedback (Harlow et al., 2013; Soules et al., 2001). 
The first section of this dissertation, Chapters 2 and 3, investigate the impact of age at the 
onset of follicular depletion in a rodent model of transitional menopause. In particular, 
the experiments herein emphasize how age at the onset of the menopause transition was 
an important factor for cognitive outcomes. Relationships among serum hormone levels 
and altered neural systems that are linked to learning and memory processes are also 
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explored with the goal of better understanding associations and interactions between 
ovarian hormones and brain regions known to be crucial for learning and memory 
processes. A summary of these findings will be described in detail below.  
 The transition to menopause is indicated by a variety of physical symptoms, 
including vasomotor symptoms (i.e., hot flashes, night sweats), urogenital symptoms 
(e.g., vaginal dryness, urgency and frequency changes in urination), dyspareunia, and 
disruptions to sleep, mood, and memory (Al-Safi & Santoro, 2014). Depending on 
severity, these symptoms can have a substantial negative impact on quality of life for 
women. Women may opt to take estrogen-containing hormone therapy to alleviate these 
symptoms. The first prescription hormone therapy was FDA-approved in the early 1940’s 
(Stefanick, 2005), and hormone-containing contraceptives came to market in the 1960’s 
(Tyrer, 1999). In this day and age, it is plausible that a woman will experience multiple, 
extended exposures to exogenous hormones 1) during reproductive years via hormone-
containing contraceptives, and 2) during perimenopausal and post-menopausal years, if 
she opts to take hormone therapy. The popularity of estrogen-containing hormone therapy 
has dwindled in recent years (Crawford et al., 2018; Sprague et al., 2012); however, 
given that the cognitive effects of hormone exposures can persist even when the drug is 
no longer detectable (Braden et al., 2011; Rodgers et al., 2010), it is necessary to 
understand how hormone-containing therapies can impact brain health. Despite a natural 
decline in endogenous estrogen and progesterone levels with age, females retain 
responsiveness to these hormones until the end of the lifespan. The type of hormone(s) 
administered, dose, route of administration, timing, and duration of hormone use are all 
factors that can influence long-term health in women who opt to take hormone therapy, 
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including an individual’s susceptibility to cognitive decline (for review, see: Koebele & 
Bimonte-Nelson, 2015). While prescriptions for hormone-containing contraceptives and 
menopausal hormone therapy operate under a one-size-fits-all approach in clinical 
settings, it has become abundantly clear in recent years that this is not an ideal strategy. A 
more personalized approach that considers life factors and individual risk is necessary to 
provide optimal treatment to alleviate disruptive symptoms while not compromising 
long-term health and cognition. Given that the average lifespan is continually increasing, 
particularly for women, it is important to find solutions that will improve quality of life in 
the post-menopausal state, which can comprise a third of a woman’s life. The second 
section of this dissertation, Chapters 4 and 5, evaluate cognitive performance on spatial 
learning and memory tasks in the presence of clinically relevant exogenous hormone 
treatments to better understand the role of these factors on cognition during aging, and 
results will be described in detail below.  
 Although a majority of women undergo natural menopause, there is a non-
negligible proportion of women who will undergo gynecological surgery during their 
lifetime. This surgery can result in abrupt surgical menopause if both ovaries are removed 
prior to the natural onset of menopause in midlife. Premature ovarian hormones loss has a 
well-documented negative impact on cognition (Bimonte & Denenberg, 1999; Farrag et 
al., 2002; Gibbs & Johnson, 2008; Nappi et al., 1999; Rocca et al., 2007, 2011, 2012, 
2009; Talboom et al., 2008; M. Wallace et al., 2006) as well as a multitude of other body 
systems (Faubion et al., 2015; Matthews, 2013; Parker et al., 2009; Rodriguez & Shoupe, 
2015). In addition, more recent findings also implicate hysterectomy, the surgical 
removal of the uterus, in an increased relative risk of developing neurodegenerative 
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diseases if the surgery is performed during the reproductive years, before natural 
menopause onset. A substantial gap in the basic science literature exists regarding the 
effects of hysterectomy on cognition and brain function during aging. The third and final 
section of this dissertation, Chapters 6, 7, and 8, explore the cognitive effects of 
variations in surgical menopause, including a novel model of hysterectomy, as well as 
propose a prospective neurobiological marker of long-term change in the brain following 
surgical menopause; collective results are discussed in detail below. Overall, this 
dissertation examines numerous factors contributing to longitudinal cognitive outcomes 
associated with reproductive senescence, and builds a new framework for understanding 
how age and menopause etiology influence cognitive outcomes across the lifespan. 
 
Age at the Onset of Follicular Depletion Matters for Memory Outcomes 
 The average onset of menopause occurs at age 52 in women (NAMS, 2014). The 
vast majority of species do not live long beyond the end of the reproductive life stage. 
Even among primates, humans are one of the few exceptions to this rule (Gems, 2014). 
The age of menopause onset has remained relatively stable, despite a continually 
increasing lifespan in humans in the 20th century, especially among women (Amundsen 
& Diers, 1970, 1973; Hawkes & Coxworth, 2013; Mennenga & Bimonte-Nelson, 2013; 
Murray et al., 2015; Regan & Partridge, 2013; Seifarth, Mcgowan, & Milne, 2012; 
Sherwin, 2003). Thus, the number of reproductive-age years is not proportionally 
increasing along with the rising average lifespan, such that women are now living a 
substantial proportion of their lives in a post-menopausal state (Sherwin, 2003). While 
most women undergo this natural transition to menopause in the fifth decade of life, there 
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are some women who undergo early-onset menopause, defined as the final menstrual 
period occurring before age 45, as well as a small percentage of women who undergo 
spontaneous premature ovarian insufficiency, wherein the final menstrual period occurs 
before age 40 (Pal & Santoro, 2002; Shuster et al., 2010; Simpson & Rajkovic, 1999). 
Because premature deprivation of ovarian hormones in a surgical context is known to 
impact cognition negatively in humans and animals, we hypothesized that an earlier onset 
of follicular depletion would be detrimental to cognition. 
Utilizing a rodent model of transitional menopause, we found that a younger age 
at the onset of follicular depletion did indeed impair spatial working memory when 
memory was taxed compared to age-matched counterparts in the early perimenopausal 
time point. Middle-aged rats performed similarly on the task, regardless of whether or not 
they were undergoing follicular depletion. In fact, Young-VCD-treated rats performed 
similarly to their Middle-Aged-VCD-treated counterparts at this early-depletion time 
point. At later time points in the post-follicular deplete state, Middle-Aged-VCD-treated 
rats tended to perform worse than their younger VCD-treated counterparts; however, it is 
significant that Young-VCD treated rats exhibited poorer spatial working memory 
performance early in the transition to follicular depletion. Among VCD-treated groups, 
there was a main effect of Age for the reference memory Morris water maze (MM) task, 
such that middle-aged animals performed worse than younger animals. However, Middle-
Aged-VCD-treated rats exhibited enhanced performance on the MM compared to age-
matched Vehicle-treated rats, indicating some potential benefit of follicular depletion for 
reference memory during aging. There was a significant decline in all ovarian follicle 
types in VCD-treated rats. Additionally, serum hormone profiles varied among treatment 
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groups, with VCD-treated rats exhibiting significantly lower progesterone and marginally 
lower estrone levels at the post-follicular depletion time point compared to their age-
matched Vehicle-treated counterparts. Overall, this was the first longitudinal evaluation 
of cognitive performance across the transition to follicular depletion in rats, and 
underscores the importance of age at the onset of the menopause as a key factor for 
interpreting cognitive outcomes. In particular, the working memory deficit observed at 
the early perimenopause time point may indicate that the critical window for intervention 
with hormone therapy varies depending on the age when the menopause transition 
begins. The onset of the transition is challenging to pinpoint in humans, as menopause is 
retrospectively confirmed one year after the final menstrual period; the transition likely 
begins many years prior, even before menopausal symptoms present. Therefore, 
developing reliable biomarkers to more accurately establish the onset of the menopause 
transition will be an important future endeavor to enhance health outcomes for women, 
regardless of age at menopause transition onset. 
Given these behavioral findings in conjunction with the known intricate links 
between ovarian hormone levels and cognition, Chapter 3 was an exploratory analysis 
using the brains of the rats in Chapter 2 to investigate potential correlations among serum 
hormone levels, the cholinergic system, and the GABAergic system, and whether 
relationships were dependent on age and ovarian follicle status. The basal forebrain was 
assessed for choline acetyltransferase (ChAT)-immunoreactive (IR) neurons. ChAT is the 
enzyme that forms acetylcholine, a neurotransmitter that has diverse functions in the 
nervous system, including a role in normal learning and memory processes. The basal 
forebrain is the primary site of acetylcholine synthesis in the brain, and long-range 
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projections from the basal forebrain to the hippocampus and surrounding areas influence 
learning and memory circuits. Of relevance to menopause and aging literature, these 
connections need to be intact in order for estrogen to exert beneficial effects on learning 
and memory; furthermore, ovarian hormone loss can impair cholinergic function (Gibbs, 
1998, 2002, 2003, 2010). Additionally, the GABAergic system, which is the primary 
inhibitory neurotransmitter system in the brain, is a key player in regulating spatial 
learning and memory. Expression of GABA-synthesizing enzymes, GAD65 and GAD67, 
was assessed in the hippocampus and surrounding cortical areas to determine whether age 
and ovarian follicle status were associated with changes in this system. Findings revealed 
subtle relationships among endogenous serum hormone levels, ChAT-IR cell counts, 
GAD expression, and memory performance in normally aging and follicle-deplete rats. 
VCD tended to increase Dorsal Hippocampus GAD65 expression and decrease 
Entorhinal Cortex GAD67 expression. The clearest relationships were observed within 
the Young-Vehicle group (aged 8-12 months at evaluation). A summary these 
correlations can be found in Figure 84 and Figure 85. For Young-Vehicle rats, serum 
17b-estradiol levels were positively correlated with GAD65 and GAD67 expression in 
the Ventral Hippocampus. Furthermore, there were significant positive correlations 
among androstenedione, progesterone, and estrone levels with ChAT-IR neuron counts in 
the vertical diagonal bands (VDB) of the basal forebrain for Young-Vehicle rats. These 
associations were not observed for Young-VCD rats. However, a negative correlation 
between Estrone levels and Entorhinal Cortex GAD67 expression was present for Young-
VCD rats, such that follicular depletion may reverse the direction of the relationships 
among GABAergic function and serum hormone levels. Overall, these effects implicate a 
 
313 
role for follicular depletion in altering relationships among circulating ovarian hormone 
levels and the cholinergic system in adult to early middle-aged rats. To the best of 
knowledge, this was the first report of age and follicular depletion status affecting 
relationships among neural systems important for learning and memory. Furthermore, 
other than a positive correlation between androstenedione levels and ChAT-IR neurons in 
the medial septum (MS) for the Middle-Aged VCD group, there were no significant 
correlations among the variables tested for Middle-Aged rats (aged 14-18 months at 
evaluation), suggesting that a critical window during which relationships among hormone 
levels and neural systems may exist. This critical window before 12 months of age could 
point to optimal time points for prevention-based interventions for cognition. Overall, 
although exploratory in nature, these findings will propel future research forward by 
providing a fundamental understanding of the key factors associated with cognitive 
outcomes in the context of transitional menopause and aging, and by offering a 
foundation for future methodical experimental manipulation of each of these variables to 
further elucidate the roles of age and follicular depletion on learning and memory 
systems.  
 
Exogenous Ovarian Hormone Therapy Influences Cognitive Performance on Spatial 
Working Memory Tasks: Unique Effects of Maze Complexity and Treatment 
Regimen 
 As noted above, although the rate of hormone therapy use has declined in the past 
two decades (Crawford et al., 2018; Sprague et al., 2012), exogenous estrogen-containing 
hormone therapy is one of the only FDA-approved treatments for menopause 
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symptomology. Estrogens are generally considered to be neuroprotective, though 
exogenous estrogen treatment can result in variable effects in rodent models, with many 
factors influencing outcomes (for review, see Koebele & Bimonte-Nelson, 2017). The 
experiment in Chapter 4 considered the influence of high- and low- demand cognitive 
experience in conjunction with estrogen therapy on cognition. Using a middle-aged 
ovariectomized (Ovx) rat model, results demonstrated that when exogenous, tonic, low-
dose 17b-estradiol treatment was administered after Ovx, prior high-demand cognitive 
experience enhanced learning and memory on a subsequent low-demand task, and prior 
low-demand cognitive experience had the potential to enhance memory on a subsequent 
high-demand cognitive task. Prior experience did not significantly impact Ovx Vehicle-
treated rats, and rats treated with a high dose of 17b-estradiol exhibited variable benefit, 
depending on the type of prior cognitive experience. Because many behavioral 
neuroscientists utilize a battery of cognitive tasks to evaluate experimental manipulations, 
findings from this experiment emphasize the importance of consistent protocol use in 
order to reliably replicate effects within and across laboratories. Indeed, the basic science 
literature reports variable effects of exogenous estrogens on cognitive outcomes. 
Depending on the experimental conditions, estrogens can have beneficial, neutral, or even 
detrimental effects on learning and memory. These results highlight novel considerations, 
including task order and task complexity, in conjunction with hormone dose and route of 
administration, when interpreting cognitive outcomes. 
Chapter 5 explored the cognitive effects of a novel progestin, drospirenone, alone 
and in combination with a synthetic estrogen commonly prescribed in oral contraceptives. 
Although it is well-established that endogenous ovarian hormones and their 
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corresponding exogenously-administered variants affect cognition, less attention has been 
paid to synthetic forms of progesterone alone and in combination with estrogens in the 
context of aging and menopause research. In order to address this, the fourth-generation 
progestin, drospirenone, was evaluated in young adult Ovx rats in a two-part study. The 
first experiment showed that drospirenone enhanced spatial working memory at a 
medium dose, which was based on the ratio of progestin-to-estrogen in combined oral 
contraceptives. However, the second experiment revealed that when this dose of 
drospirenone was administered in combination with ethinyl estradiol, beneficial effects of 
drospirenone were attenuated compared to drospirenone alone. These results extended 
prior findings from our laboratory showing divergent cognitive effects of progestin 
administration alone versus in combination with estrogen (Prakapenka et al., 2018). 
Although an optimal combination treatment still remains to be discovered, these findings 
provide new insight into the role of the commonly-prescribed progestin drospirenone on 
cognition. This was a particularly timely investigation, given recent FDA approval of a 
drospirenone-only oral contraceptive pill (US Food and Drug Administration, 2019) in 
addition to the combination formulations already available on the market.  
 
 Hysterectomy: A Novel Rodent Menopause Model and its Longitudinal Effects on 
Cognition 
 There are many ways to model the phenomenon of menopause in rodents (for 
review, see Koebele & Bimonte-Nelson, 2016). The gold standard for studying cognitive 
effects of hormone loss and exogenous hormone administration in experimental research 
settings is via Ovx, where the ovaries are surgically removed, but uterine tissue is 
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conserved. This is a valuable approach to understanding the effects of specific hormones 
and other drug treatments; indeed, much of what we know about aging and cognition in 
females comes from this “blank ovarian hormone slate” model in basic science literature. 
However, translationally, a minority of women undergo surgical menopause in their 
lifetime, and even fewer experience bilateral ovary removal without concomitant 
hysterectomy. The vast majority experience a natural, transitional menopause in midlife. 
This can be modeled with 4-vinylcyclohexene diepoxide (VCD), which initiates ovarian 
follicular depletion and results in a hormone profile more similar to a woman undergoing 
the transition to menopause. Natural reproductive senescence is typically concurrent with 
aging, making it challenging to attribute any cognitive changes observed specifically to 
ovarian hormone decline versus to aging alone. VCD is an exciting scientific 
advancement because it affords researchers the possibility to evaluate the separate effects 
of follicular depletion without the necessary confound of aging in rodent models.  
The Ovx and VCD models are indisputably valuable and provide a fundamental 
understanding of menopause and aging effects. Nevertheless, until now, a large gap in the 
literature has existed regarding the cognitive effects of hysterectomy, the second most 
common gynecological surgery, on learning and memory. The dogma in the field is that 
the non-pregnant uterus is an essentially dormant organ (Navot & Williams, 1991; Rosen 
& Cedars, 2007); any cognitive changes following gynecological surgery are thought to 
be driven by ovarian hormones. However, based on a growing body of clinical literature 
suggesting that hysterectomy with ovarian conservation increases the relative risk of 
dementia and other diseases later in life in women, we hypothesized that the uterus may 
play a unique role in regulating cognitive processes. Thus, in this dissertation, a novel 
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model of hysterectomy in rats was created to test this idea. Results of the proof-of-
concept experiment, detailed in Chapter 6, revealed that six weeks after surgery, adult 
rats with hysterectomy exhibited a working memory impairment when memory load was 
taxed compared to sham controls, as well as compared to Ovx and Ovx-Hysterectomy 
groups. Ovarian follicle counts did not significantly differ between ovary-intact groups, 
but serum ovarian hormone profiles differed between Sham and Hysterectomy rats two 
months after surgery. This was the first systematic evaluation of variations of surgical 
menopause including hysterectomy on spatial memory. It was demonstrated that 
variations in surgical menopause yielded distinct effects on working memory 
performance. Furthermore, a shift in ovarian hormone levels and FSH levels, but no 
change in ovarian morphology or corpora lutea counts, was present, suggesting that 
uterus removal may directly impact steroidogenesis in the ovaries. Broadly, this 
experiment indicated that the nonpregnant uterus is not quiescent, as its removal had 
significant effects on physiology and cognition, at least within a short-term time point 
two months after surgery.  
These unprecedented findings led to a subsequent series of experiments 
investigating the longitudinal effects of hysterectomy; that is, it was necessary to 
determine whether this observed hysterectomy-induced impairment was transient in the 
short-term time point after surgery, or if it was a long-lasting effect that impacted 
memory for the remainder of the lifespan. Findings described in Chapter 7 revealed that 
hysterectomy with ovarian conservation in adulthood resulted in working memory 
impairments present 6 weeks after surgery (Adult time point, when rats were 7 months 
old; a replication of findings in Chapter 6), 7 months after surgery (Middle-Aged time 
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point, when rats were 12 months old), and 12 months after surgery (Aged time point, 
when rats were 18 months old). In contrast to the results presented in Chapter 6, no 
differences in serum progesterone, androstenedione, or 17b-estradiol levels were detected 
between ovary-intact groups at any time point. Ovx and Ovx-Hysterectomy groups 
exhibited significantly decreased progesterone levels compared to ovary intact groups, a 
replication of prior findings (Koebele et al., 2019). Although this lack of replication for 
ovarian steroid hormone levels is difficult to reconcile, it is possible that a difference in 
detection method (ELISA versus RIA for 17b-estradiol levels) as well as ELISA kit-to-
kit variability could be responsible for these divergent results. Furthermore, it is 
important to keep in mind that endogenous ovarian hormone levels fluctuate across the 
estrous cycle and become irregular with age, making any one sample challenging to 
interpret broadly. For that reason, FSH levels are the gold standard for evaluating 
reproductive status in women over and above serum hormone levels at any given time 
point. Thus, serum FSH and LH levels will provide valuable insight into whether 
hysterectomy resulted in disrupted hypothalamic-pituitary-ovarian feedback compared to 
sham controls. These serum gonadotropin evaluations are currently underway for this 
experiment. In addition to the lack of differences in serum sex-steroid hormone measures 
at all time points, there were no statistically significant differences between Sham and 
Hysterectomy groups’ ovarian follicle and corpora lutea counts at any given time point, a 
replication of findings in Chapter 6. This is an important observation, as it suggests that 
ovarian structure and function were not uniquely altered following hysterectomy at any 
given time point compared to reproductive-tract-intact rats’ ovaries. The present 
understanding in the field is that ovarian function may become compromised following 
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hysterectomy in women of reproductive age, leading to earlier ovarian failure. These 
current findings challenge the concept of accelerated ovarian aging after hysterectomy in 
adulthood, and collectively point to a primary role for the uterus itself in mediating 
cognition that is not secondary to ovarian changes. 
It is noteworthy that there were age-related changes in both ovarian follicle counts 
and serum ovarian hormone levels, regardless of hysterectomy status, in ovary-intact rats. 
Acknowledging that this experiment was a cross-sectional design where separate cohorts 
of rats were tested at different time points, we ran an exploratory analysis of age-related 
changes in serum hormone levels and follicle counts. There was a main effect of Age for 
all follicle types, including the ovarian follicle pool [Primordials: F(2,48)=25.836, p < 
0.0001] and growing follicles [Primaries: F(2,48)=3.65, p < 0.05; Secondaries: 
F(2,48)=39.33, p < 0.0001; Antrals: F(2,48)=8.21, p < 0.001]. Fisher’s PLSD post hoc 
analyses indicated that Adult rats had more primordial follicles than Middle-Aged rats (p 
< 0.0001) and Aged rats (p < 0.0001) (Figure 86A), more primary follicles than Middle-
Aged rats (p < 0.01) and Aged rats (p < 0.05) (Figure 86B), more secondary follicles than 
Middle-Aged rats (p < 0.0001) and Aged rats (p < 0.0001) (Figure 86C), and more antral 
follicles than Middle-Aged rats (p < 0.05) and Aged rats (p < 0.001) (Figure 86D). 
Additionally, Aged rats had fewer secondary follicles than Middle-Aged rats (p < 0.0001) 
(Figure 86C). There were no significant Age differences for Corpora Lutea counts 
(Figure 86E). This age-related decrease in ovarian follicle counts, but not corpora lutea, is 
a replication of prior work in our laboratory (Koebele et al., 2017), supporting the idea 
that rodents experience some follicular depletion with age (Gosden et al., 1983) in 
accordance with the onset of estrous acyclicity (for review, see: Finch, 2014). Age-
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related serum hormone level changes were also present in ovary-intact rats, regardless of 
hysterectomy status. There was no main effect of Age for Progesterone levels (Figure 
87A); however, when Hysterectomy rats were evaluated separately, there was a marginal 
main effect of Age [F(2,15)=3.48, p = 0.06], with an exploratory Fisher’s PLSD post hoc 
test indicating that Aged Hysterectomy rats had higher progesterone levels than Adult (p 
< 0.05) and Middle-Aged (p < 0.05) Hysterectomy counterparts. There was a main effect 
of Age for Androstenedione [F(2,44)=18.03, p < 0.0001; Figure 87B], where Aged rats 
exhibited elevated androstenedione levels compared to Adult rats (p < 0.0001) and 
Middle-Aged rats (p < 0.0001). Last, there was a main effect of Age for 17b-estradiol 
levels [F(2,31)=3.35, p < 0.05; Figure 87C], where Aged rats had significantly decreased 
17b-estradiol levels compared to Adult rats (p < 0.01). These data correspond well with 
the ovarian follicle data, given the observed decrease in estrogen-producing ovarian 
follicles in old age, while progesterone-producing corpora lutea did not show significant 
changes, and androstenedione is primarily produced by ovarian interstitial cells (Dyer & 
Erickson, 1985). Overall, age appeared to be the primary factor impacting physiological 
measures of steroid hormone levels and ovarian follicle counts over and above the 
presence of the uterus, suggesting that the ovaries remain functional following 
hysterectomy until the onset of natural reproductive senescence. 
 The last chapter of this dissertation detailed an investigation into a prospective 
neurobiological marker of long-term change, ΔFosB, in the brains of the aging rats that 
underwent variations of gynecological surgery in Chapter 7. Delta FosB is a transcription 
factor and product of the immediate early gene fosB, and has been recognized for having 
unusual long-term stability, making it a putative “sustained molecular switch” (Nestler et 
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al., 2001) associated with long-term reorganizational processes in the brain. Much of the 
scientific literature to this point has been focused on the role of ΔFosB expression in 
addiction and drug dependency (Nestler et al., 2001; Ruffle, 2014), but ΔFosB has 
recently been implicated in learning and memory as well (Eagle et al., 2015; Manning et 
al., 2019). Additionally, ΔFosB expression increases hippocampal cdk5 expression, a 
gene important for synaptic plasticity and a regulator of extracellular signal-regulated 
kinase (ERK1/2) signaling, all of which can be affected by hormones and aging, and 
influence learning and memory. Thus, ΔFosB expression was a prime candidate to 
explore as a marker of long-term change in the context of variations of surgical 
menopause and aging. Results revealed that within the Entorhinal Cortex, rats that had 
their ovaries removed (Ovx and Ovx-Hysterectomy groups) had lower full-length FosB 
expression compared to ovary-intact groups at the Middle-Aged time point. Ovx rats also 
tended to have lower ΔFosB expression compared to Hysterectomy rats at this time point, 
7 months after surgery. During the Aged time point, 12 months after surgery when rats 
were 18 months old, Ovx rats had lower ΔFosB expression compared to Sham rats in the 
Entorhinal Cortex as well. Next, FosB and ΔFosB expression were evaluated across Age 
time points within each brain region of interest to determine whether age differentially 
affected FosB and ΔFosB protein expression within each surgery group. For all surgical 
variations, there was a significant decrease in Dorsal Hippocampus ΔFosB expression at 
the Aged time point. Within the Entorhinal Cortex, ovary-intact groups (Sham rats and 
Hysterectomy rats) displayed a transient increase in full-length FosB expression in 
Middle-Age, whereas Ovx and Ovx-Hysterectomy rats did not. The Sham group and the 
Hysterectomy group also showed greater ΔFosB expression in Middle-Age compared to 
 
322 
the Adult time point, with sustained expression at the Aged time point. Ovx and Ovx-
Hysterectomy groups did not show a statistically significant increase in ΔFosB 
expression with age. Overall, changes in ΔFosB expression in the Dorsal Hippocampus 
appeared to be an age-mediated effect, while expression in the Entorhinal Cortex may be 
influenced by an interaction between age and ovarian hormone milieu. Given that the 
Entorhinal Cortex is an information gateway between the hippocampus and other cortical 
areas, this suggests that changes in ovarian hormones with age and surgical menopause 
variations play a role in influencing long-term neural reorganization and/or adaptation. 
Furthermore, taking into account the role of ΔFosB expression in relation to other 
important gene expression changes and signaling cascades involved in learning and 
memory, this was an important step toward understanding the neural circuits involved in 
longitudinal behavioral changes associated with surgical menopause variations.  
 
Future Directions 
These cumulative findings have contributed to our understanding of the 
behavioral and brain changes associated with age and surgical menopause, and have 
paved the way toward many new paths to explore. The question for future research 
remains: are these observed cognitive and brain changes primarily driven by alterations in 
the ovaries following hysterectomy, or does the uterus have a definitive, direct impact on 
learning and memory processes? Direct sensory and autonomic nervous system 
innervation of the non-pregnant, virgin rat uterus has recently been described (Brauer & 
Smith, 2015; Gnanamanickam & Llewellyn-Smith, 2011). Estrogens are known to 
influence sympathetic neurite growth and retraction within the uterus via neurotrophic 
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factors (Krizsan-Agbas, Pedchenko, Hasan, & Smith, 2003; Wessels, Wu, Leyland, 
Wang, & Foster, 2014; Zoubina, Mize, Alper, & Smith, 2001). As such, nervous system 
plasticity occurs naturally throughout the reproductive cycle; it is undoubtedly interrupted 
following gynecological surgery. Given the direct connections between the uterus and the 
nervous system, it is plausible that neurotransmitter systems closely associated with 
sensory and autonomic communication may be affected by the removal of the uterus, 
even when the ovaries are preserved. For example, using a whole-mount uterine horn 
preparation, it was demonstrated that the uterine tissue was densely populated with 
tyrosine hydroxylase-IR axons innervating blood vessels and the different muscle layers 
(Gnanamanickam & Llewellyn-Smith, 2011). Tyrosine hydroxylase is the rate-limiting 
enzyme in the synthesis of dopamine, a fundamental neurotransmitter involved in many 
regulatory systems, including learning and memory. Estrogen is a known dopamine 
modulator (Yoest, Cummings, & Becker, 2014). Dopamine also plays a key role in 
cognition and affect, possibly via estrogen regulation (for review, see: Almey et al., 2015; 
Jacobs and D’Esposito, 2011; Yoest et al., 2014). Furthermore, dopamine dysregulation 
is a defining characteristic of Parkinson’s disease development and progression, and may 
play a role in Alzheimer’s disease as well (Martorana & Koch, 2014). Given the reported 
increased risk of Parkinson’s disease and dementia in women who experienced 
hysterectomy, the collective evidence makes dopamine an excellent candidate for future 
investigation in the context of gynecological surgery and cognition. Indeed, disruptions to 
the ovary-uterus-brain feedback loop following hysterectomy and other variations in 
gynecological surgery may significantly alter neural signaling initiating from the 
sympathetic, parasympathetic, and sensory connections in the uterus, resulting in long-
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term changes in the trajectory of brain aging. Other prospective neurobiological factors 
associated with ΔFosB expression, including changes in ERK1/2 signaling, CREB 
expression, cdk5 expression, and KNDy neurons, are all viable contenders to probe for 
future evaluations in order to further our knowledge of interactions between variations in 
gynecological surgery and aging with the brain and behavior. This novel model of 
hysterectomy affords significant advancement in the field of behavioral 
neuroendocrinology, opening the door to many more questions revolving around the 
ovary-uterus-brain connection, through which we will better our understanding of 
reproductive hormones, aging, and cognition as a whole.  
 
General Conclusions 
The female brain and body have a remarkable capacity to adapt to the constant 
ebb and flow of the reproductive cycle throughout the lifespan. Cyclicity is inherent to 
the nature of the female. Alterations to this elaborate system —whether via exogenous 
hormone treatments or by gynecological surgery, as well as through natural 
reorganizational periods such as puberty, pregnancy, and menopause— create new 
challenges for adaptation and survival. Since the early twentieth century, rodent models 
have been instrumental to our current understanding of the reproductive system, 
hypothalamic-pituitary-gonadal feedback loops, and steroid hormone effects—
particularly estrogens— on a wide range of body systems and processes, including 
cardiovascular disease, bone health, stroke, cancers, affective disorders, and cognition, 
including spatial learning, memory, and attentional processes. In addition, we have the 
advantageous capacity to evaluate behavioral and brain changes at the cellular and 
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molecular level in rodent models much more quickly than would be possible using 
human subjects. This utility affords basic scientists the opportunity to explore novel brain 
targets and drug delivery methods for favorable cognitive outcomes and healthy brain 
aging profiles that have the potential to translate to the clinical research setting. Indeed, 
rodent models of menopause, including ovary-intact, VCD, Ovx, and now hysterectomy 
variations, form the basis of our abilities as preclinical scientists to contribute to our 
understanding of the female reproductive system, as well as brain and behavioral changes 
that occur with perturbations and alterations to this system, such as removal of steroid 
hormones, depletion of ovarian follicles, or exogenous hormone therapy treatment. 
Indeed, these models allow basic scientists to systematically and methodically evaluate 
longitudinal impacts of hormones and aging, as well as directly assess brain, ovarian, 
uterine, and other body tissues from which we can glean insight into the physiological 
correlates associated with the aging female and the menopause transition. All of these 
elements showcase the utility of rodent models as translational models of human 
menopause and aid in our understanding of risk factors associated with aging and 
menopause, providing direction and potential solutions for individualized treatments for 
women in mid-life, to lower risk factors for disease, and to maintain a high quality of life.   
Accumulating evidence points to roles for both age and reproductive hormones on 
the brain and behavior throughout life. Given the continuously increasing average human 
lifespan, it is more important than ever for the field of neuroendocrinology and aging to 
better understand how aging and the long-lasting changes in gonadal hormones and 
gonadotropins that occur in midlife can affect the neural circuits and molecular 
mechanisms related to learning and memory. Thus far, discoveries have included 
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multiple neural systems, domains of function, and biochemical mediators, such as the 
basal forebrain-hippocampal cholinergic pathway, GABAergic transmission, ERK1/2 
signal transduction, ΔFosB expression, and structural brain changes. It is of particular 
interest to understand how the neurobiological and neurochemical changes associated 
with menopause and aging alter the underlying circuitry of cognitive pathways, and if 
these systems compensate by using alternative mechanisms or undergo a rewiring to 
return to homeostasis as aging occurs. Elucidating the changes in these molecular 
mechanisms with age and ovarian hormone milieu in a systematic and demonstrable 
fashion will yield insight into how and when the brain responds to endogenous hormone 
changes as well as to potential exogenous hormone treatment. This will, in turn, drive 
progress forward toward development and optimization of opportunities and choices for 
women undergoing the transition to menopause that not only addresses the undesirable 
symptoms associated with menopause, but also that potentially prevents, attenuates, or 
postpones the onset of cognitive or affective changes for at-risk women during aging. In 
order to move toward this realm of discovery, it should be recognized that ovarian 
hormones have a powerful impact on many complex and interactive neural systems that 
influence cognitive outcomes throughout life. It is only through continued methodical 
scientific evaluations that we will uncover the intricacies of these interconnected systems 
and transform our understanding of the connections between the reproductive system and 
the brain, in order to enhance the quality of life and care of women throughout the 
lifespan. Many will continue to search for the key to understanding reproductive 
hormones’ intricate relationships with cognitive processes; while we have learned much, 
we still have much to discover and unexplored routes to travel. It is often the most 
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unexpected findings that can lead down a new path in the grand scientific venture of 
discovering the truth in nature. Indeed, “still round the corner there may wait, a new road 
or a secret gate” (Tolkien, 1954).  
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Table 1. Mean ± SEM, range, and median of 17β-estradiol levels 
(pg/ml) at subset and end time points. 
 
Group Age Mean of 17β-estradiol levels±SE 
Range of 17β-
estradiol levels 
Median of 17β-
estradiol levels 
Young-
Vehicle 
8 months 
12 months 
10.07±1.32 
12.59±1.66 
8.6-12.7 
7.4-24.4 
8.90 
11.90 
Young-
VCD 
8 months 
12 months 
10.47±2.57 
13.41±1.68 
6.1-15.0 
5.5-20.7 
10.30 
14.00 
Middle-
Aged-
Vehicle 
14 months 
18 months 
15.70±2.90 
13.61±4.23 
12.4-21.5 
6.1-38.5 
13.20 
10.10 
Middle-
Aged-
VCD 
14 months 
18 months 
10.57±1.20 
12.55±1.23 
8.7-12.8 
9.0-20.3 
10.20 
11.45 
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Table 2. Mean ± SEM, range, and median of Estrone levels (pg/ml) at 
subset and end time points. 
 
Group Age Mean of Estrone levels±SE 
Range of Estrone 
levels 
Median of Estrone 
levels 
Young-
Vehicle 
8 months 
12 months 
52.9±4.74 
60.33±4.65 
45.8-61.9 
48.4-76.8 
51.00 
56.70 
Young-
VCD 
8 months 
12 months 
58.37±2.36 
50.70±2.51 
53.9-61.9 
41.8-63.0 
59.30 
49.50 
Middle-
Aged-
Vehicle 
14 months 
18 months 
68.47±7.33 
60.02±1.80 
55.0-80.2 
55.5-66.1 
70.20 
59.35 
Middle-
Aged-
VCD 
14 months 
18 months 
65.57±3.50 
53.19±2.49 
61.3-72.5 
43.2-64.6 
62.90 
52.55 
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Table 3. Mean ± SEM, range, and median of Androstenedione levels 
(ng/ml) at subset and end time points. 
 
Group Age 
Mean of 
Androstenedione 
levels±SE 
Range of 
Androstenedione 
levels 
Median of 
Androstenedione 
levels 
Young-
Vehicle 
8 months 
12 months 
0.30±0.03 
0.36±0.17 
0.24-0.34 
Undetectable – 1.27 
0.32 
0.23 
Young-
VCD 
8 months 
12 months 
0.19±0.04 
0.76±0.30 
0.11-0.24 
0.18-2.76 
0.22 
0.49 
Middle-
Aged-
Vehicle 
14 months 
18 months 
0.47±0.11 
0.83±0.16 
0.29-0.66 
0.20-1.47 
0.46 
0.70 
Middle-
Aged-
VCD 
14 months 
18 months 
1.00±0.29 
0.81±0.26 
0.48-1.49 
Undetectable-2.28 
1.02 
0.55 
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Table 4. Mean ± SEM, range, and median of Progesterone levels 
(ng/ml) at subset and end time points. 
Group Age 
Mean of  
Progesterone 
levels±SE 
Range of 
Progesterone      
levels 
Median of 
Progesterone     
levels 
Young-
Vehicle 
8 months 
12 months 
22.77±6.72 
30.30±7.38 
18.9-39.2 
4.8-68.7 
19.20 
34.4 
Young-
VCD 
8 months 
12 months 
11.23±3.41 
8.41±2.81 
5.2-17.0 
2.4-26.7 
11.50 
5.05 
Middle-
Aged-
Vehicle 
14 months 
18 months 
38.46±10.73 
40.04±10.74 
19.9-54.1 
9.7-76.8 
43.40 
45.5 
Middle-
Aged-
VCD 
14 months 
18 months 
50.67±11.26 
8.1±1.68 
29.4-67.7 
1.0-19.0 
54.9 
7.45 
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 Figure 1a: The standard model of mammalian sexual differentiation holds that male 
genitalia actively develop in the presence of androgens, while female genitalia develop in 
the absence of gonadal hormone exposure. 1b: The traditional model of sexual 
differentiation of the brain holds the same “default” concept for females as the model for 
genitalia development; the updated model builds on these concepts using new research, 
and suggests that sexual differentiation of the brain involves active processes of gonadal 
hormone exposure for both males and females. E = estrogen, T = testosterone 
 
 
 
382 
 
 
Figure 2: A flow diagram of sexual differentiation of the mammalian brain and 
phenotype. The classic model holds that genetic sex determines gonadal sex, and that 
gonadal sex determines phenotypic sex. The phenotype is directly impacted by hormone 
secretions from the gonads, occurring during early life as organizational effects, and later 
in life as activational effects. An updated model incorporates more flexibility in these 
definitions, and acknowledges newer data showing that females can be sensitive to non-
transient steroid hormone effects later in life. Further, phenotypic sex is indirectly 
impacted by genetic sex via gonadal sex and subsequent hormone release, but 
accumulating evidence demonstrates that genes can directly impact phenotypic sex as 
well.  
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Figure 3: In rodents, testosterone of testes origin indirectly masculinizes the male brain. 
Testosterone readily crosses the blood brain barrier and is converted in the brain to 17b-
estradiol via the aromatase enzyme, and this 17b-estradiol exposure results in 
masculinization. The plasma protein alpha-fetoprotein has a high binding affinity and 
capacity for estrogens in rodents. Once bound to alpha-fetoprotein, estrogen can no 
longer cross the blood brain barrier. This scenario prevents estrogen-induced brain 
masculinization in females during the early perinatal timeframe, when extra-ovarian 
estrogens are present. Remarkably, alpha-fetoprotein levels become undetectable in the 
brain after P7, around the same time that the ovaries increase in activity and produce 
detectable levels of gonadal hormones. The extended temporal period of brain sensitivity 
to gonadal hormones in females suggested in many rodent studies corresponds with the 
work showing that estrogens of ovarian origin are likely necessary for normal female 
brain development, and that they can access the brain when alpha-fetoprotein declines 
after the early perinatal period. Of note, temporally, this is after the window for normal 
brain masculinization has closed. E = estrogen, T = testosterone 
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Figure 4: Stages of Ovarian Follicle Development. Stages of ovarian follicle 
development, beginning at the primordial resting stage and growing in size and shape 
through the antral (pre-ovulatory) mature follicle. Once the ovum is ovulated, the 
remaining follicle forms the corpus luteum, a temporary endocrine structure that produces 
high amounts of progesterone and some estradiol. The corpus luteum degenerates into the 
corpus albicans if no egg fertilization occurs. 
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Figure 5: The Ovarian Hormone Cycle During the Reproductive Stage. A) The rodent 
estrous cycle is characterized by four phases. Proestrus is the shortest phase, lasting less 
than a day, wherein a critical level of increasing 17b-estradiol is thought to trigger the LH 
surge, inducing ovulation. FSH and progesterone also peak during proestrus.  The 
proestrus phase is followed by the estrus phase. In estrus, LH, FSH, and progesterone 
decline to baseline levels, while 17b-estradiol levels are moderately low. In metestrus, 
17b-estradiol is low, and a transient increase in FSH occurs. Some 17b-estradiol and high 
amounts of progesterone are released from the corpora lutea following ovulation, 
increasing circulating progesterone levels between the metestrus and diestrus phases. 
Gonadal hormones return to baseline as the estrous cycle begins again. B) The human 
menstrual cycle has three distinct phases. The follicular phase is characterized by steadily 
increasing 17b-estradiol levels. At a critical level of 17b-estradiol, LH surges, with the 
trigger for ovulation occurring in the periovulatory phase. Ovulation is followed by the 
luteal phase, wherein progesterone levels increase and 17b-estradiol is present at a 
moderate level.  
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Figure 6: Ovarian Hormone Levels in Reproductive Senescence. A) Rodents commonly 
enter a persistent estrus state during reproductive senescence (estropause), characterized 
by moderate to high 17b-estradiol levels and moderate progesterone, LH, and FSH levels 
as a result of disrupted feedback between the ovaries and hypothalamus/pituitary. b) 
Human reproductive senescence (menopause) is characterized by low, sometimes 
undetectable, levels of 17b-estradiol and progesterone, but increased levels of the 
gonadotropins, FSH and LH. 
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Figure 7: The Estrous Cycle. Representative images of the rat estrous cycle with vaginal 
cytology. Animals in estrus exhibit cornified cells in their vaginal smears. Metestrus 
smears contain a combination of cornified cells, leukocytes, needle-like, and round 
epithelial cells. Diestrus smears are characterized by a large number of leukocytes, and 
proestrus smears contain round epithelial cells and some cornified cells, sometimes 
presenting in clustered groups. 
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Figure 8: Human and Rodent Reproductive Tracts. A comparison of the human and 
rodent reproductive tracts, with analogous structures labeled. 
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Figure 9: a) A schematic of an eight-arm radial-arm maze with a subset of arms baited to 
represent a working and reference memory task. The arms are baited with a food reward 
in the land version of the maze, and a hidden platform just beneath the surface of the 
water in the water escape version of the maze. B) A schematic of the Morris water maze, 
a reference memory task, with the hidden platform positioned in the northeast quadrant of 
the maze. 
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Figure 10: Study Timeline. Age of the young and middle-aged animals in months (mo) at 
time of assessment is indicated in the arrow. Animals received training for 12 days on the 
water radial-arm maze (WRAM). A one-month interim occurred during which animals 
received Vehicle or VCD injections. After a two-day refresher, subjects were tested for 
two-day retests (RT) every other week for four months, capturing the VCD-treated 
animals’ transition from early follicular depletion to a post-follicle-deplete state. A subset 
of animals was sacrificed after RT2 to obtain a snapshot of serum hormone levels and 
ovarian follicular depletion early in the transition. Following WRAM RTs, remaining 
subjects were tested on a WRAM flexibility task, Morris water maze, and Visible 
Platform tasks prior to sacrifice.  
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Figure 11: Schematics of the behavioral battery used throughout the experiment. (a) The 
water radial-arm maze (WRAM) contains four hidden platforms beneath the surface of 
the water, represented by black circles. Subjects were each assigned a set of platform 
locations that remained constant throughout retests. Platform locations varied across 
animals and were counterbalanced for age and treatment group. After one platform was 
located on each trial, the just-found platform was removed from the maze for the 
remainder of the day. (b) The WRAM Flexibility task occurred after RT9. Each subject 
was given two familiar platform locations from their initial platform location assignment 
(e.g. arms 1,4), and two platform locations were flipped to be located in a novel arm (e.g, 
platforms in arms 3 and 7 were moved to arms 2 and 6, indicated by the red circles), 
resulting in two novel spatial locations that require updating. (c) The Morris water maze 
was a large round tub with a hidden platform submerged beneath the water’s surface in 
the northeast quadrant. The platform location remained constant across all baseline days 
and trials. Subjects were dropped off from each cardinal direction (north, south, east, and 
west) once per day. The order in which the drop off locations occurred was the same for 
all animals within a day, but varied across days. After the fourth trial on Day 5, the 
platform as completely removed from the maze to conduct the probe trial; animals were 
dropped off from the west for the probe trial. (d) The visible platform was a rectangular 
tub filled with clear water, with a black platform placed approximately 4 cm above the 
surface of the water. Opaque curtains were hung in a circular fashion around the room to 
block any spatial and geometric cues. Animals were dropped off from the south wall and 
were given 90s to reach the platform, which was located on the north wall. The platform 
location was the same for all animals within a trial, but varied across trials (left, center, 
and right of the drop off location).  
 
392 
 
 
Figure 12: (a) A schematic of the different phases of ovarian follicle growth, beginning 
with the primordial, resting follicle pool, and progressing from primary to secondary to 
antral (pre-ovulatory) stages of growth. Following ovulation of the mature egg, the 
remaining follicle becomes the corpus luteum, a temporary endocrine structure that 
secretes progesterone and low levels of estrogens. The corpus luteum eventually 
regresses into the corpus albicans, which no longer secretes ovarian hormones. Of these 
ovarian follicle stages, VCD accelerates atresia (programmed cell death) for primordial 
and primary ovarian follicles. (b) Representative ovary micrographs from each group. (i) 
Rat ovary from the Young-Vehicle group (ii) Rat ovary from the Young-VCD group (iii) 
Rat ovary from the Middle-Aged-Vehicle group (iv) Rat ovary from the Middle-Aged-
VCD group. Note that long-term exposure to VCD is indicated by the loss of corpora 
lutea structures due to ovarian failure. All micrographs are depicted at 2x and the scale 
bar is 1000 µm. 
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Figure 13: WRAM performance for Training (pre-treatment). (a) Across the 12 days of 
baseline testing, there was a main effect of Age, where Middle-Aged animals made more 
total errors than Young animals collapsed across all days of testing. (b) Average total 
errors (ln) per trial were evaluated for the asymptotic phase of testing (D7-12). Trial 3 
alone, a higher working memory load trial, revealed a main effect of Age, where Middle-
Aged animals made more errors than Young animals (* = p<0.05). 
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Figure 14: Forgetting for WRAM performance across a one-month interval. Between the 
last day of training (prior to treatment) and the first day of the refresher one month later 
(after treatment), Young-Vehicle treated animals did not exhibit significant forgetting, 
but the Young-VCD, Middle-Age-Vehicle, and Middle-Aged-VCD showed forgetting (* 
= p<0.05). 
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Figure 15: WRAM performance across the transition to follicular depletion. (a) Within 
the Young cohort, a main effect of Follicular Depletion was observed, where VCD-
treated animals made more errors than Vehicle-treated animals, and this was particularly 
evident on Trial 4 early in follicular depletion. (c) Within the Vehicle cohort, there was a 
marginal main effect of Age where Middle-Aged animals tended to make more errors 
than Young animals. (b,d) There were no significant differences within the Middle-Aged 
cohort or the VCD cohort early in follicular depletion. (e) There were no differences in 
performance in the Vehicle cohort in mid-follicular depletion. (f) Within the VCD cohort, 
there was a main effect of Age where Middle-Aged animals made more errors than 
Young animals collapsed across trial, and this was particularly evident on Trial 4 in mid-
follicular depletion. (g) There were no differences in performance in the Vehicle-treated 
cohort in post-follicular depletion. (h) For the VCD cohort, there was a marginal main 
effect of Age collapsed across trials, and a marginal Age effect on Trial 4, where Middle-
Aged animals made more errors than Young animals in post-follicular depletion (* = 
p<0.05, # = p<0.10). 
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Figure 16: Water radial-arm maze flexibility task performance. (a) From the last day of 
RT9 to the first day of the flexibility task with two flipped platform locations, all subjects 
had impaired performance on the first day of exposure to the two flipped spatial 
locations, regardless of age or follicular depletion status. (b) No differences in 
performance were noted within the Young cohort across days, regardless of follicular 
depletion status. (c) Within the Middle-Aged cohort, on the final day of the flexibility 
task, there was a marginal main effect of Follicular Depletion, where VCD-treated 
animals made more errors than Vehicle-treated counterparts. (d) No differences in 
performance were noted within the Vehicle cohort across days, regardless of age. (e) 
Within the VCD cohort, on the final day of the flexibility task, there was a marginal main 
effect of Age, where older animals made more errors than younger animals. (# = p<0.10). 
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Figure 17: Morris water maze performance, average swim distance across four trials per 
day. (a) Swim distance did not vary in the Young cohort, regardless of follicular 
depletion status. (b) Within the Middle-Aged cohort, there was a main effect of Follicular 
Depletion, where VCD-treated animals swam less distance than Vehicle-treated animals. 
(c) Swim distance did not vary in the Vehicle cohort, regardless of age. (d) Within the 
VCD cohort, there was a main effect of Age, where Young animals swam less distance 
than Middle-Aged animals across days. (* = p<0.05). 
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Figure 18: Morris water maze probe trial performance. Each treatment group, assessed 
separately, had a greater percent of total swim distance in the northeast (target) quadrant 
compared to the southwest (opposite) quadrant during the probe trial, indicating all 
animals spatially localized to the platform location, regardless of age or follicular 
depletion status. (* = p<0.05). 
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Figure 19: Visible platform performance.  All animals, regardless of age or follicular 
depletion status, decreased latency (s) to the visible platform across six trials, confirming 
that all subjects could perform the motor and visual components of water maze tasks. (* = 
p<0.05). 
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Figure 20: Circulating serum hormone levels for the subset (a-d) and end sacrifice (e-h) 
time points. (a) Mean ± SEM for 17b-estradiol serum levels (pg/ml) for the subset 
sacrifice. No differences were observed among treatment groups at the early follicular 
depletion time point. (b) Mean ± SEM for estrone serum levels (pg/ml) for the subset 
sacrifice. No differences were observed among treatment groups at the early follicular 
depletion time point. (c) Mean ± SEM for androstenedione serum levels (ng/ml) for the 
subset sacrifice. Young-VCD animals had marginally less androstenedione compared to 
age-matched controls, and to Middle-Aged-VCD animals. (d) Mean ± SEM for 
progesterone serum levels (ng/ml) for the subset sacrifice. Young-VCD animals had less 
progesterone than Middle-Aged-VCD animals at the early follicular depletion time point. 
(e) Mean ± SEM for 17b-estradiol serum levels (pg/ml) for the end sacrifice. No 
differences were observed among treatment groups at the post-follicular depletion time 
point. (f) Mean ± SEM for estrone serum levels (pg/ml) for the end sacrifice. Within the 
Young cohort and within the Middle-Aged cohort, there were marginal main effects of 
Follicular Depletion where VCD-treated animals had marginally less estrone compared to 
Vehicle-treated animals within both age groups. (g) Mean ± SEM for androstenedione 
serum levels (ng/ml) for the end sacrifice. Middle-Aged Vehicle animals had marginally 
more androstenedione than Young Vehicle animals. (h) Mean ± SEM for progesterone 
serum levels (ng/ml) for the end sacrifice. Within the Young cohort and within the 
Middle-Aged cohort, there was a main effect of Follicular Depletion wherein VCD-
treated animals had less progesterone than Vehicle-treated animals within both age 
groups. (* = p<0.05; # = p<0.10). 
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Figure 21: Ovarian follicle and corpora lutea counts for the subset (a-e) and end (f-j) 
sacrifice. (a-e) Young-VCD animals had fewer primordial, primary, secondary, and antral 
follicles compared to their Young-Vehicle controls at the subset time point. Middle-
Aged-VCD animals had fewer primordial cells and marginally fewer primary cells 
compared to Middle-Aged-Vehicles, but did not differ from their Vehicle-treated 
counterparts for secondary or antral follicle counts at the subset time point. Animals did 
not differ in corpora lutea count, regardless of age or follicular depletion status, at the 
early follicular depletion time point. (f-j) Young and Middle-Aged VCD-treated animals 
had fewer primordial, primary, secondary, and antral follicle counts and fewer corpora 
lutea compared to their respective age-matched, Vehicle-treated controls, indicating that 
VCD treatment effectively depleted ovarian follicles. Middle-Aged Vehicle animals had 
marginally fewer primordial, and significantly fewer primary and secondary ovarian 
follicles than younger Vehicle-treated animals, but did not differ for antral follicle count 
or corpora lutea counts, at the end sacrifice time point, suggesting that rodents experience 
some follicular depletion with normal aging. (* = p<0.05; # = p<0.10). 
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Figure 22: Western blot protein analysis. VCD-induced follicular depletion tended to 
increase GAD65 expression in the Dorsal Hippocampus (p=0.08), and tended to decrease 
GAD67 expression in the Entorhinal Cortex (p=0.06) compared to Vehicle controls.  
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Figure 23: Region-Specific Correlations Between Serum Hormone Levels and GAD65 
and GAD67. For Young-VCD rats, higher serum estrone (pg/mL) was associated with 
lower GAD67 expression in the Entorhinal Cortex. For Young-Vehicle rats, higher serum 
E2 (pg/mL) was associated with increased GAD67 and GAD65 expression in the Ventral 
Hippocampus (*p < 0.05). 
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Figure 24: Region-Specific Correlations Between Serum Hormone Levels and ChAT-IR 
cell counts. Increased androstenedione serum (ng/mL) were associated with increased 
ChAT-IR estimated cell counts in the medial septum of the basal forebrain for the 
Middle-Aged-VCD group (p < 0.05).  
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Figure 25: Region-Specific Correlations Between Serum Hormone Levels and ChAT-IR 
cell counts. For Young-Vehicle rats, higher serum androstenedione (ng/mL), 
progesterone (ng/mL), and estrone levels (pg/mL) were associated with more ChAT-IR 
estimated cell counts within the VDB of the basal forebrain. These associations were not 
present in age-matched counterparts that underwent follicular depletion.  
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Figure 26: ChAT-IR correlations within the basal forebrain. The number of ChAT-IR 
cells in the medial septum within the basal forebrain correlated with estimated counts in 
the vertical/diagonal bands for both young groups and for Middle-Aged Vehicle rats. The 
association between the number of ChAT-IR cells in these regions of interest did not 
reach significant for the Middle-Aged-VCD group.  
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Figure 27: ChAT-IR correlations with ovarian follicle reserve. Primordial follicle counts, 
a putative marker of ovarian reserve, positively correlated with ChAT-IR cell estimates 
within the VDB for Young-Vehicle rats, but not for age-matched VCD-treated 
counterparts. 
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Figure 28: Correlations for Spatial Memory Performance, Ovarian Hormone Levels, and 
Brain Measures. Higher endogenous levels of E2 (pg/mL) were associated with fewer 
errors on the maximum working memory load trial of the WRAM for Young-VCD-
treated rats on their last retest prior to sacrifice. For MM performance, increased GAD65 
expression in the Entorhinal Cortex, and lower GAD67 expression in the Perirhinal 
Cortex were associated with poorer performance on the last day of testing for Young-
Vehicle rats.   
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Figure 29: Working memory performance during the asymptotic phase of the WRAM. 
(A-C) Prior low-demand experience tended to impair performance for the Vehicle treated 
rats and the High-E2 treated rats compared to their naïve counterparts across all trials, 
although this was marginal and did not reach statistical significance. (D-F) When the 
moderate working memory load trial (Trial 3) was assessed alone, the Low-E2 treated 
rats with prior low-demand experience exhibited enhanced performance compared to 
Naïve Low-E2-treated rats. High-E2 treated rats with prior low-demand experience 
tended to make more errors on the moderate working memory load trial than High-E2 
treated rats naïve to the task, but this effect was marginal and did not reach significance. 
Data are presented as the mean ± SEM. * p < 0.05, # p < 0.10. 
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Figure 30: Delayed memory retention on the WRAM. (A-F) Following a four-hour delay 
between trials 2 and 3, all subjects, regardless of treatment group and prior experience, 
made more WMC errors on Trial 3 after the delay compared to Trial 3 WMC 
performance on the last day of baseline testing (Day 12). Data are presented as the mean 
± SEM. * p < 0.05, # p < 0.10. 
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Figure 31: Total errors committed on the first day of DMS testing. (A-C, E-F) Low-E2 
and High-E2 treated rats with prior high-demand experience made fewer errors than their 
naïve counterparts on trials 3-6 of DMS. (D,G) The Vehicle treated rats with high-
demand experience made fewer errors than naïve Vehicle treated rats only on trials 4-6, 
indicating that even with high-demand experience, Ovx rats without exogenous E2 
treatment require more exposures to the task before exhibiting enhanced performance 
compared to rats naïve to the task. Data are presented as the mean ± SEM. * p < 0.05, # p 
< 0.10. 
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Figure 32: Total errors committed on Days 2-8 of DMS testing. (A-F) Low-E2 treated 
rats with prior high demand experience exhibited enhanced performance on trials 2-6 of 
the DMS across baseline testing compared to Low-E2 treated rats naïve to the task. The 
High-E2 treated rats with prior experience tended to make fewer errors than the High-E2 
treated rats naïve to the task. Data are presented as the mean ± SEM. * p < 0.05, # p < 
0.10. 
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Figure 33: Delayed memory retention on the DMS. (A-D) Following a four-hour delay 
between trials 1 and 2, Vehicle treated rats and Low-E2 treated rats did not exhibit an 
impairment following the delay, regardless of prior testing experience. (E-F) Both High-
E2 treated rats naïve to the DMS and High-E2 treated rats with prior high-demand 
experience showed a significant increase in total errors committed prior to finding the 
platform on the post-delay trial. Data are presented as the mean ± SEM. * p < 0.05, # p < 
0.10. 
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Figure 34: Body weights. Body weight (grams) increased for all subjects between Ovx 
and Pump Insertion time points. Following hormone treatment initiation, Ovx rats treated 
with Low-E2 or High-E2 decreased body weights compared to Ovx-Vehicle treated rats. 
This difference between Vehicle treated rats and E2 treated rats persisted through the end 
of the experiment. Data are presented as the mean ± SEM. * p < 0.05, # p < 0.10. 
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Figure 35: Uterine wet weights at euthanization. All groups were Ovx. The Low-E2 and 
High-E2 treated rats exhibited significantly heavier uterine wet weights at sacrifice 
compared to the Vehicle treated rats. Data are presented as the mean ± SEM. * p < 0.05, 
# p < 0.10. 
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Figure 36: Study 1 Water radial-arm maze. A) During Early Acquisition, each DRSP 
dose enhanced WMC performance compared to Vehicle on a high working memory load 
trial. B) This benefit was extended to WMI errors for DRSP-Low and DRSP-Medium 
doses compared to Vehicle. C) During the Asymptotic Phase, DRSP-Medium continued 
to enhance performance compared to Vehicle treatment for WMI errors on the maximum 
working memory load trial.  
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Figure 37: Study 1 Water radial-arm maze delay. Vehicle (A) and DRSP-Low (B) treated 
rats showed impaired delayed memory retention following a six hour delay between trials 
2 and 3. DRSP-Medium (C) and DRSP-High (D) groups trended toward a delay-related 
impairment, but this effect did not reach significance in these groups. 
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Figure 38: Study 1 Morris water maze. Across Days 2-5 (A), the DRSP-Medium group 
showed enhanced performance compared to the Vehicle group (C). All groups localized 
to the target quadrant during the probe trial (E). 
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Figure 39: Study 1 Body weight and uterine weights. There were no treatment differences 
in body weight or uterine horn weights at sacrifice.  
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Figure 40: Study 1 Western blot protein analysis. There were no Treatment differences in 
IGF1-R expression, GAD65 expression, or GAD67 expression for any brain region 
evaluated.  
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Figure 41: Study 2 Water radial-arm maze. A) The DRSP group showed enhanced WMI 
performance on the high working memory load trial compared to Vehicle, EE-
Low+DRSP, and EE-High+DRSP groups. B) EE-High+DRSP treatment attenuated EE-
High impairment on the high working memory load trial during Late Acquisition. C) EE-
Low+DRSP impaired memory on the maximum working memory load trial compared to 
EE-alone treatment during Late Acquisition.  
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Figure 42: Study 2 Water radial-arm maze delay. A) The Vehicle group tended to show 
impairments following a six-hour delay B,C, E) EE-Low, EE-High, and EE-Low+DRSP 
groups showed significantly impaired working memory performance following a six-hour 
delay. D,F) The DRSP group and the EE-High+DRSP group did not significantly 
increase errors committed following a six-hour delay.  
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Figure 43: Study 2 Morris water maze. A) There were no Treatment differences across 
MM Days 2-5. B) All groups localized to the target quadrant during the probe trial. 
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Figure 44: Open field task performance. The EE-High group showed increased locomotor 
activity compared to the Vehicle group and the EE-High+DRSP group showed increased 
locomotor activity compared to the DRSP group. EE-treated groups showed evidence of 
anxiolytic behavior.   
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Figure 45: Study 2 Body weight and uterine weight. A) EE-treated groups weighed 
significantly less than Vehicle groups. The DRSP group weighed more than EE-
Low+DRSP and EE-High+DRSP groups, and tended to weigh more than the Vehicle 
group. Of note, two-group comparisons were not made between DRSP and EE-Low or 
EE-High groups. B) Uterine weights from rats treated with EE weighed significantly 
more at euthanasia. Uterine weights from the DRSP group weighed less than EE-
Low+DRSP and EE-High+DRSP groups, but did not differ from Vehicle. Of note, two-
group comparisons were not made between DRSP and EE-Low or EE-High groups.  
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Figure 46: Diagram of the surgical manipulations performed. Sham-treated rats had intact 
an uterus and ovaries, Ovx-treated rats had an intact uterus, Hysterectomy-treated rats 
had intact ovaries, and Ovx-Hysterectomy-treated rats had both the uterus and ovaries 
removed. 
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Figure 47: Study Timeline. Rats were tested on a battery of spatial working and reference 
memory tasks six weeks following surgical manipulations. One week following the last 
behavioral assay, subjects were euthanized. 
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Figure 48: Representative images from consecutive days of vaginal cytology monitoring. 
Rats in the Sham and Hysterectomy groups (i.e., rats with intact ovaries) showed normal 
4-5 day estrous cycling when examined 2-3 weeks after surgery. Ovx and Ovx-
Hysterectomy rats (i.e., rats that experienced surgical removal of the ovaries) showed 
mostly blank vaginal smear cytology two weeks after surgery, indicating successful 
removal of the ovaries. 
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Figure 49: Working memory correct errors during the early acquisition phase of the water 
radial-arm maze (days 1-4). A) There was a main effect of Surgery across all days and 
trials within the early acquisition block. B) There was a main effect of Surgery across 
Days 1-4 on the high working memory load trials (Trials 3+4). C) There was a Surgery x 
Trial interaction on high working memory load trials (Trials 3+4), with D) a main effect 
of Surgery evident on Trial 4 alone across Days 1-4. * = p < 0.05 ^ = p < 0.10 
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Figure 50: Working memory incorrect errors during the early acquisition phase of the 
water radial-arm maze (days 1-4). A) There was a Surgery x Trial interaction was present 
across Days 1-4 for WMI errors. B) There was a Surgery x Trial interaction on the high 
working memory load trials (Trials 3+4), with C) a main effect of Surgery on Trial 4 
alone. * = p < 0.05 
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Figure 51: Working memory correct errors during the asymptotic phase of the water 
radial-arm maze (days 9-12). A marginal Surgery x Trial interaction was present for 
WMC errors. ^ = p < 0.10 
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Figure 52: Working memory incorrect errors during the asymptotic phase of the water 
radial-arm maze (days 9-12).  A) A main effect of Surgery was evident across all days 
and trials within the asymptotic phase block. B) A marginal Surgery x Trial interaction 
was found across all days and trials in the asymptotic phase. C) A main effect of Surgery 
was shown for the high working memory load trials (Trials 3+4) for the asymptotic phase 
block. * = p < 0.05 ^ = p < 0.10 
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Figure 53: Water radial-arm maze delay data. A-D demonstrate working memory correct 
errors of each surgery group on Trial 3 of the last day of baseline testing (Day 12) 
compared to the number of working memory correct errors committed on Trial 3 of the 
delay day (first post-delay trial on Day 13). * = p < 0.05 ^ = p < 0.10 
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Figure 54: Weekly body weights were collected beginning on the date of surgery 
(baseline) and continued through euthanization. Body weights began to significantly 
diverge between rats with ovaries (i.e., Sham and Hysterectomy groups) versus rats 
without intact ovaries (i.e., Ovx and Ovx-Hysterectomy groups) beginning two weeks 
after surgical manipulation. * = p < 0.05 
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Figure 55: Uterine wet weights from rats that had an intact uterus throughout the 
experiment (Sham and Ovx groups). Uteri from Sham-operated rats weighed significantly 
more than those of the Ovx group, indicating successful removal of the ovaries in the 
Ovx group and a lack of ovarian hormone stimulation of the uterus. * = p < 0.05 
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Figure 56: Representative ovarian micrographs stained with hematoxylin and eosin Y-
phloxine B from A) a sham-operated rat and B) a Hysterectomy-operated rat. Low 
magnification images are 3.45x magnification with a scale bar of 500 um. High 
magnification images are at 20x magnification with a scale bar of 100 um. Corpora lutea 
are designated by orange diamonds. Primordial follicles are denoted with a green arrow. 
Secondary follicles are marked with blue stars. 
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Figure 57: Healthy ovarian follicle count estimates from groups that had intact ovaries 
throughout the experiment (Sham and Hysterectomy groups). Primordial, primary, and 
secondary follicles did not differ between groups. Hysterectomy-operated rats had 
marginally fewer antral follicles compared to Sham-operated rats. Corpora lutea counts 
did not differ between groups. ^ = p < 0.10 
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Figure 58: Circulating serum ovarian hormone levels from blood collected at 
euthanization. A) Sham-operated rats had more 17b-estradiol compared to Ovx and Ovx-
Hysterectomy groups, and marginally more 17b-estradiol compared to the Hysterectomy 
group. B) Ovx and Ovx-Hysterectomy groups had non-detectable levels of 
androstenedione at euthanization. Hysterectomy-operated rats had less circulating 
androstenedione compared to Sham-operated rats. C) Ovx and Ovx-Hysterectomy groups 
had less progesterone than Sham and Hysterectomy groups. Hysterectomy-operated rats 
had more progesterone present than Sham-operated rats. D) Ovx and Ovx-Hysterectomy 
groups had undetectable levels of AMH at euthanization. AMH levels in Hysterectomy 
and Sham rats did not differ from each other. E) Both groups without ovaries had 
increased LH levels compared to Sham and Hysterectomy groups, indicating successful 
ovary removal. LH levels did not differ between Sham and Hysterectomy groups. F) Both 
groups without ovaries had increased FSH levels compared to Sham and Hysterectomy 
groups, indicating successful ovary removal. The Hysterectomy group had increased FSH 
levels compared to the Sham group.  
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Figure 59: WRAM Learning Phase (Adult Cohort; 7 mo old, tested 6 weeks after 
surgery). A) WMC errors across trials B) WMI errors across trials C) Hysterectomy rats 
made more WMC errors on the moderate working memory load trial, Trial 3, compared 
to Ovx-Hysterectomy rats. D) Hysterectomy rats made more WMI errors on the 
maximum working memory load trial, Trial 4, compared to Sham rats. Ovx-
Hysterectomy rats tended to make fewer errors than Hysterectomy rats. E) There were no 
group differences for WMC errors on Trial 4. F) There were no group differences for 
WMI errors on Trial 4. ** p < 0.01 * p < 0.05 ^ p < 0.10 
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Figure 60: WRAM Asymptotic Phase (Adult Cohort; 7 mo old, tested 6 weeks after 
surgery). There were no group differences for any planned comparison during the 
Asymptotic phase of testing. A) WMC errors across trials B) WMI errors across trials C) 
Trial 3 WMC errors D) Trial 3 WMI errors E) Trial 4 WMC errors F) Trial 4 WMI errors 
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Figure 61: WRAM Delayed Memory Retention (Adult Cohort; 7 mo old, tested 6 weeks 
after surgery). Sham rats did not show a significant delay-induced working memory 
impairment (A). Ovx rats (B), Hysterectomy rats (C), and Ovx-Hysterectomy rats (D) 
committed more WMC errors on Trial 3 following a six-hour delay compared to the last 
day of baseline performance on Trial 3. ** p < 0.01 * p < 0.05 ^ p < 0.10 
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Figure 62: Morris Water Maze (Adult Cohort; 7 mo old, tested 6 weeks after surgery). A) 
There were no group differences in any planned comparison across days. B) Each 
Surgery group spent a  greater proportion of total distance swimming in the Target (NE) 
Quadrant compared to the Opposite (SW) Quadrant during the probe trial, indicating 
spatial localization to the platform location. **** p < 0.0001 
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Figure 63: Peripheral Measures (Adult Cohort; 7 mo old, tested 6 weeks after surgery). 
A) Body weights were tracked weekly across the experiment. At euthanasia, ovary-intact 
groups (Sham, Hysterectomy) weighed less than Ovx groups (Ovx, Ovx-Hysterectomy). 
B) Uterine wet weight was obtained at euthanasia; Sham rats had increased uterine 
weights compared to Ovx rats. C) Ovary wet weights obtained at euthanasia did not differ 
between Sham and Hysterectomy rats at this time point.  **** p < 0.0001 ** p < 0.01 * p 
< 0.05 
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Figure 64: Ovarian Follicle Counts Estimates (Adult Cohort; 7 mo old, tested 6 weeks 
after surgery). There were no differences in Primordial Follicles (A), Primary Follicles 
(B), Secondary Follicles (C), Antral Follicles (D), or Corpora Lutea Counts (E) at this 
time point. 
  
 
445 
 
Figure 65: Serum Hormone Levels (Adult Cohort; 7 mo old, tested 6 weeks after 
surgery). A) Progesterone levels were significantly decreased in Ovx groups (Ovx, Ovx-
Hysterectomy) when compared to ovary-intact groups (Sham, Hysterectomy). B) 
Androstenedione levels did not differ at this time point between Sham and Hysterectomy 
groups. C) E2 levels did not differ at this time point between Sham and Hysterectomy 
groups. ** p < 0.01. 
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Figure 66: WRAM Learning Phase (Middle-Aged Cohort; 12 mo old, tested 7 months 
after surgery). A) WMC errors across trials B) WMI errors across trials C) Hysterectomy 
rats made more WMC errors on the moderate working memory load trial, Trial 3, 
compared to Ovx and Ovx-Hysterectomy rats. Sham rats tended to make fewer errors 
than Hysterectomy rats. D) Hysterectomy rats made more WMI errors on the maximum 
working memory load trial, Trial 4, compared to Sham rats and Ovx rats. E) There were 
no group differences for WMC errors on Trial 4. F) Hysterectomy rats made more WMI 
errors on Trial 4 compared to Ovx-Hysterectomy rats. ** p < 0.01 * p < 0.05 ^ p < 0.10 
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Figure 67: WRAM Asymptotic Phase (Middle-Aged Cohort; 12 mo old, tested 7 months 
after surgery). There were no group differences for any planned comparison during the 
Asymptotic phase of testing. A) WMC errors across trials B) WMI errors across trials C) 
Trial 3 WMC errors D) Trial 3 WMI errors E) Trial 4 WMC errors F) Trial 4 WMI errors 
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Figure 68: WRAM Delayed Memory Retention (Middle-Aged Cohort; 12 mo old, tested 
7 months after surgery). A) Sham rats tended to make more WMC errors on Trial 3 
following a six-hour delay compared to performance on the last day of baseline testing. 
B) Ovx rats did not significantly increase in errors following a six-hour delay. C) 
Hysterectomy rats tended to make more WMC errors on Trial 3 following a six-hour 
delay compared to performance on the last day of baseline testing. D) Ovx-Hysterectomy 
rats made more WMC errors on Trial 3 following a six-hour delay compared to 
performance on the last day of baseline testing. * p < 0.05 ^ p < 0.10 
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Figure 69: Morris Water Maze (Middle-Aged Cohort; 12 mo old, tested 7 months after 
surgery). A) There were no group differences in any planned comparison across days. B) 
Each Surgery group spent a greater proportion of total distance swimming in the Target 
(NE) Quadrant compared to the Opposite (SW) Quadrant during the probe trial, 
indicating spatial localization to the platform location. **** p < 0.0001 
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Figure 70: Peripheral Measures (Middle-Aged Cohort; 12 mo old, tested 7 months after 
surgery). A) Body weights were tracked weekly across the experiment. At euthanasia, 
ovary-intact groups (Sham, Hysterectomy) weighed less than Ovx groups (Ovx, Ovx-
Hysterectomy). The Ovx group tended to weigh less than the Ovx-Hysterectomy group. 
B) Uterine wet weight was obtained at euthanasia; Sham rats had increased uterine 
weights compared to Ovx rats. C) Ovary wet weights obtained at euthanasia did not differ 
between Sham and Hysterectomy rats at this time point.  **** p < 0.0001 *** p < 0.001 ^ 
p < 0.10 
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Figure 71: Ovarian Follicle Counts (Middle-Aged Cohort; 12 mo old, tested 7 months 
after surgery). There were no differences in Primordial Follicles (A), Primary Follicles 
(B), Secondary Follicles (C), Antral Follicles (D), or Corpora Lutea Counts (E) at this 
time point. 
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Figure 72: Serum Hormone Levels (Middle-Aged Cohort; 12 mo old, tested 7 months 
after surgery). A) Progesterone levels were significantly decreased in Ovx groups (Ovx, 
Ovx-Hysterectomy) when compared to ovary-intact groups (Sham, Hysterectomy). B) 
Androstenedione levels did not differ at this time point between Sham and Hysterectomy 
groups. C) E2 levels did not differ at this time point between Sham and Hysterectomy 
groups. ** p < 0.01 * p < 0.05. 
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Figure 73: WRAM Learning Phase (Aged Cohort; 18 mo old, tested 12 months after 
surgery). A) WMC errors across trials B) WMI errors across trials C) There were no 
group differences for WMC errors on Trial 3 for any planned comparison. D) There were 
no group differences for WMI errors on Trial 3 for any planned comparison. E) 
Hysterectomy rats tended to make more WMC errors on Trial 4 when compared to Sham 
rats and compared to Ovx rats. F) Hysterectomy rats made more WMI errors on Trial 4 
compared to Sham rats and compared to Ovx rats; Ovx-Hysterectomy rats tended to 
make fewer WMI errors than Hysterectomy rats on Trial 4 at this time point. ** p < 0.01 
* p < 0.05 ^ p < 0.10 
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Figure 74: WRAM Asymptotic Phase (Aged Cohort; 18 mo old, tested 12 months after 
surgery). A) WMC errors across trials B) WMI errors across trials C) There were no 
group differences for WMC errors on Trial 3 for any planned comparison. D) There were 
no group differences for WMI errors on Trial 3 for any planned comparison. E) 
Hysterectomy rats tended to make fewer WMC errors on Trial 4 compared to Ovx rats, 
although this effect did not reach statistical significance. F) There were no group 
differences for WMI errors on Trial 4 for any planned comparison. ^ p < 0.10 
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Figure 75: WRAM Delayed Memory Retention (Aged Cohort; 18 mo old, tested 12 
months after surgery). A) Sham rats made more WMC errors on Trial 3 following a six-
hour delay compared to performance on the last day of baseline testing. Ovx rats (B), 
Hysterectomy rats (C), and Ovx-Hysterectomy rats (D) did not exhibit a significant 
increase in WMC errors following a six-hour delay compared to performance on the last 
day of baseline testing within each group. ** p < 0.01 
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Figure 76: Morris Water Maze (Aged Cohort; 18 mo old, tested 12 months after surgery). 
A) There were no group differences in any planned comparison across days. B) Each 
Surgery group spent a greater proportion of total distance swimming in the Target (NE) 
Quadrant compared to the Opposite (SW) Quadrant during the probe trial, indicating 
spatial localization to the platform location. *** p < 0.001 ** p < 0.01 * p < 0.05 
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Figure 77: Peripheral Measures (Aged Cohort; 18 mo old, tested 12 months after 
surgery). A) Body weights were tracked weekly across the experiment. At euthanasia, 
Sham rats weighed less than Ovx rats. B) Uterine wet weight was obtained at euthanasia; 
Sham rats had increased uterine weights compared to Ovx rats. C) Ovary wet weights 
obtained at euthanasia tended to be increased in Hysterectomy rats compared to Sham 
rats, after correcting for body weight.  **** p < 0.0001 * p < 0.05 ^ p < 0.10 
  
 
458 
 
Figure 78: Ovarian Follicle Counts (Aged Cohort; 18 mo old, tested 12 months after 
surgery). There were no differences in Primordial Follicles (A), Primary Follicles (B), 
Antral Follicles (D), or Corpora Lutea Counts (E) at this time point. Hysterectomy rats 
tended to have fewer Secondary Follicles compared to Sham rats, although this effect did 
not reach statistical significance (C). ^ p < 0.10 
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Figure 79: Serum Hormone Levels (Aged Cohort; 18 mo old, tested 12 months after 
surgery). A) Progesterone levels were significantly decreased Ovx rats when compared to 
Sham rats and compared to Hysterectomy rats. Ovx-Hysterectomy rats tended to have 
lower Progesterone levels compared to Hysterectomy rats. B) Androstenedione levels did 
not differ at this time point between Sham and Hysterectomy groups. C) E2 levels did not 
differ at this time point between Sham and Hysterectomy groups. **** p < 0.0001 *** p 
< 0.001 ^ p < 0.10. 
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Figure 80: FosB and ΔFosB Expression in the Entorhinal Cortex. A) The Adult cohort 
did not exhibit changes in FosB or B) ΔFosB expression in the Entorhinal Cortex. C) 
Middle-Aged Ovx rats had less FosB expression compared to Sham rats and compared to 
Hysterectomy rats. Ovx-Hysterectomy rats had less FosB expression compared to 
Hysterectomy rats and marginally less FosB expression compared to Sham rats. D) 
Middle-Aged Hysterectomy rats tended to exhibit greater ΔFosB expression compared to 
Ovx rats and Ovx-Hysterectomy rats. E) Aged rats did not exhibit altered FosB 
expression. F) Aged Ovx rats had less ΔFosB expression than Sham rats.  
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Figure 81: Age Effects on FosB and ΔFosB Expression in the Frontal Cortex. There was 
no significant age-related change in FosB expression (A, C, E, G) or ΔFosB expression 
for any surgery group (B, D, F, H).  
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Figure 82: Age Effects on FosB and ΔFosB Expression in the Dorsal Hippocampus. 
There were no age-related changes in FosB expression with age in any surgery group (A, 
C, E, G). However, all subjects, regardless of surgery type, exhibited an decrease in 
ΔFosB expression in the Aged time point, when rats were 18 months old (B, D, F, H).  
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Figure 83: Age Effects on FosB and ΔFosB Expression in the Entorhinal Cortex. A) 
Sham rats showed a transient increase in FosB expression in Middle Age. B) Sham rats 
had more ΔFosB expression in the Middle-Aged cohort and the Aged cohort compared to 
the Adult cohort. C) Ovx rats did not exhibit changes in FosB expression across the three 
cohorts in the Entorhinal Cortex. D) ΔFosB expression tended to increase in Middle-
Aged Ovx rats compared to Adult Ovx rats. E) Hysterectomy rats tended to exhibit 
greater FosB expression in the Middle-Aged cohort compared to the Adult cohort. 
However, FosB expression was lower in the Aged cohort than the Middle-Aged cohort. 
F) Adult Hysterectomy rats had lower ΔFosB expression compared to the Middle-Aged 
cohort and tended to have lower ΔFosB expression compared to the Aged cohort. G) 
Ovx-Hysterectomy rats did not exhibit changes in FosB expression across the three 
cohorts. H) Ovx-Hysterectomy rats did not exhibit changes in ΔFosB expression across 
the three cohorts.  
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Figure 84: Age and Follicular Depletion Hormone Correlation Summary. Young-Vehicle 
rats (8-12 months of age) exhibited positive correlations between serum estrone, 
androstenedione, and progesterone levels, as well as ovarian follicle reserve estimates 
with ChAT-IR neurons in the vertical/diagonal bands within the basal forebrain, such that 
higher circulating levels of these hormones were associated more ChAT-IR cells in this 
brain region. Furthermore, higher 17b-estradiol levels were associated with more GAD65 
and GAD67 expression in the Ventral Hippocampus. Age-matched counterparts that 
underwent VCD-induced follicular depletion at 6 months of age did not exhibit these 
correlations; however, there was a negative association between estrone levels and 
Entorhinal Cortex GAD67 expression, where higher estrone levels were associated with 
less GAD67 expression. Middle-Aged-VCD rats (14-18 months of age) that underwent 
VCD-induced follicular depletion at 12 months of age exhibited a positive correlation 
between androstenedione levels and ChAT-IR neurons in the medial septum, but Vehicle-
treated, age-matched counterparts did not exhibit any associations between circulating 
hormone levels and brain measures. 
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Figure 85: Age and Follicular Depletion Behavior Correlation Summary. Young-Vehicle 
rats (8-12 months old) exhibited a positive correlation between Entorhinal Cortex 
GAD65 expression and MM Swim Distance, such that higher GAD65 expression was 
associated with a longer swim distance to platform, indicating poorer performance. 
Conversely, Young-VCD rats showed a negative association between serum 17b-
estradiol levels and working memory errors on the WRAM, where higher 17b-estradiol 
was associated with fewer working memory errors on the maximum working memory 
load trial, an indication of better performance. There were no associations between 
behavior measures and physiological measures in Middle-Aged rats (14-18 months old), 
regardless of follicular depletion status.  
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Figure 86: Hysterectomy Aging Ovarian Follicle Age Effect. Adult rats had more 
primordial (A), primary (B), secondary (C), and antral (D) follicles compared to Middle-
Aged and Aged rats. Secondary follicles also significantly decreased from Middle-Age to 
Aged time points (C). Corpora lutea counts did not significantly differ with age. 
  
 
467 
 
 
Figure 87: Hysterectomy Aging Serum Hormone Age Effect. A) Progesterone levels did 
not significantly change with age B) Androstenedione levels were increased in Aged rats 
compared to Adult and Middle-Aged time points C) Adult rats had higher serum 17b-
estradiol levels compared to Aged rats.  
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APPENDIX A 
TINTO DE VERANO 
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TINTO DE VERANO 
 
Ingredients 
 
1 bottle red wine 
 
1 bottle lemon Fanta or Squirt soda 
 
Garnish: Cinnamon and lemon twist 
 
 
Instructions 
 
Pour 8 oz of red wine into a glass. Combine with citrus-flavored soda to taste. Sprinkle 
cinnamon on top. Add a lemon twist for garnish, if desired. Serve chilled or with ice. 
Enjoy! 
 
 
Ingredientes 
 
 
1 botella de vino tinto 
 
1 botella de refresco con sabor cítrico  
 
Adorno: Canela y cáscara de limón 
 
 
Instrucciones 
 
Sírvase una copa de vino tinto (250 mL). Combine con el refresco cítrico a su gusto. 
Espolvoree la canela encima. Añada una cáscara de limón si desea. Sírvase frío o con 
hielo. ¡Disfrute! 
 
